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Within the mammalian host, bacteria are exposed to a large number of 
nutritional and chemical stimuli. Modification of gene transcription, in response 
to environmental signals, enables bacteria to compete and adapt within their 
preferred niches. D-serine is a host metabolite that has become a focus in recent 
years due to its diverse roles in neurotransmission and signalling in humans, as 
well as its unique role in affecting gene expression in bacteria. Indeed, previous 
work from the Roe laboratory revealed that D-serine played a critical role in 
controlling the expression of a main virulence determinant in 
enterohaemorrhagic Escherichia coli (EHEC), the type three secretion system 
(T3SS). Conversely, some commensal and extraintestinal pathogenic E. coli 
(ExPEC) can catabolise D-serine, using it as a carbon source. 
Uropathogenic E. coli (UPEC) and neonatal meningitis-associated E. coli (NMEC) 
represent two clinically relevant pathotypes of ExPEC, that are causal agents of 
a spectrum of diseases in mammals from uncomplicated urinary tract infections 
(UTIs), to bacteraemia, and meningitis. ExPEC are distinct amongst E. coli in 
their ability to colonise several anatomical niches within the host. ExPEC strains 
are able to survive outside of the intestine, partly due to their ability to 
catabolise a diverse range of host metabolites, including D-serine. UPEC and 
NMEC carry a locus, dsdCXA, for D-serine metabolism. DsdC, a LysR-type 
transcriptional regulator (LTTR), autoregulates its own expression and further 
controls the expression of DsdX, a D-serine inner membrane transporter and 
DsdA, a D-serine deaminase that catabolises D-serine into pyruvate and 
ammonia. Strikingly, NMEC strains carry two copies of the dsdCXA locus: 
dsdCXA1 and dsdCXA2. 
Metabolism and virulence are often interlinked in bacteria, with host 
metabolites, in addition to being carbon sources, acting as environmental signals 
that can affect bacterial gene expression. It was thus hypothesised that D-
serine, which is abundant in the brain and urinary tract, may act as an 
environmental stimulus that enables two ExPEC pathogens to sense their 
environment and modify their gene expression, through the regulatory actions of 
DsdC. 
 15 
In this work, using a combination of chromatin immunoprecipitation coupled 
with next generation sequencing (ChIP-Seq) and RNA sequencing (RNA-Seq), the 
direct regulon of DsdC in two prototypical UPEC and NMEC strains, CFT073 and 
CE10, was elucidated, in the presence and absence of D-serine. It was shown 
that DsdC bound to distinct regions of both the CFT073 and CE10 genome, 
indicating that DsdC has been tailored for strain-specific lifestyles. In CFT073, it 
was shown that DsdC bound and affected expression of genes involved in 
colibactin synthesis, a bacterial genotoxin. Furthermore, it was revealed that in 
CE10, DsdC bound and affected expression of several genes involved in outer 
membrane-associated virulence, such as capsular and LPS biosynthesis genes. 
Using a range of biochemical techniques, it was established that DsdC, upon 
exposure to D-serine, modified the O-antigen structure of CE10. Furthermore, it 
was revealed that DsdC1, but not DsdC2, affected the survival of CE10 against 
K1-specific bacteriophages, through the regulation of the O-acetyltransferase 
gene neuO, elucidating a distinct role for the homologous proteins. Collectively, 
this work describes how regulation by DsdC has been tailored to suit strain-
specific lifestyles in two ExPEC strains and further enhances our understanding 
of how bacterial pathogens sense their environment and mediate pathogenesis.
16 
Author’s declaration 
I hereby declare that this thesis is the result of my own work and has been 
composed for the degree of PhD at the University of Glasgow. This work has not 
been submitted for any other degree at this or any other institution. All work 
presented was performed by myself unless otherwise stated. All sources of 
information and contributions to the work have been specifically acknowledged 
in the text. 




Chapter 1 Introduction 
  
 18 
 Escherichia coli 
Escherichia coli is a Gram-negative, facultative anaerobe, first described by 
Theodor Escherich in the late nineteenth century (Hacker & Blum-Oehler, 2007). 
For decades, it has been used as a model organism for bacterial studies, often 
being considered as the molecular biology ‘workhorse’ of the laboratory (Hacker 
& Blum-Oehler, 2007). E. coli is both a commensal and pathogenic organism, 
commonly found within the microbiota of mammals and birds (Rasko et al., 
2008). The composition of the microbiome is dynamic, however, E. coli is one of 
109 species that form the core baseline microbiome in healthy controls (King et 
al., 2019). Commensal E. coli are typically found within the caecum and colon of 
the large intestine in mammals, residing in the mucus layer covering the 
epithelial cells (Li et al., 2015; Poulsen et al., 1994; Tenaillon et al., 2010). 
Typically, E. coli is one of the first bacterial species that colonises neonates 
(Casaburi et al., 2021), providing benefits to the host including preventing the 
colonisation of other pathogens (reviewed in Tenaillon et al., 2010). Conversely, 
through both intestinal and extraintestinal disease, E. coli is thought to kill more 
than 2 million humans per year (reviewed in Tenaillon et al., 2010). 
E. coli is broadly divided into eight main phylogenetic groups: A, B1, B2, C, D, E, 
F, and G (Denamur et al., 2021). An additional group closely related to D, 
termed H, has also been suggested (Lu et al., 2016). Analysis of multiple E. coli 
genomes has revealed large differences in size between strains, varying from 4.2 
to 6 Mbp, corresponding to 3,900 to 5,800 genes respectively (reviewed in 
Denamur et al., 2021). This genetic diversity can be ascribed to the relative 
plasticity of the E. coli genome (Touchon et al., 2009). Indeed, through 
horizontal gene transfer (HGT), genes can be acquired laterally, on mobile 
genetic elements (MGE) such as transposons, plasmids, bacteriophages or 
genomic islands (reviewed in Juhas, 2015). Studies have suggested that up to 
75% of genes in each genome have been acquired through HGT (reviewed in 
Juhas, 2015). Many of the characteristic virulence factors carried by E. coli are 
encoded on pathogenicity-associated islands (PAI) and are inserted into the 
genome in tRNA ‘hotspots’ (Johnson & Russo, 2002). The genome size of E. coli 
is finite however, with multiple selective pressures often dictating acquisition or 
loss of genetic elements. Earlier studies reported that all E. coli shared a core 
genome of ~2,000 genes, with the remaining genes obtained from a pangenome 
 19 
of ~18,000 (Touchon et al., 2009). However, ~26 new genes are purported to be 
identified with each new strain sequenced, leading to the suggestion that the 
pangenome now consists of ~75,000 genes (reviewed in Denamur et al., 2021). 
This would indicate that the E. coli genome is potentially inexhaustible. 
Through HGT and evolution, several pathotypes of E. coli have emerged across 
the phylogroups. Based upon clinical data, E. coli is classified into three main 
groups: commensal strains; intestinal pathogenic E. coli (InPEC); and 
extraintestinal pathogenic E. coli (ExPEC) (Russo & Johnson, 2000). Within the 
InPEC group, there are six main E. coli pathotypes recognised: Shiga-toxin 
producing/enterohaemorrhagic E. coli (STEC/EHEC); enteropathogenic E. coli 
(EPEC); enteroinvasive E. coli (EIEC); enteroaggregative E. coli (EAEC); 
enterotoxigenic E. coli (ETEC); and diffusely adherent E. coli (DAEC) (Russo & 
Johnson, 2000). These pathotypes cause enteric disease and, although there is 
some overlap, they each have a distinct repertoire of virulence factors (Russo & 
Johnson, 2000). 
Conversely, whilst InPEC pathogenesis is consigned to the intestinal tract, ExPEC 
strains can infect almost any organ or anatomical region within the host (Russo & 
Johnson, 2000). There are several pathotypes that comprise ExPEC strains: 
neonatal meningitis-associated E. coli (NMEC); uropathogenic E. coli (UPEC); and 
sepsis-associated E. coli (SEPEC). ExPEC strains predominantly reside 
asymptomatically within the intestinal tract, causing disease only upon egression 
of the gut (Johnson & Russo, 2002). ExPEC strains often employ a range of 
virulence factors such as adhesins, toxins, and host avoidance systems, to help 
them survive in extraintestinal niches (Kaper et al., 2004). 
 Extraintestinal pathogenic E. coli (ExPEC) 
ExPEC isolates are able to infect multiple anatomical niches within the host, 
causing urinary tract, bloodstream, prostate, and further infections (Manges et 
al., 2019). ExPEC isolates have been defined as carrying at least two of the 
following virulence factors: P-fimbriae (pap); S-fimbriae/F1C-fimbriae (sfa/foc); 
Dr binding proteins (afa/draBC); capsule (kpsM II); or the aerobactin receptor 
(iutA) (Dale & Woodford, 2015). Indeed, it is the collection of virulence factors 
that enables ExPEC strains to cause disease, with no single virulence factor 
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acting as the causal agent (Dale & Woodford, 2015). The virulence factor profiles 
of ExPEC isolates are therefore highly variable; however, as with all E. coli, 
ExPEC strains have an outer membrane layer comprising lipopolysaccharides 
(LPS) among other components. E. coli LPS plays a key role in virulence and 
protection of the cell from environmental and immune system insults 
(Ebbensgaard et al., 2018). 
 
Figure 1-1 Composition of the Gram-negative cell wall. Adapted from 
Schwechheimer & Kuehn, 2015. A Gram-negative cell envelope is composed of 
three elements: an outer membrane; peptidoglycan; and an inner membrane. 
The inner leaflet of the outer membrane is composed of phospholipids, and the 
outer leaflet is composed of LPS and envelope proteins (porins). The cytoplasmic 
membrane (or inner membrane) is composed of a phospholipid bilayer. Between 
the two membranes is the periplasm, which contains the peptidoglycan layer. 
LPS is composed of three components: lipid A, a hydrophobic protein that 
embeds the LPS structure into the outer membrane; the core polysaccharide 
which is comprised of multiple sugars; and the hypervariable O-antigen, which 
comprises numerous repeating sugar units (reviewed in Liu et al., 2020). In non-
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encapsulated E. coli, the LPS is exposed to the host environment and is often 
the first line of defence against the host (reviewed in Bertani & Ruiz, 2018). 
Fundamentally, LPS is a structural component of the outer membrane, and 
functions as a permeability barrier to the environment (reviewed in Bertani & 
Ruiz, 2018). However, LPS is also an endotoxin, with lipid A activating the host 
immune response and the inflammatory system (reviewed in Raetz & Whitfield, 
2002). The host’s immune response is dependent on the concentration of LPS, 
with high concentrations of LPS inducing fever and increasing the heart rate 
within the host, which can lead to septic shock and death (reviewed in Wang & 
Quinn, 2010). Alternatively, due to the hypervariability of the O-antigen, E. coli 
can evade the immune response and so is protected from host-mediated lysis 
and phagocytosis (reviewed in Bertani & Ruiz, 2018). The LPS therefore plays a 
key role in protection and virulence in ExPEC, and indeed all E. coli, strains. 
1.2.1 Neonatal meningitis-associated E. coli (NMEC) 
prevalence and pathogenesis 
Neonatal meningitis is a severe disease that contributes to neonatal morbidity 
and mortality worldwide, and is characterised as the inflammation of the 
meninges during the first 28 days of life (Khalessi & Afsharkas, 2014). The 
incidence of bacterial-associated neonatal meningitis ranges from 0.25-1 per 
1,000 live births (Khalessi & Afsharkas, 2014). However, it has been reported 
that the incidence of meningitis is much greater in lower-income countries, 
where it can be as high as 0.8-6.1 per 1,000 live births (reviewed in Ku, Boggess 
& Cohen-Wolkowiez, 2015). The mortality rate in lower-income countries is 
~40%, with some 50,000 new-borns dying every year, thereby making meningitis 
one of the five most prevalent neonatal infections worldwide (reviewed in 
Bonacorsi & Bingen, 2005). For the neonates that survive, neurological sequelae 
can occur in 30-50% of cases, presented as learning difficulties, blindness, 
hydrocephalus, and hearing loss (reviewed in Mann & Jackson, 2008). 
E. coli is the second largest etiological agent of neonatal meningitis, after Group 
B Streptococcus (reviewed in Bonacorsi & Bingen, 2005). Indeed, NMEC is the 
cause of 20-40% of the cases that occur in the USA annually (reviewed in Russo & 
Johnson, 2003). The most common way in which meningitis develops in neonates 
is by a primary blood stream infection. Initially, NMEC is acquired in the neonate 
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from the mother’s flora, or from environmental sources (reviewed in Bonacorsi & 
Bingen, 2005). NMEC then establishes itself within the intestinal tract, before 
translocating to the bloodstream (reviewed in Bonacorsi & Bingen, 2005). Once 
there is sufficient bacteraemia (103 colony forming units (CFU)/ml) within the 
bloodstream, NMEC penetrates the blood-brain barrier (BBB), invading the 
central nervous system (CNS) (Huang et al., 1995; reviewed in Xie, Kim & Kim, 
2004). Once NMEC passes through the BBB and enters the cerebral spinal fluid 
(CSF), it is liberated from the immune system and is therefore able to 
proliferate freely (reviewed in Polin & Harris, 2001). Natural bacterial lysis 
subsequently causes release of bacterial cell wall products, which act as stimuli 
for the release of host inflammatory cytokines, and it is this response that 
causes meningitis (reviewed in Polin & Harris, 2001). 
Although the mechanism has not been fully elucidated, a key step in NMEC 
pathogenesis is traversal of the BBB. The BBB is a structural barrier that is 
formed by human brain microvascular endothelial cells (HBMEC), pericytes and 
astrocytes, and which protects the brain from a number of insults (reviewed in 
Kim, 2012). NMEC has been shown to attach to the BBB using several factors 
including FimH of the type I pili, which binds to the host receptor CD48, and 
outer membrane protein A (OmpA) which binds to the host receptor ECGP96 
(Khan et al., 2007; Prasadarao, 2002; Prasadarao et al., 1996). Further, 
transposon mutagenesis revealed that NMEC invasion also occurs through the 
actions of proteins that are termed the invasion of brain endothelial cell (Ibe) 
adhesins, although the receptors for this are unknown (Huang et al., 1995, 
1999). These interactions trigger a cascade of host cell signalling pathways, 
resulting in an increase in intracellular Ca2+, which stimulates actin cytoskeleton 
rearrangements, a prerequisite for NMEC invasion (Khan et al., 2007; Maruvada 
& Kim, 2012). Cytotoxic necrotising factor 1 (CNF1) also contributes to NMEC 
invasion of the BBB, and has been shown to play a role in host cell myosin 
rearrangement, as well as actin rearrangement (Khan et al., 2002; Essler et al., 
2003; reviewed in Croxen & Finlay, 2010). CNF1 binds to the host receptor 67LR, 
inducing cytoskeleton rearrangements, promoting internalisation of NMEC into 
HBMECs (Kim et al., 2005). These data reveal the multifactorial processes that 
NMEC can use in order to attach and traverse the BBB. 
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Figure 1-2 Mechanisms of NMEC invasion of the BBB. Adapted from Croxen & 
Finlay, 2010. Attachment of NMEC to the BBB is mediated by type 1 pili binding 
to the host receptor CD48 and OmpA binding to the host receptor ECG96. These 
interactions mediate an increase in intracellular Ca2+ which stimulates actin 
rearrangements. Further, release of CNF1 mediates binding to host receptor 
67LR which causes myosin rearrangements, enabling NMEC to invade the brain 
endothelial cells. 
1.2.2 NMEC K1 polysialic acid capsule 
Survival within the blood is crucial for eliciting pathogenesis at the BBB 
interface, as high bacteraemia is required (Huang et al., 1995). NMEC strains 
therefore characteristically have an antiphagocytic capsule that surrounds the 
cell and provides protection from the host immune response (reviewed in Croxen 
& Finlay, 2010). There are over 70 distinct capsular (K) antigens found in E. coli 
(Jann & Jann, 1992), however, the K1 antigen is often over-represented in NMEC 
infection, with a study showing that 84% of isolates recovered from the CSF of 
neonates with meningitis had the K1 capsular polysaccharide (Robbins et al., 
1974). Furthermore, mutants devoid of the K1 capsule were unable to be 
detected in the CSF in an in vivo rat model, indicating the importance of the K1 
capsule to infection (Kim et al., 1992). 
A key survival mechanism of bacteria is the ability to evade the host immune 
response. Indeed, as discussed above, there are over 70 distinct capsular (K) 
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antigens that have been found in E. coli (Jann & Jann, 1992), with each K 
antigen differing in its sugar composition, thereby presenting the host immune 
system with a range of differing structures. Moreover, the K1 polysaccharide is 
homopolymer of a2,8-linked sialic acid residues, which in itself is a molecular 
mimic of the host polysialic acid of the neural cell adhesion molecule (N-CAM) 
(reviewed in Silver & Vimr, 1990). K1 polysaccharides are therefore weakly 
immunogenic in mammals and do not stimulate synthesis of antibodies (reviewed 
in Silver & Vimr, 1990). 
The mammalian complement system also plays a crucial role in defending the 
host against pathogens and represents one of the main mechanisms of innate 
immunity (Dunkelberger & Song, 2010). The complement system can be 
activated through three major pathways: classical, lectin and alternative 
(Dunkelberger & Song, 2010). The K1 capsule has been reported to play a role in 
the ability of NMEC to evade complement-mediated killing, with strains that lose 
the ability to synthesise K1 subsequently losing serum resistance properties 
(Cross et al., 1986; Leying et al., 1990). Factor H, the main soluble regulator of 
the alternative complement pathway, has been reported to bind to polyanions, 
such as the K1 polysialic acid capsule (reviewed in Abreu & Barbosa, 2017). This 
interaction has been suggested to downregulate the alternative complement 
pathway, thus impairing the membrane attack complex (reviewed in Abreu & 
Barbosa, 2017). Moreover, the presence of an extracellular polysaccharide, such 
as the K1 capsule, is thought to mask underlying bacterial cell surface structures 
that could activate the complement system (reviewed in Silver & Vimr, 1990). 
The K1 capsular polysaccharide therefore plays a key role in the virulence of 
NMEC isolates, enabling them to evade and resist the host immune system. 
1.2.3 Further NMEC-associated virulence factors 
As well as the K1 capsule, NMEC strains use a wide range of virulence factors in 
order to survive and evade the host. These factors include iron acquisition 
systems, invasion proteins (ibe), toxins (CNF1), and a cryptic type three 
secretion system (T3SS), termed the Escherichia coli type III secretion system 2 
(ETT2) (Lu et al., 2011; Wijetunge et al., 2015). CNF1 is a protein toxin that can 
be produced by NMEC, and which induces the development of stress fibres in 
epithelial cells via the Rho pathway (Lemichez et al., 1997). An early study 
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suggested that CNF1 induced high lethality when injected into mice and caused 
the formation of multi-nucleated cells in vitro (Lemichez et al., 1997). 
Furthermore, CNF1 has been reported to activate NF-kB in epithelial cells, 
thereby stimulating the expression of pro-inflammatory factors (reviewed in 
Fabbri, Travaglione & Fiorentini, 2010). Conversely, further research reported 
that injection of the entire CNF1 toxin caused no lethal effects in animals, and 
reported that CNF1 might instead play a role in protecting the host cell from 
apoptotic stimuli (reviewed in Fabbri, Travaglione & Fiorentini, 2010). Although 
this has not been proven, this protection may facilitate NMEC survival within the 
niche by keeping the host cell alive. However, CNF1 plays a key role in invasion 
of NMEC into the CNS (Khan et al., 2002), indicating that although its role in the 
host has not been fully elucidated, it is an important virulence determinant for 
NMEC. 
T3SS are macromolecular protein syringes that are unique to Gram-negative 
bacteria, and are used to inject virulence factors into host cells or bacterial 
competitors (reviewed in Slater et al., 2018). The T3SS spans the inner and 
outer membranes of Gram-negative bacteria, with a needle-like filament 
protruding into the environment. In E. coli, the T3SS is best characterised in 
EHEC and EPEC strains, which can use the T3SS to form attaching and effacing 
lesions on host cells and deliver effector proteins (Mellies et al., 1999; Moon et 
al., 1983). In EHEC and EPEC, the genes for the T3SS are carried on a 
pathogenicity-associated island (PAI) termed the locus of enterocyte effacement 
(LEE) (McDaniel et al., 1995). Intriguingly, some NMEC strains have been 
reported to carry the apparatus genes of a cryptic secondary T3SS, ETT2 (Yao et 
al., 2009). This secondary T3SS was originally first described in EHEC, having 
undergone widespread mutational attrition, rendering it unable to form a 
functional secretion system (Ren et al., 2004). However, studies have reported 
that the ETT2 plays a role in virulence in bloodstream isolates of E. coli, with 
mutations in CE10 of the ETT2 leading to defects in invasion and intracellular 
survival in HBMECs (Yao et al., 2009). Although the role of the ETT2 has not 
been fully elucidated, this data does indicate that the ETT2 is an important 
virulence factor in NMEC. 
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1.2.4 Uropathogenic E. coli (UPEC) prevalence and 
pathogenesis 
Urinary tract infections (UTIs) are a common disease, and are estimated to 
affect up to 150 million people per year, posing a significant economic and 
health burden upon society (Flores-Mireles et al., 2015). Indeed, it is estimated 
that the societal cost of UTIs in the United States alone is some $3.5 billion per 
year (Flores-Mireles et al., 2015). UTIs are often referred to as being either 
uncomplicated or complicated infections. Uncomplicated UTIs are classified as 
lower UTIs, which affect the urinary tract/bladder (cystitis), or as upper UTIs, 
which affect the upper urinary tract/kidneys (pyelonephritis) (Mazzulli, 2012). 
These often occur in otherwise healthy individuals and can cause symptoms of 
dysuria and fever. Complicated UTIs often develop in individuals with underlying 
illnesses or who are immunocompromised, amongst other factors (Mazzulli, 
2012). Complicated UTIs can lead to severe pyelonephritis, renal scarring and 
end-stage disease (Melekos & Naber, 2000). UTIs are caused by a range of 
different pathogenic organisms, including Klebsiella pneumoniae, Proteus 
mirabilis and Staphylococcus saprophyticus (Mazzulli, 2012). However, the most 
common infectious agent of UTIs is UPEC. Indeed, 75-95% of uncomplicated UTIs 
are associated with UPEC strains (Hooton, 2012). 
The urinary tract was previously classed as a sterile environment, however, 
metagenomic analysis of the urinary tract has revealed a wealth of information, 
indicating the existence of a urogenital microbiome (Thomas-White et al., 
2018). UPEC pathogenesis occurs when UPEC strains translocate from the gut and 
colonise the periurethral and urethra (reviewed in Flores-Mireles et al., 2015). 
UPEC can then ascend into the bladder lumen and adhere, using type 1 fimbriae 
(T1F) which bind to uroplakin receptors on bladder epithelial cells (Connell et 
al., 1996; Mulvey et al., 1998). This binding, and further interactions, stimulates 
invasion of the epithelial cells and triggers local actin rearrangement, resulting 
in internalisation of the attached UPEC (Martinez et al., 2000). UPEC can then 
proliferate within the host cell and biofilm-like complexes are formed, termed 
intracellular bacterial communities (IBCs) (Anderson et al., 2003). The formation 
of IBCs protects UPEC from neutrophils, antibiotics and other environmental 
insults (Anderson et al., 2003). Subsequent UPEC invasion and attachment 
results in an influx of polymorphonuclear neutrophils (PMNs), which cause tissue 
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damage and apoptosis of the bladder cells (Mulvey et al., 1998; Haraoka et al., 
1999; reviewed in Croxen & Finlay, 2010). Left untreated, some UPEC strains can 
disseminate to the kidney, causing pyelonephritis, and further, penetrate 
through the endothelial cells into the bloodstream, resulting in bacteraemia 
(reviewed in Kaper, Nataro & Mobley, 2004) (Fig 1-3). 
 
Figure 1-3 Mechanism of UPEC pathogenesis progression within the host. (A) 
Adapted from Kaper, Nataro & Mobley, 2004. (1) UPEC contaminate the urethra 
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and ascend to the bladder. (2) UPEC bind to the epithelial cells of the bladder 
and invade. (3) Some UPEC ascend up the ureters to the kidney. (4) After 
disseminating to the kidney, UPEC can release haemolysins, damaging host 
epithelial cells. (5) UPEC can disseminate further, crossing the cell barrier into 
the blood supply to initiate bacteraemia. (B) Adapted from Croxen & Finlay, 
2010. UPEC attach to the uroplakin receptor on the bladder epithelial cells using 
T1F. This binding stimulates an unknown pathway which mediates invasion into 
the host cell. UPEC then form IBCs within the host cell. These interactions cause 
an influx of PMNs. Apoptosis of the bladder cells occurs. UPEC strains can 
disseminate from the bladder to the kidneys. 
1.2.5 UPEC-associated virulence factors 
There are four main phylogenetic groups in which UPEC strains have been 
identified; A, B1, B2, and D, highlighting the diversity of the pathotype (Terlizzi 
et al., 2017). Indeed, there is not a single set of virulence determinants that 
defines the UPEC pathotype. UPEC strains possess numerous virulence factors 
that enable them to cause disease in hosts. These include structural mechanisms 
such as fimbriae, pili, and flagella, as well as secreted mechanisms such as outer 
membrane proteins (OMPs), iron-acquisition systems and bacterial toxins (Najafi 
et al., 2018; Shah et al., 2019; Welch et al., 2002). 
UPEC secrete several bacterial toxins, including colibactin and a-haemolysin 
(Welch et al., 2002). a-haemolysin is encoded on the hlyCABD operon in E. coli 
and is a member of the repeats-in-toxin (RTX) family of toxins (Felmlee, Pellett 
& Welch, 1985; reviewed in Welch, 2016). In vitro studies have revealed that a-
haemolysin is cytotoxic to renal cells (Mobley et al., 1990). Indeed, a-
haemolysin has been reported to oligomerise and integrate into the host cell 
membrane, resulting in pore formation and subsequent lysis of the host cell 
(Bhakdi & Tranum-Jensen, 1986; Benz et al., 1989; reviewed in Flores-Mireles et 
al., 2015). This mechanism has been reported to facilitate the acquisition of iron 
and nutrients for the bacteria (reviewed in Flores-Mireles et al., 2015). Further, 
a-haemolysin has been reported to be involved in pathways that could trigger 
exfoliation of the epithelial cells, exposing deeper layers of host cells for further 
UPEC colonisation (Dhakal & Mulvey, 2012). 
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A further important virulence factor for UPEC are iron-acquisition systems. Iron 
is limited within the urinary tract, however it is essential for bacterial growth 
(Watts et al., 2012). Bacteria therefore utilise siderophore systems for 
scavenging iron. Siderophore systems comprise of siderophores, which are low-
molecular-weight Fe3+-chelating compounds, and a membrane receptor, which 
internalises the siderophore-bound iron (reviewed in Flores-Mireles et al., 2015). 
In E. coli, four different siderophore systems have been identified (Watts et al., 
2012), indicating the importance of iron-acquisition to UPEC. Two siderophores, 
aerobactin and yersiniabactin, have been reported to be the most critical in iron 
acquisition in the urinary tract (Garcia et al., 2011). Further, genomic studies in 
vivo using UPEC strain UTI89 revealed, relative to samples obtained from the 
caecum, IBCs showed a marked increase in expression of components of iron-
acquisition systems (Reigstad et al., 2007), again indicating the importance of 
iron-acquisition in UPEC pathogenesis. 
 Bacterial transcriptional regulation 
Fine-tuning of gene expression in response to environmental cues is a key 
survival mechanism for bacteria. Gene expression occurs when template DNA is 
transcribed into mRNA by RNA polymerase, followed by translation of the mRNA 
into a functional protein by ribosomal machinery. Transcription can be split into 
three main steps: initiation, elongation, and termination. Transcriptional 
regulation can occur at any stage within the transcription process, but most 
frequently occurs within the initiation stage (reviewed in Browning & Busby, 
2004). 
1.3.1 Initiation of transcription 
All bacterial transcriptional initiation is dependent on RNA polymerase (RNAP). 
The core enzyme of RNAP is comprised of five subunits: two large b subunits, b 
and b’; two identical a subunits; and a w subunit. The two a subunits consist of 
two domains, an a-N-terminal domain (aNTD) and an a-C-terminal domain 
(aCTD). The aNTD is responsible for the assembly of the b subunits, which is the 
active site of the polymerase, and the aCTD plays a role in regulating 
transcription and binds to DNA (reviewed in Browning & Busby, 2004; Murakami, 
2015). The w subunit of RNAP had long remained elusive to scientists; however, 
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research has revealed that it plays a structural role in maintenance of b’ and 
further acts as a chaperone of b’ to the enzyme assembly (Fig. 1-4A) (reviewed 
in Mathew & Chatterji, 2006). 
Although RNAP is required for transcription, it can only weakly bind in an 
indiscriminate fashion to promoter DNA (reviewed in Ghosh, Bose & Zhang, 
2010). Directed transcription cannot be initiated without an additional protein, a 
s factor, which is used to recognise specific promoter sequences. Promoter 
sequences consist of several unique elements, including the -10 and -35 
consensus sequence, and it is these two sequence motifs that are recognised by 
the s factor. The combined complex of RNAP and s factor is called the 
holoenzyme, and it is this complex that can bind to DNA and initiate targeted 
transcription (Fig.1-4B) (reviewed in Browning & Busby, 2016). Once the s factor 
has recruited the RNAP and formed a holoenzyme, it interacts with the promoter 
region, forming a closed complex (RPc). This closed complex can then switch to 
an open complex (RPo), which involves the unwinding of ~12 bp of double 
stranded DNA (dsDNA). The template strand of DNA is then loaded into the RNAP 
active site for RNA synthesis. The s factor is released and RNAP enters the 
elongation phase (Fig.1-4C). Many factors can influence the initiation of 
transcription including s factors, transcription factors (TFs), ligands, and 




Figure 1-4 Initiation of transcription by bacterial RNA polymerase. (A) General 
structure of RNAP assembly, adapted from Murakami, 2015. (B) A graphical 
representation of the RNAP holoenzyme, adapted from Browning & Busby, 2004. 
The two b subunits, b and b’, form the catalytic part of the RNAP, assembled 
together by aNTD. The aCTD binds to the promoter region DNA, upstream of the 
-35 and -10 elements. The s factor binds to the -10 and -35 elements, initiating 
transcription. (C) A graphical representation of transcription initiation, adapted 
from Browning and Busby, 2016. The RNAP holoenzyme binds to the promoter 
region, forming a closed complex. The closed complex can then switch to an 
open complex and the dsDNA is unwound. The template strand of DNA is loaded 
into the active site and RNA transcript is formed. The s factor is then released 
and RNAP enters the elongation phase. 
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1.3.2 Sigma (s) factors 
As discussed above, s factors are used to recognise specific sequences of 
promoter regions, directing the RNAP to the appropriate transcriptional start 
sites (TSS) and initiating strand separation of DNA to form the transcription 
bubble. Bacteria have multiple s factors, with E. coli carrying seven: s70, s54 
(sN), sFecI, s24 (sE), s28 (sF), s32 (sH), s38 (sS). s70 is the essential housekeeping s 
factor, which regulates the transcription of thousands of genes. Conversely, the 
other six s factors are referred to as the alternative s factors, regulating genes 
involved in numerous stress responses as detailed in Table 1-1 (reviewed in 
Ishihama, 2000). All E. coli s factors belong to the s70 family, except s54 which 
is evolutionarily unrelated to the other s factors (Lonetto, Gribskov & Gross, 
1992; reviewed in Merrick, 1993). 
Sigma (s) factor  Sigma (s) factor regulon 
s70  Housekeeping 
s54 (sN) Nitrogen stress response 
sFecI Ferric citrate transport 
s24 (sE) Heat shock response/cell envelope stress 
s28 (sF) Flagella/chemotaxis response 
s32 (sH) Heat shock response 
s38 (sS) Stationary phase/general stress response 
Table 1-1 E. coli s factors and their respective regulons. A table of the seven 
E. coli s factors and the functions they regulate. 
The concentration of each s factor is dependent on cell growth conditions: s70 is 
reported to be the most abundant, and has the highest affinity for RNAP 
(reviewed in Ishihama, 2000; Paget, 2015). Each s factor is composed of 
multiple domains, with s70 comprised of four domains: s1.1, s2, s3, and s4. Each 
domain has DNA binding properties, except for s1.1, which has been reported to 
have a role in allowing access to the RNAP active site. The other domains bind to 
the promoter region: s2 binds to the -10 element, s3 binds to the extended -10 
element, and s4 binds to the -35 element (reviewed in Feklístov et al., 2014). As 
the different s factors guide the RNAP to different promoter regions depending 
on the growth conditions and stresses, s factors represent a simple mechanism 
of gene regulation in bacteria. The activity of s factors, and subsequent 
directed bacterial gene expression, is further controlled by anti-s factors. Anti-s 
 33 
factors can sequester s factors, impeding RNAP binding. Indeed, in E. coli 
stationary phase growth, Rsd interacts with s70 domains s2 and s4, preventing 
binding to the RNAP and the -35 element, allowing s38 to bind to RNAP, 
promoting expression of stationary phase related genes (reviewed in Paget, 
2015). Gene regulation by s factors is therefore both a simple and complex 
mechanism of gene regulation in bacteria. Conversely, transcription often 
cannot occur without the presence of a further protein or ligand, such as TFs. 
1.3.3 Transcription factors (TFs), nucleoid associated 
proteins (NAPs), and two-component systems (TCS) 
Both TFs and NAPs are DNA-binding proteins that can influence gene regulation. 
Around 300 genes in E. coli have been predicted to be DNA-binding proteins, 
indicating the importance of these regulatory elements to the cell (Babu &  
Teichmann, 2003a; Martínez-Antonio & Collado-Vides, 2003). However, it has 
been estimated that just seven of these TFs control up to 50% of all regulated 
genes (Martínez-Antonio & Collado-Vides, 2003). TFs are often expressed in 
response to host environmental stimuli, with some TFs auto-regulating 
themselves (reviewed in Browning & Busby, 2004; Maddocks & Oyston, 2008). 
In order to regulate gene expression, TFs are reliant on recognising DNA motifs 
at promoter regions (D’haeseleer, 2006; Goethals et al., 1992). Most TFs 
therefore carry a DNA-binding motif, although this is usually insufficient to 
facilitate binding, and thus most TFs bind as dimers (reviewed in Browning, 
Butala & Busby, 2019). TFs activate or repress the expression of genes by several 
mechanisms, usually depending on environmental signals. There are two general 
mechanisms for activation of genes by TFs: simple activation and activation by 
conformational change (Fig. 1-5). In simple activation, the TF binds upstream of 
the promoter element and recruits RNAP by directly interacting with either the 
s4 element or the aCTD (Zhou, Zhang & Ebright, 1993; Busby & Ebright, 1994). 
TFs can also positively regulate gene expression by binding to, or near, the 
promoter element and altering the conformation, realigning the -10 and -35 
element, and thus enabling RNAP to bind (Heldwein & Brennan, 2001). 
TFs can also repress gene expression. There are three general mechanisms 
through which this can occur: steric hinderance, DNA looping, and locking RNAP 
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at the promoter (Fig. 1-5). The simplest form of gene repression occurs when 
repressors bind within the promoter element, thereby causing steric hinderance 
and occluding RNAP from the site (Jacob & Monod, 1961). Further, to repress 
gene expression, singular or multiple TFs may bind to promoter-distal sites and 
thus DNA looping may occur, thereby hindering RNAP from binding to the 
promoter element (Vörös et al., 2017). Finally, TFs can block gene expression by 
locking RNAP at the promoter region and thus transcription cannot proceed 
(Grainger et al., 2008). Although these are the main mechanisms of TF 
regulation, there are numerous other mechanisms that can involve multiple TFs 
at complex promoter regions (Browning, Butala & Busby, 2019). 
 
Figure 1-5 The five general mechanisms of gene activation and repression, 
mediated by TFs. Adapted from Browning, Butala & Busby, 2019. (A) and (B) are 
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two general methods of TF activation. (A) TF binds to the target DNA and 
recruits RNAP to the promoter element, enabling trancription. (B) TF binds to 
the promoter elemnt and adjusts the positioning of the -10 and -35, thus 
enabling the RNAP to bind and transcription to proceed. (C), (D) and (E) are 
three general methods of TF repression. (C) TF binds within the promoter 
element, thereby sterically hindering RNAP from binding, thus repressing 
transcription. (D) Multiple TFs bind near the promoter element, causing DNA 
looping, thus occluding RNAP binding and thereby repressing transcription. (E) 
RNAP binds to the promoter element, however the TF locks it into position, 
thereby repressing transcription. 
Unlike TFs, most NAPs bind to DNA in a promiscuous fashion, often in A:T-rich 
regions (Grainger et al., 2006). NAPs are in high abundance within the cell, 
effecting numerous transcriptional responses (Azam et al., 1999). E. coli has at 
least 12 different NAPs, with H-NS being the most well characterised (Babu & 
Teichmann, 2003a; Martínez-Antonio & Collado-Vides, 2003; reviewed in Dillon & 
Dorman, 2010). H-NS is often referred to as the ‘genome guardian’, recognising 
and binding to A:T-rich regions of DNA, and thus silencing transcription (Grainger 
et al., 2006; reviewed in Dorman, 2007). As well as affecting gene regulation, 
NAPs also play a role in the organisation and folding of the nucleoid. In vitro 
studies have revealed that NAPs are able to bend, bridge, wrap and cluster the 
DNA following binding, with these mechanisms also affecting transcription (Wolf 
et al., 1999; Dame, Wyman & Goosen, 2000; reviewed in Browning, Grainger & 
Busby, 2010). Intriguingly however, a recent paper that has redefined the 
fundamental concepts of transcription initiation suggests that, due to the 
overlap in functions with TFs, NAPs should no longer be considered a separate 
class to TFs (Mejía-Almonte et al., 2020). 
Two-component systems (TCS) are further regulatory factors of gene expression. 
Prototypical TCS comprise of a sensor kinase and a response regulator (reviewed 
in Mitrophanov & Groisman, 2008). The sensor kinase is usually exposed to the 
environment and responds to environmental signals by modifying the 
phosphorylated state of the response regulator. The phosphorylation of the 
response regulator causes a modification in the biochemical properties of the 
protein and thus enables it to bind to DNA and elicit transcriptional control over 
genes (reviewed in Mitrophanov & Groisman, 2008). 
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Regulation through DNA-binding proteins enables a fine-tuning of gene 
expression in response to environmental signals. This allows bacteria to utilise 
their genetic material in an appropriate manner, usually enabling them to gain a 
competitive edge over other bacteria. Although originally TFs were thought to 
be exclusively proteins, new research has revealed that there are other 
molecules that play a key role in modulating bacterial gene transcription, 
including ppGpp and regulatory RNAs (Magnusson et al., 2005; Mejía-Almonte et 
al., 2020). This further highlights the importance of transcriptional regulation 
within bacteria. 
1.3.4 LysR-type transcriptional regulators (LTTR)  
Although TFs are comprised of many distinct protein families, one of the largest 
groups of prokaryotic TFs are the LysR-type transcriptional regulators (LTTRs) 
(Pareja et al., 2006). Originally, LTTRs were described as negatively 
autoregulating themselves and transcriptionally activating a single divergently 
transcribed gene (Lindquist et al., 1989). However, further research has 
revealed that LTTRs can be global regulators, affecting the regulation of 
multiple operons including metabolism, virulence and cell division (reviewed in 
Maddocks & Oyston, 2008).  
LTTRs are typically similar in terms of shape, with the N-terminus comprising of 
a highly conserved helix-turn-helix (HTH) motif that interacts with the major 
groove of DNA, and a less-conserved C-terminus that is comprised of a co-
inducer binding domain (Henikoff et al., 1988; Muraoka et al., 2003; Schell, 
1993). Due to poor solubility, the crystal structures of LTTRs have been notably 
difficult to solve (Ezezika et al., 2007); however, in 2003, the first full length 
structure of a LTTR, CbnR, was solved (Muraoka et al., 2003). CnbR was resolved 
as a tetramer (Muraoka et al., 2003), which corresponded with previous data 
that LTTRs are often functionally active as dimers and tetramers (McFall et al., 
1998).  
In transcriptional activation, most LTTRs bind as dimers at two regions within 
the promoter region, the regulatory binding site (RBS) and the activation binding 
site (ABS) (McFall et al., 1998). The dimers then interact, forming tetramers, 
causing the DNA to bend. RNAP is then recruited to the region, although no 
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transcriptional activity occurs in the absence of the co-inducer. When the co-
inducer binds this causes a relaxation of the DNA, allowing activation of 
transcription (Monroe et al., 1990; McFall et al., 1997; reviewed in Maddocks & 
Oyston, 2008) (Fig 1-6). There are exceptions to this, however, with the LTTRs 
Nac and NodD3 not requiring a co-inducer (reviewed in Schell, 1993). 
 
Figure 1-6 A representation of LTTR activation. Adapted from Maddocks & 
Oyston, 2008. (A) Shows two LTTR dimers binding at the regulatory binding site 
(RBS) and the activation binding site (ABS). (B) The LTTR dimers interact, 
forming a tetramer and causing the DNA to bend. RNAP binds at the promoter 
region, but in the absence of a co-inducer, no transcriptional regulation occurs. 
(C) The co-inducer binds to the LTTR tetramer, and the DNA bend relaxes, 
enabling RNAP to interact with the LTTR, thus activating transcription of the 
gene. 
1.3.5 Transcriptional elongation and termination 
Although transcriptional regulation occurs most frequently within the initiation 
phase of transcription, it can also occur in transcriptional elongation and 
termination. Once the RNAP has ‘escaped’ the initiation transcription phase, the 
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transcription cycle proceeds with elongation. The speed and termination of the 
elongation phase can be influenced by regulatory factors, with NusG and NusA 
suppressing or enhancing pausing (reviewed in Washburn & Gottesman, 2015). 
There are two main types of transcriptional termination; intrinsic termination 
(therefore template encoded), or termination that requires accessory factors 
such as Rho and Mfd (reviewed in Washburn & Gottesman, 2015). Intrinsic 
termination occurs at inverted GC-rich sequence repeats that form an RNA 
hairpin, which is then followed by a poly-A residue tail (Wilson & Von Hippel, 
1995). There are three main proposed models as to how this mechanism works 
(reviewed in Roberts, 2019), with the ‘forward translocation’ model suggesting 
that RNA hairpin formation drives RNAP and the transcription bubble 
downstream without further RNA transcript elongation, thereby freeing the 
transcript from RNAP and decreasing the stability of the elongation complex 
(Santangelo & Roberts, 2004; Yarnell & Roberts, 1999). The intrinsic termination 
mechanism relies on template encoded RNA hairpins, whereas Rho-dependent 
termination relies on the ATP-dependent Rho protein. Rho binds to rut sites in 
Rho-dependent terminators and translocates along the RNA 5’-3’ to the RNAP 
(reviewed in Washburn & Gottesman, 2015). This causes the RNAP complex to 
disassociate from the DNA, terminating transcription; although the mechanism 
for this is currently unclear. 
Regulation of termination can occur in both a positive manner as 
antiterminators, or a negative manner as anti-antiterminators (reviewed in 
Henkin, 2000). BglG, a TF of the E. coli bgl operon, acts as an antiterminator, 
binding to the bgl leader RNA transcript, blocking the formation of a terminator 
sequence, thereby allowing expression of the bgl operon (Arnster-Choder & 
Wright, 1993). Conversely, the trp RNA-binding attenuation protein (TRAP) in B. 
subtilis acts as an anti-antiterminator of the tryptophan biosynthesis pathway, 
binding to the nascent trp leader transcript, thereby blocking formation of an 
antiterminator structure, resulting in transcription termination (Babitzke, 1997). 
1.3.6 Elucidating the roles of transcription factors 
As discussed above, transcriptional regulation can occur within any step of the 
transcription process. However, it most frequently occurs within the 
 39 
transcription initiation stage. Encoding DNA-binding proteins that can modulate 
gene expression in response to environmental signals enables bacteria to survive 
under fluctuating conditions. Bacterial genomes encode hundreds of TFs, and 
identifying all of their targets has been a major challenge (reviewed in Wade, 
2015). However, with the advent of next generation sequencing, two genome-
scale approaches, chromatin immunoprecipitation coupled with next-generation 
sequencing (ChIP-Seq) and RNA-sequencing (RNA-Seq), have been utilised to map 
TF regulons (reviewed in Wade, 2015). 
ChIP-Seq is a method that is now routinely used in elucidating the genome wide 
binding of TFs (Barski et al., 2007; Johnson et al., 2007; Mikkelsen et al., 2007; 
Robertson et al., 2007). TFs are cross-linked to the genome, lysed, and the DNA 
is fragmented by sonication. The TF-bound DNA is then immunoprecipitated out 
of the solution and converted into a library for next generation sequencing. The 
reads generated from this analysis are then mapped back to a reference 
genome, and the enrichment of bound genomic regions can then be determined 
against a control sample (reviewed in Wade, 2015). Although this reveals a 
wealth of information about the TF, it is insufficient to reconstruct the regulon. 
RNA-Seq is therefore used to compare RNA levels between the wild-type (WT) 
and a TF-mutant strain, thus determining the direct and indirect regulon of a TF. 
For RNA-Seq, RNA is extracted from the samples and undergoes mRNA 
enrichment or rRNA depletion, followed by cDNA synthesis (reviewed in Stark, 
Grzelak & Hadfield, 2019). The samples are then converted into a library for 
next generation sequencing. The reads generated from this analysis are then 
aligned to the reference genome and are used to analyse differential gene 
expression (DGE) between samples. Thus, combining the ChIP-Seq and the RNA-
Seq data reveals the direct regulon of a TF. 
 The role of host metabolites in bacterial virulence 
1.4.1 Host metabolites affect bacterial gene 
expression 
The mammalian host is a complex environment, where competition for space 
and resources is often at its greatest. Rapid responses to environmental cues 
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enable bacteria to adapt to preferred niches, resulting in maximised 
competitiveness, usually through the deployment of virulence machinery or by 
altering nutrient uptake (reviewed in O’Boyle et al., 2020). A prime example of 
this is the complex environment of the gastrointestinal tract (reviewed in 
Cameron & Sperandio, 2015). Indeed, within the intestine there are abundant 
host metabolites, including free fatty acids, amino acids, and vitamins (reviewed 
in Li et al., 2018).  
Pathogenic bacteria, for example EHEC, utilise these host metabolites to modify 
gene expression, in order to compete against the resident microbiota (reviewed 
in Cameron & Sperandio, 2015). EHEC deploy a T3SS, which enables them to 
form attaching and effacing lesions on host epithelia (McDaniel et al., 1995; 
Moon et al., 1983). The T3SS is encoded on the LEE, which in turn is controlled 
by a master regulator Ler (McDaniel et al., 1995; Mellies et al., 1999). 
Expression of ler can be directly regulated by the transcriptional regulators Cra 
and KdpE, which sense the levels of carbon sources available; in gluconeogenic 
conditions, expression of ler is promoted, whereas glycolytic conditions inhibits 
expression of ler and thus the formation of the T3SS is inhibited (Njoroge et al., 
2012). Moreover, other host metabolites have been shown to affect the 
regulation of the LEE in EHEC strains. Indeed, the host metabolite fucose has 
been demonstrated to effect expression of the LEE (Pacheco et al., 2012). FusKR 
is a TCS that senses the mucosal sugar fucose, found in abundance in the 
intestine. In response to sensing fucose, FusK phosphorylates and FusR represses 
transcription of ler, thereby inhibiting formation of the T3SS, speculatively to 
prevent early expression of the energetically costly production of the T3SS 
(Pacheco et al., 2012). Further, there are numerous more host signals that can 
affect the expression of the LEE PAI and subsequently the production of the T3SS 
(reviewed in Cameron & Sperandio, 2015; Connolly, Finlay & Roe, 2015). The 
two examples presented here represent how EHEC can choose to deploy a 
virulence determinant, the T3SS, in response to sensing host metabolite signals, 
and thus enable deployment and attachment at the opportune moment for 
maximal effectiveness. 
Host-derived free fatty acids can also affect bacterial gene regulation (reviewed 
in Li et al., 2018). In Staphylococcus aureus, the type seven secretion system is 
activated by cis-unsaturated fatty acids (Lopez et al., 2017). Moreover, it is not 
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solely pathogenic bacteria that regulate gene expression in response to 
environmental signals. Campylobacter jejuni is both a commensal and 
pathogenic organism that resides within the intestinal tract (Luethy et al., 
2017). In order to coordinate expression of genes required for commensal 
colonisation, C. jejuni has been shown to respond to lactate (Luethy et al., 
2017). Indeed, in response to lactate, which is present in high concentrations in 
the avian upper intestinal tract and where C. jejuni have been demonstrated to 
have a reduced ability to colonise, the expression of genes required for 
commensal colonisation were repressed (Luethy et al., 2017). These examples 
therefore indicate that adapting gene expression in response to environmental 
signals is widespread within bacteria, enabling them to survive in the 
competitive niches of the mammalian and avian host. 
1.4.2 Elucidating the regulon of bacterial transcription 
factors in response to environmental signals 
As discussed in 1.3.3, altering gene expression in response to environmental 
signals is often mediated through TFs or TCS (Fig. 1-7). However, through the 
advent of next generation sequencing, studying the effect of a TF in response to 
a signal is no longer restricted to a single region or pathogenicity island 
(reviewed in Wade, 2015). Indeed, through the combined use of ChIP-Seq and 
RNA-Seq, a TFs regulon, in response to an environmental signal, can be now 
elucidated in an unbiased global manner (reviewed in Wade, 2015). 
 
Figure 1-7 TF gene regulation mechanisms in response to environmental 
signals. Adapted from O’Boyle et al., 2020. (A) Signals are sensed and 
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recognised by TFs inside the bacterial cell. In this figure, this enables 
recruitment of the RNAP to the promoter region, activating transcription of 
target genes. However, TFs activated by environmental signals can also repress 
transcription of target genes. (B) A signal is sensed by an exposed sensor kinase, 
that phosphorylates in response. The phosphoryl group is then transferred to a 
TF, or cognate response regulator, which mediates the expression of target 
genes. 
Recent work on the human pathogen Bordetella pertussis has shown how the 
TCS, BvgAS, integrates virulence and metabolism through the phosphorylation of 
BvgA (BvgA~P) (Moon et al., 2017). Using RNA-Seq, Moon et al., 2017 elucidated 
the regulon of BvgA under non-modulating conditions, where BvgA was 
phosphorylated (BvgA(+)), and modulating conditions, where phosphorylated 
BvgA was undetectable (Bvg(-)). In this study, BvgA was observed affecting the 
transcript levels of 550 genes in B. pertussis (Moon et al., 2017). It was observed 
that BvgA~P increased expression of virulence genes including ptxABDEC, the 
pertussis toxin genes and fimABCD, the fimbriae genes (Moon et al., 2017). 
Conversely, when BvgA was unphosphorylated (Bvg(-)), this lead to an 
upregulation of various metabolic pathways including fatty acid metabolism and 
the glyoxylate pathway (Moon et al., 2017). These marked differences in 
regulation suggest that BvgA has adapted to suit the specific lifestyle of the 
bacterium. Indeed, when B. pertussis is in the host, BvgA~P directly activates 
virulence genes required for colonisation, whereas in the BvgA(-) mode, which 
has been suggested to be involved in transmission of the pathogen, the 
metabolic changes could potentially enhance survivability of the pathogen (Moon 
et al., 2017). 
In Brucella abortus, VjbR is a LuxR-type transcriptional regulator that has been 
reported to play a role in expression of known virulence genes (Kleinman et al., 
2017). To understand the global role of VjbR in B. abortus, ChIP-Seq and RNA-
Seq were performed under acidic conditions that mimic the in vivo environment 
B. abortus initially encounters within the host. The ChIP-Seq analysis revealed 
that VjbR was able to bind to 235 regions of DNA, with 37 of those mapped 
regions correlating with differentially expressed genes (Kleinman et al., 2017). 
These included genes involved in the virB operon (which is responsible for the 
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type four secretion system) and also genes involved in the electron transport 
chain (Kleinman et al., 2017). Conversely, a previous study which looked at the 
direct transcriptional effects of VjbR-mediated regulation in Brucella melitensis, 
in a rich medium, revealed direct regulation of genes BAB1_0660 and BAB1_1335 
(Uzureau et al., 2010). Although, there were ChIP-Seq peaks in the 
aforementioned regions in the acidic environment study, there was no 
transcriptional effects observed, which indicated that VjbR was able to bind 
under two different environmental conditions but only elicited a transcriptional 
response in the ‘correct’ environment (Kleinman et al., 2017). 
However, the differences in results observed could also be due to the fact that 
the studies utilised two different strains of Brucella. Indeed, recent work in the 
Roe laboratory has revealed that even highly conserved TFs have been tailored 
to suit strain-specific lifestyles. The LTTR, YhaJ, was demonstrated to directly 
regulate unique gene sets within two E. coli pathotypes (Connolly et al., 2019). 
Using a combination of ChIP-Seq and RNA-Seq the direct regulon of YhaJ was 
established in UPEC and EHEC (Connolly et al., 2019). In EHEC, YhaJ bound to 23 
chromosomal locations and when compared with the RNA-Seq data, was revealed 
to directly activate expression of T3SS components (Connolly et al., 2019). 
Conversely, in UPEC, YhaJ bound to 7 chromosomal locations, and was shown to 
activate expression of T1F, a key virulence determinant (Connolly et al., 2019). 
These results therefore indicated that YhaJ had been repurposed within E. coli 
to suit strain-specific lifestyles. Bacteria often mediate gene expression in 
response to environmental signals and cues. The studies discussed here highlight 
how using a combination of ChIP-Seq and RNA-Seq, a TFs regulon can be 
elucidated between different environmental conditions, revealing the intricate 
dynamics of bacterial regulation. 
 D-serine and the dsdCXA locus 
1.5.1 The role of D-amino acids 
Host-derived amino acids are often one of the most prevalent metabolites within 
the gut (Li et al., 2018). Amino acids, except glycine, can be present in two 
enantiomer states, D- or L-enantiomers, and these chiral forms can be 
spontaneously converted, usually by racemases (reviewed in Genchi, 2017). L-
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amino acids are often used in protein synthesis, as this chiral form is more 
energetically preferred, although recent reports have indicated the increasing 
discoveries of D-amino acids in some proteins (Genchi, 2017; Zagon et al., 1994). 
Intriguingly, although D-amino acids do not typically become incorporated into 
protein, they have been found to be present in high concentrations in most 
species and to fulfil specific biological functions (Genchi, 2017). 
D-amino acids have been shown to play a role in murine mucosal defence against 
pathogens (Sasabe et al., 2016). In mammals, D-amino acid oxidase (DAO) is 
produced at the host-microbe interface in intestinal epithelial cells, in response 
to microbial synthesised D-amino acids (Sasabe et al., 2016). DAO is a 
flavoenzyme that can convert D-amino acids into a-keto acids and the 
antimicrobial product, H2O2. In vitro studies revealed DAO-produced H2O2 
impacted the survival of Vibrio cholerae and Vibrio parahaemolyticus, thus 
protecting the small intestine from these pathogens (Sasabe et al., 2016). 
Moreover, D-amino acids have been shown to stimulate M1 macrophages, whilst 
also promoting survival of intestinal naïve B cells (Suzuki et al., 2021). 
Furthermore, D-amino acids have also been shown to play a role in disease 
progression in humans, in both neurological and renal diseases (reviewed in 
Friedman, 2010). 
D-amino acids are derived in mammals in three main ways: conversion of L-
amino acids by racemases; release from microbial sources; and dietary 
consumption (Genchi, 2017). D-amino acids can be obtained from the diet and 
are highly prevalent in dairy and fermented products, with 100 g of Emmental 
cheese resulting in an intake of 70 mg of D-amino acids (Zagon et al., 1994). 
Moreover, processing of food also induces the formation of D-amino acids, with 
exposure to heat and or changes in pH increasing the concentration (Zagon et 
al., 1994). However, approximately one third of human D-amino acid content 
derives from microbial synthesis (reviewed in Friedman, 2010; Genchi, 2017). 
Microorganisms synthesise D-amino acids, releasing them into the environment 
or incorporating them into the bacterial cell wall (Lam et al., 2009). Indeed, D-
alanine, D-aspartic acid, and D-glutamic acid have all been found in the 
bacterial peptidoglycan (Zagon et al., 1994). D-amino acids in the peptidoglycan 
have been demonstrated to provide resistance to proteases, as well contributing 
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to the architecture of the peptidoglycan (Lam et al., 2009; reviewed in Cava et 
al., 2011). 
The most abundant D-amino acids in mammals are D-serine and D-aspartate 
(Genchi, 2017). Although the presence of DAO was found in 1935, it was not until 
the early 1990’s that D-serine was found in mammalian tissues (Nishikawa, 
2011). D-serine is produced in higher organisms, often converted from L-serine 
by the serine racemase, in astrocytes and neurons within the brain; although it 
can also accumulate from dietary sources and intestinal bacteria (Pollegioni & 
Sacchi, 2010; Zagon et al., 1994). D-serine has been found to be prevalent in 
multiple niches of the body, including the brain, spinal cord, retina, kidney, 
bone, and urine (reviewed in Nishikawa, 2011). 
1.5.2 The D-serine metabolism locus, dsdCXA 
Within the human host, bacteria are often competing for space and resources, 
which has led to the diversification of carbon source utilisation within bacteria 
(Hibbing et al., 2010). In 1950, Maas and Davis described how, upon exposure to 
increased levels of D-serine, E. coli could not proliferate due to inhibition of the 
pantothenic acid pathway (Maas & Davis, 1950). However, it was later 
discovered that E. coli K12 carried dsdA, a gene encoding a D-serine deaminase, 
and thus could metabolise D-serine, converting it to pyruvate and ammonia 
(McFall, 1964). Further work by McFall and colleagues pioneered the early 
research on the D-serine metabolism locus in E. coli, revealing a secondary gene 
of the locus, dsdC (McFall, 1967). dsdC encoded a LTTR that was shown to 
positively regulate dsdA, whilst negatively autoregulating itself (McFall & 
Heincz, 1983; Nørregaard-Madsen et al., 1995). However, it was not until 1995, 
after DNA sequencing, that the dsdCXA locus was fully annotated, concluding a 
middle gene of the operon, dsdX, which was later revealed to be a D-serine 
transporter (Anfora & Welch, 2006; Nørregaard-Madsen et al., 1995). Thus, the 
D-serine metabolism pathway was elucidated. In the absence of D-serine, DsdC 
negatively auto-regulates its own transcription. Upon exposure to D-serine, DsdC 
induces the transcription of dsdXA, thus enabling greater expression of DsdA, 
which is then able to break down D-serine into pyruvate and ammonia 
(Nørregaard-Madsen et al., 1995). Pyruvate is then transported into the Krebs 
cycle, for use as a carbon source. Furthermore, DsdX was revealed to be the 
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second D-serine transporter, as D-serine is also able to enter the bacterial cell 
via CycA (Fig. 1-8) (Anfora & Welch, 2006). 
 
Figure 1-8 Predicted model of the dsdCXA locus and subsequent D-serine 
catabolism. Adapted from Anfora & Welch, 2006. D-serine enters the bacterial 
cell through DsdX and CycA, the two D-serine transporters. D-serine then 
interacts with DsdC, causing an increase in expression of dsdX and dsdA. DsdA 
breaks down D-serine into ammonia and pyruvate, which subsequently enters the 
Krebs cycle. 
Strikingly, the dsdCXA locus was found to be absent in some strains of E. coli. A 
global comparison of three E. coli strains revealed that in EHEC, the dsdCXA 
locus had been replaced by genes that encoded for sucrose utilisation, cscRAKB 
(Roesch et al., 2003). D-serine is present in high concentrations within the 
urinary tract and the brain, however is in low abundance within the intestine 
(Nishikawa, 2011), indicating that E. coli strains have adapted to metabolise the 
carbon sources available. 
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1.5.3 D-serine as an environmental signal for bacterial 
gene regulation 
D-amino acids can be utilised in bacteria in three main ways: as a carbon source; 
as an environmental signal for regulation; and as components of peptides and 
the bacterial cell wall (reviewed in Cava et al., 2011). Indeed, previous studies 
have revealed that D-amino acids are involved in numerous regulatory pathways 
including: regulating the amount of peptidoglycan produced in stationary phase 
Vibrio cholerae; inhibiting spore germination in Bacillus species; and inducing 
the disassembly of Bacillus subtilis biofilms (Lam et al., 2009; Kolodkin-Gal et 
al., 2010; reviewed in Cava et al., 2011). 
As discussed above, D-serine can be metabolised in strains that carry the D-
serine deaminase, DsdA. Indeed, it was the presence of this regulated and intact 
dsdCXA locus in the UPEC strain CFT073 that drew the focus of Welch and 
colleagues (Roesch et al., 2003). In an in vivo mouse model, it was 
demonstrated that a DdsdA mutant “hypercolonised” the bladder and was 
recovered 300 times more frequently than the WT (Roesch et al., 2003). 
Furthermore, the DdsdA mutant was demonstrated to be more motile than the 
WT (Roesch et al., 2003). Moreover, it was reported in an in vivo mouse model, 
that a DdsdA strain had upregulated virulence genes that encode P-fimbriae, F1C 
fimbriae and haemolysin, relative to the WT (Haugen et al., 2007). These results 
indicated that the accumulation of D-serine affected the gene expression and 
virulence status of UPEC. However, the authors later established that the DdsdA 
mutant phenotypes, and subsequent further study results, were due to an 
unrecognised secondary mutation in rpoS, and dsdA neither positively or 
negatively affected urinary tract colonisation (Hryckowian et al., 2015). 
Although UPEC and other E. coli strains can metabolise D-serine, many of the 
diarrheagenic E. coli strains have lost this capacity (Roesch et al., 2003). 
Indeed, Roesch et al., 2003 revealed that out of 60 urinary tract and urosepsis E. 
coli isolates, 49 could metabolise D-serine as the sole carbon source, whereas 
only 4 out of 74 diarrheal E. coli strains were able to. In the EHEC strain EDL933, 
it was revealed that the dsdCXA locus was truncated and had been partially 
replaced by the genes encoding sucrose utilisation, cscRAKB (Roesch et al., 
2003). Strikingly, further research revealed that in EHEC, exposure to D-serine 
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resulted in activation of the SOS response and repression of the T3SS (Connolly 
et al., 2015). As discussed above, the T3SS enables EHEC strains to form 
attaching and effacing lesions on host epithelia and is encoded on the LEE 
(reviewed in Turner, Connolly & Roe, 2018). It was demonstrated that 26 out of 
the 42 genes that encode the LEE were downregulated in response to D-serine 
exposure, and furthermore in an in vitro cell model there were 77% fewer 
infected host cells relative to the non-D-serine control (Connolly et al., 2015). 
As exposure to D-serine had repressed the T3SS irrespective of D-serine 
catabolism, the authors hypothesised that carriage of both dsdCXA and the LEE 
would be rare (Connolly et al., 2015). Indeed, it was demonstrated that only 
1.6% of 1,591 strains carried both the LEE and dsdCXA, suggesting a genetic 
incompatibility between the two loci (Connolly et al., 2015). 
Further roles of D-serine as an environmental signal effecting gene regulation 
have been elucidated, including in the uropathogen Staphylococcus 
saprophyticus (Korte-Berwanger et al., 2013). Exposure to D-serine was 
demonstrated to upregulate Ssp, a surface-associated lipase and known 
virulence factor of S. saprophyticus (Korte-Berwanger et al., 2013). 
Furthermore, the DdsdA mutant was revealed to have a significant disadvantage 
in comparison to the WT in in vivo coinfection experiments (Korte-Berwanger et 
al., 2013). Moreover, D-serine has been shown to repress gene expression of 
several virulence associated genes in methicillin resistant S. aureus (MRSA) 
(Iwata et al., 2021). agrA, icaA, sarS, dltD, and sdrD were all repressed upon 
exposure to D-serine and thus inhibited the attachment and biofilm formation of 
MRSA (Iwata et al., 2021). Further, utilisation of D-serine also contributed to the 
fitness of Proteus mirabilis during polymicrobial catheter-associated urinary 
tract infections (Brauer et al., 2019). 
These studies therefore highlight the diverse responses that bacteria undergo in 
response to exposure to the host metabolite, D-serine. Indeed, recent research 
has indicated that the transcriptional response to D-serine is distinct even within 
the same species of bacteria that can utilise D-serine (Connolly et al., 2021). In 
two pathotypes of E. coli that carry the dsdCXA locus, UPEC and NMEC, exposure 
to D-serine induced differential expression of 55 genes in NMEC and 140 genes in 
UPEC, with only 12 genes commonly differentially regulated in both strains 
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(Connolly et al., 2021). This indicated that even within strains of the same 
species that can metabolise D-serine, exposure to the host metabolite results in 
distinct transcriptional responses. 
1.5.4 DsdC, the LysR-type transcriptional regulator 
The D-serine metabolism locus comprises of three genes: dsdC, the LTTR; dsdX, 
the D-serine inner membrane transporter; and dsdA, the D-serine deaminase 
(Nørregaard-Madsen et al., 1995). In 1967, McFall first described DsdC as a 
potential regulatory protein that regulated dsdA, with further research 
confirming that DsdC affected the transcription of dsdA and not the translation 
(Heincz & McFall, 1978; McFall, 1967). DsdC was demonstrated to be resolutely 
required for the activation of dsdA, with rate of enzyme synthesis increasing 
3,000-5,000 fold upon exposure to D-serine (Bornstein-Forst et al., 1987). 
Although DsdC has been shown to be the transcriptional regulator of the dsdCXA 
operon in E. coli, it is unknown whether DsdC plays any further roles in 
regulation. 
 Aims of project 
D-serine is a host metabolite for strains of E. coli that can live in extraintestinal 
niches of the body. D-serine is present in high concentrations within the urinary 
tract and the brain; however, it is in low abundance within the intestine. 
Indeed, E. coli strains living in the intestine have lost the ability to catabolise D-
serine, replacing the D-serine tolerance locus (dsdCXA) with a sucrose utilisation 
locus (cscRAKB). NMEC and UPEC are both E. coli pathotypes that can metabolise 
D-serine, carrying the dsdCXA locus. Strikingly, NMEC pathotypes have been 
discovered carrying two copies of the dsdCXA locus, potentially indicating its 
importance for the strain. In addition to being carbon sources, host metabolites 
can also be environmental signals that can affect gene expression. DsdC is known 
to regulate the dsdCXA locus, however any further regulatory roles are currently 
unknown. As metabolism and virulence are often interlinked processes, it has 
been hypothesised that DsdC may regulate other genes in UPEC and NMEC. Thus, 
the three specific aims of this work were: 
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1. To elucidate the direct regulon of the TF DsdC, in the presence and 
absence of D-serine, in two pathotypes of E. coli, UPEC (strain CFT073) 
and NMEC (strain CE10). 
2. To elucidate whether there was any significance in CE10 carrying two 
copies of dsdC: dsdC1 and dsdC2. 
3. To establish whether DsdC regulation mediated any phenotypes that 
affected the physiology of CFT073 and CE10. 
Chapter 2 describes the materials and methods used in this thesis. Chapter 3 
discusses the use of ChIP-Seq and RNA-Seq, which was performed to elucidate 
the direct regulon of DsdC, in the presence and absence of D-serine. Chapter 4 
discusses the validation of the techniques used in Chapter 3 and the annotation 
of the binding motif of DsdC. Finally, Chapters 5 and 6 delve into the potential 
phenotypes mediated by DsdC regulation in CFT073 and CE10.
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Chapter 2 Materials and methods 
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2.1 Bacterial strains, plasmids, growth media and 
chemicals 
2.1.1 Strains and plasmids used in these studies 
Strain Characteristics Source 
CFT073 Wild type UPEC O6:H1:K2 Prof Rodney 
Welch (Welch et 
al., 2002) 
CFT073DsdC-FLAG UPEC strain with FLAG-tag attached to 
the dsdC gene 
Roe lab 
inventory 
CFT073 DdsdC UPEC dsdC knockout Roe lab 
inventory 
CE10 Wild type NMEC O7:K1 Prof Kwang Sik 
Kim (Lu et al., 
2011) 
CE10DsdC1-FLAG NMEC strain with FLAG-tag attached to 
the dsdC1 gene 
Roe lab 
inventory 
CE10 DdsdC1 NMEC dsdC1 knockout Roe lab 
inventory 
CE10DsdC2-FLAG NMEC strain with FLAG-tag attached to 
the dsdC2 gene 
Roe lab 
inventory 
CE10 DdsdC2 NMEC dsdC2 knockout Roe lab 
inventory 
CE10 DDdsdC1/2 NMEC dsdC1/dsdC2 knockout Roe lab 
inventory 
CE10 DneuO NMEC neuO knockout This study – Dr 
James PR 
Connolly 
Nissle 1917  Probiotic E. coli strain Dr Donal Wall 




Nissle dsdC knockout This study 
MG1665 Lab strain K-12 E. coli Roe lab 
inventory 
DH5a Commercial E. coli storage strain Invitrogen 
BL21 DE3 Commercial E. coli overexpressing strain Invitrogen 
Table 2-1 Bacterial strains and associated characteristics used in these 
studies.  
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Plasmid Characteristics Source 
pMAL-c5X Plasmid for 
overexpression of N-
terminal maltose binding 
protein (MBP) tagged 
proteins (AmpR) 
New England Biolabs  
pMAL-c5X_dsdC MBP-tag overexpression 
plasmid with CFT073 
derived dsdC inserted 
between BamHI and 
HindIII (AmpR) 
This study 
pMAL-c5X_dsdC1 MBP-tag overexpression 
plasmid with CE10 
derived dsdC1 inserted 
between BamHI and 
HindIII (AmpR) 
This study 
pMAL-c5X_dsdC2 MBP-tag overexpression 
plasmid with CE10 
derived dsdC2 inserted 
between BamHI and 
HindIII (AmpR) 
This study 
pSR Plasmid used for DNase 
foot-printing (AmpR) 
Dr Douglas Browning 
pSR_dsdCX1 pSR with CE10 derived 
dsdCX1 intergenic region 
inserted between EcoRI 
and HindIII (AmpR) 




Roesch et al., 2003. 
pET-28A Plasmid for 
overexpression of C-
terminal His tagged 
proteins (KanR) 
Roe lab inventory 
pET-28A_dsdC1 His-tag overexpression 
plasmid with CE10 
derived dsdC1 inserted 
between BamHI and 
HindIII (KanR) 
This study 
pKD3 Template plasmid for 
Lambda Red mutagenesis 
(KanR) 
Datsenko and Wanner., 
2000. 
pKD4 Template plasmid for 
Lambda Red mutagenesis 
(CmR) 
Datsenko and Wanner., 
2000. 
pKD46  Lambda Red 
recombinase expressing 
plasmid (AmpR) 
Datsenko and Wanner., 
2000. 
pACYC184 Multicopy plasmid (CmR) Roe lab inventory 
pdsdC pACYC184 with CFT073 
derived dsdC 








Roe lab inventory 




Roe lab inventory 





pgapAp_neuO pACYC184 with the gapA 
promoter region fused to 
neuO (CmR) 
This study 
Table 2-2 Bacterial plasmids used in this thesis.  
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2.1.2 Bacterial growth 
Bacteria were inoculated using a single colony and grown in 5 ml of Luria-Bertani 
broth (LB) overnight (16 hours) at 37oC, 200 RPM (New Brunswick Scientific 
controlled environment incubator shaker). The cultures were then diluted into 
fresh media the following day at a concentration of 1/100, until the desired 
OD600 had been reached. If growth curves were being undertaken, the bacteria 
were grown until hour 8. 
2.1.3 Storage of strains 
For each bacterial strain, a single colony was taken from a LB plate, and grown 
overnight (16 hours) at 37oC, 200 RPM (New Brunswick Scientific controlled 
environment incubator shaker). 0.75 ml of this culture was added to a sterile 
tube with the addition of 1 ml sterile glycerol (40%) and peptone (2%). The 
stocks were then frozen at -80oC. 
2.1.4 Chemicals and reagents 
All chemicals used in this thesis were purchased from Merck, Invitrogen, Sigma-
Aldrich and ThermoFisher Scientific unless otherwise stated. PCR primers, 1kb 
Plus DNA ladder and SeeBlue Plus 2 protein standard were all purchased from 
Invitrogen. Chemiluminescent Western blotting substrates: Femto, Pierce ECL, 
and Pierce ECL Plus were all purchased from ThermoFisher Scientific. Restriction 
enzymes were purchased from New England Biolabs. Antibodies: Anti-FLAG, Anti-
MBP and Anti-Mouse HRP conjugate were purchased from Sigma-Aldrich; Anti-
Rabbit HRP conjugate was purchased from Invitrogen; and Phospho-Histone 
H2A.X (Ser139/Tyr142) and Beta-tubulin antibodies were purchased from Cell 
Signalling Technologies. Antibiotics were used at their recommended working 
concentrations; ampicillin at 100 µg/ml, chloramphenicol at 25 µg/ml and 
kanamycin at 50 µg/ml. 
2.1.5 Growth media and buffers 
All growth media and buffers were prepared using either nuclease free water 
(nfH2O) or distilled deionised water (ddH2O) and sterilised either by autoclaving 
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or filtration (0.2 µM). Solid media was prepared by adding 15 g/L agar to liquid 
media before autoclaving. All growth medias and buffers were made to 1 litre 
unless stated otherwise. The relevant components were added to 950 ml ddH2O, 
the pH was adjusted, and media topped to 1 litre before sterilisation. 
Ingredient  Quantity 
Tryptone 10 g 
Yeast extract  5 g 
NaCl 10 g 
Table 2-3 LB recipe; pH 7.5 
Ingredient  Quantity 
Tryptone 20 g 
Yeast extract  5 g  
NaCl 0.5 g 
KCl (1 M) 2.5 ml 
MgSO4 (1 M) 2 ml 
Table 2-4 Super optimal broth with catabolite repression (SOC) recipe; pH 
7.0. Preceding usage, 5 ml of MgCl2 (2 M) and 20 ml of glucose (1 M) was added. 
Ingredient  Quantity  
M9 salts (5X) 200 ml 
Table 2-5 M9 minimal media recipe; pH 7.5. Preceding usage; 20 ml of 20% 
Glucose, 2 ml of 1M MgSO4 and 100 µl of 1M CaCl2. 
Ingredient  Concentration 
Hepes-KOH pH 7.5 50 mM 
Sodium deoxycholate 0.1% 






Triton X-100 1% 
NaCl 150 mM 
Table 2-6 FA lysis buffer (150mM). 
Ingredient  Concentration 
Hepes-KOH pH 7.5 50 mM 
Sodium deoxycholate 0.1% 
SDS 0.1% 
EDTA 1 mM 
Triton X-100 1% 
NaCl 500 mM 
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Table 2-7 FA lysis buffer (500mM). 
Ingredient  Concentration 
Tris-HCl (pH 8.0) 10 mM 
LiCl 250 mM 
Sodium deoxycholate 0.5% 
Nonidet P-40 0.5% 
EDTA 1 mM 
Table 2-8 ChIP wash buffer. 
Ingredient  Concentration 
Tris-HCl (pH 7.5) 50 mM 
SDS 1% 
EDTA 10 mM 
Table 2-9 ChIP elution buffer. 
Ingredient  Concentration 
Tris-HCl (pH 7.5) 10 mM 
EDTA 1 mM 
Table 2-10 Tris-EDTA (TE) buffer. 
Ingredient  Concentration 
Tris-HCl (pH 7.5) 20 mM 
NaCl 150 mM 
Table 2-11 Tris buffered saline (TBS). 
Ingredient  Quantity  
10X phosphate buffered 
saline (PBS) 
100 ml 
Tween-20 0.4 ml 
Table 2-12 Phosphate buffered saline Tween (PBST). 
Ingredient  Quantity  
Tris 242 g 
Acetic acid (glacial) 57.1 ml 
EDTA 0.5M (pH 8.0) 100 ml 
Table 2-13 Tris-acetate-EDTA (TAE). 
Ingredient  Quantity  
Glycine 3.75 g 
SDS 0.25 g 
Tween-20 2.5 ml 
Table 2-14 Western blot stripping buffer (pH 2.2).
58 
Ingredient  Quantity  
Methanol 500 ml 
Coomassie 2 g 
Acetic acid 100 ml 
Table 2-15 Coomassie blue. 
Ingredient  Quantity  
Tris (pH 6.8) 1 M 
SDS 8.52 g 
Bromophenol blue 0.43 g 
Glycerol 42.6 ml 
b- mercapthenol 4.97 ml 
Table 2-16 4X sample buffer (*100 ml volume). 
Ingredient  Concentration 
Tris 20 mM 
NaCl 200 mM 
EDTA 1 mM 
Table 2-17 MBP binding buffer. 
Ingredient  Concentration 
Tris 20 mM 
NaCl 200 mM 
EDTA 1 mM 
Maltose 10 mM 
Table 2-18 MBP elution buffer. 
Ingredient  Concentration 
Tris 50 mM 
NaCl 200 mM 
Imidazole 40 mM 
Glycerol 10 % 
Table 2-19 His-tag purification buffer. 
Ingredient  Concentration 
Tris 50 mM 
NaCl 200 mM 
Imidazole 500 mM 
Glycerol 10 % 
Table 2-20 His-tag elution buffer.
59 
Ingredient  Quantity 
Nutrient Broth No2 18 g  
Agar  6.3 g  
Table 2-21 PB agar. 
Ingredient  Concentration 
MgSO4 1 mM 
CaCl2 4 mM 
NaCl 1 mM 
Tris-HCl (pH 7.8) 0.05 M 
Table 2-22 Phage buffer. 
Ingredient  Quantity 
Nutrient Broth No2 20 g  
Agar 3.5 g  
Table 2-23 Phage top agar (PTA). 
2.2 Molecular and genetic techniques 
2.2.1 Polymerase chain reaction (PCR), primers and 
PCR purification 
Primers were designed using Primer3web or NCBI PrimerBLAST. They were 
designed (unless stated differently) to be around 20 bp long, with a Tm between 
55-65oC. Primers involved in cloning were designed to have the relevant 
restriction enzyme flanks. Primers were ordered from Life Technologies and 
came as lyophilised samples and were made to a concentration of 100 µM. 
Working stocks of 10 µM were prepared for use in PCR reactions.  
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Primer name Description Sequence (5’ – 3’) 
DsdC_FLAG_CHECK_ALL_F Forward check for DsdC-FLAG tag  GTTTGGCGATATGACGGTGA 
DsdC_FLAG_CHECK_UPEC_
R Reverse check for CFT073 DsdC-FLAG tag  TTCGACGCCAAGAAGAAGTG 
DsdC1_FLAG_CHECK_NME
C_R Reverse check for CE10 DsdC1-FLAG tag TTCGACGCCAAGAAGATGTG 
DsdC2_FLAG_CHECK_NME
C_R Reverse check for CE10 DsdC2-FLAG tag CGACTCCGGTACATACGACA 
DsdC_ChIP_qPCR_1_ALL_F 
Forward for ChIP-PCR for the intergenic region between 
dsdCX  CGCAGGCTGACAAACGATAA 
DsdC_ChIP_qPCR_1_ALL_R 





Forward for ChIP-PCR for CFT073, for a transcriptionally 
silent gene (citF)  CGATGATGGAAAGCGCAGAA 
CitF_ChIP_qPCR_NMEC_F 
Forward for ChIP-PCR for CE10, for a transcriptionally 
silent gene (citF)  GATGATGGAAAGCGCAGAGG 
CitF_ChIP_qPCR_ALL_R 
Reverse for ChIP-PCR for a transcriptionally silent gene 
(citF)  ATCACATCGAAATCAGCGCC 
MBP_CHECK_DSDC_F Forward check for pMAL-C5X insertion CGCGCAGACTAATTCGA 
MBP_CHECK_DSDC_R Reverse check for pMAL-C5X insertion CCTACTCAGGAGAGCGTTC 
DsdC_Clone_U1_MBP_F 






















Forward for the ChIP peak region for EMSA for dsdC region 
on CE10 CGTGCTCACAACCCAGATTT 
EMSA_DsdC_CE10_R 
Reverse for the ChIP peak region for EMSA for dsdC region 
on CE10 CCTGGCTGCCACTTCAAAAG 
EMSA_EnvR_CE10_F 
Forward for the ChIP peak region for EMSA for envR region 
on CE10 CCAAAAGCGCGTTATTTACCC 
EMSA_EnvR_CE10_R 














BLA_EMSA_F Forward for the beta-lactamase (bla) CCGCCTCCATCCAGTCTATT 
BLA_EMSA_R Reverse for the beta-lactamase (bla) GGTCGCCGCATACACTATTC 
CTX_EMSA_F Forward for the cholera toxin (ctx) CGGGCAGATTCTAGACCTCC 
CTX_EMSA_R Reverse for the cholera toxin (ctx) TGGATGAGGACTGTATGCCC 
UPEC_EMSA_FimB_F 
Forward for the ChIP peak region for EMSA for fimB region 
on CFT073 ACCCGAAGTGATGTGGCTAT 
UPEC_EMSA_FimB_R 





Forward for the ChIP peak region for EMSA for waaV region 
on CE10 TATTCCTGGCAGACGAAACG 
EMSA_WaaV_R 
Reverse for the ChIP peak region for EMSA for waaV region 
on CE10 AGCCACGAATGAAAAGCAGT 
All_DsdC_qPCR_F Forward to check relative expression of dsdC using RT-qPCR GTTTGGCGATATGACGGTGA 
NMEC_UPEC_DsdC1_qPCR_
R 
Reverse to check relative expression of CFT073/CE10 




Reverse to check relative expression of CE10 dsdC2 using 
RT-qPCR ACTGACAAGACTGACATACCTG 
gapA_qPCR_F Forward for housekeeping control (gapA) used in RT-qPCR TTTCCGTGCTGCTCAGAAAC 
gapA_qPCR_R Reverse for housekeeping control (gapA) used in RT-qPCR GGCCGTGAGTGGAGTCATAT 
pSR_check_F Forward check pSR insertion CCGAAAAGTGCCACCTGAC 
pSR_check_R Reverse check pSR insertion CGACAAGTTGCTGCGATTCT 
dsdC1_insert_pSR_footpri
nt_F 
Forward to clone the dsdCX1 intergenic region into pSR 





Reverse to clone the dsdCX1 intergenic region into pSR 
plasmid for footprinting with HindIII RE 
GCGAAGCTTCCTGGCTGCCAC
TTCAAAAG 
waaV_qPCR_F Forward for waaV gene expression using RT-qPCR TATACGCAAGGCGCAAGGAC 
waaV_qPCR_R Reverse for waaV gene expression using RT-qPCR TCCCGTCTCATGTTGTCTGG 
neuB_qPCR_F Forward for neuB gene expression using RT-qPCR AAAAGCCAAAGAGGCCGGT 
neuB_qPCR_R Reverse for neuB gene expression using RT-qPCR  
CTGCCTTAGGTGCAATAGCTG
A 
neuO_qPCR_F Forward for neuO gene expression using RT-qPCR 
TCGGTAGAAGAACGACAATAG
GT 
neuO_qPCR_R Reverse for neuO gene expression using RT-qPCR ATGCAGTCATGGCCAATTGT 
neuO_EMSA_ChIPsite_F Forward for EMSA to check ChIP peak binding site for neuO 
CAAGACTCAAGACTCGTTTTCC
A 






















neuO_184_F Check forward for neuO lambda red mutagenesis in CE10 
TGAAGTCAGCCCCATACGATG
CCGCTGACTGATAATGACG 
neuO_184_R Check reverse for neuO lambda red mutagenesis in CE10 
CAATCCATGCCAACCCGTTCCA
TTACCGCGGTTAATGCCC 
EMSA_ClbR_F Forward for EMSA for validation of ChIP at clbR region TGTTGACTTGGTGTTAGCGG 
EMSA_ClbR_R Reverse for EMSA for validation of ChIP at clbR region 
GGTGGCTGTATCAATTCATAC
CC 
EMSA_ClbA_F Forward for EMSA for validation of ChIP at clbA region 
AGCTTGGTGTCGATATTGAAC
A 
EMSA_ClbA_R Reverse for EMSA for validation of ChIP at clbA region GGTGATGAGTGGAGAGGCTA 
qPCR_ClbA_F Forward for clbA gene expression using RT-qPCR TAGCCTCTCCACTCATCACC 
qPCR_ClbA_R Reverse for clbA gene expression using RT-qPCR TCAATTCTGCCCATTTGACGA 
qPCR_ClbR_F Forward for clbR gene expression using RT-qPCR ACCCGTTATCTCTGCGTGAA 
qPCR_ClbR_R Reverse for clbR gene expression using RT-qPCR 
TCTCATTCCTGTTAGCAATGTG
T 
qPCR_ClbM_F Forward for clbM gene expression using RT-qPCR GCAGGTATACGACAGGGACA 
qPCR_ClbM_R Reverse for clbM gene expression using RT-qPCR TTACTCGTGTTGTTGCCGTG 











Check forward for dsdC lambda red mutagenesis in Nissle 
1917 CGCAGGCTGACAAACGATAA 
DsdC_Nissle_check_R 
Check reverse for dsdC lambda red mutagenesis in Nissle 
1917 GCTCTCCAATATTCGACGCC 
NeuO_ChIP_qPCR_R 
Reverse for ChIP-PCR of the neuO region - EMSA_neuO is 
forward to match GCCATCGACACTCAACATCA 
WaaV_ChIP_qPCR_F Forward for ChIP-PCR of the waaV region  
TCAAGTGAAATACCAACATGCA
A 
WaaV_ChIP_qPCR_R Reverse for ChIP-PCR of the waaV region  GCTCATCGTGTTCTCTTGCC 
NeuB_ChIP_qPCR_R 
Reverse for ChIP-PCR of the neuB region - EMSA_neuB is 
forward to match TCCTTATTCTCGATGTCTGCAA 
kpsF_EMSA_F Forward for EMSA for validation of ChIP at kpsF region CGGCCAGATTTAATTCCGCA 
kpsF_EMSA_R Reverse for EMSA for validation of ChIP at kpsF region GCCCACCTATTTAACACACTCC 
kpsM_EMSA_F Forward for EMSA for validation of ChIP at kpsM region ACTGAGGGATGGTGTTGGTT 
kpsM_EMSA_R Reverse for EMSA for validation of ChIP at kpsM region TGCGTAACAACACCTGCAAT 
kpsF_qPCR_F Forward for kpsF gene expression using RT-qPCR GGGCACGTTATTCTTTCGGG 
kpsF_qPCR_R Reverse for kpsF gene expression using RT-qPCR GTAATCATGCCCAGATCGCC 
kpsM_qPCR_F Forward for kpsM gene expression using RT-qPCR GGGGTATTTGTGGGCGATTC 
kpsM_qPCR_R Reverse for kpsM gene expression using RT-qPCR CGGTGCATAACGTAACCCAA 
pACYC-184_gibson_F Forward for pACYC-184 linearisation TGAATGGAAGCCGGCGGC 
pACYC-184_gibson_R Reverse for pACYC-184 linearisation CATACACGGTGCCTGACTGC 
pACYC_neuO_gibson_F Forward for neuO for gibson assembly  
GCAGTCAGGCACCGTGTATGT
TATTGCGTGAGCTTCGC 
neuO_gapAp_gibson_R Reverse for neuO for gibson assembly  
GGTGGAATATATGTCAAGACT
CAAGACTCAAG 
gapAp_neuO_gibson_F Forward for gapA promoter for gibson assembly  
GTCTTGACATATATTCCACCAG
CTATTTG 
gapAp_pACYC_R Reverse for gapA promoter for gibson assembly  
GTGCCGCCGGCTTCCATTCAC
GTAATTGCCCTTTAAAATTC 
Table 2-24 Oligonucleotides used in this study.  
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The DNA polymerase used was GoTaq Green Master Mix (Promega) or Q5 High-
Fidelity 2X Master Mix (NEB). A single colony of bacteria was mixed with 50 µl of 
nfH2O and used as a template for the PCR reaction. 
Component  Volume  
GoTaq Green Master Mix 2X 10 µl  
Template DNA  1 µl 
Forward and reverse primer (10 µM) 0.5 µl each 
nfH2O 8 µl 
Table 2-25 Volumes used for a PCR reaction. 
Extension time was altered dependent on the size of PCR product with the 
general rule of 1 minute per 1 Kb of amplification. Thermocyclers were set for 
30 cycles (Eppendorf Mastercycler Nexus gradient). 
Step Temperature (oC) Time (min) Cycles 
Initial 
denaturation 
95 5.00 1 
Denaturation 95 0.25 30 
Annealing  55 0.25 
Extension 72 0.50 
Final extension 72 10.00 1 
Table 2-26 Thermocycler conditions for PCR. 
DNA was purified using 25-100 µl of PCR product and the QIAQuick PCR 
purification kit (QIAGEN) to the manufacturer specifications. Purified DNA was 
eluted in 30 µl of nfH2O and concentrations measured using the NanoDrop DS-11+ 
Spectrophotometer (DeNovix). 
2.2.2 Plasmid purification 
5 ml of overnight culture containing the plasmid were centrifuged at 13,000 g 
for 5 minutes. Using the QIAprep Spin Miniprep kit (QIAGEN), plasmid DNA 
purification was performed to the manufacturer specifications. Plasmid DNA was 
eluted in 30 µl of nfH2O and concentrations measured using the NanoDrop DS-11+ 
Spectrophotometer (DeNovix). 
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Plasmids were also purified using the QIAprep Spin Maxiprep kit (QIAGEN) and 
were performed to the manufacturer specifications. Plasmid DNA was eluted in 
30 µl of nfH2O. 
2.2.3 Restriction enzyme digest and DNA ligation 
For restriction enzyme digests, 1 µg of purified DNA (2.2.1) was incubated with 1 
µl of the respective restriction enzyme (NEB), 2 µl of respective buffer and 
made up to an overall volume of 20 µl using nfH2O. These were incubated at 
37oC for 1 hour, unless specified differently. The digests were run on a 1% 
agarose TAE gel and the samples purified using the QIAquick Gel extraction kit 
(QIAGEN) (2.2.6). 
Digested DNA was ligated into linearised plasmid at a ratio of 3:1 respectively. 1 
µl of T4 ligase (NEB) and 2 µl of T4 buffer (NEB) were added to the reaction with 
nfH2O to a total volume of 10 µl. These were incubated at room temperature for 
2 hours. 5 µl of the sample was used for transformation and added to 50 µl of 
competent cells and transformed either using heat shock transformation (2.2.5) 
or electrocompetent cell transformation (2.2.6). These were plated onto 
antibiotic plates for selected screening and positive colonies were confirmed by 
both PCR and DNA sequencing (Eurofins). 
2.2.4 Preparation of competent cells 
A single colony was inoculated in 5 ml of LB and grown to an OD600 of 0.4 at 
37oC, 200 RPM (New Brunswick Scientific controlled environment incubator 
shaker). The cells were centrifuged at 3,750 g for 5 minutes at 4oC. The 
supernatant was removed, and the cells were washed and centrifuged at 15,000 
RPM three times in 1 ml of ice cold ddH2O. Cells were then suspended in 50 µl of 
ice cold ddH2O and used in transformations. 
2.2.5 Heat shock transformation  
50 µl of competent cells was mixed with 5 µl of ligated plasmid and incubated 
on ice for 30 minutes. The samples were then heat shocked at 42oC for 30 
seconds and samples placed back on ice for 2 minutes. 950 µl of pre-warmed 
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SOC was added to each reaction and incubated for 1 hour at 37oC. 100 µl of the 
reaction was then plated out onto the antibiotic selective plate. 
2.2.6 Electrocompetent cell transformation  
50 µl of competent cells was mixed with 5 µl of ligated plasmid and incubated 
on ice for 5 minutes. The samples were added to a pre-chilled electroporation 
cuvette and shocked at 2,500 volts in an Eporator electroporator (Eppendorf). 
950 µl of pre-warmed SOC was added to each reaction and incubated for 1 hour 
at 37oC. 100 µl of the reaction was then plated out onto the antibiotic selective 
plate. 
2.2.7 Agarose gel electrophoresis and gel purification 
of DNA 
1% agarose TAE gels were used for gel electrophoresis. 10,000X GelRed Nucleic 
acid gel stain (Cambridge Bioscience) was added to the liquid agarose. A 1kb 
Plus DNA ladder (Invitrogen) was used as the molecular weight marker. Gels 
were run for 40 minutes at 100 volts. The DNA was visualised using a UV 
transilluminator. 
DNA that needed to be purified from the agarose gels was extracted using 
QIAquick Gel extraction kit (QIAGEN) to the manufacturer specifications, and 
purified DNA was eluted in 30 µl of nfH2O. 
2.2.8 Phenol:chloroform extraction and ethanol 
precipitation 
For phenol:chloroform extractions, samples were made up to 400 µl and mixed 
with an equal volume of phenol:chloroform:isoamillic alcohol 25:24:1 (PCIA) 
(Sigma Aldrich). These were centrifuged at maximum speed for 5 minutes. After 
the centrifugation, the top layer was dispensed into a new Eppendorf and 400 µl 
of chloroform:isolamillic alcohol 24:1 (CIA) (Sigma Aldrich) was added. The 
samples were then inverted several times carefully and centrifuged at maximum 
speed for 1 minute. After centrifugation, the top layer was again dispensed into 
a new Eppendorf and 40 µl of sodium acetate, 1 µl of GlycoBlue Coprecipitant 15 
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mg/ml (ThermoFisher Scientific) and 800 µl of 100% ethanol was added to the 
samples. The samples were then inverted several times and the stored in the -
80oC for 1 hour. The samples were then centrifuged at maximum speed for 20 
minutes at 4oC. The supernatant was discarded and 1 ml of 70% ethanol was 
added. The samples were centrifuged for a further 5 minutes at maximum 
speed. The supernatant was then carefully removed, and the samples were left 
to airdry. The pellets were then suspended in appropriate media, nfH2O or TE 
buffer. 
2.2.9 Lambda Red genetic recombination 
This method was carried out as described in Datsenko and Wanner, 2000. For 
this technique, concentrated PCR product of the resistance cassette, from either 
pKD3 or pKD4, was generated with 50 bp overhangs directly adjacent to the gene 
of interest to be knocked out. Four 50 µl PCR reactions were set up and checked 
by gel electrophoresis, before they were pooled. A phenol:chloroform extraction 
and ethanol precipitation (2.2.8) was then completed on the PCR product. 
Strains desired for gene knock outs were transformed with pKD46 prior to the 
recombination, with recovery at 30oC. A transformed colony was inoculated into 
5 ml of LB broth, 100 µg/ml ampicillin and 100 µl of 1M arabinose, the inducer 
of the Lambda Red system. Cultures were grown at 30oC at 200 RPM (New 
Brunswick Scientific Innova 44 incubator shaker series) until an OD600 of 0.3 was 
reached. Cultures were then centrifuged at 3,750 g for 5 minutes and the 
supernatant removed. The pellet was suspended three times in 1 ml of ice-cold 
ddH2O and centrifuged at 10,000 g for 1 minute, with the supernatant removed. 
The pellets were suspended in a final volume of 50 µl of ddH2O and mixed with 1 
µg of PCR purified DNA. These samples were then added to pre-chilled 
electroporation cuvettes and electroporated. 500 µl of SOC was immediately 
added and the samples recovered at 37oC at 200 RPM (New Brunswick Scientific 
Innova 44 incubator shaker series). 200 µl of the reaction was plated out onto 
selection plates and incubated at 37oC. Colonies were then screened by PCR and 
gel electrophoresis. Successful recombinants were then plated on LB at 42oC to 
get rid of the resistance cassette, leaving a clean mutant. 
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2.2.10 Gibson assembly 
Primers were designed for Gibson assembly using the NEBuilder assembly tool 
(NEB). Sequences were amplified by PCR with the relevant overhangs and 
pACYC184 was linearised. Gibson assemblies were carried out using a Gibson 
Assembly Cloning Kit (NEB) to the manufacturer specifications. The following 
reaction was set up on ice; 0.5 pmols of vector:insert at a ratio of 1:1, 10 µl of 
NEBuilder HiFi DNA Assembly Master Mix, and nfH2O to a total volume of 20 µl. 
Samples were incubated in a thermocycler at 50oC for 15 minutes. 2 µl of the 
sample was transformed into DH5α using the heat shock method (2.2.5). The 
samples were then sequenced to ensure for correct alignment and insertion. 
2.3 Genomic and transcriptomic techniques 
2.3.1 Chromatin immunoprecipitation (ChIP) 
The ChIP experiment was based on methods previously established by Bonocora 
and Wade, (2015) with minor alterations. Prior to the ChIP experiment 
commencing, protein A sepharose beads (CL4B; GE Healthcare), in a 50% TBS 
slurry, were pre-blocked overnight with 0.1% and 1% bovine serum albumin 
(BSA).  
For the ChIP, duplicate CFT073DsdC-FLAG, CE10DsdC1-FLAG and CE10DsdC2-FLAG strains 
were grown in 50mL of M9 minimal media for 5 hours at 200 RPM (New Brunswick 
Scientific Innova 44 incubator shaker series). Further, duplicate CFT073DsdC-FLAG, 
CE10DsdC1-FLAG and CE10DsdC2-FLAG strains were grown in 50mL of M9 minimal media 
for 3 hours at 200 RPM (New Brunswick Scientific Innova 44 incubator shaker 
series), before they were spiked with 1 mM D-serine, and grown for a further 2 
hours. Non-tagged CFT073 WT and CE10 WT samples were also grown in parallel, 
to be used as negative control in the ChIP (Table 2-27).
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ChIP sample ChIP sample name 
CFT073 WT NT01 
CE10 WT NT02 
CFT073DsdC-FLAG + 1mM D-ser NT03 
CFT073DsdC-FLAG + 1mM D-ser NT04 
CFT073DsdC-FLAG NT05 
CFT073DsdC-FLAG NT06 
CE10DsdC1-FLAG + 1mM D-ser NT07 
CE10DsdC1-FLAG + 1mM D-ser NT08 
CE10DsdC1-FLAG NT09 
CE10DsdC1-FLAG NT10 
CE10DsdC2-FLAG + 1mM D-ser NT11 
CE10DsdC2-FLAG + 1mM D-ser NT12 
CE10DsdC2-FLAG NT13 
CE10DsdC2-FLAG NT14 
Table 2-27 ChIP samples and nomenclatures given. 
 
Samples were crosslinked with 1% formaldehyde for 20 minutes before the 
reaction was stopped by addition of 0.5 M glycine. The samples were 
centrifuged, washed with TBS, and suspended in FA lysis buffer with 4 mg/ml 
lysozyme and incubated at 37oC for 30 minutes. Samples were then sonicated for 
2x15 cycle runs (30 seconds on/off) (Bioruptor Pico; Diagenode). The samples 
were then centrifuged at maximum speed for 5 minutes and the chromatin 
(supernatant) was removed. A 20µL input sample was saved at this point for 
ChIP-PCR.  
For immunoprecipitation of the samples, 60 µl of 1% BSA Protein A sepharose 
bead slurry was added to the chromatin and rotated for 2 hours at 4oC. This step 
was performed to reduce background noise. The lysate was then removed by 
centrifugation at 4,000 g for 1 minute. 60 µl of 0.1% BSA Protein A sepharose 
bead slurry was then added to the lysate, along with 4 µl of M2 anti-FLAG 
antibody, and rotated overnight at 4oC. The protein A Sepharose beads are able 
to bind to the anti-FLAG antibody, which in turn has bound to the DsdCFLAG-DNA. 
The beads were then pelleted by centrifugation at 4,000 g for 1 minute, the 
lysate removed, and the beads suspended in 700 µl of FA lysis buffer (150 mM 
NaCl) and transferred to a Spin-X column (Corning). These columns were then 
rotated at room temperature for 3 minutes, before centrifugation for 1 minute 
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at 4,000 g, and removal of the supernatant. 2 further washes, rotations and 
centrifugation with FA lysis buffer (150 mM NaCl) were performed. This was 
followed by one wash, rotation and centrifugation with FA lysis buffer (500 mM 
NaCl), followed by one wash, rotation and centrifugation with ChIP wash buffer. 
A final wash, rotation and centrifugation in TE buffer was performed before 
columns were transferred to dolphin nosed tubes. The supernatant was 
incubated with 100 µl of ChIP elution buffer at 65oC for 10 minutes. Samples 
were then eluted by centrifugation at 4,000 g for 1 min. The samples, and the 
inputs collected earlier, were then de-crosslinked by boiling for 10 minutes. The 
supernatants were then concentrated using the phenol:chloroform extraction 
method, followed by ethanol precipitation described in 2.2.8. The ChIP DNA and 
inputs were then air-dried before resuspending in 12 µl nfH2O. 
2.3.2 Chromatin immunoprecipitation coupled with 
next generation sequencing (ChIP-Seq) 
The ChIP samples were then sent to the University of Glasgow Polyomics where 
DNA concentration was measured using a Qubit HS DNA kit (ThermoFisher 
Scientific). Due to low DNA concentration, another set of duplicate ChIP samples 
were obtained for CFT073 WT, CFT073DsdC-FLAG and CE10DsdC2-FLAG, with and 
without D-serine, and the ChIP samples were then pooled together before 
sequencing (Table 2-28).  
ChIP sample ChIP sample name 
CFT073 WT NT01, NT01B, NT01C 
CE10 WT NT02 
CFT073DsdC-FLAG + 1mM D-ser NT03, NT03B 
CFT073DsdC-FLAG + 1mM D-ser NT04, NT04B 
CFT073DsdC-FLAG NT05, NT05C 
CFT073DsdC-FLAG NT06, NT06B 
CE10DsdC1-FLAG + 1mM D-ser NT07 
CE10DsdC1-FLAG + 1mM D-ser NT08 
CE10DsdC1-FLAG NT09 
CE10DsdC1-FLAG NT10 
CE10DsdC2-FLAG + 1mM D-ser NT11, NT11B 
CE10DsdC2-FLAG + 1mM D-ser NT12, NT12B 
CE10DsdC2-FLAG NT13, NT13B 
CE10DsdC2-FLAG NT14, NT14B 
Table 2-28 Pooled ChIP samples and their nomenclatures. 
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University of Glasgow Polyomics then generated a ChIP-Seq library which was 
prepared using a NEBNext Ultra II DNA library prep kit for Illumina (NEB). The 
libraries were quantified using the Qubit HS DNA kit (ThermoFisher Scientific). 
The profiles and the size of the libraries were analysed on the Bioanalyser High 
Sensitivity DNA ChIP (Agilent). Illumina next generation sequencing was 
performed on the samples using an Illumina NextSeq 500 platform (75 bp length; 
single end). 
2.3.3 ChIP-Seq analysis 
Reads were quality assessed (minimum Phred threshold of 20) with FastQC 
(Babraham Bioinformatics) before importing into CLC Genomics Workbench 7. 
Raw fastq files were aligned to the CFT073 and CE10 reference genomes (NCBI 
accession numbers respectively; NC_004431.1 and CP003034). The ChIP-Seq 
analysis tool software was used, and the DsdCFLAG-tagged samples were then 
aligned against the mock ChIP WT control samples to establish enrichment. The 
maximum p-value for calling enriched peaks was set to £0.05. 
Peaks were called from two biological replicates and checked manually to 
ensure they were the correct bimodal peak shape. Regions that did not conform 
were omitted. As ChIP-Seq is known to predict false positives, it was decided 
that each peak that was called would be manually checked (from the lowest p-
value generated) until there were at least 10 ‘peaks’ in a row that did not 
conform to the bimodal peak shape and then the manual search would cease. 
2.3.4 ChIP-PCR 
Prior to library generation, ChIP-PCR was done to ensure enrichment of target 
DNA over the non-FLAG tagged control. The conditions used are described in 
Table 2-29. This enrichment was measured by calculating the signal over the 
background using fold enrichment 2-DDCT (DCT = CTChIP – CTCONTROL). The region 
between dsdCX was used as it was the only verified binding site of DsdC. Regions 
of citF were used as controls for non-specific enrichment.
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Cycle step Temperature (oC) Time (minutes) Cycles 
Initial 
denaturation 
95 1 1 
Denaturation 95 0.25 40 
Extension 60 0.5 
Table 2-29 Thermocycler conditions for ChIP PCR. 
2.3.5 RNA extraction and DNase treatment 
RNA extraction was carried out using the PureLink RNA Mini Kit (ThermoFisher 
Scientific). CFT073, CE10, and corresponding isogenic DdsdC strains, were grown 
in triplicate, in M9 minimal media for 5 hours at 37oC, 200 RPM (New Brunswick 
Scientific Innova 44 incubator shaker series). Further, CFT073, CE10, and 
corresponding isogenic DdsdC strains, were grown in triplicate, in M9 minimal 
media for 3 hours at 37oC, 200 RPM (New Brunswick Scientific Innova 44 
incubator shaker series), before being spiked with 1 mM D-serine and grown for a 
further 2 hours. The OD600 of the samples was adjusted to 1.0. 1 ml of culture 
was then centrifuged for 10 minutes at maximum speed and the supernatant 
discarded. The pellet was suspended in 1 ml of RNA protect (QIAGEN) and 
incubated at room temperature for 10 minutes. The samples were centrifuged 
for a further 10 minutes at maximum speed and the supernatant discarded. To 
the samples, 100 µl of TE solution containing lysozyme (10 mg/ml) was added 
with 0.5 µl 10% SDS and vortexed until the pellet was suspended. These were 
left to incubate for 5 minutes at room temperature. 350 µl of lysis buffer with 
1% 2-mercaptoethanol was added to the samples and vortexed to mix. 250 µl of 
100% ethanol was added to the samples and vortexed vigorously to remove any 
visible precipitation.  
The samples were then transferred to a PureLink RNA Mini Kit spin column and 
centrifuged at maximum speed for 15 seconds. The flow through was discarded 
and 700 µl of Wash Buffer 1 was added to the same column and centrifuged at 
maximum speed for 15 seconds. The flow through was discarded again and 500 
µl of Wash Buffer 2 was added to the same column and centrifuged at maximum 
speed for 15 seconds. This was repeated again with 500 µl of Wash Buffer 2. The 
column was then centrifuged for 1 minute at maximum speed, the supernatant 
discarded, and the column was inserted into a new recovery tube. 100 µl of 
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nfH2O was added to the centre of the column and incubated at room 
temperature for 1 minute. The column was then centrifuged for 1 minute at 
maximum speed. The samples were then DNase treated. 4 µl of TURBO DNase 
(ThermoFisher Scientific) and 10 µl of 10X TURBO DNase buffer was added to 
each sample. The samples were centrifuged at maximum speed for 30 seconds, 
mixed gently and incubated for 60 minutes at 37oC. During the 60 minutes 
incubation, the samples were vortexed and centrifuged every 15 minutes. 
The samples were then analysed on a NanoDrop DS-11+ Spectrophotometer 
(DeNovix) and by electrophoresis on an agarose gel. Readings between 1.8 and 
2.0 of 260/280 absorbance were accepted values on the NanoDrop. Further 
analysis was done by a groEL PCR check to ensure that there was no DNA present 
in the RNA samples. 
The RNA from the samples was then concentrated using phenol:chloroform 
extraction method followed by ethanol precipitation outlined in 2.2.8. The 
samples were then airdried and suspended in 100 µl of TE buffer. The samples 
were then normalised to a total concentration of 10 ng/µl in 100 µl. 
2.3.6 Quantitative real time PCR (RT-qPCR) 
RNA samples were extracted as detailed above (2.3.5) and normalised to a total 
concentration of 10 ng/µl. The LunaScript RT SuperMix kit (NEB) was used for 
the cDNA synthesis of the RNA samples. For each reaction: 2 µl of 5X LunaScript 
RT SuperMix, 7 µl of nfH2O, and 1 µl of RNA template was used. These samples 
were put on the thermocycler (Eppendorf Mastercycler Nexus gradient) under 
the following conditions (Table 2-30).  
Cycle step Temperature (oC) Time (minutes) 
Annealing  25 2 
cDNA synthesis  55 10 
Heat inactivation 95 1 
Table 2-30 Thermocycler conditions for LunaScript RT SuperMix cDNA 
synthesis. 
This was then followed by RT-qPCR performed on a CFX-Connect Real-Time PCR 
detection system (BIORAD) using the Luna Universal qPCR Master Mix kit (NEB). 1 
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µl of cDNA was added to 10 µl of 2X Luna Universal qPCR Master Mix, 1 µl of 
forward and reverse primers (10 µM) respectively, and 7 µl of nfH2O. The 
reactions were performed in duplicate and each gene that was analysed was 
performed in biological triplicate. Two controls were used for the RT-qPCR, a no 
reverse transcriptase control and a no template control.  
Cycle step Temperature (oC) Time (minutes) Cycles 
Initial 
denaturation 
95 1 1 
Denaturation 95 0.25 40 
Extension 60 0.5 
Table 2-31 Thermocycler conditions for RT-qPCR. 
All primers used in RT-qPCR were checked for efficiency prior to the 
experiment, using the thermocycler conditions described in Table 2-31. Primers 
are detailed in Table 2-24. 5 standards were made using template cDNA of 100, 
20, 4, 0.8 and 0.16 ng/µl. Primers were only used if they had efficiency between 
90-110%. The data was then analysed using the CFX-Connect BIORAD software, 
according to the 2-DDCT method. 
2.3.7 Transcriptome profiling by RNA-Seq 
RNA samples were extracted as detailed above (2.3.5). RNA quality was assessed 
by Agilent Bioanalyzer 2100. Samples were subjected to ribosomal depletion 
using MICROBExpress (ThermoFisher Scientific) according to the manufacturer’s 
instructions. Library preparation and sequencing was carried out at the 
University of Glasgow Polyomics facility. Sequencing libraries were prepared 
with the TrueSeq Stranded mRNA Library Prep kit (Illumina) according to 
manufacturer’s instructions. Sequencing was carried out on the 
Illumina NextSeq 500 platform with at least 10 million 75 bp single end reads 
being obtained. Reads were quality assessed (minimum Phred threshold of 
20) with FastQC (Babraham Bioinformatics) before importing into CLC Genomics 
Workbench (Qiagen) and mapping to the CFT073 and CE10 reference genome and 
plasmids respectively (NCBI accession number: NC_004431.1, CP003034, 
CP003035, CP003036, CP003037, CP003038) using default CLC mapping 
parameters. Differential expression was assessed using the empirical analysis of 
differential expression (EdgeR) with genes displaying absolute fold changes of ≥ 
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1.5; ≤ -1.5 and having a false-discovery rate corrected p-value of ≤0.05 being 
considered. Pairwise comparison of WT and either DdsdC or DDdsdC1/2 was 
conducted to identify any changes in gene expression caused by the removal of 
the transcription factor DsdC. Pairwise comparison of WTD-ser and either DdsdCD-
ser or DDdsdC1/2D-ser was used to identify the extent gene expression in the 
presence of D-serine. Further pairwise comparisons were done with WTD-ser and 
either DdsdCD-ser + pDsdA, or DDdsdC1/2D-ser + pDsdA1/2 to identify gene 
expression caused by DsdC and the inducement of D-serine, and not by the toxic 
effects of D-serine accumulation. 
RNA-Sequencing was completed prior to this PhD commencing and the raw data 
is available on the European Nucleotide Archive (ENA) under accession numbers: 
Strain ENA accession numbers 
UPEC ERS4281315 - ERS4281325, ERS4281353 
NMEC ERS4281326 - ERS4281334, ERS4281354 - ERS4281356 
Table 2-32 European Nucleotide Archive (ENA) accession numbers for RNA-
Sequencing data. The accession numbers on ENA for the RNA-Seq data 
“Establishing the global regulatory role of DsdC in UPEC and NMEC”. 
2.3.8 Sanger sequencing 
For samples less than 1 Kb that required sequencing, primers were designed 
around the sequence of interest. The sequence was then amplified using PCR 
and purified using a QIAquick PCR purification kit (QIAGEN). Purified PCR 
products and primers were then sent to Eurofins Genomics for Sanger 
sequencing. Results were returned as FASTA files and Clustal Omega (EMBL-EBI) 
was used for multiple sequence alignment. 
2.4 Biochemical techniques 
2.4.1 SDS-PAGE and Coomassie staining 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
Coomassie staining were used to analyse whole cell and purified protein 
samples, using the NuPAGE system (Invitrogen). The samples were grown under 
ChIP-Seq growth conditions; 3 hours grown in M9 minimal media at 37oC, 200 
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RPM (New Brunswick Scientific Innova 44 incubator shaker series), spiked with or 
without 1 mM of D-serine and left to grow for a further 2 hours. The samples 
were normalised using OD600 and centrifuged at 4oC for 3 minutes at 10,000 g. 
The supernatant was discarded, and the pellet was suspended in 75 µl of ddH2O 
and 25 µl of sample buffer (Table 2-16). Samples were then heated for 10 
minutes at 95⁰C. 
An alternative method was also used. The samples were grown up and 
normalised using OD600, before being centrifuged at 10,000 g for 3 minutes. The 
supernatant was discarded and 100 µl of BugBuster Protein Extraction Reagent 
(Merck) was added to the sample. The samples were then vortexed every 10 
minutes for 30 minutes. The samples were centrifuged again for 3 minutes at 
10,000 g. The samples were then standardised again using a bicinchoninic acid 
(BCA) protein assay (Sigma Aldrich). 25 µl of 4X NuPAGE LDS sample buffer 
(Invitrogen) was added to the samples which were then heated for 10 minutes at 
95⁰C. 
Pre-cast NuPAGE 4-12% Bis-Tris gels (Invitrogen) were used. 15 µl of sample was 
loaded onto the gel and run in NuPAGE MES buffer (Invitrogen) at 180 volts for 40 
minutes, until the dye front had reached the end of the gel. SeeBlue Plus 2 was 
used as the molecular weight ladder. SDS-PAGE gels were then either transferred 
for Western blotting (2.4.4) or Coomassie stained. The gels were stained for 1 
hour in Coomassie blue stain (Table 2-15) and destained overnight in ddH2O. 
Coomassie stained SDS-PAGE gels were then imaged on a transilluminator (BIO-
RAD ChemiDoc MP Imaging system). 
2.4.2 Protein overexpression of recombinant proteins 
The CE10 and CFT073 dsdC genes were cloned into the maltose binding protein 
(MBP) overexpression plasmid pMAL-C5X and used for overexpression in E. coli 
BL21 DE3 cells. Several trial over-expression methods were tested before large 
scale over-expression and purification commenced. Single colonies were used to 
inoculate LB and were incubated for 16 hours at 37oC, 200 RPM (New Brunswick 
Scientific controlled environment incubator shaker). These overnight cultures 
were then used to inoculate fresh LB and grown to an OD600 of 0.6 at 200 RPM, 
37oC (New Brunswick Scientific Innova 44 incubator shaker series). The samples 
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were then induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and 
left to grow for a further 3 hours at 37oC, 200 RPM. The samples were then 
centrifuged at 7,000 g for 10 minutes and the supernatant removed. The pellet 
was suspended in 75 µl of nfH2O and 25 µl of 4X sample buffer (Table 2-16) and 
heated to 95oC for 10 minutes. Samples were then run on pre-cast NuPAGE 4-12% 
Bis-Tris gels and Coomassie stained (2.4.1) or Western blotted (2.4.5). The CE10 
dsdC1 gene was also cloned into the overexpression plasmid pET-28A and used 
for overexpression in E. coli BL21 DE3 cells. 
2.4.3 Protein purification of recombinant proteins 
Prior to purification of the MBP-tagged proteins, the plasmids were freshly 
transformed into BL21 DE3. A single colony was then inoculated and left 
overnight at 37oC at 200 RPM (New Brunswick Scientific controlled environment 
incubator shaker). The overnight culture was then diluted into 1L of LB and 
antibiotic and grown to an OD600 of 0.6 at 37oC, 200 RPM (New Brunswick 
Scientific Innova 44 incubator shaker series). 1 mM of IPTG was added and left to 
grow for a further 3 hours, 225 RPM, at 37oC. The samples were centrifuged for 
20 minutes at 5,000 g and the supernatant removed. The samples were 
centrifuged again, at 7,500 g for 10 minutes to remove any final supernatant. To 
the pellet, 35 mg of lysozyme was added with cOmplete EDTA-free protease 
inhibitor cocktail (Promega), DNase I and 35 ml of MBP binding buffer (Table 2-
17). The sample was sonicated on ice, 10 seconds ON and 30 seconds OFF for 20 
cycles and centrifuged for 40 minutes at 15,000 g. The supernatant was removed 
and filtered through a 0.22 µM filter. 15 µl of the sample was removed at this 
stage to use as a control. The sample was then run through the MBP HP column 
(GE Healthcare) using a MasterFlex L/S (Cole-Parmer). The flow-through was 
collected to use as a control. The column was washed with 5 column volumes 
(CVs) of MBP binding buffer (Table 2-17), followed by 5CVs of MBP elution buffer 
(Table 2-18), eluting into 2 mL fractions. 5 µl of 4X sample buffer (Table 2-16) 
was added to 15 µL of each of the fractions and heated to 95oC for 10 minutes. 
Samples were then run on pre-cast NuPAGE 4-12% Bis-Tris gels and Coomassie 
stained (2.4.1) in order to determine which fraction contained the purified 
recombinant protein. These samples were then aliquoted and kept for long term 
storage at -80oC. 
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Prior to purification of the His-tagged protein, the same protocol was used as 
above, with the exception of 35 ml of His binding buffer (Table 2-19) was added 
to the pellet instead of MBP binding buffer. The sample was then either run 
through the HisTrap HP column (GE Healthcare) using a MasterFlex L/S (Cole-
Parmer) or a HisTrap HP column (GE Healthcare) using an AKTA Start (University 
of Glasgow Protein Purification Service). For the MasterFlex L/S the flow-
through was collected to use as a control. The column was washed with 5 
column volumes (CVs) of His binding buffer (Table 2-19), followed by 5CVs of His 
elution buffer (Table 2-20), eluting into 2 mL fractions. 5 µl of 4X sample buffer 
(Table 2-16) was added to 15 µL of each of the fractions and heated to 95oC for 
10 minutes. Samples were then run on pre-cast NuPAGE 4-12% Bis-Tris gels 
(Invitrogen) (2.4.1) and Coomassie stained (2.4.1) in order to determine which 
fraction contained the purified recombinant protein. These samples were then 
aliquoted and kept for long term storage at -80oC. For the AKTA Start, this was 
performed by the University of Glasgow Protein Purification Service. Fractions 
were run on pre-cast NuPAGE 4-12% Bis-Tris gels and Coomassie stained (2.4.1). 
2.4.4 BCA protein assay 
To measure the concentration of the recombinant protein, a BCA Protein Assay 
was used (Pierce, ThermoFisher Scientific). This was completed using the 
standard microplate protocol according to the manufacturer specifications. 
Briefly, standards of BSA were made to concentrations between 25 µg/ml to 
2000 µg/ml. A BCA working reagent was made by mixing 50 parts of BCA Reagent 
A with 1 part of BCA Reagent B. 25 µl of each standard and recombinant protein 
was added to a 96 well microplate in technical duplicates. 200 µl of working 
reagent was added to each of the wells and the plate was briefly vortexed. The 
plate was then covered and incubated for 30 minutes at 37oC. Absorbance was 
measured on a FLUOstar Optima plate reader (BMG Labtech) at 562 nm. A 
standard curve was prepared by plotting the 562 nm measurement for each BSA 
standard against its concentration in µg/ml. The standard curve was then used 
to measure the relative concentration of the recombinant protein. 
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2.4.5 Using Factor Xa to cleave the MBP-DsdC 
recombinant protein 
The recombinant protein was cleaved of its MBP tag. Using 1 mg/ml of 
recombinant protein, 200 µg/ml of Factor Xa Protease (NEB) was added to the 
sample. The samples were left at room temperature and 5 µl of sample was 
removed at 2-, 4-, 6- and 24-hours intervals. 1.5 µl of 4X sample buffer was 
added to the samples, heated for 10 minutes, and run on pre-cast NuPAGE 4-12% 
Bis-Tris gels and Coomassie stained (2.4.1). A control using no Factor Xa 
protease was used to check for complete cleavage. 
2.4.6 Western blotting 
Following SDS-PAGE (2.4.1) the gel was then transferred to either an Amersham 
Protran NC Nitrocellulose membrane (ThermoFisher Scientific) or Immobilon-P 
polyvinylidene fluoride (PVDF) membrane (Millipore) using the XCell SureLock 
Transfer system (Invitrogen). The transfer was run at 30 volts for 60 minutes in 
NuPAGE transfer buffer (Novex). The membrane was then blocked in 5% milk 
(Marvel) in PBST for 60 minutes. Primary antibody was added in 1% milk in PBST 
and left at room temperature rocking for 60 minutes. Membranes were washed 3 
times in PBST for 10 minutes before being incubated with the secondary 
antibody for 60 minutes at room temperature. Membranes were washed again 3 
times in PBST. Either Pierce ECL Western Blotting Substrate, SuperSignal West 
Femto Maximum Sensitivity Substrate or Pierce ECL Plus Western Blotting 
Substrate was added to the membrane for 5 minutes. These were transferred to 
either the transilluminator or the C-digit (Li-Cor) and exposed; or exposed to 
Medical X-ray Blue film (Carestream) and developed using a film processor. 





FLAG Mouse 1/1,000 1/2,000 
GroEL Rabbit 1/10,000 1/10,000 
DnaK Mouse 1/3,000 1/6,000 
MBP Mouse 1/2,000 1/5,000 
Phospho-Histone H2A.X 
(Ser139/Tyr142) 
Rabbit 1/1,000 1/2,500 
Beta tubulin Rabbit 1/10,000 1/10,000 
Table 2-33 Antibody concentrations used for Western blotting. 
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2.4.7 Electrophoretic mobility shift assay (EMSA) 
The EMSA assays were completed using a DIG gel shift kit (2nd generation) to the 
manufacturer specifications using DIG wash and block buffer set (Roche) and 
performed in duplicate. Purified MBP-tagged protein (2.4.3), was used for this 
experiment. Promoter regions, which were analysed from the ChIP-Seq data set, 
thought to contain DsdC DNA-binding sites were amplified using PCR and 
confirmed by agarose gel electrophoresis. These were then purified by QIAquick 
gel extraction kit (QIAGEN) for use as binding probes. The EMSA probes were 
then DIG-labelled as to the manufacturer specifications, 100 ng of purified DNA 
was adjusted to a final volume of 10 µL in sterile distilled water. 4 µL labelling 
buffer (5X), 4 µL CoCl2 solution, 1 µL DIG-ddUTP solution and 1 µL of terminal 
transferase (400 U) was added to the probes on ice, mixed and centrifuged 
briefly. The probes were then incubated at 37⁰C for 15 minutes before being 
returned to the ice. The reaction was stopped by adding 2 µL of 0.2 M EDTA (pH 
8.0) and 3 µL of sterile distilled water. This gave the labelled probes a final 
concentration of 4 ng/µL. The efficiency of probe labelling was tested by using 
serial dilutions and spotting 1 µL of DIG labelled probe onto positively charged 
nylon membrane (Roche). The probe was cross-linked to the membrane using UV 
light for 20 minutes. The membrane was washed in DIG washing buffer and 
incubated for 5 minutes at room temperature. The membrane was blocked for 
30 minutes using DIG blocking solution and then blocked for a further 30 minutes 
using DIG antibody solution. Membranes were washed twice for 15 minutes in 
DIG wash buffer and then incubated in DIG detection buffer for 2 minutes. 
Membranes were then placed on cling film and 1 ml of CSPD working solution 
was applied to the membrane. Cling film was immediately placed on top 
covering the membrane and left to incubate at room temperature for 5 minutes. 
The excess liquid was then lightly squeezed out of the cling film and sealed. The 
sealed membranes were then incubated for 10 minutes at 37oC and exposed on 
the transilluminator (BIO-RAD Chemidoc). 
For the EMSAs: 4 µL of binding buffer, 1 µL of poly [d(I-C)], 1 µL of poly L-lysine, 
1 µL of DIG labelled probe and 11 µL of nfH2O, were added for each reaction. 
Differing concentrations of purified protein was added to the reactions. These 
were mixed carefully on ice and incubated at room temperature for 15 minutes. 
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The samples were placed back onto ice and 5 µL of loading buffer was added to 
each reaction. 20 µL of sample was then loaded onto a pre-run NOVEX 6% 
retardation gel (Invitrogen) and ran in 0.5X TBE buffer at 100 V for 1 hour and 45 
minutes. The gel was then transferred onto a positively charged nylon 
membrane (Roche), using the XCell SureLock Transfer system, at 30 V for 1 hour. 
The membranes were then cross-linked using UV light for 20 minutes. The 
protocol then follows the same procedure as stated above for the probes. 
2.4.8 DNase I footprinting 
This was performed at the University of Birmingham under the supervision of Dr 
Douglas Browning, who then completed the experiment. Briefly, the dsdCX 
intergenic promoter region fragment was cloned into the pSR vector using EcoRI 
and HindIII. Fragments were sequenced to ensure correct insertion. pSR-dsdCX 
was purified using a QIAGEN MaxiPrep kit (detailed in 2.2.2) with a 
concentration of at least 100 µg of DNA needed for DNase I footprinting. The 
fragments were then cut using HindIII and incubated for 3 hours at 37oC, before 
being phosphotase treated with calf intestinal phosphatase (CIP). The fragments 
were then precipitated using a phenol:chloroform extraction followed by an 
ethanol precipitation (outlined in 2.2.8). Samples were suspended in 50 µl of TE. 
The fragments were then further cut with AatII, incubated for 3 hours at 37oC. 
The samples were then run on a 7.5% acrylamide gel. If the band was the 
appropriate size, based upon on a molecular ladder, it was cut from the gel and 
the DNA was electroeluted from the gel slice. Electroelution occurred by 
preparing dialysis tubing, inserting the gel slice into the tubing and adding 200 
µL of 0.1X TBE. These were then run for 20 minutes at 40 mA. The supernatant 
was removed from the tubing and placed in an Eppendorf. The tube was washed 
with a further 200 µL of sterile H2O and the supernatant removed and combined 
with the sample. The fragments were precipitated using a phenol:chloroform 
extraction followed by an ethanol precipitation (outlined in 2.2.8). 0.5 µL of 
sample was run on a 7.5% acrylamide gel to check for DNA. The fragments were 
then able to be radiolabelled. For each 20 µL reaction: 8 µL of DNA fragment, 8 
µL of sterile H2O, 2 µL of PNK buffer, 1 µL of ATP g P32, and 1 µL of T4 
polynucleotide kinase (NEB) was used. This was incubated at 37oC for 30 
minutes. The unincorporated nucleotides were then removed by passing the 
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samples through a Sephadex G-50 column. The filtration of the DNA fragments 
from the unincorporated nucleotides was done by adding 200 µL of Sephadex G-
50 beads to a spin column. This was allowed to settle for 5 minutes, before 
centrifugation at low speed (3.5 g) occurred for 2 minutes. The DNA fragments 
were then pipetted onto the beads and centrifuged for 2 minutes (3.5 g). The 
supernatant was kept as the 32P-end radiolabelled DNA fragments, and the 
columns disposed of appropriately. 
For DNase I footprinting, each 20 µL reaction was made up as follows: 0.2 µL of 
32P-end labelled DNA fragment, 2 µL of 10X HEPES buffer, 1 µL of 10 mg/ml-1 
BSA, 1 µL of 0.6 mg/ml-1 Herring sperm DNA, varying concentrations of DsdC, 
and H2O to bring the volume up to 20 µL. Samples were then incubated for 20 
minutes at 37oC and 2 µL of DNase I was added to the sample for 40 seconds 
before the reaction was stopped with 200 µL of DNase I stop solution. The 
samples were then precipitated using phenol:chloroform extraction followed by 
ethanol precipitation (outlined in 2.2.8). The samples were suspended in loading 
buffer and heated to 90oC for 2 minutes. The samples were loaded onto a 6% 
denaturing gel with a GA ladder and visualised on a Bio-Rad PMI imager. 
2.5 Phenotypical assays 
2.5.1 Silver staining 
Samples were prepared for silver staining using the ChIP-Seq growth conditions; 
3 hours grown in M9 minimal media at 37oC, 200 RPM, spiked with or without 1 
mM of D-serine and left to grow for a further 2 hours (New Brunswick Scientific 
Innova 44 incubator shaker series). Samples were centrifuged for 3 minutes at 
12,000 g. 100 µL of BugBuster was added to each of the samples and left to 
incubate at room temperature for 30 minutes, vortexing every 10 minutes. The 
samples were centrifuged at 12,000 g for 3 minutes and 25 µL of 4X LDS NuPAGE 
sample buffer was added. Samples were heated to 95oC for 10 minutes. 
Proteinase K (NEB) was added to the samples at a concentration of 25 µg and 
incubated at 60oC for 1 hour. The samples were then run on a pre-cast NuPAGE 
4-12% Bis-Tris gel (2.4.1). 
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Silver staining was carried out using the SilverQuest Silver Staining kit 
(ThermoFisher Scientific) to the manufacturer specifications. The gel was 
washed briefly in ddH2O before 100 ml of fixative solution was added for 20 
minutes. The gel was then washed in 30% ethanol for 10 minutes, before 100 ml 
of sensitising solution was added for a further 10 minutes. 30% ethanol was 
added to the gel for 10 minutes, before the gel was washed in ddH2O for 10 
minutes. The gel was incubated for 15 minutes in 100 ml of staining solution and 
washed in ddH2O for 1 minute. 100 ml of developing solution was added to the 
gel and incubated for 4-8 minutes until bands started to appear. 10 ml of 
stopper was immediately to the gel and the gel was incubated for a further 10 
minutes being gently agitated. The gel was washed for a final time in ddH2O and 
imaged on the transilluminator. All experiments were completed in triplicate. 
2.5.2 Serum killing assay 
This protocol was adapted from Sarkar et al., 2014. The E. coli strains were 
grown overnight in LB at 37oC, 200 RPM (New Brunswick Scientific controlled 
environment incubator shaker). The cultures were washed twice in PBS and 
suspended to an OD600 of 0.8. 50 µl of each culture was mixed with 50 µl of 
human sera (Life Science Group) and incubated at 37oC for 90 minutes at 120 
RPM (New Brunswick Scientific controlled environment incubator shaker). This 
was serially diluted and plated on LB plates. As a control 50 µl of each culture 
was also mixed with 50 µl of heat inactivated serum, where the serum was 
incubated at 56oC for 30 minutes prior to the experiment. This was to ensure the 
complement cascade was inactivated. Samples were also mixed separately with 
50 µl of PBS and serially diluted. This experiment was performed in triplicate. 






2.5.3 K1 bacteriophage titre and plaque assay 
E. coli strains were grown in LB at 37oC, 200 RPM for 16 hours (New Brunswick 
Scientific controlled environment incubator shaker). The strains were diluted 
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1/100 in M9 minimal media and grown until an OD600 of 0.6 was reached. 100 µl 
of bacterial culture was added to 3 ml of warm PTA agar, spread onto PB plates, 
and allowed to dry. Serial dilutions of K1 bacteriophage (SSI Diagnostica) were 
done in phage buffer and 10 µl of each dilution was spotted onto the plates in 





Plaque size was also measured using ImageJ software (Fiji). All experiments 
were completed in triplicate. 
2.5.4 K1 bacteriophage killing assay 
For the bacteriophage killing assay, E. coli strains were grown in LB at 37oC, 200 
RPM for 16 hours (New Brunswick Scientific controlled environment incubator 
shaker). The strains were diluted 1/100 in M9 minimal media in a 96 well 
microplate and grown for 3 hours in a humidity chamber at 37oC, 200 RPM (New 
Brunswick Scientific Innova 44 incubator shaker series). 1 µl of K1 phage (SSI 
Diagnostica) was added to the strains and the OD600 was measured every 30 
minutes or hour for 3 hours using a FLUOstar Optima plate reader (BMG 
Labtech). All experiments were completed in triplicate. 
2.6 In vitro cell infection models and microscopy 
2.6.1 HeLa cell culture maintenance 
HeLa cell lines were cultured and maintained in Dulbecco’s Minimal Eagles 
Medium (DMEM), containing 20% (v/v) FBS (foetal bovine serum) and 20 mM L-
glutamine, at 37oC, 5% CO2. Cells were cultured in T75 vented flasks and kept 
until passage 25. The cells were split after the flasks had reached 80% 
confluency. For splitting, 2 ml of Trypsin-EDTA was added to the flasks and left 
at 37oC, 5% CO2 for 5 minutes. 8 ml of pre-warmed DMEM media was added to 
the flasks and the cells were removed from the flask. Cells were counted using a 
haemocytometer. 
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2.6.2 Infection assays on HeLa cell lines 
For the genotoxin assays on the HeLa cell lines, 24-well tissue culture plates 
were coated in a 0.5% (v/v) collagen for 30 minutes prior to seeding. The 
collagen solution was removed, and the cells were washed once with PBS. 
40,000 cells were seeded per well and left for 24 hours, at 37oC, 5% CO2 to form 
a confluent monolayer. The Nissle strains were grown in minimal essential 
medium, HEPES modification (MEM-HEPES) media, with or without 1 mM D-serine 
for 4.5 hours at 200 RPM, 37oC and normalised to an OD600 of 0.1 (New Brunswick 
Scientific Innova 44 incubator shaker series). For an MOI of 400; 200 µl of 
bacteria was added to each well, with 300 µl of MEM-HEPES, supplemented with 
1% (v/v) L-glutamine. The cells were centrifuged at 200 g for 2 minutes and 
incubated for 4 hours at 37oC, 5% CO2. The cells were washed once with PBS and 
the media replaced with MEM-HEPES, supplemented with 1% (v/v) L-glutamine 
and 50 µg/ml gentamicin. The cells were incubated for a further 4 hours at 37oC, 
5% CO2. 100 µl of 1X sample buffer (Table 2-16) was added to each well and left 
for 5 minutes. The cells were removed and boiled for 10 minutes for Western 
blot analysis (2.4.6). To visualise the genotoxic effect on the host cells via 
Western blotting, phosphorylated Histone H2A.X (Cell Signalling Technologies) 
antibodies were used. 
Additionally, cells were also used in immunofluorescence microscopy to visualise 
genotoxic effects. The infection was carried out as above, with some minor 
changes. The cells were seeded at 40,000 cells per well onto 0.5% (v/v) 
collagen-coated coverslips and left for 24 hours at 37oC, 5% CO2 to form a 
confluent monolayer. The Nissle strains were grown in MEM-HEPES, with or 
without 1 mM D-serine for 4.5 hours at 200 RPM, 37oC and normalised to an OD600 
of 0.1 (New Brunswick Scientific Innova 44 incubator shaker series). For an MOI 
of 400; 200 µl of bacteria was added to each well, with 300 µl of MEM-HEPES, 
supplemented with 1% (v/v) L-glutamine. The cells were centrifuged at 200 g for 
2 minutes and incubated for 4 hours at 37oC, 5% CO2. The cells were washed 
once with PBS and the media replaced with MEM-HEPES, supplemented with 1% 
(v/v) L-glutamine and 50 µg/ml gentamicin. The cells were incubated for a 
further 48 hours at 37oC, 5% CO2. The cells were washed twice with PBS and 250 
µl of 4% paraformaldehyde (PFA) (w/v) was added to each well and left for 20 
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minutes. The cells were washed three times with PBS and 250 µl of 0.1% Triton 
X-100 was added to each well and left for 5 minutes. Host cell actin was stained 
with AlexaFluor-555 Phalloiden (Invitrogen), which was added to each well and 
left to rock in darkness for 1 hour. The cells were washed again three times with 
PBS and the coverslips were mounted onto 4 µl of VECTASHIELD (Vector 
Laboratories) on microscope slides. These were left to dry for a few minutes and 
secured using clear nail varnish. Slides were imaged on a Zeiss M1 Axioskopp 
microscope and deconvolved using Zen Pro software. 
2.6.3 hCMEC/D3 cell culture maintenance 
hCMEC/D3 (Merck), the blood-brain barrier cell line, were cultured and 
maintained in hCMEC/D3 ENDOGro-LS Complete medium (Merck), containing 
ENDOGro Basal Medium, ENDOGro-LS Supplement (0.2% v/v), rh epidermal 
growth factor (5 ng/ml), ascorbic acid (50 µg/ml), L-glutamine (10 mM), 
hydrocortisone hemisuccinate (1 µg/ml), heparin sulfate (0.75 U/ml), FBS (2% 
v/v), and recombinant human fibroblast growth factor (1 ng/ml). A 1:20 
Collagen T1 Rat Tail (Sigma) solution was used to coat the T75 flasks prior to 
seeding. Cells were cultured in T75 vented flasks, at 37oC, 5% CO2 and kept until 
passage 10. For splitting, 2 ml of Trypsin-EDTA was added to the flasks and left 
at 37oC, 5% CO2 for 5 minutes. 8 ml of pre-warmed hCMEC/D3 ENDOGro-LS 
Complete media was added to the flasks and the cells were removed. Cells were 
counted using a haemocytometer. 
2.6.4 Adhesion and invasion assays on hCMEC cell 
lines 
For the adhesion and invasion assays on the hCMEC cell lines; 24-well tissue 
culture plates were coated in a 0.5% (v/v) collagen solution for 1 hour prior to 
seeding and kept at 37oC. The collagen solution was removed, and wells were 
washed once with PBS. 40,000 cells were seeded per well and left for 24 hours 
to form a confluent monolayer. The CE10 strains were grown in M9 minimal 
media for 5 hours, with or without the addition of 1 mM D-serine spiked in at 
hour 3, at 37oC, 200 RPM, and normalised to an OD600 of 0.1 (New Brunswick 
Scientific Innova 44 incubator shaker series). For an MOI of 100; 50 µl of bacteria 
was added to each well with 450 µl of hCMEC/D3 ENDOGro-LS Complete media. 
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The cells were centrifuged at 200 g for 2 minutes and incubated for 2 hours at 
37oC, 5% CO2. 
For the adhesion assay, the cells were washed three times with 500 µl of PBS, 
with the washes kept to serially dilute in PBS and calculate the CFU/ml. 300 µl 
of 1% Triton X-100 was added to the wells and left for 5 minutes. The cells were 
removed from the wells and serially diluted in PBS and the CFU/ml was 
calculated. Bacterial counts were analysed in GraphPad Prism 8. 
For the invasion assay, the cells were washed three times with 500 µl of PBS, 
with the washes kept to serially dilute in PBS and calculate the CFU/ml. 500 µl 
of hCMEC/D3 ENDOGro-LS Complete media with 100 µg/ml of gentamicin was 
added to the cells and left to incubate at 37oC, 5% CO2 for a further hour. 300 µl 
of 1% Triton X-100 was added to the wells and left for 5 minutes. The cells were 
removed from the wells and serially diluted in PBS and the CFU/ml was 
calculated. Bacterial counts were analysed in GraphPad Prism 8. 
2.7 Bioinformatic analysis 
2.7.1 Bioinformatic analysis and databases used 
DNA and protein sequences were obtained using NCBI. Multiple sequence 
alignments were done using NCBI BLAST 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) or Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/). Venny 2.1.0 was used for Venn 
diagram analysis (https://bioinfogp.cnb.csic.es/tools/venny/). Reverse 
Complement was used to convert a DNA sequence into its reverse complement 
(https://www.bioinformatics.org/sms/rev_comp.html). Bioline was used for six-
frame translation of nucleotide sequences 
(https://www.bioline.com/media/calculator/01_13.html). SnapGene was used 
to visualise plasmid maps and restriction cloning. GraphPad Prism 8 was used to 
create diagrams. Figures were made using Microsoft PowerPoint. 
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2.7.2 ChIP-Seq and RNA-Seq bioinformatic analysis 
ChIP and RNA-Seq analysis was carried out on CLC Genomics Workbench 7 (CLC 
Bio). Functional characteristics were assigned to predicted targets using 
UniPROT Knowledgebase and the GO functions (https://www.uniprot.org). MEME 
was used to predict DNA-protein binding motifs (https://meme-
suite.org/meme/). 
2.7.3 Statistical analysis 
Statistical analysis was carried out on GraphPad Prism unless stated otherwise. 
For analysis between 2 samples, an unpaired Student t-test was used. RT-qPCR 
analysis was computed using CFX-Connect BIORAD software, according to the 2-
DDCT method.
87 
Chapter 3 Investigating the global binding of 
DsdC and its role on gene expression in 




The capacity to utilise different carbon sources contributes to the ability of 
ExPEC to thrive in niches of the body that are otherwise less favourable. D-
serine is a host metabolite present in the body, particularly in the urinary tract 
and the brain. Recent works have described the numerous ways in which D-
serine can affect the physiology of many bacteria, including inhibiting the 
formation of the T3SS in EHEC, inhibiting adherence and biofilm production in 
MRSA and contributing to the increased fitness of P. mirabilis in catheter-
associated UTIs (Brauer et al., 2019; Connolly et al., 2015; Iwata et al., 2021). 
DsdC is a LTTR that regulates the D-serine metabolism locus in E. coli by 
upregulating the dsdXA operon whilst negatively autoregulating itself 
(Nørregaard-Madsen et al., 1995). The dsdCXA locus is important for ExPEC, with 
344 out of 427 strains from the B2 clade positively carrying the dsdCXA locus 
(Connolly et al., 2015). Moreover, E. coli K1 strains often carry two unlinked 
copies of dsdCXA, with 73% of 41 K1 strains carrying two copies; thus highlighting 
the importance of D-serine metabolism to these strains (Moritz & Welch, 2006). 
DsdC is therefore a highly conserved transcription factor in ExPEC strains, 
although strikingly it has been lost in many InPEC strains. A recent study showed 
that concurrent carriage of the LEE and dsdCXA was a rare occurrence in E. coli, 
with only 1.6% of 1,591 strains tested carrying both, suggesting a genetic 
‘incompatibility’ between the two loci (Connolly et al., 2015). Indeed, D-serine 
inhibits the formation of the T3SS, a key virulence determinant of EHEC and 
EPEC strains, providing a powerful selective pressure to lose dsdCX in these E. 
coli pathotypes (Connolly et al., 2015). 
DsdC is known to autoregulate itself and the dsdXA operon. However, any wider 
regulatory functions are currently unknown. This work therefore aimed to 
identify whether DsdC regulated genes beyond the dsdCXA locus and whether 
exposure to D-serine led to any global effects on regulation in two clinically 
important ExPEC strains, CFT073 and CE10. CFT073 and CE10 are two prototypic 
UPEC and NMEC strains respectively and were selected due to their carriage of 
the dsdCXA operon and thereby their ability to metabolise D-serine. Although 
they are both ExPEC, they utilise distinct mechanisms to infect and persist 
within the host. 
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CFT073 is a highly virulent UPEC strain that was isolated from a patient with 
acute pyelonephritis (Mobley et al., 1990). Previous reports have indicated that 
D-serine may influence pathogenesis of CFT073, with a DdsdA mutant reportedly 
showing “hypercolonisation” and “hypermobility” in comparison to the WT 
(Roesch et al., 2003). However, further research revealed these “hyper” 
phenotypes were due to an unrecognised secondary mutation in rpoS, rather 
than the DdsdA mutation (Hryckowian et al., 2015). Nonetheless, D-serine 
remains an important factor for UPEC colonisation, with expression of dsdA and 
dsdX increasing 2.4-8.3-fold and 7.4-7.8-fold respectively in UPEC strain 83972 in 
vivo (Roos & Klemm, 2006).  
CE10 is a K1 NMEC strain that was isolated from the CSF of a patient with 
meningitis (Yao et al., 2006). Like many K1 NMEC strains, CE10 carries two 
unlinked copies of the dsdCXA locus. It has been hypothesised that NMEC may be 
able to use D-serine as a carbon source for growth in the brain or as an 
environmental signal for gene expression (Moritz & Welch, 2006). Indeed, it has 
recently been shown that D-serine affects the transcriptome of CE10, causing 
differential expression of 55 genes and intriguingly repressing genes involved in 
acid tolerance (Connolly et al., 2021). This work aimed to understand whether 
both copies of the NMEC CE10 DsdC were homologous in functionality. This 
chapter sought to address these questions by characterising the roles of CFT073 
DsdC and CE10 DsdC1 and DsdC2. ChIP-Seq and RNA-Seq experiments were used 
to assess the global binding and the transcriptional response of CFT073 and CE10 
DsdC in the presence and absence of D-serine. 
3.2 DsdC and D-serine metabolism 
3.2.1 Structural differences of DsdC 
As with many NMEC K1 isolates, CE10 is interesting as it carries two copies of the 
dsdCXA locus. As it is yet unknown why CE10 carries two copies, the differences 







Figure 3-1 Multiple sequence alignments of the amino acid sequence of CFT073 and CE10 DsdC.
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Figure 3-1 Multiple sequence alignments of the amino acid sequence of 
CFT073 and CE10 DsdC. The sequence for CFT073 DsdC was downloaded from 
NCBI Reference Sequence: NC_004431.1; protein ID WP_001327519.1. For CE10 
DsdC1 and DsdC2, the sequences were downloaded from the GenBank file 
CP003034.1; protein ID AEQ13502.1 and AEQ14956.1 respectively. (A) The 
multiple sequence alignment of CFT073 DsdC vs CE10 DsdC1, CFT073 DsdC vs 
CE10 DsdC2, and CE10 DsdC1 vs CE10 DsdC2, using NCBI Protein BLAST with the 
standard parameters used. This was visualised using NCBI Multiple Sequence 
Alignment Viewer 1.20.0 with the colouring reflecting Rasmol Amino Acid 
colours. Each amino acid is rendered in a different colour. (B) The multiple 
sequence alignment of CFT073 DsdC, CE10 DsdC1 and CE10 DsdC2 was generated 
on Clustal Omega (EMBL-EBI). Grey shading indicates differences in amino acid 
sequence. 
Figure 3-1 shows the multiple sequence alignments of CFT073 DsdC and CE10 
DsdC1 and DsdC2. This analysis revealed that the amino acid sequence of the 
three DsdCs were highly conserved, with few differences between them. Indeed, 
a protein BLAST confirmed that DsdC was highly conserved with >98% percentage 
identity, as presented in Table 3-1. 













98 0 98.38 
Table 3-1 Amino acid sequence homology between the DsdCs. Data derived 
from the NCBI protein BLAST. Query cover is the percentage of the sequences 
aligned, E-value is the Expect value which describes the number of hits expected 
to be seen by chance, and percentage identity is the extent of which two amino 
acid sequences are similar. 
However, there were a few differences between the amino acid sequences. 
Figure 3-1(B) indicated that there was a small cluster of differences between 
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codon 182 and 199, and differences towards the end of the gene. Using Pfam 
(EMBL-EBI), DsdC was modelled to visualise the predicted domains of a classical 
LTTR. 
 
Figure 3-2 Visualisation of the predicted domains of DsdC. Using the CE10 
DsdC1 amino acid sequence, UniProt entry A0A0E0V7F3, a Pfam model was 
generated to predict the HTH DNA binding domain and the predicted LysR 
substrate binding domain on CE10 DsdC1. E-values of these domains were 4.2e-
16 and 3.5e-25 for the HTH and substrate binding domain respectively. E-values 
are based upon searching the Pfam-A family against UniProtKB using hmmsearch 
(Pfam version 34.0; EMBL-EBI). The data was visualised and exported from 
SnapGene. 
Based upon the data obtained in Figure 3-2, it appeared that the differences in 
the amino acid sequence between CE10 DsdC1, DsdC2 and CFT073 DsdC were in 
the predicted substrate binding domain. As they were clustered closely 
together, the difference in amino acids has potentially caused a change in the 
tertiary structure, thus potentially altering the properties of the co-inducer 
binding pocket. Theoretically, this could enable a different substrate to bind to 
the TF. Table 3-2 shows the amino acid changes between CE10 DsdC1 and DsdC2. 
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CE10 DsdC1 CE10 DsdC2 
Amino acid Chemical property Amino Acid Chemical property 
Tyrosine (Y) Polar uncharged 
(also hydrophobic) 
Asparagine (N) Polar uncharged 




Glutamine (Q) Polar uncharged Threonine (T) Polar uncharged 
Arginine (R) Positive electronic 
charge 
Serine (S) Polar uncharged 
Table 3-2 Differences between the amino acid sequences in the substrate 
binding domain. The differences in amino acids and their chemical properties 
between CE10 DsdC1 and DsdC2 in the substrate binding domain. 
The main differences highlighted in Table 3-2 were the changes between alanine 
(hydrophobic) to aspartic acid (negatively charged) and arginine (positively 
charged) to serine (uncharged). The chemical properties of amino acids can 
affect the folding of proteins. Hydrophobic amino acids are often buried within 
the core of the protein, whereas polar uncharged amino acids are often 
hydrophilic, clustering at the surface of a protein. The changes between the 
CE10 DsdC1 and DsdC2 structures may therefore result in a difference in the 
folding of the tertiary protein structure. 
3.2.2 The role of DsdC in D-serine metabolism 
Previous work by McFall and colleagues demonstrated that the transcriptional 
regulator DsdC was needed for D-serine metabolism in the laboratory E. coli 
strain K12 (Heincz et al., 1984; Nørregaard-Madsen et al., 1995). As CE10 
contains two copies of this transcriptional regulator, both copies were assessed 
for functionality in D-serine metabolism. Furthermore, deletion of the regulator 






Figure 3-3 Growth profiles of WT and DdsdC in M9 minimal media 
supplemented with D-serine. Growth curves of CFT073 (A) and CE10 (B) in M9 
minimal media supplemented with 1 mM of D-serine, measured as OD600 over 
time. Growth curves shown represent mean values of triplicate experiments with 
error bars indicating standard error of the mean (SEM). 
Qualitative assessment of Figure 3-3(A) revealed that deletion of the regulator 
did not affect the growth of CFT073. This was the same for CE10 in Figure 3-
3(B), where deletion of either the single regulators or the double regulator did 
not appear to impact growth. Figure 3-3(A) confirmed previous reports that DsdC 
was required for D-serine metabolism, with the CFT073 DdsdC mutant unable to 
grow in the presence of D-serine. Figure 3-3(B) showed that ΔdsdC1 and ΔdsdC2 
could both metabolise D-serine, whereas the double ΔΔdsdC1/2 mutant could 
not. There appeared to be no difference in the growth between ΔdsdC1 and 
ΔdsdC2 when D-serine was supplemented into the media. These results indicated 
that both DsdC1 and DsdC2 were functionally redundant in enabling metabolism 
of D-serine, and it also appeared that one was not dominant to the other. This 
was also shown using minimal media sole carbon source plates in which D-serine 
was the only carbon source present (Fig. 3-4). 
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Figure 3-4 Growth profiles of WT and ΔdsdC on sole carbon source plates. 
Growth on minimal media plates where the sole carbon source was 10 mM D-
serine. Depicting the characteristic growth profile of CFT073 (A) and CE10 (B) 
and isogenic mutants. 
Figure 3-4(B) showed that both ΔdsdC1 and ΔdsdC2 could metabolise D-serine on 
the sole carbon source plates, with each appearing to grow as effectively as the 
other. However, as expected, the double ΔΔdsdC1/2 could not grow. 
Furthermore, the growth phenotype was restored when dsdC1 and dsdC2 were 
transformed into pACYC184 and complemented back into the double ΔΔdsdC1/2 






Figure 3-5 Growth profiles of WT, DdsdC and DdsdC + pDsdC in M9 minimal 
media supplemented with D-serine. Growth curves of CFT073 (A) and CE10 (B) 
in M9 minimal media supplemented with 1 mM of D-serine, measured as OD600 
over time. Growth curves shown represent mean values of triplicate experiments 
with error bars indicating the SEM. 
Qualitative assessment of Figure 3-5 revealed that when pDsdC was 
complemented back into the mutant, the growth phenotype was almost restored 
to WT levels in both CFT073 (A) and CE10 (B), although there was a slight growth 
lag. Nonetheless, pDsdC1 and pDsdC2 both appeared to grow comparably when 
complemented back into the double mutant ΔΔdsdC1/2. This data correlated 
with previous reports that DsdC is essential in both CFT073 and CE10 for the 
metabolism of D-serine, with the complementation of pDsdC restoring growth. 
Furthermore, the results indicated that DsdC1 and DsdC2 appear to be 
functionally redundant with regard to D-serine metabolism. 
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3.3 Growth conditions and native expression of DsdC 
3.3.1 Experimental design and growth conditions for 
the ChIP and RNA-Seq 
Based on previous data from the Roe laboratory, it was established that the 
ChIP-Seq experiment would be performed under conditions matching an existing 
RNA-Seq experiment. Bacterial strains were grown in M9 minimal media for 3 
hours at 37oC, 200 RPM. A subset was spiked with 1 mM D-serine, and all samples 
were grown for a further 2 hours at 37oC, 200 RPM. These experiments were 
designed to test the direct and indirect regulatory response of DsdC in relation 
to D-serine exposure. These conditions were chosen to limit the toxic effects 
that occurs within the DdsdC strains when D-serine is added to the samples at 





Figure 3-6 Growth profiles of WT and DdsdC in M9 minimal media spiked with 
D-serine. Growth curves of CFT073 (A) and CE10 (B) in M9 minimal media spiked 
with 1mM of D-serine at hour 3, measured as OD600 over time. Growth curves 
shown represent mean values of triplicate experiments with error bars indicating 
SEM. 
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Qualitative assessment of Figure 3-6 revealed when D-serine was spiked into 
CFT073 WT and ΔdsdC mutant at hour 3 (Fig. 3-6A), there was a slight growth 
defect. This growth defect was also present in CE10 (Fig. 3-6B), although not to 
the same extent. The growth in CE10 and ΔΔdsdC1/2 mutant was restored to 
that of the samples which had no additional D-serine by hour 6. CFT073 and 
CE10 were both sampled at hour 5, during the logarithmic growth phase of the 
bacteria, when cell uniformity is most likely. 
3.3.2 Native expression of DsdC 
To establish if DsdC was being expressed at the time point chosen for the ChIP-
Seq, the native expression of DsdC was analysed for CFT073 and CE10, in the 
presence and absence of D-serine. All copies of DsdC were chromosomally FLAG-
tagged to ensure only the native levels of expression were observed. These were 
then qualitatively assessed to ensure that the DsdC-FLAG tagged strains grew 





Figure 3-7 Growth profiles of WT and DsdCFLAG mutants in M9 minimal media, 
spiked with D-serine. DsdCFLAG tagged E. coli were assessed in M9 minimal 
media to ensure growth was similar to the non-FLAG tagged WT, measured as 
OD600 over time. This was performed with and without addition of 1 mM D-serine 
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at hour 3 for CFT073 (A) and CE10 (B). Growth curves shown represent mean 
values of triplicate experiments with error bars indicating SEM. 
No qualitative differences were observed in growth between WT and DsdCFLAG 
tagged strains (Fig. 3-7), indicating that engineering the FLAG tag to DsdC had 
had no impact upon growth. The native expression of DsdC was then analysed 
using SDS-PAGE and Western blot analysis (Fig. 3-8). 
 
Figure 3-8 The native protein expression of DsdC in CFT073 and CE10. 
Western blot analysis of DsdCFLAG expression from whole cell lysate of CFT073 
and CE10 at the time point hour 5, in the presence and absence of D-serine, 
cultured in M9 minimal media. CFT073 and CE10 WT were used as negative 
controls. CFTC represents CFT073DsdC-FLAG, CE10C1 represents CE10DsdC1-FLAG, and 
CE10C2 represents CE10DsdC2-FLAG This figure is representative of 3 separate 
experiments. 
Western blot analysis revealed the relatively low abundance of CFT073 DsdC, in 
comparison to CE10 DsdC1 and DsdC2, in both the presence and absence of D-
serine (Fig. 3-8). This finding potentially indicates that there are different 
regulatory mechanisms that control DsdC expression between the two strains. 
Western blot analysis also revealed that there was no difference in expression 
between DsdC1 and DsdC2, suggesting that there was no preferential favour to 
either DsdC1 or DsdC2 in the cell. When D-serine was spiked into the samples, it 
caused expression of all three DsdCs to increase, which correlates with previous 
findings. As a control, anti-DnaK antibody and Ponceau stain was used to ensure 
normal housekeeping expression and no differential loading of samples. In 
addition to investigating the native protein expression of DsdC at hour 5, the 
transcriptional levels of dsdC were also analysed. 
 100 
 
Figure 3-9 RT-qPCR fold change levels of dsdC in response to D-serine. RT-
qPCR analysis of the transcriptional fold change levels of CFT073 dsdC, CE10 
dsdC1 and CE10 dsdC2, with * denoting significance of p-value £0.05. The purple 
dashed line indicates the baseline expression of dsdC at hour 5. (A) CFT073 dsdC 
with a fold change of 2.46 and a p-value of 0.00027. (B) CE10 dsdC1 with a fold 
change of -1.24 and a p-value of 0.9. (C) CE10 dsdC2 with a fold change of -1.63 
and a p-value of 0.7. 
Figure 3-9 indicated that for CE10 dsdC1 and dsdC2, there was no significant 
difference in gene expression between the addition or absence of D-serine at 
hour 5, suggesting that dsdC expression had reverted to basal levels. Conversely, 
CFT073 dsdC was shown to be significantly upregulated when D-serine was 
spiked in (2.46-fold higher; p-value 0.0002). This suggests that potentially DsdC 
is regulated differently between the two strains, as both transcriptionally and 
translationally they function differently. 
3.4 The global binding profile of CFT073 DsdC and CE10 
DsdC1 and DsdC2 
Until 2007, TF studies were limited to a small number of genetic locations, 
usually based upon prior knowledge of where a TF would be likely to be bound. 
However, with the advent of ChIP-Seq it is now possible to map protein-DNA 
interactions in an unbiased, high-throughput manner across the whole genome 
(Barski et al., 2007; Johnson et al., 2007; Mikkelsen et al., 2007; Robertson et 
al., 2007). To assess natively where DsdC was binding on the ExPEC genomes, 
DsdCFLAG tagged strains were genetically engineered and a ChIP-Seq experiment 
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performed. The conditions used for the ChIP-Seq experiment were performed to 
correlate with a previous RNA-Seq experiment and are described in Figure 3-10. 
 
 
Figure 3-10 Graphical representation of the ChIP aspect of ChIP-Seq. 2 
biological replicates of the DsdCFLAG tagged strains were grown in M9 minimal 
media for 3 hours, 200 RPM at 37oC. 1 mM of D-serine was added to a subset of 
the samples and the samples were incubated for a further 2 hours. Proteins were 
then cross-linked to the DNA using formaldehyde and the DNA was sheared into 
200-300 bp fragments by sonication. The DNA fragments bound by DsdC were 
immunoprecipitated out and the cross-links were reversed. The isolated DNA was 
then sent for Illumina sequencing. A non-FLAG tagged WT was used as a mock 
ChIP control. 
Once the chromatin was immunoprecipitated and cross-links reversed, the 
samples were sent for library preparation and Illumina Next Generation 
sequencing at Glasgow Polyomics, performed by Julia Galbraith. The reads were 
quality controlled (QC) checked, uploaded onto CLC Genomics Workbench 7 and 
mapped against the CFT073 and CE10 reference genomes; NCBI accession 
numbers NC_004431.1 and CP003034 respectively. The Transcription Factor 
ChIP-Seq tool was then used to analyse the genomic coverage of the reads, 
 102 
identifying a set of positive regions with very apparent peaks. The mock ChIP 
experiment was used as a negative example for the software. Once the positive 
and negative regions were identified, the software builds a filter which was used 
to identify other genomic regions, of which the read coverage profile matches 
the characteristic peak shape (Fig. 3-11). Figure 3-12 shows the peak shapes 
generated for CFT073DsdC FLAG, CE10DsdC1-FLAG and CE10DsdC2-FLAG tagged samples. 
 
Figure 3-11 Canonical ChIP-Seq peak shape. The canonical peak shape of a 
transcription factor based upon the Hotelling Observer filter used in CLC 
Genomic Workbench 7 (QIAGEN). The green line indicates the forward read and 
the red line indicates the reverse read. Figure adapted from CLCBio (QIAGEN). 
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Figure 3-12 Peak shape filter score for CFT073DsdC-FLAG, CE10DsdC1-FLAG and 
CE10DsdC2-FLAG. The blue and black lines represent the ChIP forward and reverse 
strands respectively, whilst the red and aqua lines represent the mock ChIP 
control forward and reverse sample respectively. This shape should give the 
classical bimodal peak that genuine ChIP peaks must adhere to. (A) Peak shape 
filter score for CFT073DsdC-FLAG with D-serine; (B) CE10DsdC1-FLAG with D-serine; (C) 
CE10DsdC2-FLAG with D-serine. This data was obtained from CLC Genomics 
Workbench 7 (QIAGEN). 
The CFT073 peak shape filter scores observed in Figure 3-12 represented the 
canonical TF peak shape that genuine TF peaks must adhere to. However, the 
CE10 peak shape score appeared to be slightly broader in frame. Subsequently, 
the peaks were manually checked to look at the binding profiles. Interestingly, 
two distinct peak shapes emerged from the ChIP-Seq data (Fig. 3-13). The first 
peak shape (Fig. 3-13A/C/E) was the canonical TF peak shape, whereas the 















Figure 3-13 Expanded view of ChIP-Seq peaks from CE10. An expanded view of the ChIP-Seq peaks from CE10DsdC1-FLAG and CE10DsdC2-
FLAG highlighting the differences in binding patterns. (A, C and E) show the canonical ChIP TF binding peak. (B, D and F) show a broader 
peak encompassing small sections of the genome.
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Due to the high number of false positives associated with ChIP-Seq, peaks called 
by the software were manually checked until there were 10 in a row that did not 
conform to the canonical TF shape. Table 3-3 shows the number of ChIP-Seq 
peaks called by the CLC software, and after manual inspection the number of 
peaks that were deemed to be “true” binding peaks (data listed in 
Supplementary Table S1-6). 





Number of “true” ChIP-
Seq peaks 
CFT073DsdC-FLAG 375 88 
CFT073DsdC-FLAG + 1mM D-
serine 
1,115 129 
CE10DsdC1-FLAG 7,001 95 
CE10DsdC1-FLAG + 1mM D-
serine 
5,724 217 
CE10DsdC2-FLAG 4,820 140 
CE10DsdC2-FLAG + 1mM D-
serine 
5,498 177 
Table 3-3 Analysis of the ChIP-Seq peaks called from the CLC ChIP-Seq 
analysis software. The number of statistically significant peaks (p-value £0.05) 
called using CLC and a summary of the potential “true” direct binding sites of 
DsdC that was established after manual inspection of the ChIP-Seq data. 
As Table 3-3 shows, the CLC software predicted >250 peaks for CFT073DsdC-
FLAGand >1,000 peaks for CE10DsdC1-FLAG and CE10DsdC2-FLAG. Upon manual inspection 
however, many of these were deemed false positives and the number of “true” 
DsdC binding peaks ranged between 88 and 217 peaks. These results indicated 
that DsdC was more than just the transcriptional regulator for D-serine 
metabolism and that it was significantly binding to multiple regions across the 
genome. 
3.4.1 Genome wide binding of DsdC 
Using the ChIP-Seq data, the global binding profile of DsdC was overlayed onto 











Figure 3-14 The global binding profile of CFT073DsdC-FLAG, CE10DsdC1-FLAG and CE10DsdC2-FLAG.
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Figure 3-14 The global binding profile of CFT073DsdC-FLAG, CE10DsdC1-FLAG and 
CE10DsdC2-FLAG. The global binding profile of the genomic regions bound by DsdC. 
Significant peaks (p-value £0.05) of interest are labelled above each track map 
in black. (A) CFT073DsdC-FLAG ChIP-Seq peak score in the presence and absence of 
D-ser; (B) CE10DsdC1-FLAG ChIP-Seq peak score in the presence and absence of D-
ser; (C) CE10DsdC2-FLAG ChIP-Seq peak score in the presence and absence of D-ser. 
Analysis of Figure 3-14 indicated that the DsdC peaks were distributed across the 
whole genome, and that DsdC was not solely binding in a single region. These 
results indicated that DsdC could potentially be a global regulator, and was not 
just acting locally on the dsdCXA locus. The track maps of the ChIP-Seq peak 
scores (Fig. 3-14A-C) highlighted how similar the DsdC binding profiles were in 
the presence or absence of D-serine. Indeed, upon further analysis of the ChIP-
Seq data, it was revealed that there was no difference in binding patterns 
between presence and absence of D-serine in each of the data sets. Further, 
there was no difference in binding patterns observed between CE10 DsdC1 and 
DsdC2. Peaks that appeared to be unique to DsdC1 were in fact present in the 
DsdC2 sample, and vice versa, but had not made the “canonical” TF shape cut-
off. It is therefore likely that there was no real difference in binding sites 
between the two homologous TFs. Instead, any differences observed were likely 
to be due to experimental artefacts. In contrast, there were differences 
observed between the binding sites for DsdC in CE10 and CFT073, indicating for 
the first time that there was strain-specific regulation mediated by DsdC. 
3.4.2 Functional characterisation of the ChIP-Seq hits 
and strain-specific binding of DsdC 
Functional analysis and characterisation was carried out on the ChIP-Seq hits. 
Genes with the 5’ end closest to the nearest associated ChIP binding peak were 
assumed to be the gene regulated by DsdC (Fig. 3-15). 
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Figure 3-15 Functionality of the genes predicted as direct binding targets of 
DsdC. Genes with 5’ ends closest to the nearest associated ChIP binding peak 
were functionally characterised using UniProtKB GO functional groupings 
(Bateman et al., 2021). Functional groups were broken down into broad 
categories such as metabolism and virulence associated genes for (A) CFT073DsdC-
FLAG + D-ser and (B) CE10DsdC1-FLAG + D-ser. 
Functional analysis of the genes predicted to be regulated by CFT073 DsdC 
revealed great insight into the potential roles of the TF. Indeed, 18% of the 
genes (24/129) that were bound were involved in transport or were membrane 
associated. These included genes such as pitB, a phosphate transporter; c5298, a 
hexuronate transporter; and garP, a galactarate transporter. Intriguingly, DsdC 
also bound to several virulence associated regions in CFT073: 7% of the genes 
(9/129) were associated with fimbriae production, including papA, fimE, and 
fimA, and 5% of the genes (7/129) were associated with LPS biosynthesis 
including rfaJ, waaL and waaV. These were segregated from the general 
‘virulence associated’ functional grouping to highlight the large abundance of 
genes within these categories. The remaining functional groups included genes 
involved in metabolism (15/129), other regulators (10/129), virulence associated 
(9/129), transcription and translation (5/129), electron transport (2/129), and 
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uncharacterised (48/129). These results illustrated that DsdC binds to a wide 
range of genes that are involved in multiple different functional mechanisms in 
CFT073, further indicating the possibility of DsdC as a global regulator. 
As the ChIP binding profiles had revealed no differences in binding pattern 
between CE10 DsdC1 and DsdC2, the data set of CE10DsdC1-FLAG + D-ser was used 
as a representative of the group. Gene ontology (GO) analysis revealed the 
largest functional group bound by DsdC was transport and membrane associated 
genes which accounted for 25% of the targets (55/217). These included genes 
such as fepE, a ferric enterobactin transporter; fucP, an L-fucose transporter; 
and feoA, a ferrous iron transporter. Further, DsdC was also shown to bind to 
genes involved in LPS and capsular biosynthesis (14/217), with targets such as 
neuO and neuB. The K1 capsule plays an essential role in NMEC pathogenicity 
and is encoded on the kps operon. This operon is not present in CFT073, 
potentially therefore alluding to strain-specific regulation by DsdC of a key 
virulence mechanism in CE10. The remaining functional groups included genes 
involved in metabolism (31/217), fimbriae (14/217), other regulators (27/217), 
virulence associated (17/217), transcription and translation (5/217), phage 
encoded (2/217), electron transport (3/217) and uncharacterised (49/217). 
These results all indicated a global role of DsdC in binding to the CE10 genome. 
Interestingly, the global binding and functional analysis of the ChIP-Seq results 
had revealed strain-specific binding of DsdC in CFT073 and CE10. Indeed, highly 
conserved TFs have recently been shown to be “repurposed”, uniquely 
controlling separate gene sets in different bacteria and tailoring gene regulation 
to suit strain-specific lifestyles (reviewed in O’Boyle et al., 2020). A comparison 
of the ChIP-Seq binding peaks between CFT073DsdC-FLAG and CE10DsdC1-FLAG, both in 
the presence of D-serine, was therefore made (Fig. 3-16; Supplementary Table 
7). NCBI BLAST was used to map gene sequences to the relevant reference 
genome for gene homology. 
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Figure 3-16 Strain-specific binding of DsdC. A Venn diagram highlighting the 
difference in binding sites between CFT073DsdC-FLAG and CE10DsdC1-FLAG, in the 
presence of D-serine. NCBI BLAST was used to assess homology of genes. Diagram 
made on Venny 2.1.0 (Oliveros, 2007). 
Figure 3-16 showed that 35% of targets (90 genes) predicted to be bound by DsdC 
were common to both CFT073 and CE10. Functional characterisation of the 
commonly bound genes revealed functions involved in both core processes of the 
cell such as metabolism and transport but also virulence associated genes, 
specifically LPS biosynthesis genes and putative fimbrial genes (Fig. 3-17). 
 
Figure 3-17 Functional analysis of common binding peaks between 
CFT073DsdC-FLAG and CE10DsdC1-FLAG. A graphical representation of the shared 
binding peaks and their associated gene functionality between CFT073DsdC-FLAG 
and CE10DsdC1-FLAG. 
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Notably however, there were differences between the data sets, with CE10 
DsdC1 uniquely binding to 127 regions of the genome, and CFT073 DsdC uniquely 
binding to 39, indicating that there was strain-specific binding by DsdC (Fig. 3-
16). Of the 39 putatively bound genes that were unique to the CFT073 data set, 
26 of these were specific to CFT073 and had no homology in CE10. The 13 other 
genes all had homology in CE10 and contained a peak in the CE10 data set; 
however, the peaks did not meet the peak threshold criteria. Therefore, only 
the 26 genes that were completely unique to CFT073 will be discussed (Fig. 3-
18A). 
 
Figure 3-18 Strain-specific functionality of DsdC binding sites. A graphical 
representation of the unique binding peaks and their associated gene ontology in 
(A) CFT073DsdC-FLAG and (B) CE10DsdC1-FLAG. 
Functional analysis revealed virulence associated genes were one of the largest 
functional groups in the unique CFT073 DsdC binding data set (4/26) and 
included the genes tssB and yheE. These genes are involved in the type 6 
secretion system (T6SS) and a putative type 2 secretion system (T2SS) 
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respectively. Both of these mechanisms are utilised by bacteria to secrete 
effector molecules into the host or neighbouring bacteria and are key virulence 
mechanisms. Furthermore, it was shown that DsdC also bound uniquely to clbR, 
the regulator of colibactin biosynthesis. Colibactin is a bacterial genotoxin 
produced by UPEC and has recently been associated with colorectal cancer in 
humans. The other genes uniquely bound by CFT073 DsdC were found to be 
involved in metabolism (2/26), transport and membrane associated (2/26), 
fimbriae (3/26), transcription and translation (2/26) and uncharacterised 
(12/26). These results indicated that DsdC bound uniquely to multiple genes, 
and strikingly to several virulence associated genes, indicating that DsdC has 
potentially been tailored in CFT073 strains. 
Of the 127 genes that were unique to the CE10 data set, 67 of these were 
specific to CE10, 25 had homology in CFT073 but no peak, and 35 had homology 
in CFT073 and had a peak but did not meet the peak threshold criteria (Fig. 3-
16). Therefore, only the 92 genes that appeared to be completely unique to 
CE10 will be discussed (Fig. 3-18B). Interestingly, many of the potential genes 
bound by CE10 DsdC were also found to be associated with virulence. Indeed, 
capsular and LPS genes (5/92), fimbriae genes (6/92) and general virulence 
associated genes (12/92) accounted for 26% of the unique CE10 hits. Notably, 
genes involved in the NMEC putative secondary T3SS ETT2, were shown to be 
bound by DsdC. This virulence factor is not carried by CFT073 (Ren et al., 2004) 
and again could indicate a role for DsdC in strain-specific regulation. The other 
genes found to be bound uniquely by CE10 DsdC were involved in metabolism 
(10/92), transport and membrane associated (19/92), other regulators (9/92), 
transcription and translation (2/92), phage encoded (2/92), electron transport 
(1/92), and uncharacterised (26/92). These results all indicate that DsdC has 
been tailored in ExPEC to mediate different regulatory pathways specific to 
individual strain requirements. 
3.4.3 Genomic context of DsdC binding 
Where on the genome a TF binds to, in relation to the 5’ end of a gene, can 
reveal a lot about the dynamics of the TF. Indeed, the canonical TF model is 
that TFs bind at the 5’ region of a gene, usually in intergenic non-coding regions. 
The genomic context of DsdC binding were therefore analysed (Fig. 3-19).
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Figure 3-19 Genomic context of ChIP-Seq binding hits. The position of the 
ChIP-Seq binding peak in terms of intergenic and intragenic regions of the 
genome for (A) CFT073DsdC-FLAG + D-ser and (B) CE10DsdC1-FLAG + D-ser. The distance 
(bp) of the ChIP-Seq binding peak position in relation to the start of the 5’ end 
of the gene for (C) CFT073DsdC-FLAG + D-ser and (D) CE10DsdC1-FLAG + D-ser. Raw data 
for figures are in Supplementary Table S1-6. 
Figure 3-19(A-B) shows the majority of the CFT073 and CE10 DsdC ChIP peaks 
were binding to intergenic regions of the genome, 81% and 74% respectively. 
However, there were peaks that were binding in ORFs, with 19% of the CFT073 
peaks (25/129) and 26% of the CE10 peaks (57/217) binding in intragenic regions. 
The distance of the binding peak, in relation to the 5’ end of the gene, was also 
analysed (Fig. 3-19C-D). As would be expected of a canonical TF, DsdC binds 
mainly at the 5’ end of the gene, with most peaks being in the 0 bp ‘bin’ away 
from the 5’ end. However, there was a vast range in binding site distance for 
DsdC, with 7 and 31 binding sites over 150 bp downstream of the 5’ end for 
CFT073 and CE10 respectively. A large proportion of the peaks were downstream 
to the 5’ end of the gene with 122 out of 127 CFT073 DsdC peaks and 198 out of 
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217 CE10 DsdC peaks fitting this description. These results all indicated that 
DsdC was binding as a classical TF, with the majority of peaks being intergenic 
and near the TSS of the gene. 
Further analysis of the ChIP-Seq data could be performed in relation to the DsdC 
binding motif. A binding motif is the common consensus sequence that a TF uses 
to recognise and bind to DNA. The generally accepted LTTR binding motif 
consists of a 13 bp sequence T-N11-A, although this can vary in base pair 
composition and length (Goethals et al., 1992; Maddocks & Oyston, 2008). 
Although ChIP-Seq maps DNA-TF interactions at a high resolution, this resolution 
is not high enough to map the TF binding motif (Wade, 2015), and therefore the 
MEME-Suite software was used to generate the DsdC binding motif (Bailey et al., 
2009). The 60 most significant predicted peaks of CE10DsdC1-FLAG + D-ser were 
used to generate the binding motif. The standard parameters were used in the 
MEME-Suite software with advanced options stating a motif minimum width of 11 
bp and maximum width of 27 bp. The software was to run until 10 motifs had 
been found. However, no significant binding motifs under these parameters were 
generated. As there had been two types of binding patterns observed in the 
ChIP-Seq data analysis, the search was refined using only the top 20 predicted 
binding regions that had a canonical peak shape. The same advanced options 
were used and three statistically significant predicted binding motifs were 
generated (Fig. 3-20). 
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Figure 3-20 Predicted DsdC binding motifs. Predicted DsdC binding motifs that 
were generated from the CE10DsdC1-FLAG + D-ser dataset using MEME-Suite. These 
binding motifs were statistically significant with E-values of (A) 5.5e-007, (B) 
1.2e-002, and (C) 3.3e-002. 
Figure 3-20 presents three predicted DsdC binding motifs generated from the 
ChIP-Seq data. The LTTR binding box is the consensus sequence T-N11-A, 
however, none of the motifs generated fit that consensus sequence. Conversely, 
Figure 3-20(A) predicts two T-N11-A sequences joined together and Figure 3-
20(C) predicts a consensus sequence of T-N24-A. Although these predictations are 
statistically significant, DNase I footprinting should be used to experimentally 
validate the binding motif. Together, the data presented here indicated that 
DsdC is a global TF, that binds in intergenic and intragenic regions across the 
genome. 
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3.5 Transcriptomic regulon of CFT073 DsdC and CE10 
DsdC1/2 
Although DsdC was shown to bind globally across the genome in the ChIP-Seq 
binding data, this did not demonstrate transcription of downstream genes. 
Indeed, direct binding of a TF does not necessarily equate to a transcriptional 
response. Global transcriptome profiling by RNA-Seq can identify the direct and 
indirect regulon of a given TF, revealing novel networks and pathways. 
Therefore, to determine whether DsdC was playing a direct regulatory role in 
CFT073 and CE10, a transcriptomics experiment was carried out, comparing the 
RNA levels between WT and mutant, in the presence and absence of D-serine. 
This was performed by Dr Nicky O’Boyle, as described in 2.3.7, with the 
conditions used represented in Figure 3-21. 
 
Figure 3-21 Conditions used in the RNA-Seq experiment. A graphical 
representation of the conditions used in the RNA-Seq experiment in CFT073 and 
CE10. Condition 1 examined the transcriptional changes between “WT vs. 
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DdsdC” (or DDdsdC1/2 for CE10). Strains were grown for 5 hours in M9 minimal 
media. Condition 2 examined the transcriptional changes between “WTD-ser vs. 
DdsdCD-ser” (or DDdsdC1/2D-ser for CE10). Strains were grown for 3 hours in M9 
minimal media, 1 mM of D-serine was added, and strains were grown for a 
further 2 hours. Condition 3 examined the transcriptional changes between 
“WTD-ser vs. DdsdC + pDsdAD-ser” (or DDdsdC1/2 + pDsdAD-ser for CE10). Strains 
were grown for 5 hours in M9 minimal media with 1 mM D-serine added in from 
the start. 
Figure 3-21 shows a graphical representation of the three conditions used in the 
RNA-Seq experiment. All conditions were performed in M9 minimal media, at 
37oC, 200 RPM. Condition 1 examined the transcriptional changes between “WT 
vs. DdsdC”. This pairwise comparison sought to reveal any roles of the TF DsdC 
in the absence of D-serine. Condition 2 examined the transcriptional changes 
between “WTD-ser vs. DdsdCD-ser”. This condition was chosen to show the role of 
DsdC in the presence of D-serine. The samples were spiked with 1 mM D-serine 
at hour 3, to minimise any toxic side effects of D-serine on the mutant as 
described in 3.2.2 and 3.3.1. Further, as there was the potential that D-serine 
accumulation, even after spiking at hour 3, could cause detrimental effects upon 
the mutant and affect changes in gene regulation, pDsdA was complemented 
into the DdsdC mutant (condition 3). As DsdA is the D-serine deaminase, this 
experimental condition would reveal the transcriptional changes between “WTD-
ser vs. DdsdCD-ser”, whilst theoretically minimising any potential D-serine 
accumulation side effects. 
3.5.1 DsdC differentially regulates genes in the 
presence and absence of D-serine 
The reads from the RNA-Seq experiment were quality assessed and mapped to 
the CFT073 and CE10 genome and plasmids (NCBI accession number: 
NC_004431.1, CP003034, CP003035, CP003036, CP003037, CP003038) using CLC 
Genomics Workbench 7. Differential expression was assessed using the empirical 
analysis of differential expression (EdgeR) with genes displaying absolute fold 
changes of ≥ 1.5; ≤ -1.5 and having a false-discovery rate corrected p-value of 
≤0.05 being considered. Pairwise comparisons were done using the three 
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conditions stated above (Fig. 3-21). This analysis was performed by Dr Nicky 
O’Boyle prior to this PhD commencing. Table 3-4 shows a summary of the total 
number of differentially expressed genes (DEGs). Full differential expression 
data is available on ENA under the accession numbers detailed in Chapter 2. 








No. of genes 
upregulated 
No. of genes 
downregulated 
CFT073 WT vs. 
DdsdC (condition 
1) 
47 29 18 
CFT073 WTD-ser vs. 
DdsdCD-ser 
(condition 2) 
1067 542 525 
CFT073 WTD-ser vs. 
DdsdC + pDsdAD-ser 
(condition 3) 
175 162 12 
CE10 WT vs. 
DDdsdC1/2 
(condition 1) 
82 42 40 
CE10 WTD-ser vs. 
DDdsdC1/2D-ser 
(condition 2) 
436 287 149 
CE10 WT + D-ser 
vs. DDdsdC1/2 + 
pDsdA1/2D-ser 
(condition 3) 
552 300 252 
Table 3-4 Summary of DEGs from the RNA-Seq experiment. A summary of the 
total number of DEGs from each pairwise comparison, and subdivided into 
number of DEGs upregulated and downregulated. Genes were classed as DEGs if 
they displayed absolute fold changes of ≥ 1.5; ≤ -1.5 and had a false-discovery 
rate corrected p-value of ≤0.05.
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Figure 3-22 Volcano plots of CFT073 RNA-Seq transcriptome data. This data 
displays the Log2 fold change in genes for the pairwise comparisons between (A) 
DdsdC compared to the WT; (B) DdsdC compared to the WT in the presence of 1 
mM D-serine; (C) DdsdC + pDsdA compared to the WT in the presence of 1 mM D-
serine. Significant DEG (p-value £0.05) are displayed in red, with the grey line 
indicating the p-value cut off for DEGs.
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Figure 3-23 Volcano plots of CE10 RNA-Seq transcriptome data. This data 
displays the Log2 fold change in genes for the pairwise comparisons between (A) 
DDdsdC1/2 compared to the WT; (B) DDdsdC1/2 compared to the WT in the 
presence of 1 mM D-serine; (C) DDdsdC1/2 + pDsdA1/2 compared to the WT in 
the presence of 1 mM D-serine. Significant DEG (p-value £0.05) are displayed in 
red, with the grey line indicating the p-value cut off for DEGs. 
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Table 3-4 displays the total number of DEGs from each pairwise comparison 
(visualised in the volcano plots; Fig. 3-22 and 3-23). Condition 1, “WT vs. 
DdsdC”, yielded the least amount of DEGs for both CFT073 and CE10, 47 and 82 
respectively. For CFT073, the fold changes of DEGs were relatively low, with all 
but 5 of the DEGs having fold changes ranging between >3 and <-3. The most 
upregulated DEG, purE, had a 3.07-fold change (p-value 7.61E-04), and the two 
most downregulated DEGs bar dsdC, c1089 and fruB, had a -6.97 (p-value 0.03) 
and -3.64-fold change (p-value 5.08E-04) (Fig. 3-22A). The low fold change was 
also reflected in the CE10 data, in which all but 5 of the DEGs had fold changes 
between >3 and <-3. The most upregulated DEG, artJ, was 4.32-fold higher (p-
value 5.31E-18) and the most downregulated DEG bar dsdC2, neuO, was -7.9-fold 
lower (p-value 1.66E-20) (Fig. 3-23A). Interestingly dsdC1 was not a DEG in the 
CE10 condition 1 dataset. These results indicated that, in the absence of D-
serine, DsdC is playing a limited role in gene expression in both CFT073 and 
CE10.  
Conversely, when D-serine was added to the experiment (condition 2), the 
number of DEGs increased vastly, to 1,067 and 436 in CFT073 and CE10 
respectively (Table 3-4; Fig. 3-22B and 3-23B). Furthermore, in condition 2, the 
fold changes observed were also more pronounced. In the CFT073 “WTD-ser vs. 
DdsdCD-ser”, the two most up-regulated genes, yhaU and glnK, had fold changes 
of 208.42 (p-value 2.76E-80) and 141.49 (p-value 6.33E-39), and the two most 
downregulated genes bar dsdC, c4437 and c1142, had fold changes of -22.35 (p-
value 0.04) and -22.18 (p-value 0.04). Indeed, 246 DEGs had fold changes 
ranging between >3 and <-3. This increase in fold change levels was also 
reflected in the “CE10 WTD-ser vs. DDdsdC1/2D-ser” transcriptomic comparison. 
The two most upregulated genes, ais and CE10_0081, had fold changes of 38.93 
(p-value 0.01) and 33.97 (p-value 0.01) and the two most downregulated genes 
bar dsdC2, rhaB and neuO, had fold changes of -24.76 (p-value 0.05) and -4.57 
(p-value 8.56E-10). These results indicated that in the presence of D-serine 
there is a greater transcriptional effect of DsdC in both CFT073 and CE10. 
Indeed, the differences in number of DEGs was substantial between absence and 
presence of D-serine. To rule out any potential adverse side effects that may 
have arisen from D-serine accumulation in the DdsdCD-ser mutant, and therefore 
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any potential changes to the transcriptome as a consequence, dsdA was 
transformed into pACYC184 and complemented into DdsdC (condition 3). 
Notably, there was a pronounced difference in the number of genes 
differentially expressed between the CFT073 “WTD-ser vs. DdsdC + pDsdAD-ser” 
data set, in comparison to “WTD-ser vs. DdsdCD-ser”; the number of DEGs dropped 
from 1,067 to 175. This result indicated that the majority of DEGs present in the 
“WTD-ser vs. DdsdCD-ser” pairwise comparison was likely due to D-serine 
accumulation and toxicity within the cells. The degree of fold change was also 
less pronounced with only 7 genes, including dsdA and dsdC having fold changes 
of >3 and <-3. The two most significant upregulated genes bar dsdA, yjiY and 
c0881 had fold changes of 41.57 (p-value 0) and 32.38 (p-value 9.42E-03), and 
the two most downregulated genes bar dsdC, c3818 and c5343 had fold changes 
of -4.6 (p-value 0.04) and -2.76 (p-value 0.03). When the two D-serine data sets 
were overlapped, there were 56 genes that were commonly differentially 
expressed, although only 6 of these were transcriptionally differentially 
expressed in the same direction: metL, bfr, yfiD, dsdC, c3149, and c2566. 
There was also a difference in the number of genes differentially expressed 
between the CE10 “WTD-ser vs. DDdsdC1/2 + pDsdA1/2D-ser” data set, in 
comparison to “WTD-ser vs. DdsdCD-ser”; the number of DEGs increased from 436 to 
552, with 38 of these DEGs having fold changes of >3 and <-3. The two most 
significant upregulated genes bar dsdA1 and dsdA2, gadE and yfiD had fold 
changes of 16.68 (p-value 1.45E-04) and 11.59 (p-value 8.38E-90). Notably, in 
this pairwise comparison dsdC2 was downregulated -210.52-fold (p-value 1.61E-
07), whereas dsdC1 was downregulated -36.41 (p-value 2.32E-03). The two most 
downregulated genes bar dsdC1 and dsdC2, CE10_4853 and mdtJ, had fold 
changes of -161.47 (p-value 2.44E-13) and -11.2 (p-value 7.77E-07). These 
results indicated that addition of pDsdA to DDdsdC1/2D-ser caused more 
differential gene expression, suggesting that overexpression of pDsdA put the 
cell under undue stress. When the two CE10 D-serine data sets were overlapped, 
this revealed 124 common DEGs, although only 30 of these were transcriptionally 
differentially expressed in the same direction (Table 3-5).
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 Condition 2 
CE10 WTD-ser vs. DDdsdC1/2D-ser 
Condition 3 
CE10 WTD-ser vs. DDdsdC1/2 + 
pDsdA1/2D-ser 
Fold change FDR p-value Fold change FDR p-value 
kpsT 3.03 2.08E-04 1.66 1.04E-04 
neuA 4.32 1.99E-06 2.01 1.11E-08 
neuB 6.93 9.96E-08 1.99 6.19E-09 
neuE 4.27 6.44E-04 3.1 3.41E-11 
neuC 6.57 1.99E-06 2.31 2.56E-11 
neuS 6.89 1.30E-04 3.98 2.71E-16 
neuO -4.57 8.56E-10 -8.15 5.07E-71 
papA2 2.46 6.43E-04 1.57 2.50E-03 
metQ 1.59 1.65E-04 2.5 5.03E-07 
wbbD 10.02 5.74E-04 1.98 2.00E-02 
wbbA 6.17 1.02E-03 1.98 2.00E-02 
rfaY 2.33 1.00E-02 1.73 8.36E-03 
wbbC 7.38 8.82E-05 2.12 1.35E-03 
wzx 7.6 2.05E-05 2.29 3.87E-04 
waaW 2.04 1.00E-02 1.88 1.67E-04 
waaT 2.31 1.30E-03 2.06 1.13E-05 
vioA 3.71 5.23E-04 2.25 1.48E-07 
waaV 2.12 3.00E-02 4.25 2.40E-10 
gudD 4.29 5.68E-06 1.68 2.00E-02 
hdhA 2.39 3.06E-03 1.64 3.07E-03 
metL 3.05 2.70E-09 1.55 6.10E-04 
metB 5.32 3.64E-19 1.7 3.93E-05 
CE10_1649 -2.9 1.77E-05 -3.17 3.31E-14 
repB 1.95 4.00E-02 1.59 2.19E-03 
gnsB 7.02 7.90E-06 2.69 6.58E-11 
dsdC2 -74.42 1.15E-05 -210.52 1.61E-17 
yjiY 21.21 2.55E-38 1.82 1.00E-02 
dppA 1.65 3.00E-02 1.53 6.36E-04 
CE10_1029 2.09 4.51E-03 1.51 8.11E-03 
CE10_3484 7.12 1.67E-07 2.54 6.15E-06 
Table 3-5 Commonality of DEGs between CE10 condition 2 and condition 3 
datasets. Fold change and FDR p-values for the 30 common genes that 
overlapped between the CE10 “WTD-ser vs. DDdsdC1/2D-ser” and “WTD-ser vs. 
DDdsdC1/2 + pDsdA1/2D-ser” pairwise comparisons. Genes that had an increase in 
fold change values are shown in green, and genes that had a decrease in red. 
GO analysis was used to assess the functionality of the DEGs for the pairwise 
comparisons. The combined datasets of condition 2 and condition 3 (“WTD-ser vs. 
DdsdCD-ser” and “WTD-ser vs. DdsdC + pDsdAD-ser”) were used. Figure 3-24 shows 
the up- and down-regulated genes for the pairwise comparisons in their 
functional groups as determined by UniProtKB.
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A Condition 1 DEGs 
CFT073 WT vs. DdsdC 
B Condition 2 + 3 combined DEGs 








Condition 1 DEGs 




Condition 2 + 3 combined DEGs 





Figure 3-24 Functional characteristics of the DEGs using the CFT073 and CE10 transcriptomic data. Genes that were differentially 
expressed (p-value £0.05) were characterised using GO analysis from UniProtKB into broad functional groups; (A) CFT073 WT vs. DdsdC; 
(B) combined gene list from condition 2 and 3 (CFT073 WTD-ser vs. DdsdCD-ser); (C) CE10 WT vs. DDdsdC1/2; (D) combined gene list from 
condition 2 and 3 (CE10 WTD-ser vs. DDdsdC1/2D-ser) 
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Figure 3-24 shows in the absence of D-serine, functional group patterns largely 
indicated that metabolism was one of the most affected functional groups. 
Indeed, in the CFT073 data set 15 of the 47 DEGs were involved in metabolism 
processes. Further functional analysis revealed DEGs involved in DNA replication 
(1/47), electron transport (2/47), ribosomal assembly (1), ribosomal proteins 
(6/47), stress response (3/47), transcriptional regulation (3/47), transport and 
membrane associated (9/47), virulence associated (1/47), and uncharacterised 
(6/47). This was also reflected in CE10, were 29 of the 82 DEGs were metabolism 
related. Similarly to CFT073, many DEGS were involved in transport or were 
membrane associated (18/82). Functions also included cell division (4/82), 
cofactors (1/82), DNA modification (2/82), phage associated (1/82), ribosomal 
proteins (2/82), stress response (3/82), transcriptional regulators (3/82), 
virulence associated (7/82), and uncharacterised (12/82). These results 
indicated that in the absence of D-serine, DsdC regulates core processes of the 
cell. Indeed, only 1 DEG was associated with virulence in the CFT073 data set 
when D-serine was absent, fimG (1.88-fold change; p-value 1.5E-03), a protein 
involved in cell adhesion. 
Overlap of the CFT073 D-serine transcriptomic data sets had revealed only 6 
DEGs that were transcriptionally differentially expressed in the same direction. 
GO analysis of these 6 DEGs revealed no functional group patterns: metL (lysine 
biosynthesis), bfr (bacterioferritin), yfiD (putative radical cofactor), dsdC 
(transcriptional regulator), c3149 (hypothetical), and c2566 (hypothetical) (Fig. 
3-24B). Strikingly, GO analysis of the DEGs overlapped in the CE10 D-serine data 
sets revealed a link between D-serine and virulence (Fig. 3-24D). Indeed, there 
were three functional groups that were associated with NMEC virulence: capsule 
(7/30), LPS (9/30), and fimbriae (1/30). Further functions also included genes 
involved in lipoprotein (1/30), metabolism (5/30), plasmid maintenance (1/30), 
prophage (1/30), transcriptional regulator (1/30), transport (2/30) and 
uncharacterised (2/30). These results indicated that DsdC in the presence of D-
serine is involved in the regulation of capsule and LPS, two important virulence 
determinants in NMEC. 
Global transcriptome profiling using RNA-Seq had revealed the novel regulon of 
DsdC, in the presence and absence of D-serine. Intriguingly, genes involved in 
core processes like cell division and ribosomal proteins were differentially 
 126 
expressed when D-serine was absent. However, in the presence of D-serine in 
CE10, the regulon became virulence associated with differential expression of 
capsule and LPS biosynthesis genes. These results may indicate that D-serine is 
being used by the bacteria as a signal involved in virulence associated 
mechanisms. To establish if the DEGs were caused by direct DsdC regulation, or 
if this was due to indirect effects such as DsdC involved in the regulation of 
another TF or the toxic effects of D-serine, the ChIP-Seq binding data and the 
RNA-Seq transcriptomic data was compared. 
3.5.2 DsdC directly regulates a small, but virulence 
associated, regulon in NMEC strain CE10 
To understand the direct role of DsdC on gene expression in CFT073 and CE10, 
the binding and transcriptomic datasets were compared. The comparisons of the 
data are presented in Figure 3-25 and the common genes list is presented in 
Supplementary Table S8. 
    

















Figure 3-25 Direct regulation of DsdC in CFT073 and CE10. Venn diagram 
showing commonality between the binding sites in the ChIP-Seq data compared 
to the differential gene expression from the transcriptomic data for DsdC. (A) 
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CFT073 with no D-serine, (B) CFT073 + 1 mM D-serine, (C) CE10 with no D-ser 
and (D) CE10 + 1 mM D-serine. 
Figure 3-25 revealed there was little overlap between the DsdC binding and 
transcriptomic data. Indeed, for CFT073 DsdC, in both the presence and absence 
of D-serine, the only overlap between the datasets was dsdC (Fig. 3-25(A-B)). 
These results therefore indicated that DsdC plays no direct role in regulation in 
CFT073, bar D-serine metabolism. For CE10 (Fig. 3-25C), when D-serine was 
absent there were only 4 genes that appeared to be directly regulated by DsdC: 
dsdC2, ypdI (putative lipoprotein), gadB (acid tolerance) and neuO (capsule). 
When D-serine was present this increased to 9, and solely included genes 
involved in capsule production and LPS biosynthesis bar dsdC2: neuA, neuB, 
neuO, rfaY, wbbC, wzx, waaT, and waaV. These results indicated a direct role of 
DsdC in CE10 gene regulation in both the presence and absence of D-serine. 
Strikingly, in the presence of D-serine, a direct role of DsdC in the regulation of 
capsule and LPS expression emerged, two key virulence mechanisms in NMEC. 
These results could therefore indicate that DsdC has been tailored in CE10 to 
regulate a strain-specific phenotype. 
3.6 Discussion 
3.6.1 DsdC is absolutely required for D-serine 
metabolism but has no effect on growth in general 
As has been reported extensively elsewhere, DsdC is absolutely required for D-
serine metabolism (Nørregaard-Madsen et al., 1995). The data presented here 
concurs, showing that D-serine concentrations relative to host levels inhibited 
the growth of the DdsdC mutants completely, with growth only restored with 
complementation of pDsdC (Fig. 3-3, 3-4, and 3-5). Further, deletion of the 
regulator did not appear to affect growth, with no defects reported when DdsdC 
was grown in minimal media. This correlates with data reported in P. mirabilis, 
where deletion of the operon did not affect growth where other carbon and 
nitrogen sources were available (Brauer et al., 2019). 
Gene duplication is present in many bacterial genomes. Indeed, 94 genes in 
CFT073 are duplicated, with some of these duplications revealed to be 
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pathotype specific (Bernabeu et al., 2019). 30 out of 41 K1 strains tested were 
reported to carry two copies of the dsdCXA operon, with both copies functional 
in D-serine metabolism (Moritz & Welch, 2006). CE10 also carries two unlinked 
copies of the dsdCXA operon. To establish functional redundancy of D-serine 
metabolism between the two copies, single DdsdC1 and DdsdC2 mutations were 
made. Figure 3-3 and 3-4 revealed both DsdC1 and DsdC2 were functionally 
redundant in regard to D-serine metabolism. Further, when the native levels of 
expression of both DsdC1 and DsdC2 were analysed, there appeared to be no 
difference in protein expression (Fig. 3-8). Gene duplications are often 
associated with adaption of cells to changing environments (Bernabeu et al., 
2019). As stated in 3.2.1 there are small changes in the amino acid structure 
between CE10 DsdC1 and DsdC2, with most changes occurring in a small cluster 
in the predicted substrate binding domain. Speculatively, these differences 
could cause changes in the tertiary structure of the protein, potentially altering 
the specificity of the binding pocket and allowing a different substrate to bind. 
DsdC1 and DsdC2 could therefore be recognising different co-inducers in CE10. 
Although this is an interesting hypothesis, determining the specific co-inducers 
for DsdC was not carried out in this work. However, as the ChIP-Seq global 
binding data revealed, under the conditions that were used, there were no clear 
differences in differential binding sites between DsdC1 and DsdC2, suggesting 
therefore that they are likely to play a redundant role in CE10. 
3.6.2 DsdC is a global transcription factor that binds to 
multiple regions on the genome 
Although Anfora et al., 2007, speculated a larger role in gene regulation for 
DsdC in ExPEC strains; this is to our knowledge, the first report that DsdC plays a 
role in E. coli gene regulation, beyond D-serine metabolism. Analysis of the 
ChIP-Seq binding data revealed that DsdC bound to multiple regions of the 
genome, with CE10DsdC1-FLAG in the presence of D-serine, binding to 217 regions 
(Table 3-3; Supplementary Table S1-6). As Maddocks and Oyston (2008) 
reviewed, LTTRs can be local or global regulators, and indeed previous studies 
on LTTRs have revealed a range in the number of binding sites. YhaJ, a LTTR in 
E. coli had shown binding to 7 peaks in CFT073, whereas MetR, a LTTR in 
Streptococcus pneumoniae had shown binding to 52 loci of the genome, and 
OxyR, a LTTR in Pseudomonas aeruginosa showed binding to 122 regions 
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(Connolly et al., 2019; Wei et al., 2012; Zhang et al., 2021). Strikingly, NAPs 
such as Fis and H-NS can bind up to 1,464 and 458 regions of the E. coli genome 
respectively (Kahramanoglou et al., 2011). The number of ChIP peaks generated 
from this experiment was more akin to a global LTTR and indicated that DsdC is 
not just binding to the dsdCX region but is binding throughout the genome. 
The canonical TF model, based on early work by Jacob and Monad on the lac 
operon, is that TFs bind within the TSS at the 5’ region of a gene, usually in 
intergenic non-coding regions. Many of the DsdC ChIP-Seq peaks fitted this 
model, although ~25% of the ChIP-Seq peaks obtained were binding in intragenic 
regions. Singh et al., (2014) reported that in the E. coli exhCABD operon, there 
were multiple intragenic promoters. Further, mapping of the NikR regulon using 
a combination of ChIP-Seq and RNA-Seq in Helicobacter pylori revealed 
intragenic binding, with 41 out of 72 peaks positioned within annotated genes 
(Vannini et al., 2017). This phenomenon does not appear to be limited to 
bacteria either. Research in archaeal operons and coding sequences revealed the 
presence of intragenic promoters, with 11 TFs reported to bind inside operons 
and annotated genes (Koide et al., 2009). Intragenic binding therefore appears 
to be widespread. 
Intragenic binding of TFs could have arisen due to a limitation on space within 
the chromosome or due to the TF previously regulating a gene that has since 
been lost due to chromosomal rearrangement (Galagan et al., 2012). 
Alternatively, binding in these intragenic regions could be to prevent 
transcriptional elongation or hinder processing. TF binding site (TFBS) positions 
in relation to the promoter have been suggested to be an important factor in 
determining regulatory function, with TF repressors more likely to bind 
downstream of the promoter than TF activators (Babu & Teichmann, 2003b). 
One study showed that a third of repressor binding sites occurred after the TSS 
(Babu & Teichmann, 2003b). This could suggest that DsdC may be binding in 
intragenic regions of the gene to hinder transcription. Although intergenic peaks 
were considered the norm for transcriptional regulation, an unexpected 
observation of ChIP-Seq data has been that many TFBS occur within the ORF 
(Wade, 2015). The results presented here correlate with that finding, with DsdC 
showing binding in both intergenic and intragenic sites. 
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Further genomic analysis of the ChIP-Seq hits revealed that DsdC bound mainly 
in the TSS of the gene, in the ‘0 bp bin’. This is typical of a LTTR which often 
binds at -35 to +20 bp sites (Maddocks & Oyston, 2008). However, there was a 
range in distance of DsdC binding sites, with 7 TFBS being further than 150 bp 
upstream from the TSS in CFT073DsdC-FLAG. Although unusual, this has been 
reported in prokaryotes before, with several TFs binding >150 bp upstream of 
the TSS (reviewed in Galagan, Lyubetskaya & Gomes, 2012). Indeed, AraC binds 
280 bp upstream to the PBAD TSS and mediates gene expression by DNA looping 
(Dunn et al., 1984). A further study revealed that VjbR, a LuxR-type 
transcriptional regulator, bound to the genome >300 bp upstream of the TSS; 
although, there was preferential binding between 20 and 140 bp upstream 
(Kleinman et al., 2017). The data presented here therefore seems consistent 
with previous reports of TFBS. 
3.6.3 DsdC binds in a strain-specific manner in two 
ExPEC pathotypes 
As the DsdC ChIP-Seq data had revealed multiple binding sites on the genome, 
functional characteristic analysis of the putatively bound genes was carried out. 
This analysis revealed that DsdC bound to genes involved in multiple different 
processes ranging from metabolism to electron transport and even virulence, 
suggesting that DsdC plays a global role in two ExPEC strains, and does not 
simply regulate one functional group. This is also the case for the LTTR OxyR. A 
ChIP-exo experiment in E. coli MG1665 revealed, under oxidative stress 
conditions, OxyR bound to genes involved in detoxification and DNA damage 
repair, as well as amino acid biosynthesis, cell wall synthesis and metal ion 
transport (Seo et al., 2015). Furthermore, a ChIP-chip experiment of the LTTR, 
LeuO, revealed binding to 178 genes on the genome of Salmonella enterica 
serovar Typhimurium, with gene functions ranging from housekeeping to 
virulence-associated (Dillon et al., 2012). 
GO functional analysis upon the CE10 DsdC ChIP-Seq hits revealed similar binding 
patterns to CFT073; however, there were also differences suggesting that DsdC 
has been tailored for strain-specific regulation. Indeed, in CFT073 there was 
binding to tssB and yheE. tssB and yheE (gspC in K12) are genes involved in the 
T6SS and a putative T2SS respectively (Korotkov et al., 2011; Navarro-Garcia et 
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al., 2019). These are both mechanisms utilised by bacteria to secrete virulence 
effectors into the host or close neighbouring bacteria, with one study revealing, 
in UPEC, the T2SS was important for persistent infection in the upper urinary 
tract (Kulkarni et al., 2009). Although NMEC reportedly has an orthologue of the 
T6SS (Navarro-Garcia et al., 2019), there were no homologues of tssB nor yheE 
found in CE10. Furthermore in CFT073, DsdC was shown to bind to clbR, the 
colibactin master regulator (Wallenstein et al., 2020). Colibactin is a bacterial 
genotoxin found on the pks island and has been linked with colorectal cancer 
(CRC). Although many B2 E. coli strains carry the pks island (Faïs et al., 2018), 
CE10, which is in phylogroup D, does not carry it.  
In CE10 it was shown that DsdC uniquely bound to genes involved in the K1 
capsule and the putative T3SS, ETT2. The ETT2 in the past has been termed 
‘cryptic’ due to lack of understanding of what role it played. However, it has 
been suggested to play an important role in bloodstream isolates of E. coli, with 
mutations in CE10 of the ETT2 leading to defects in invasion and intracellular 
survival in HBMECs (Yao et al., 2009). Recently Fox et al., (2020), analysed 
bloodstream E. coli isolates and found that strains from the sequence type (ST) 
69 lineage contained an intact ETT2, indicating its importance in virulence. As 
CFT073 does not carry these genes, these results taken together, indicate that 
DsdC has been tailored in ExPEC strains, mediating different regulatory pathways 
that are important to the individual strains requirement. 
The central dogma for many years has been that TFs regulate the same set of 
genes in different strains of the same species, indeed even in different bacteria. 
Perez and Groisman (2009a) revealed that the homologous TF PhoP was shown to 
regulate the same ‘ancestral’ set of genes in two different bacterial species, S. 
Typhimurium and Yersinia pestis. However, recent studies have started showing 
the potential repurposing and tailoring of TFs for strain-specific regulation. 
Recent work from the Roe group has shown that the conserved TF YhaJ directly 
regulates strain-specific virulence mechanisms, regulating expression of T3SS 
components and effectors in EHEC, whilst in UPEC regulating T1F expression 
(Connolly et al., 2019). Indeed, even homologous TFs have recently been shown 
to regulate different pathways. Xanthomonas campestris pv campestris carries 
two sigma factor 54 proteins, RpoN1 and RpoN2. Recent data indicates that 
these two homologues have distinct roles in pathogenesis in X. campestris, with 
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RpoN2 regulating flagellation, and RpoN1 potentially regulating fatty acid 
synthesis (Li et al., 2020). Although this is an important observation, it should 
also be noted that these two proteins share only 56% of residues. 
The results presented here indicate that there is strain-specific binding in two 
ExPEC pathotypes, by the conserved TF DsdC. The relative plasticity, but finite 
size, of the E. coli genome has led to several distinct E. coli pathotypes 
emerging; indeed, CFT073 and CE10 both utilise distinct virulence mechanisms 
whilst infecting the host. As they both are able to use D-serine as a carbon 
source, DsdC likely plays a role in the success of these two ExPEC strains. 
Further, it is likely, due to the need of newly acquired genes to be integrated 
into ‘ancestral’ networks (Perez & Groisman, 2009b), DsdC has been tailored to 
bind in a strain-specific manner. 
3.6.4 DsdC directly regulates a small subset of 
virulence-associated genes in NMEC strain CE10 
As direct binding does not always equate to a transcriptional response, a 
comparison between the global binding data and the transcriptomics experiment 
was made. Intriguingly, there was little direct regulation of genes observed 
when comparing the ChIP-Seq and RNA-Seq data. DsdC is therefore binding to 
the genome but not causing a direct regulatory effect upon many genes. This 
was initially surprising, although several other studies have reported results of 
TF binding but no transcriptional responses being observed. ChIP-chip analysis of 
the TF RutR in E. coli strain BW2511 revealed 14 out of the 20 peaks observed 
were intragenic, and appeared to play little to no role on transcription (Shimada 
et al., 2008). In H. pylori, a combined ChIP-Seq and RNA-Seq analysis of NikR 
revealed the presence of ‘transcriptionally orphaned’ NikR binding sites, with no 
apparent role in transcription (Vannini et al., 2017). Further, in B. abortus, 
ChIP-Seq analysis combined with RNA-Seq, revealed binding of VjbR to 235 
regions of DNA, with only 37 of those correlating with differentially expressed 
genes (Kleinman et al., 2017). 
As the E. coli genome is ever-evolving, it has been suggested that these non-
regulatory bindings could be evolutionary relics, with the genes the TF used to 
regulate since ‘lost’ from the genome (Shimada et al., 2008). Moreover, it has 
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also been suggested that there could be binding on the genome at non-
regulatory sites so that the cell can maintain an optimum amount of TF present 
(MacQuarrie et al., 2011). Indeed, it has been described for the lac repressor 
that up to 98% is bound to sites other than the lac operator (Lin & Riggs, 1975). 
This hypothesis was also proposed by Vannini et al., (2017), theorising that NikR 
bound to the genome at dedicated ‘parking bays’, in order to maximise the 
concentration of the regulator in certain regions. Furthermore, one study that 
made a genome-wide reconstruction of the OxyR/SoxRS regulon in E. coli 
MG1655, suggested that co-regulation could play a role in not seeing a 
transcriptional effects; with co-regulating TFs taking over the regulatory role 
when the relevant TF is missing (Seo et al., 2015). 
There were also limitations within the experiments presented in this thesis. Due 
to the nature of the project, the two global experiments were carried out 
separately, with the RNA-Seq experiment performed prior by Dr Nicky O’Boyle. 
Although every effort was made to limit the differences in experimental setup, 
small discrepancies between the procedures may have arisen, potentially 
contributing to the differences between the binding and transcriptomic data. To 
minimise variation for RNA-Seq, Gao et al., (2021) performed all biological 
replicate experiments on the same day. Further, the same samples were then 
used for observing bacterial motility by microscopy and video analysis, enabling 
a direct comparison of the two experiments (Gao et al., 2021). The technique of 
using the same samples for combination experiments, should potentially be used 
for future comparison experiments, thereby limiting any possible variation 
observed. 
Further, there is the possibility that the RNA-Seq samples were taken at a time 
point where the transcriptional effects of DsdC, after induction of D-serine, 
were no longer being observed. Vibrio coralliilyticus has been reported to 
differentially regulate 2,705 genes, 10 minutes after exposure to an inducer 
(Gao et al., 2021). After 60 minutes, the number of DEGs dropped to 2,235 
genes (Gao et al., 2021). Strikingly, only 30% of DEGs were shared between the 
10- and 60-minute data sets, indicating that sampling time is a relevant factor 
when making observations of transcriptional responses. Another recent study 
that observed the transcriptional effects of the regulator ppGpp, identified a 
transcriptional response in 757 genes 5 minutes after induction (Sanchez-
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Vazquez et al., 2019). This data therefore begs the question of whether the 
RNA-Seq sampling time point (120 minutes post-induction) was potentially taken 
too late, and had the time point been taken earlier after induction, would more 
overlap have been seen between the two global sequencing data sets? Future 
studies could answer this by sampling and performing RNA-Seq or RT-qPCR 
studies over a gradient of time post-induction. 
The large number of non-regulatory binding sites, compared to the relatively low 
number of regulatory binding sites, could also be down to the nature of the 
ChIP-Seq experiment. ChIP-Seq data is known to produce false positives (Pickrell 
et al., 2011); indeed, one study using Drosophila melanogaster embryos 
revealed 3,000 non-specific ChIP-Seq peaks, that they described as ‘Phantom 
Peaks’ (Jain et al., 2015). Marx (2019) discussed the occurrence of phantom 
ChIP-Seq peaks which can arise from non-specific antibody binding at promoter 
elements. Further, some regions of the genome are ‘hyper-ChIPable’, leading to 
false positive data outputs (Marx, 2019). However, as a non-tagged control was 
used in the DsdC analysis, the number of false positives obtained in this data set 
should be limited. 
In CFT073, in both the presence and absence of D-serine, the only gene common 
between the binding and transcriptomic data sets was dsdC. Conversely in CE10, 
in the absence of D-serine, DsdC bound and showed differential expression of 4 
genes. GO analysis of these genes revealed there was no functional group 
consensus that DsdC is binding to. Strikingly, in the presence of D-serine for 
CE10, all of the genes that overlapped in the global binding and transcriptomic 
data sets were involved in virulence, bar dsdC2. Indeed, the 8 genes were all 
involved in LPS and K1 capsular biosynthesis, two major virulence determinants 
of NMEC. This data indicated that DsdC directly regulates a small, but virulence-
associated regulon in CE10. 
3.6.5 The indirect regulon of DsdC 
As discussed above, at the time points sampled, there was little overlap 
between the binding and transcriptomic data sets, indicating that DsdC 
indirectly regulates multiple processes within the cell. In the absence of D-
serine DsdC was found to, indirectly, differentially regulate 46 and 78 genes in 
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CFT073 and CE10 respectively. Upon exposure to D-serine, 1,055 and 411 genes 
were, indirectly, differentially expressed in CFT073 and CE10 respectively. This 
data indicated that DsdC was more transcriptionally active in the presence of its 
suspected co-inducer, D-serine, which is comparable with other LTTRs 
(Maddocks & Oyston, 2008). However, the increased number of DEGs could also 
be due to the toxic side effects of D-serine accumulation in the DdsdC 
background. DsdC is required for expression of dsdA, the D-serine deaminase, 
which breaks down D-serine into pyruvate and ammonia (Nørregaard-Madsen et 
al., 1995). In the absence of DsdA, D-serine becomes toxic to the cell by 
inhibiting the L-serine and pantothenate pathway (Cosloy & McFall, 1973; Maas 
& Davis, 1950). By including the pDsdA plasmid in the transcriptomics 
experiment it was hoped to alleviate the problem of D-serine accumulation and 
corresponding toxicity. 
Indeed, in the CFT073 data set the number of DEGs dropped dramatically from 
1,067 to 174. However, upon comparing the two data sets it was revealed that 
only 6 were transcriptionally differentially expressed in the same direction. This 
could be an accurate representation of the DsdC regulon, although, it was also 
considered the possibility that overexpression of pDsdA was exerting a toxic 
effect within the cell. Conversely, in CE10 the number of DEGs increased from 
436 to 552 when pDsdA was overexpressed. When the two data sets were 
compared only 30 genes were transcriptionally differentially expressed in the 
same direction. Therefore, it is possible that the overexpression of pDsdA is 
causing a metabolic burden upon the cell, thus affecting the transcriptomic 
response (Bolognesi & Lehner, 2018). As the primary interest of this work was in 
elucidating the direct role of DsdC, the remainder of the work presented in this 
thesis will focus upon the genes that were present in both the global binding 
data and the transcriptomics data sets. 
3.6.6 DsdC as a canonical transcription factor and a 
nucleoid associated protein 
Intriguingly, two distinct patterns emerged from the ChIP-Seq binding data: 
peaks that were canonical in shape, and peaks that were broader and covered 
larger sections of the genome. The canonical binding profile of a TF is that it 
binds as a ‘narrow’ peak in the TSS of the gene it is regulating, whereas 
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‘broader’ peaks are usually associated with histones (Starmer & Magnuson, 
2016). Figure 3-13 highlighted the differences in these binding profiles with the 
narrow binding peak spanning a few hundred base pairs whereas the broader 
peak spanned much larger regions, in the case of the LPS biosynthesis region 
>6,000 bp. Although most prokaryotes do not contain histones, NAPs have been 
described previously as being ‘histone-like’ in manner (Dillon & Dorman, 2010). 
Indeed, the NAP H-NS often binds to longer regions of DNA; a study in E. coli 
showed binding up to 1,759 bp, whereas in S. Typhimurium the average binding 
region was 1,500 bp, however it had been noted to increase to 10,750 bp (Dillon 
et al., 2010; Kahramanoglou et al., 2011). As it appears for DsdC, H-NS also has 
the ability of binding in longer and shorter regions. Kahramanoglou et al., (2011) 
found that the shorter regions tended to behave as canonical TFs whereas the 
longer regions enfolded large regions of the genome, likely acting as a 
transcriptional silencer. 
These results could indicate that DsdC is acting in both a classical TF manner 
and a NAP. Indeed, the lines between the two have often been blurred (Dorman 
et al., 2020), and a recent paper redefining fundamental concepts in 
transcriptional initiation has suggested that as NAPs often have functions that 
overlap TFs, they should no longer be defined as two separate classes (Mejía-
Almonte et al., 2020). Therefore, it is entirely plausible that DsdC is acting both 
as a TF and as a NAP. This would also correlate to the ChIP-Seq binding data that 
indicates that ~25% of the peaks are binding in intragenic regions. NAPs such as 
H-NS are known to bind intragenic regions, silencing transcription (Singh et al., 
2014). It could also explain why many of the ChIP-Seq binding hits are not 
associated with direct regulatory functions. Hypothetically DsdC is acting more 
like a NAP and is involved in chromosomal organisation, and is therefore binding 
along the genome in order to potentially fine tune bending, bridging or wrapping 
of DNA (Dame, 2005). This hypothesis could also explain why a classical T-N11-A 
motif was not obtained when the sequence data was analysed on MEME. NAPs 
are known to bind to the genome with low sequence specificity (Wade, 2015), 
and it was not until canonical TF binding peaks were used that the MEME 
software generated a statistically significant motif. Indeed, LTTRs are known to 
rely on DNA shape rather than on nucleotide sequence in recognising their DNA 
targets, a trait that is shared by NAPs (Dorman et al., 2020). Given this data, 
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this could indicate that DsdC potentially acts as both a canonical TF and as 
global NAP. 
3.6.7 Conclusion 
To our knowledge, the work presented here is the first evidence that DsdC plays 
a role in E. coli beyond regulating the D-serine metabolism locus. Using global 
binding and transcriptomic data, it has been revealed that DsdC binds globally 
across the CFT073 and CE10 genome. Further, it has been shown that although 
there were many overlaps, DsdC bound in a strain-specific manner in two ExPEC 
strains, binding to colibactin synthesis genes in CFT073 and ETT2 effector genes 
in CE10. Moreover, using transcriptomics it was shown that DsdC differentially 
regulates multiple genes outside the dsdCXA locus. Strikingly, overlap of the 
transcriptomic and binding data in CE10 revealed a small subset of genes that 
were common to both sets, all involved in LPS and K1 capsular biosynthesis. 
These results together indicate, that over time, DsdC has been tailored for 
strain-specific regulation of virulence factors.
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Chapter 4 Validation of the global sequencing 
data and purification of the LysR-type 
transcriptional regulator, DsdC 
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4.1 Introduction 
Regulatory control of genes in response to environmental cues is central to 
bacterial survival (Browning & Busby, 2016). Indeed, the rapid recognition of 
environmental signals and subsequent change in gene expression allows bacteria 
to survive in fluctuating environmental conditions (Shimizu, 2013). Control of 
bacterial gene expression is a multifaceted process, with multiple regulatory 
mechanisms that can influence both transcription and translation (Browning & 
Busby, 2004; Starosta et al., 2014). Bacteria that are pathogenic, or that can 
survive in multiple niches within the host, often carry larger numbers of 
regulatory elements, including TFs, reflecting their adaptability to diverse host 
environments (Bervoets & Charlier, 2019). UPEC and NMEC are two versatile 
ExPEC pathotypes that can cause serious disease in humans (Kaper et al., 2004). 
ExPEC strains predominantly reside asymptomatically within the gut, causing 
disease upon egression (Johnson & Russo, 2002). Within the urinary tract, UPEC 
strains often survive in a nutritionally depleted environment, containing mostly 
amino acids and small peptides, whereas NMEC strains can translocate from the 
mucosal epithelium to the bloodstream and traverse the BBB into the CNS (Alteri 
et al., 2009; Silver & Vimr, 1990). Although UPEC and NMEC can reside in 
distinct niches of the human body, they both utilise D-serine as a carbon source. 
In E. coli, DsdC is a TF that regulates the D-serine metabolism locus. 
In Chapter 3, results from global binding and transcriptomic experiments 
demonstrated that DsdC bound to a large number of genetic regions in 
prototypic UPEC and NMEC strains and caused differential gene expression upon 
exposure to D-serine. This chapter aims to validate the RNA-Seq data presented 
in Chapter 3 using RT-qPCR analysis, demonstrating that DsdC affects expression 
of genes involved in capsular and LPS biosynthesis. Moreover, to explore the 
ChIP-Seq binding results presented in Chapter 3 and to demonstrate that DsdC 
directly binds to regions of the CE10 and CFT073 genome, DsdC (CFT073), DsdC1 
(CE10) and DsdC2 (CE10) were purified. As LTTRs are generally known to be 
insoluble proteins, a maltose binding protein (MBP) tag was used to enhance the 
solubility of the DsdC fusion protein (Sachdev & Chirgwin, 2000). Furthermore, 
DsdC1 (CE10) was also tagged with a 6xHis tag. The purified DsdC was then used 
in electrophoretic mobility shift assays (EMSA) to confirm binding of DsdC to its 
own promoter and also to an LPS glycosyltransferase gene, waaV. Finally, the 
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functionality of a TF often relies on the recognition of specific DNA sequences at 
a promoter (reviewed in Browning, Butala & Busby, 2019). The binding motif of 
DsdC is currently unknown and therefore this chapter aimed, using DNase I 
footprinting and purified DsdC, to elucidate the binding motif. 
4.2 Validating the RNA-Seq transcriptomic data using RT-
qPCR 
As discussed in Chapters 1 and 3, global transcriptome profiling by RNA-Seq can 
identify the regulon of a TF, measuring differences in RNA levels between WT 
and isogenic mutants. RT-qPCR is often used as validation for RNA-Seq data and 
is a sensitive method that measures gene quantification (Fang & Cui, 2011). The 
RNA-Seq data presented in Chapter 3 revealed a number of genes that were 
differentially expressed in the CE10 DDdsdC1/2 background upon exposure to D-
serine. 
Several of these genes were related to LPS biosynthesis and K1 capsular 
production. Validation of the RNA-Seq data was therefore carried out on genes 
of biological interest, including neuB, waaV, kpsF and neuO. RNA was extracted 
from CE10 WT and DDdsdC1/2 isogenic mutants. The samples were cultured in 
M9 minimal media for 3 hours and spiked with 1 mM D-serine and left to 
incubate for a further 2 hours. RT-qPCR analysis on three biological replicates 
confirmed and validated the RNA-Seq results. Upon exposure to D-serine, gene 
expression of neuB (1.56-fold; p-value 0.000038), waaV (1.36-fold; p-value 
0.0091), and kpsF (1.91-fold; p-value 0.0042) were significantly increased in the 
DDdsdC1/2 mutant compared to CE10 WT, whereas gene expression of neuO was 
decreased (-2.36-fold; p-value 0.026) (Table 4-1; Fig. 4-1). These results 
validated the RNA-Seq data, indicating that DsdC affects the regulation of genes 
involved in CE10 LPS and capsular biosynthesis.
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Gene RNA-Seq 
   Fold change         p-value 
RT-qPCR 
  Fold change       p-value 
neuB 1.99 6.19E-09 1.56 3.8E-05 
waaV 2.12 0.03 1.36 9.1E-03 
kpsF 1.71 9.07E-03 1.91 4.2E-03 
neuO -4.57 8.56E-10 -2.36 2.6E-02 
Table 4-1 Comparisons of the RNA-Seq and RT-qPCR data. A direct comparison 
of the fold changes and respective p-values from the RNA-Seq and RT-qPCR data 
for several biologically relevant genes; neuB, waaV, kpsF and neuO, for which 
fold change was measured in the CE10 DDdsdC1/2 mutant relative to the CE10 
WT, in the presence of D-serine. 
 
Figure 4-1 RT-qPCR analysis of capsular and LPS biosynthesis genes. RT-qPCR 
validation of the RNA-Seq data showed increased fold changes for (A) neuB, (B) 
waaV, and (C) kpsF, in the CE10 DDdsdC1/2 mutant relative to the CE10 WT, in 
the presence of D-serine. (D) shows the decreased fold change in neuO in the 
CE10 DDdsdC1/2 mutant relative to the CE10 WT, in the presence of D-serine. 
The purple dashed line indicates baseline expression of each gene in CE10 WT. 
Gene expression analyses were based off three biological repeats. * denotes 
p£0.05; ** p£0.01; *** p£0.001; **** p£0.0001; ns (no significance) p>0.05. 
Results from a previous RNA-Seq experiment had revealed that in CFT073, genes 
involved in colibactin production were down-regulated upon exposure to D-
serine (Connolly et al., 2021). Colibactin is a bacterial genotoxin produced by 
some strains of E. coli and has been linked to CRC in humans. Interestingly, 
analysis of the RNA-Seq data presented in Chapter 3 for the pairwise comparison 
of CFT073 vs. DdsdC had revealed poor coverage for the colibactin biosynthesis 
region. As analysis of the ChIP-Seq data had revealed a peak at the intergenic 
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region between the colibactin master regulator, clbR, and a colibactin synthesis 
gene, clbB; RT-qPCR analysis was performed on clbR and another colibactin 
gene, clbA. RNA was extracted from CFT073 WT and DdsdC isogenic mutants. 
The samples were cultured in M9 minimal media for 3 hours and spiked with 1 
mM D-serine and left to incubate for a further 2 hours. RT-qPCR analysis on 
three biological replicates revealed a 2.02-fold (p-value 0.0003) increase in gene 
expression of the colibactin regulator, clbR, in the DdsdC mutant background 
(Fig. 4-2A). Moreover, upon exposure to D-serine, clbR gene expression increased 
further to 4.58-fold (p-value 0.0003) in the DdsdC mutant background (Fig. 4-
2A), indicating that in the presence of D-serine, DsdC represses the colibactin 
master activator. In the presence of D-serine, expression of clbA was also 
increased in the DdsdC mutant background (2.85-fold; p-value 0.0008) (Fig. 4-
2B). 
 
Figure 4-2 RT-qPCR analysis of colibactin genes. RT-qPCR analysis of two 
colibactin genes (A) clbR and (B) clbA, showing the levels of fold change in the 
CFT073 DdsdC mutant relative to the CFT073 WT. The purple dashed line 
indicates baseline expression of each gene in CFT073 WT. * denotes p£0.05; ** 
p£0.01; *** p£0.001; **** p£0.0001; ns (no significance) p>0.05. 
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4.3 Overexpression and purification of the LTTR, DsdC 
4.3.1 Cloning and overexpression of DsdC with MBP 
and His tags 
To purify DsdC, both an MBP tag and a 6xHis tag were used. Using the DNA 
sequence of dsdC (CFT073), dsdC1 (CE10) and dsdC2 (CE10), BamHI and HindIII 
restriction sites were amplified onto the 5’ and 3’ ends respectively. The 
product was then cloned on to the MBP in the pMAL-C5X vector, with the MBP 
tag at the N-terminal of dsdC. dsdC1 (CE10) was also cloned onto a 6xHis tag on 
the pET-28a vector. The recombinant vectors were then cloned into the E. coli 
strain BL21 DE3 for overexpression. 
Both MBP and 6xHis tag vectors rely on IPTG, a molecular mimic of allolactose, 
for activation of recombinant proteins. Small scale overexpression trials were 
performed with various concentrations of IPTG, time and temperature, to 
determine the best conditions for overexpression (Table 4-2). Western blot 
analysis and Coomassie staining revealed bands at ~78 kDa, which corresponded 
to the predicted molecular weight of DsdC (~36 kDa) and MBP tag (~42 kDa), and 
~38 kDa for the His tagged DsdC1. It was established that 3 hours induction of 1 









37 0.1mM 3 
37 0.3mM 3 
37 0.5mM 3 
37 0.7mM 3 
37 1.0mM 3 
28 1.0mM 16 
32 1.0mM 16 
Table 4-2 Conditions used in overexpression trials of DsdC recombinant 
protein. To maximise overexpression of DsdC, samples were grown in LB to an 
OD600 of 0.6. The samples were then induced with several differing 




Figure 4-3 Coomassie Blue and Western blot analysis of the small-scale 
overexpression trials of DsdC. Overexpression trial of (A) pMAL-C5X_DsdC1 
(CE10) and pMAL-C5X_DsdC2 (CE10) and (B) pMAL-C5X_DsdC (CFT073). “–” 
indicates no IPTG induction, “+” indicates induction of IPTG. Cell lysate 
indicated large bands between 62 and 98 kDa, with the MBP-DsdC fusion ~78 
kDa. (C) Overexpression test of pET-28a-DsdC1 (CE10). “–” indicates no IPTG 
induction, “+” indicates induction of IPTG. Cell lysate indicated a band at ~38 
kDa. (D) Western blot analysis of recombinant MBP-DsdC for CE10 DsdC2, CE10 
DsdC1, and CFT073 DsdC, using anti-MBP antibody. “–” indicates no IPTG 
induction, “+” indicates induction of IPTG. Analysis indicated a band between 62 
and 98 kDa, with the MBP-DsdC fusion ~78 kDa. 
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4.3.2 Purification of the recombinant DsdCs 
Using the information obtained from the small-scale overexpression trials 
detailed above, full scale recombinant protein overexpression and purification of 
MBP-DsdC and His-DsdC was then performed. Cells were grown in 1 L of LB and 
induced with 1 mM IPTG. Cells were pelleted and resuspended in either MBP or 
His binding buffer and sonicated. The supernatant was then purified using 
affinity chromatography in either a MBP HP column or a HisTrap HP column. The 
elution fractions were then run on an SDS-PAGE gel to determine which elution 
fraction contained the purified recombinant protein (Fig. 4-4). Analysis of the 
gels revealed that DsdC purified in as a monomer when attached with an MBP-
tag but potentially as a monomer and as a dimer when attached with a His-tag, 
as indicated by the red arrows. However, column purification is a crude method 
of protein purification and there were other bands present on all of the gels. 
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Figure 4-4 Purification of DsdC. SDS-PAGE analysis of purified DsdC, with the red arrows indicating the predicted size for DsdC-tagged
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complexes. Lane 1, SeeBlue +2 ladder; lane 2, whole cell lysate; lanes 3-4, flow-
through; lanes 5-15, elution fractions. The large band at ~78 kDa indicates (A) 
pMAL-C5X_DsdC1 (CE10) complex; (B) pMAL-C5X_DsdC2 (CE10) complex; (C) 
pMAL-C5X_DsdC (CFT073) complex. Purification of the (D) 6xHis-DsdC1 
(pET28a_DsdC1) complex revealed two oligomeric states of DsdC1 at ~38 kDa 
and ~62 kDa. 
4.3.3 Cleavage of MBP-DsdC tag 
The MBP tag was used in purification to alleviate the potential solubility issue of 
DsdC. However, it is a large protein complex that could potentially interfere 
with DsdC’s protein structure and function (Waugh, 2011). Therefore, Factor Xa 
was used for a trial cleavage experiment, performed on pMAL-C5X_DsdC1 to 
remove the MBP tag (Fig. 4-5). The trial cleavage experiment revealed that after 
24 hours of digestion with Factor Xa, the recombinant protein was almost fully 
digested, leaving the singular MBP and DsdC proteins. However, upon cleavage 
with Factor Xa, the proteins precipitated out of solution, forming aggregates, 
suggesting that MBP was required for the solubility of DsdC. 
 
Figure 4-5 Cleavage of MBP tag from DsdC. SDS-PAGE showing the trial 
cleavage experiment of MBP from DsdC1 using Factor Xa over 24 hours. The 
black arrows indicate the DsdC-MBP complex and the singular MBP and DsdC 
proteins. 
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4.4 Validating DsdC binding through electrophoretic 
mobility shift assays (EMSA) 
The ability of DsdC to bind to regions of the CFT073 and CE10 genome, as 
indicated by the ChIP-Seq data, was assessed using purified DsdC protein and the 
EMSA technique. EMSAs detect protein-DNA interactions in vitro and relies on 
the observation that protein-DNA complexes run slower in electrophoresis than 
free nucleic acid (Hellman & Fried, 2007). Regions of the CFT073 and CE10 
genome that had been bound by DsdC in the ChIP-Seq experiment were 
amplified by PCR and DIG-labelled using the DIG gel shift kit (Roche). The DNA 
regions were then mixed with increasing concentrations of purified DsdC 
(CFT073), DsdC1 (CE10), or DsdC2 (CE10). EMSA analysis confirmed that DsdC 
bound to its own promoter region, and DsdC1 and DsdC2 also bound to the LPS 
glycosyltransferase gene, waaV (Fig. 4-6 and 4-7). 
 
Figure 4-6 DsdC binds to the intergenic region upstream of the dsdC start 
codon. EMSA assay of DsdC1 (CE10), DsdC2 (CE10) and DsdC (CFT073) binding to 
the dsdC-dsdX intergenic region. Increasing concentrations of DsdC were used, 
as indicated by the triangle above the gel. DNA retardation was observed with 
the DsdC-DNA complexes remaining at the top of the gel whilst the free DNA ran 
further down the gel. EMSA experiments were performed in duplicate, with 
similar results obtained each time. 
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Figure 4-7 DsdC binds to the region upstream of the waaV start codon. EMSA 
assay of DsdC1 (CE10) and DsdC2 (CE10) binding to the waaV-waaW region. 
Increasing concentrations of DsdC were used, as indicated by the triangle above 
the gel. DNA retardation was observed with the DsdC-DNA complexes remaining 
at the top of the gel whilst the free DNA ran further down the gel. EMSA 
experiments were performed in duplicate, with similar results obtained each 
time. 
These results correlated with previous findings that DsdC was able to bind to its 
own promoter, typical of a LTTR (Nørregaard-Madsen et al., 1995). DsdC1 and 
DsdC2 were also shown to bind to the LPS glycosyltransferase gene, waaV. 
Together these data implied that DsdC was able to bind to regions of the 
genome outside of the dsdC-dsdXA intergenic region, validating the ChIP-Seq. 
Strikingly however, no other sites were able to be validated by EMSA. Indeed, 
multiple regions identified from the ChIP-Seq were tested including espX4, kpsF, 
neuO, fimB, clbR, neuB, gadB, and envR, however no shifts in DNA were 
observed in the presence of DsdC (Fig. 4-8). Both cleaved and intact MBP-DsdC 




Figure 4-8 EMSAs did not show binding of DsdC to ChIP-Seq identified regions. 
(A) EMSA assay showing no DsdC binding to the predicted DsdC binding site for 
neuO. Increasing concentrations of DsdC were used, as indicated by the triangle 
above. (B) EMSA assay showing no DsdC binding to the predicted DsdC binding 
site for kpsF. Increasing concentrations of DsdC were used, as indicated by the 
triangle above. (C) EMSA assay showing no DsdC binding to the predicted DsdC 
binding site for clbR. Increasing concentrations of DsdC were used, as indicated 
by the triangle above. (D) EMSA assay showing no DsdC binding to the predicted 
DsdC binding site for neuB. Increasing concentrations of DsdC were used, as 
indicated by the triangle above. A positive DNA retardation control was used in 
the form of the dsdC-dsdX intergenic DNA and a negative control of using ctx 
DNA, a gene absent in E. coli. EMSA experiments were performed in duplicate, 
with similar results obtained each time. 
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4.5 Elucidating the binding motif of DsdC 
Although the resolution of ChIP-Seq is high and gives vast amounts of information 
regarding potential binding sites, it does not give sufficient resolution to resolve 
the binding motif at the nucleotide level. DNase I footprinting is a technique 
that detects protein-DNA interaction by subjecting DNA to digestion by DNase I. 
DNA that is bound by the protein, will be protected from digestion, thereby 
revealing the specific binding motif of the protein (Galas & Schmitz, 1978). As 
discussed in Chapter 1, LTTRs typically bind as dimers in two distinct places in 
the promoter region; at a regulatory binding site (RBS) -35 to +20 bp and at an 
activation binding site (ABS) -40 to -20 bp (Fig. 4-9) (Goethals et al., 1992;  
McFall et al., 1998). They often bind to a palindromic DNA sequence, referred to 
as the LTTR box, consisting of a T-N11-A sequence, which is present at the RBS 
site but not the ABS site. To elucidate the binding motif of DsdC, the dsdC-dsdX 
intergenic region was radiolabelled and using purified MBP-DsdC, a DNase I 
footprint was performed. This was performed at the University of Birmingham in 
conjunction with Dr Douglas Browning, who completed the experiment. 
 
Figure 4-9 A graphical representation of LTTR binding. LTTRs typically bind as 
dimers in two distinct places within a promoter region, in the RBS (regulatory 
binding site) and the ABS (activation binding site), adapted from Maddocks & 
Oyston, 2008. 
The DNase I footprint revealed two distinct binding sites of DsdC within the 
dsdC-dsdX intergenic region, as indicated in Figure 4-10. The first protected site 
was a 19 bp region that overlapped the predicted -10 site of dsdC, as predicted 
by RegulonDB. This site contained a putative T-N11-A LTTR box. The second 
protected site was a 47 bp region that was closer to the start codon of dsdC. 
This site contained two putative LTTR boxes, a T-N24-A LTTR box and a 
secondary T-N11-A LTTR box further along the region. Strikingly, addition of D-
serine to the footprint caused a reduction in binding to the second protected 
region. These results revealed the novel binding motif for DsdC and suggested 
that D-serine influences the strength of DsdC binding to target promoters. 
 152 
 
Figure 4-10 Elucidating the binding motif of DsdC. (A) DNase I footprinting 
analysis revealed the protected region (red) of the CE10 genome, where DsdC1 
(CE10 derived) and DsdC2 (CE10 derived) were bound to the dsdC1-dsdX1 region, 
in the presence and absence of D-serine (lanes 2-6). Lanes 1 and 4 indicate no 
protein controls and lane 7 indicates uncut fragment. (B) Organisation of the 
intergenic region between dsdC and dsdX. Nucleotides in bold signify the start 
codon of the gene above. Nucleotides underlined in green signify the -10 and -35 
region of dsdX as reported by Nørregaard-Madsen, Mcfall and Valentin-Hansen, 
(1995). Nucleotides underlined in purple signify the -10 and -35 region of dsdC as 
predicted by RegulonDB. Nucleotides in bold and in red signify the protected 
region of the genome, revealing the binding motif of DsdC. Highlighted above 
the binding motifs are potential DsdC LTTR binding boxes of T-N24-A and T-N11-A. 
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4.6 Discussion 
4.6.1 Differential gene expression of LPS and capsular 
biosynthesis genes validates the RNA-Seq data 
The RNA-Seq data reported in Chapter 3 revealed there was differential 
expression in 30 genes in the pairwise comparison between CE10 WT and 
DDdsdC1/2, upon exposure to D-serine. Strikingly, most of these genes were 
involved in capsular and LPS biosynthesis, two key virulence determinants of 
NMEC. RT-qPCR was used to measure the differences in transcript levels in four 
genes related to the capsule and LPS, and thus demonstrated the validity of the 
RNA-Seq data (Table 4-1). These results further indicated that DsdC plays a role 
in regulation of NMEC specific pathogenic traits, repressing expression of 
capsular and LPS biosynthesis genes, whilst activating expression of neuO, an O-
acetyltransferase. 
Furthermore, RT-qPCR analysis was carried out on two colibactin genes, clbR 
and clbA. Colibactin is a bacterial genotoxin that can be produced by UPEC 
strains and is synthesised by genes encoded on a 54-kb genomic island 
(Nougayrède et al., 2006). clbR and clbA are transcribed divergently from the 
main operon, with clbR the master regulator of colibactin production 
(Wallenstein et al., 2020). Examination of the clb region in the RNA-Seq data 
revealed poor coverage and so no analysis could be made in regard to 
differential expression of the colibactin synthesis genes between the CFT073 WT 
and DdsdC. RT-qPCR analysis of clbR revealed a 2-fold increase in gene 
expression between DdsdC mutant and WT, which further increased to 4.58-fold 
upon exposure of D-serine. This data implies that DsdC represses the colibactin 
synthesis activator in CFT073, suggesting a novel role for DsdC in regulation of a 
bacterial genotoxin. 
The differential expression of the K1 capsular biosynthesis genes in CE10 and the 
colibactin synthesis genes in CFT073, in response to exposure to D-serine, 
further indicates that DsdC has been tailored for strain-specific lifestyles in 
ExPEC. Adapting to a specific niche within the host is a multifactorial process, 
often involving the alteration of carbon source intake and expression of 
virulence factors involved in host colonisation (reviewed in O’Boyle et al., 2020). 
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Virulence factors are often encoded on genetic islands (Ho-Sui et al., 2009), 
which is indeed the case for the K1 capsule and colibactin synthesis genes which 
reside on the kps and pks islands respectively (Nougayrède et al., 2006; Silver & 
Vimr, 1990). As genetic islands are often acquired through HGT, they must be 
integrated into a cells already established regulatory network (Perez & 
Groisman, 2009b). Ancestral TFs are therefore often repurposed and tailored to 
accommodate the newly integrated genomic islands (Perez & Groisman, 2009a; 
Connolly et al., 2019; reviewed in O’Boyle et al., 2020). As metabolism and 
virulence gene expression are two closely linked processes within the bacterial 
cell (reviewed in Poncet et al., 2009), hypothetically exposure to D-serine in the 
urinary tract and the brain, mediated through DsdC, may be used as signal to 
alter the regulation of colibactin and capsular biosynthesis, two key virulence 
factors of ExPEC. This is an interesting hypothesis which further chapters in this 
thesis will try and elucidate. 
4.6.2 DsdC shows direct binding to dsdCX and to the 
LPS glycosyltransferase gene, waaV 
DsdC is a LTTR, which in the past have generally been reported to be insoluble 
proteins (Ezezika et al., 2007). A common method to overcome protein 
insolubility is by using a fusion protein strategy. This involves cloning a gene of 
interest onto a plasmid that will increase the solubility. These plasmids often 
contain the genes encoding glutathione S-transferase (GST), thioredoxin A or 
MBP (Kapust & Waugh, 1999; Young et al., 2012). To purify DsdC, both an MBP 
and a 6xHis tag was used. Small-scale overexpression trials revealed that 1 mM 
IPTG was sufficient for overexpression of the recombinant protein, with both 
recombinant proteins appearing to be overexpressed at similar levels. 
The ChIP-Seq data reported in Chapter 3 revealed that DsdC bound to multiple 
regions of the CE10 and CFT073 genome. Indeed, it was shown that in CE10 DsdC 
bound to 217 regions and in CFT073 DsdC bound to 129 regions (Table 3-3). To 
validate the ChIP-Seq data, purified DsdC was used in EMSAs to detect binding to 
predicted regions. DsdC1 and DsdC2 (CE10) were shown to bind to the region 
upstream of the waaV gene and to the intergenic region between dsdCX, but not 
to any of the other ChIP-Seq predicted sites. DsdC (CFT073) was only shown to 
bind to the intergenic region between dsdCX. Although the ChIP-Seq data had 
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indicated multiple regions of DsdC binding, there are several explanations for 
why these were not evident in the EMSAs. Indeed, EMSAs are in vitro techniques 
and therefore environmental components required for native binding may have 
been absent. Additionally, LTTRs often require a co-inducer in order to bind 
(reviewed in Maddocks & Oyston, 2008), and although D-serine was tested in the 
EMSAs and did not appear to elicit an effect, the concentration may have been 
insufficient for facilitating in vitro binding. Further as TFs sometimes work in 
tandem with other TFs (Martínez-Antonio & Collado-Vides, 2003), potentially in 
vitro binding was not evident because a secondary TF was required. Indeed, it 
has been reported that DsdC and catabolite repressor protein (CRP) can co-
regulate the dsdXA locus, with CRP presence increasing expression of the genes 
7-fold (Nørregaard-Madsen et al., 1995). Furthermore, although crude 
preparations of protein are routinely used in EMSAs, the protein quality could 
have been affected by various enzymes still in the preparation, affecting the 
efficiency of the binding (Holden & Tacon, 2011). 
Conversely, although many of the ChIP-Seq binding sites were unable to be 
validated in vitro, DsdC binding was still shown in the upstream region of the 
waaV gene. Further, the RNA-Seq and RT-qPCR data revealed differential gene 
expression of waaV, indicating that DsdC directly regulates an LPS biosynthesis 
gene, a key virulence mechanism in NMEC. Suggested future studies to validate 
the ChIP-Seq could include testing a different solubility tag for DsdC 
overexpression, perhaps GST. Moreover, further steps could be performed in the 
purification of DsdC, such as size exclusion chromatography and post tag 
cleavage. These future studies may then be able to validate more of the ChIP-
Seq results presented here. 
4.6.3 Elucidating the DNA binding motif of DsdC using 
DNase I footprinting 
Although the ChIP-Seq analysis revealed a wealth of information regarding DsdC 
binding, it did not reveal the specific binding motif of DsdC. LTTRs often 
function as tetramers, binding as dimers at the RBS and ABS site within the 
intergenic region upstream of the promoter (McFall et al., 1998; Schell, 1993). 
Typically, LTTRs have been found to protect large regions of DNA, often 
between 50-60 bp (Muraoka et al., 2003). LTTRs often bind to a palindromic DNA 
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sequence, termed the LTTR box, consisting of the sequence T-N11-A, although 
this can vary both in size and nucleotide composition (Goethals et al., 1992). 
Conversely, it has recently been suggested that LTTRs rely heavily on DNA shape 
rather than on nucleotide sequence when recognising target DNA (Dorman et al., 
2020). Strikingly, the DsdC footprint revealed two distinct protection sites in the 
intergenic region between dsdC-dsdX. The first protected site was 19 bp in 
length and contained a putative A-N11-T box. This site was closer to the start 
codon of dsdX and could indicate the potential binding region of DsdC when 
regulating dsdXA. The second protected region was 47 bp in length, indicative of 
a tetramer binding. This region contained two putative LTTR boxes, T-N24-A and 
T-N11-A. This site was closer to the start codon of the dsdC gene and could 
indicate the binding region of DsdC to its own promoter. Indeed, this was further 
indicated when D-serine was added to the reaction. LTTRs are known to 
negatively auto-regulate themselves, with transcription occurring when the 
protein has been dissociated from the promoter, often because it is interacting 
with the co-inducer (reviewed in Maddocks & Oyston, 2008). D-serine addition to 
the footprint caused a reduction in binding to the secondary protected region, 
suggesting that DsdC had been dissociated from the promoter region. Therefore, 
using DNase I footprinting, the DsdC binding motif has been elucidated. It is a 47 
bp binding region, likely indicating that DsdC binds as a tetramer, in conjunction 
with other LTTR reports. 
4.6.4 Conclusion 
To survive in fluctuating and competitive environmental conditions, bacteria 
maintain gene expression under tight regulatory control. Such is the importance 
of gene regulation, E. coli has devoted 6% of its genome to encoding gene 
regulatory elements and encodes up to 300 putative TFs (Martínez-Antonio & 
Collado-Vides, 2003). As discussed in Chapter 3, ChIP-Seq and RNA-Seq are both 
powerful global tools that can be used in an unbiased manner to elucidate a TFs 
regulon. These tools were used to elucidate the regulon of DsdC in CE10 and 
CFT073, revealing that DsdC bound in a global manner to multiple regions of the 
genome, and upon exposure to D-serine, affected the expression of 30 genes in 
CE10. In this chapter, using RT-qPCR, the RNA-Seq data was validated, 
demonstrating differential expression of LPS and capsular biosynthesis genes in 
the CE10 DDdsdC1/2 background. Furthermore, differential gene expression of 
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the colibactin synthesis genes in the CFT073 DdsdC background was revealed, 
indicating a potential role of DsdC in colibactin synthesis. Using EMSAs, two of 
the ChIP-Seq binding peaks were validated and it was demonstrated that DsdC 
directly binds to an LPS glycosyltransferase gene, a key virulence factor in 
NMEC. Moreover, using DNase I footprinting, the binding motif of DsdC was 
elucidated, revealing a 47 bp region close to the dsdC start codon, indicating 
that DsdC binds as a tetramer. These results combined further highlight that 
DsdC plays a larger role in gene regulation beyond D-serine metabolism and 
further suggests that DsdC has been tailored in ExPEC strains for strain-specific 
lifestyles.
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Chapter 5 DsdC influences susceptibility of 
neonatal meningitis-associated Escherichia coli 
strain CE10 from K1 bacteriophages, through the 





Gene expression is a tightly regulated process in bacteria, often governed by 
environmental signals and cues. In Chapters 3 and 4, the novel roles of DsdC in 
CFT073 and CE10 gene regulation were discussed. Intriguingly, it was discovered 
that DsdC bound and altered gene expression of capsular and LPS biosynthesis 
genes in CE10 in the presence of the host metabolite, D-serine. The LPS and 
capsule are a bacterium’s first line of defence against the host immune system, 
and thus are deemed two key virulence factors in a bacterium’s arsenal. There 
are over 70 distinct capsular (K) antigens found in E. coli (Jann & Jann, 1992), 
however, the K1 antigen is often over-represented in NMEC infection (Robbins et 
al., 1974). The K1 capsular polysaccharide is comprised of Neu5Ac polysialic 
acid, and has been reported to play a role in NMEC’s ability to evade 
phagocytosis and enhance serum resistance (reviewed in Silver & Vimr, 1990; 
Croxen & Finlay, 2010). Furthermore, molecular mimicry of the host polysialic 
acid of N-CAM, results in the poor immunogenicity and enhanced survival of the 
K1 capsule strains within the host (reviewed in Silver & Vimr, 1990). Moreover, 
the K1 capsule is also phase variable, with the polysialic acids that comprise the 
capsule able to O-acetylate (Orskov et al., 1979). 
Strikingly, irrespective of D-serine presence, neuO was one of the most 
downregulated genes in the CE10 DDdsdC1/2 transcriptomics in relation to the 
CE10 WT. NeuO is a capsular O-acetyltransferase that was first described in E. 
coli in 2005 by Deszo et al., (2005). O-acetylation of capsular polysaccharide is a 
mechanism used by many bacteria and fungi including Streptococcus 
pneumoniae, Neisseria meningitidis and Cryptococcus neoformans (reviewed in 
O’Meara & Alspaugh, 2012; Geno et al., 2015; Tzeng, Thomas & Stephens, 2016). 
Considerable research has been performed in N. meningitidis where O-
acetylation has been shown to be involved in protection from serum bactericidal 
activities, immunogenicity and physiology (Fusco et al., 2007), indicating O-
acetylation plays a role in virulence in N. meningitidis. Conversely, in E. coli the 
role of capsule O-acetylation has been less clear, with one study reporting O-
acetylated strains had an increased virulence in patients, whereas another study 
revealed no difference in virulence between O-acetylated and non-O-acetylated 
strains in a neonatal mouse model of infection (Colino & Outschoorn, 1999; Frasa 
et al., 1993). Further findings have suggested that O-acetylation may play more 
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of an environmental role, with strains that were O-acetylated enhancing 
desiccation resistance (Mordhorst et al., 2009). 
neuO, the O-acetyltransferase in E. coli, was originally described as being 
encoded on the prophage CUS-3, which is integrated in the NMEC genome in the 
hypervariable region between dsdC-argW (Deszo et al., 2005). NeuO-mediated 
O-acetylation is phase variable and is modulated by slipped strand mispairing 
(SSM) of 7 highly repeated nucleotides (5’-AAGACTC-3’). This contingency locus 
occurs at the start of the ORF of neuO, in a region termed the polyY region (Fig. 
5-1). Multiples of 3 heptanucleotides will result in an active protein; whereas 
loss or gain of anything other than 3 heptanucleotides will result in a 
translational frame shift, and in an inactive truncated protein. This chapter will 
discuss the role of DsdC in the regulation of the capsular O-acetyltransferase, 
neuO, and any phenotypes observed from this regulation using a K1 
bacteriophage killing assay. 
 
Figure 5-1 Phase variability of neuO. The phase variability of neuO is mediated 
by slipped strand mispairing of DNA during DNA replication. This often occurs in 
bacteria within regions of highly repeated nucleotides, with an example shown 
as the inset. This contingency locus occurs in the polyY region of neuO, at the 
start of the ORF. Multiples of 3 heptanucleotides (5’-AAGACTC-3’) result in an 
active protein. Loss or gain of anything over than 3 heptanucleotides results in 
an inactive, truncated protein. 
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5.2 The binding dynamics of DsdC on the neuO gene 
Comparative transcriptomics had revealed neuO, an O-acetyltransferase, was 
one of the most down-regulated differentially expressed genes in the CE10 data 
sets, irrespective of exposure to D-serine (Fig 3-23). Analysis of the CE10DsdC 
ChIP-Seq binding profiles revealed that DsdC bound in the ORF of neuO (Fig. 5-
2A). There also appeared to be a secondary peak, indicated by the gold dashed 
line on Figure 5-2(A), at the end of the gene. However, upon further analysis, 
the origin of the reads were unable to be confirmed as specific to that region. 
 
Figure 5-2 neuO binding dynamics. (A) DsdC1 and DsdC2 ChIP binding peaks for 
neuO, in the presence and absence of D-serine, are shown to be intragenic. The 
gold dashed line indicates the two binding peaks of DsdC for neuO. (B) A 
graphical representation of the two binding peaks of neuO. The peak to the left 
of the gold dashed line showed single reads mapping in both the forward (green) 
and reverse (red) direction. The peak to the right of the gold dashed line showed 
non-specific read mapping (yellow), indicating it matched to somewhere else on 









































5.3 NeuO is not carried on the mobile genetic element, 
CUS-3, in NMEC CE10 
Original reports stated that neuO was encoded on the prophage CUS-3, and was 
integrated within the RS218 genome, a prototypical NMEC K1 strain, in the 
hypervariable region between dsdC-argW (Deszo et al., 2005). Intriguingly, 
analysis of the CE10 genome revealed that neuO was encoded 2 mb upstream of 
dsdC (Fig. 3-14). Nucleotide BLAST analysis of the 40 kb CUS-3 genetic island 
from the RS218 genome against the CE10 genome revealed 38 out of the 59 
genes that encode CUS-3 had no similarity to any region in the CE10 genome. 
Using PHASTER, a database that identifies prophage sequences within the 
genome (Arndt et al., 2016), 15 prophage regions were identified in the CE10 
genome. This included a 16.2 kb region immediately upstream of neuO, between 
824561 and 840854 bp. This region was shown to carry an incomplete prophage 
of 15 genes. The incomplete prophage found had homology to the bacteriophage 
HK620. Using EasyFig (Sullivan et al., 2011), a linear BLAST comparison was 
made between CUS-3 in RS218 and the incomplete prophage in CE10 (Fig. 5-3). 
This analysis revealed homology at the start of the CUS-3 prophage and the 
incomplete prophage between neuO and the endosialidase gene. Further 
homology was revealed at the end of the CUS-3 prophage and the incomplete 
prophage, between several hypothetical proteins. However, there was no 
similarity between 37 genes in the central region of CUS-3. This suggests that if 
CUS-3 originally carried neuO into CE10, the phage has since been excised, 
although neuO has been retained. These results therefore indicate that neuO in 
CE10 is no longer linked to the prophage CUS-3. 
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Figure 5-3 neuO is not encoded on CUS-3 in the CE10 genome. Linear BLAST analysis using EasyFig revealed little to no homology over 
the central region of CUS-3 to the incomplete prophage of CE10, indicating CUS-3 has been lost, or was never present. Shaded blocks 
between sequences represent homologous regions, shaded according to BLASTn. Coloured arrows indicate GO functionality. 
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5.4 DneuO does not affect growth of CE10 
In order to establish if any future phenotypes found in the DdsdC mutants were 
mediated via NeuO, a DneuO mutant was generated in CE10 using the Lambda 
Red mutagenesis system, and provided by Dr James Connolly. To ensure there 
were no growth defects with the DneuO mutant that could contribute to any 
phenotypes observed, a growth curve was performed in M9 minimal media, in 
the presence and absence of D-serine, and qualitatively assessed (Fig. 5-4). The 
DneuO mutation appeared to have no effect on growth in M9 minimal media in 
comparison to the WT. neuO was also cloned into pACYC184 and transformed 
into DneuO, with the growth also comparable to the WT. 
 
Figure 5-4 Growth profiles of WT and DneuO mutant in M9 minimal media, in 
the presence and absence of D-serine. Growth curves of CE10 and isogenic 
mutants in M9 minimal media in the presence and absence of 1mM D-serine, 
measured as OD600 over time. Growth curves shown represent mean of triplicate 
experiments with error bars indicating SEM. 
5.5 NeuO transcription is regulated via DsdC and mediates 
protection against K1 bacteriophages 
The K1 capsule is a known barrier to many bacteriophages, including the lytic T7 
bacteriophage (Scholl et al., 2005). K1-specific phages, however, often carry 
endosialidases which have the ability to degrade the a2,8-linked polysialic acid 
capsule (Stummeyer et al., 2006). As the ChIP and RNA-Seq data had indicated 
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that DsdC was regulating neuO, it was hypothesised that this may affect the 
capsule and therefore the ability of the K1 bacteriophage to bind and lyse the 
cell. As previously described in Goh et al., 2017, a K1-specific bacteriophage 
was purchased from SSI Diagnostica, and the ability of the bacteriophage to lyse 









1 mM D-serine 
Figure 5-5 Quantification of viral titre in CE10 WT and isogenic mutants. The 
plaque forming units (PFU)/ml of the CE10 WT and isogenic mutants in (A) the 
absence of D-serine and (B) the presence of D-serine. The plaque assays were 
performed in triplicate with each replicate portrayed as a circle in the graph. 
Statistical non-paired Student’s t-tests were performed on GraphPad Prism 8, 
comparing isogenic mutants against the CE10 WT. ns denotes a p>0.05. 
Quantifying the viral titre showed the lytic effect the K1 bacteriophage was 
having upon CE10 and the DdsdC and DneuO isogenic mutants (Fig. 5-5). It was 
apparent from the PFU/ml, regardless of exposure to D-serine, there was no 
difference in the lytic activity of the K1 bacteriophage. It appears therefore that 
the K1 bacteriophage was lysing all of the bacteria comparably. However, 
although there was no difference observed in the phage titre results there was a 
difference in the size and morphology of plaques formed. Figure 5-6 shows the 


















CE10 DDdsdC1/2  CE10 DneuO 
Figure 5-6 DdsdC1 and DneuO present a large plaque phenotype. Images of phage plaques taken after infection on bacterial lawns of 
(A) CE10, (B) DdsdC1, (C) DdsdC2, (D) DDdsdC1/2, (E) DneuO. These images are representative of 3 independent experiments. Scale bars 
were generated on Fiji ImageJ software. (F) Quantitative analysis of plaque sizes measured in mm. 
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Statistical non-paired Student’s t-tests were performed on GraphPad Prism 8, 
comparing isogenic mutants against the CE10 WT. * denotes a p-£0.05; ns>0.05. 
Significant differences in mean plaque size were observed comparing WT (1.15 
mm) with DdsdC1 (3.6 mm), DDdsdC1/2 (3.65 mm) and DneuO (3.8 mm), but not 
DdsdC2 (1.6 mm). This indicated that NeuO plays a role in protection from K1-
bacteriophage induced lysis and that regulation of bacteriophage protection is 
likely DsdC1-specific. Further, there were also differences in the plaque 
morphology between samples. All of the plaques presented as clear, which is 
common for lytic phages, however some of the plaques formed on DdsdC1, 
DDdsdC1/2 and DneuO mutants contained haloes (Fig. 5-7). These larger plaques 
with haloes surrounding them were not present on either the CE10 WT or DdsdC2 
plaques over 3 biological replicates. These results indicated a difference in the 
plaque phenotype presented between the WT and DdsdC2 in comparison to 
DdsdC1 and DneuO. 
 
Figure 5-7 Representation of the haloes surrounding the plaques formed on 
DneuO. An image of haloes surrounding the plaques that were representative of 
plaques formed on DdsdC1, DDdsdC1/2 and DneuO mutants. The black arrow 
signifies the halo. 
The observation of a difference in phage plaque morphology suggested a 
difference in the K1 bacteriophage lytic lifestyle between WT and mutants 
(Abedon, 2021). A K1 bacteriophage killing assay, based on a method previously 
described in Goh et al., 2017, was therefore performed to assess the rate of lysis 
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in CE10 and isogenic mutants. Briefly, the bacteria were grown on a microtitre 
plate for 3 hours in M9 minimal media, ensuring they were in logarithmic phase, 
as can be seen in Figure 5-8. 1 µl of K1 phage suspension was added to the 
samples and OD600 was measured every 30 minutes for 3 hours. 
 
Figure 5-8 Growth profiles of WT and mutants in M9 minimal media, on a 
FLUOstar plate reader. Growth curves of CE10 and mutants in M9 minimal 
media, measured as OD600 over time on a FLUOstar Optima plate reader. Growth 
curves shown represent mean of triplicate experiments with error bars indicating 
SEM. 
Figure 5-8 shows the growth profiles of CE10 and mutants on the FLUOstar 
Optima plate reader, measured over 16 hours. Qualitative assessment of Figure 
5-8 revealed that the WT and mutants grew comparably, and therefore any 
effect observed in the K1 phage killing assay would be likely due to lysis by the 
bacteriophage. As lysis can start occurring quickly after addition of 
bacteriophage (Wang et al., 1996), the OD600 was measured every 30 minutes for 
3 hours (Fig. 5-9). Statistical non-paired Student’s t-tests were performed at 




Figure 5-9 NeuO protects against K1 bacteriophage lysis, mediated via DsdC1. 
A K1 bacteriophage killing assay was performed on CE10 and isogenic DdsdC and 
DneuO mutants. (A) Two distinct WT phenotypes emerged in the K1 
bacteriophage killing assay; WT colonies that could survive K1 bacteriophage-
mediated lysis (blue) and WT colonies that couldn’t (purple). OD600 of the 
samples measured 1.5-hours PI of K1 bacteriophage. (B) OD600 of the samples 
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measured 1.5- and 3-hours PI of K1 bacteriophage. (C) K1 bacteriophage killing 
assay measured as OD600 over time. The samples were measured every 30 
minutes PI of K1 bacteriophage for 3 hours. Statistical non-paired Student’s t-
tests were performed using GraphPad Prism on (A) and (B), comparing infected 
samples to uninfected samples. * denotes p£0.05; ** p£0.01; *** p£0.001; **** 
p£0.0001; ns p>0.05. 
Strikingly, the K1 bacteriophage killing assay revealed two distinct phenotypes 
from the clonal CE10 WT population (Fig. 5-9(A)); one set that was almost 
completely lysed, and one set that had no significant difference in killing in 
comparison to the non-infected sample. Through SSM of the polyY region, NeuO 
is phase variable. Therefore, NeuO can either be in a “phase ON” state and O-
acetylating the capsule, or in a “phase OFF” state and no O-acetylation of the 
capsule occurs. Sequencing of the WT colonies revealed those that were 
associated with higher levels of protection from the K1 bacteriophage were 
NeuO “phase ON” and those that were almost entirely lysed were NeuO “phase 
OFF” (Table 5-1). These results indicated that the phase variation of NeuO 
mediates protection against K1 bacteriophage-mediated lysis. 
Figure 5-9(B) shows the K1 bacteriophage killing results 1.5- and 3-hours PI. At 
1.5-hours, significant differences were observed when comparing non-infected 
to infected samples in WT “phase OFF”, DdsdC1, DDdsdC1/2 and DneuO 
colonies. Conversely, DdsdC2 infected with K1 bacteriophage showed no 
significant killing in comparison to the non-infected sample, nor did the WT 
“phase ON” colonies. At 3-hours PI, WT “phase OFF” colonies were almost 
entirely lysed and the DdsdC1, DDdsdC1/2 and DneuO mutants were fully killed. 
Significant differences were also observed between non-infected and infected 
WT “phase ON” and DdsdC2 colonies at this time point. Figure 5-9(C) shows the 
growth dynamics of CE10 and isogenic mutants in the K1 bacteriophage killing 
assay, measured every 30 minutes PI. Killing of the DdsdC1, DDdsdC1/2 and 
DneuO mutants occurs within 30 minutes PI. By 4.5 hours they are almost 
completely lysed, with complete lysis occurring at hour 5. WT “phase OFF” 
colonies behave similarly to DdsdC1 and are lysed by hour 5.5. WT “phase ON” 
colonies and the DdsdC2 mutant were not killed as quickly and there was still 
survival at hour 6 (3 hours PI). 
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These data corresponded with the plaque size assays, which showed that 
DdsdC1, DDdsdC1/2 and DneuO mutants all presented significantly larger plaques 
in comparison to the WT and DdsdC2 mutant. These data combined potentially 
implies that O-acetylation of the capsule, mediated by NeuO, is used by the cell 
to stop K1 bacteriophage-mediated lysis. This protection is transient however, 
with the NeuO “phase ON” colonies starting to be lysed at 3-hours PI. These data 
also implies that neuO regulation is DsdC1-specific, with DsdC2 not eliciting the 
same “hyper-susceptibility” to K1 bacteriophage. To determine if it was a DsdC1 
and NeuO mediated phenotype, pDsdC1 and pNeuO were transformed into 
DdsdC1 and DneuO. Furthermore, as pDsdC1 and pNeuO contained their 
respective native promoter sequences, the GapA promoter region was also 
assembled onto the 5’ end of neuO and cloned into pACYC184 for the K1 
bacteriophage killing assay. This was performed in order to elicit a greater 
transcriptional response of neuO. 
 
Figure 5-10 Complementation of NeuO restores protection against K1 
bacteriophage-mediated lysis. A K1 bacteriophage killing assay measured as 
OD600. (A) pDsdC1 transformed into DdsdC1, measured 1.5-hour PI; (B) pNeuO 
and pGapAp-NeuO transformed into DdsdC1, measured 1.5-hour PI; (C) pNeuO 
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and pGapAp-NeuO transformed into DneuO, measured 1.5-hour PI. Statistical 
non-paired Student’s t-tests were performed using GraphPad Prism 8 between 
uninfected sample and infected sample, and further between infected sample 
and infected sample with the complement plasmid. * denotes p£0.05; ** p£0.01; 
*** p£0.001; **** p£0.0001; ns p>0.05. 
Figure 5-10 (A) shows the complementation of pDsdC1 in the DdsdC1 background 
did not restore protection against the K1 bacteriophage. Therefore, a strategy 
was devised in which to assemble the GapA promoter onto DsdC1 in place of its 
native promoter in order to facilitate a strong constitutive transcription. 
However, this work is still ongoing. Figure 5-10 (B) and (C) show pNeuO 
complemented back into DdsdC1 and DneuO with its native promoter and also 
with the GapA promoter. pNeuO restores moderate protection from the K1 
bacteriophage in the DdsdC1 background (Fig. 5-10B). pGapAp-NeuO was able to 
give greater protection and in both mutant backgrounds there was significant 
protection from the K1 bacteriophage, compared to the infected sample (Fig. 5-
10B/C). These data therefore suggests that NeuO, when sufficiently over-
expressed, can protect the cell from K1 bacteriophages. Furthermore, as the 
pGapAp-NeuO complement had restored some protection from the K1 
bacteriophage in the phage killing assay, the phage plaque size assay was 
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Figure 5-11 Complementation of pGapAp-NeuO restores the phage plaque 
size phenotype to WT levels. Complementation of pGapAp-NeuO in DdsdC1 and 
DneuO restored the small plaque phenotype that was observed on the CE10 WT 
bacterial lawn. Images of phage plaques taken after infection on bacterial lawns 
of (A) CE10 WT; (B) DneuO; (C) DdsdC1 + pGapAp-NeuO; (D) DneuO + pGapAp-
NeuO. Images are representative of three independent experiments. Scale bars 
were generated on Fiji ImageJ software. (E) Quantitative analysis of phage 
plaque sizes. Statistical non-paired Student’s t-tests were performed using 
GraphPad Prism 8. * denotes p£0.05; ** p£0.01; *** p£0.001; **** p£0.0001; ns 
p>0.05. 
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Complementing pGapAp-NeuO into the DdsdC1 and DneuO mutants restored the 
small phage plaque size that was characteristic of infection on CE10 WT lawns 
and revealed no significant difference in plaque size between WT and 
complement (Fig. 5-11). Moreover, it was demonstrated that there was a 
significant difference in plaque size between DdsdC1 and DneuO mutants, and 
the pGapAp-NeuO complemented mutants (Fig. 5-11E). Furthermore, the 
complementation also removed the halo effect that had been seen on the 
DdsdC1 and DneuO bacterial lawns. When all of these data are combined, a 
DsdC1-specific regulatory role over neuO starts to emerge. It appears as though 
NeuO, an O-acetyltransferase, regulated through DsdC1, is able to mediate 
protection against K1 bacteriophages. 
5.5.1 Phase variation of neuO influences susceptibility 
to K1 bacteriophage killing 
As noted above during the K1 phage killing assays, two distinct phenotypes 
emerged from clonal CE10 WT populations: those that were protected against 
the K1 bacteriophage and those that were lysed in similar rates to the DdsdC1 
and DneuO mutants (Fig. 5-9A). Those colonies were sequenced and revealed 
those that were able to protect from the K1 bacteriophage-mediated lysis were 
NeuO “phase ON” and those that were lysed were NeuO “phase OFF” (Table 5-
1). 
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Table 5-1 Sequencing results of the NeuO polyY region in 10 CE10 WT 
colonies. Sequencing results of the first 192 nucleotides (64 codons) of the NeuO 
polyY region in 10 independent CE10 WT colonies. Six frame translation from 
the ATG start codon revealed the amino acid sequence and consequently the 
“phase ON/OFF” status of the colony. The red stars indicate a stop codon. The 
blue and green “SRLKTQD” amino acids indicate the polyY region. The number 
of 5’-AAGACTC-3’ heptanucleotides in each polyY region of NeuO is also 
indicated. 
Table 5-1 revealed the differences in sequence variability of the NeuO polyY 
region of the CE10 WT colonies. Indeed, although any multiple of 3 
heptanucleotides would result in a “phase ON” colony, all “phase ON” colonies 
were 18 heptanucleotides long. Further, again, although any loss or gain of other 
than 3 heptanucleotides would result in a “phase OFF” colony, all the “phase 
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OFF” colonies were either 17 or 19 heptanucleotides long. As phase variation is 
described as a random event (Henderson et al., 1999); the percentage of CE10 







      Sequencing data 
 
  
      Experimental data 
Figure 5-12 Graphical representation of the number of CE10 WT NeuO “phase 
ON” and “phase OFF” colonies. Number of NeuO “phase ON” and “phase OFF” 
colonies from (A) sequencing data and (B) experimental data from the K1 
bacteriophage killing assay. 
The number of “phase ON” colonies identified appeared to be greater than the 
number of “phase OFF” colonies (Fig. 5-12). In the experimental data, a colony 
was deemed “phase OFF’ if it had been completely lysed or mostly lysed by hour 
6 (3 hours PI). Populations that were protected from the K1 bacteriophage-
mediated lysis were deemed “phase ON”. From 31 K1 phage killing experiments, 
68% were “phase ON” (21/31), whereas “phase OFF” colonies accounted for 32%. 
The sequencing data revealed a similar proportion of “phase OFF” colonies (40% 
(4/10)), whereas 60% (6/10) where “phase ON”. 
5.5.2 Phase variation affects transcriptional levels of 
neuO 
An RT-qPCR comparison of neuO in the DdsdC1 mutant background, in relation to 
the CE10 WT, showed a 4.3-fold reduction in expression (Fig. 5-13A). However, 
the p-value was not significant at 0.051. As the phase state of NeuO had 
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affected the CE10 WT phage killing assay, it was hypothesised that it may also 
have an effect on observable transcript levels. For this experiment, colonies 
were deemed “phase ON” or “phase OFF” due to prior survival or lysis in the K1 
bacteriophage killing assay. 
 
Figure 5-13 Phase variation of NeuO affects transcriptional expression. Phase 
variation affects the transcription of neuO. (A) The WT was a mixed population 
of “phase ON” and “phase OFF” colonies. (B) Individual expression values for the 
colonies used in (A). (C) The WT was a population of “phase OFF” colonies. (D) 
The WT was a population of “phase ON” colonies. The purple dashed line 
indicates baseline expression of neuO in CE10 WT. Gene expression analyses 
were based off three biological repeats. * denotes p£0.05; ** p£0.01; *** 
p£0.001; **** p£0.0001; ns p>0.05. 
Figure 5-13 indicated that the phase variation of NeuO in the CE10 WT affected 
transcriptional expression. Indeed, when the WT was a mixed population, there 
was no significant difference in fold changes in the DdsdC1 and DDdsdC1/2 
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backgrounds, -4.32 (p-value 0.051) and -3.64 (p-value 0.1) respectively (Fig. 5-
13A). However, when three “phase ON” colonies were used, there was a 
significant reduction in expression of neuO -42.35-fold (p-value 0.0004) in the 
DdsdC1 background and -35.51-fold (p-value 0.0004) in the DDdsdC1/2 
background (Fig. 5-13D). Moreover, when three WT “phase OFF” colonies were 
used as the control, neuO expression was reduced to -2.75-fold (p-value 0.006) 
and -2.28-fold (p-value 0.01) in the DdsdC1 and DDdsdC1/2 backgrounds 
respectively (Fig. 5-13C). Although these colonies were not sequenced, it is clear 
that the WT and DdsdC2 colonies have variable levels of neuO transcript, 
whereas the DdsdC1 and DDdsdC1/2 colonies did not (Fig 5-13B). Here it has 
been shown that the WT and DdsdC2 display both high and low levels of neuO 
transcript, whereas DdsdC1 was consistently low. This is consistent with the 
previous findings of variation in the CE10 and DdsdC2 backgrounds, in the K1 
bacteriophage killing assay, compared to the relative consistency of the DdsdC1 
and DDdsdC1/2 backgrounds that was observed. Due to the consistency observed 
from DdsdC1 in the K1 bacteriophage assay and consistently low levels of neuO 
transcript, it was hypothesised that potentially the extent of NeuO phase 
switching was playing a role in the DdsdC1 phenotype. To test this, 10 DdsdC1 
and 10 DdsdC2 colonies were sequenced at the NeuO polyY region.
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11  DdsdC2_1 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_2 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_3 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_4 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_5 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_6 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_7 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_8 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_9 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 






11  DdsdC2_10 MSRLKTQDSRLKTQDSRLKTQDSRLKTQDS
RLKTQDSRLKTQDSFSIDDNGSGNIFVCGD
LVNS… 
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Table 5-2 Sequencing results of the NeuO polyY region in 10 CE10 DdsdC1 and DdsdC2 colonies. Sequencing results of the first 192 
nucleotides (64 codons) of the NeuO polyY region in 10 independent CE10 DdsdC1 and DdsdC2 colonies. Six frame translation from the 
ATG start codon revealed the amino acid sequence and consequently the “phase ON/OFF” status of the colony. The red stars indicate a 
stop codon. The number of 5’-AAGACTC-3’ heptanucleotides in each polyY region of NeuO is also indicated. 
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The data contained within Table 5-2 revealed that all of the DdsdC1 mutants 
that were sequenced were “phase OFF” whereas all of the DdsdC2 mutants were 
“phase ON”. Intriguingly, all of the DdsdC1 “phase OFF” colonies were 11 
heptanucleotides long, whereas the DdsdC2 “phase ON” colonies were all 18 
heptanucleotides long. The proportion of experimentally determined DdsdC1 and 
DdsdC2 NeuO “phase ON” and “phase OFF” colonies from the K1 bacteriophage 






        CE10 DdsdC1 
 
         CE10 DdsdC2 
Figure 5-14 DdsdC1 is constituently NeuO “phase OFF”. Number of NeuO 
“phase ON” and “phase OFF” colonies from the K1 bacteriophage killing assay 
experimental data for (A) DdsdC1 and (B) DdsdC2. 
Using the K1 bacteriophage killing assay data, “phase ON” and “phase OFF” 
states were assigned to the DdsdC1 and DdsdC2 mutants. A colony was deemed 
“phase OFF” if it had been completely lysed or mostly lysed by hour 6 (3 hours 
PI). Those that were still able to mediate protection from the K1 bacteriophage 
were deemed “phase ON”. Figure 5-14 revealed all of the DdsdC1 colonies were 
NeuO “phase OFF”. By hour 6, the cells had been completely lysed in 100% of 
experiments (17/17). This corresponds with the sequencing data, where 100% of 
the colonies sequenced were “phase OFF”. It appears therefore that DdsdC1 has 
a permanently “phase OFF” NeuO. Conversely, for the DdsdC2 mutant, although 
it appeared in the sequencing data that all of the colonies were “phase ON”, in 
the phage killing assay there were two occasions out of 44 were DdsdC2 colonies 
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were “phase OFF” (4.5%). Although this is significantly lower than the WT “phase 
OFF” variability of ~32%, it does imply that the DdsdC2 mutant may also be able 
to undergo phase switching, but at a lower rate. Taken together, these data 
suggests that DsdC1 directly regulates the phase state of neuO, however the 
underlying mechanism of this regulation was not investigated and will be subject 
to further work. 
5.6 Discussion 
5.6.1 The CUS-3 prophage is not present in the CE10 
genome 
When neuO was first described in 2005, it was suggested to be genetically linked 
to the prophage CUS-3 (Deszo et al., 2005). CUS-3 was integrated into the RS218 
genome in the hypervariable region between dsdC and argW. Indeed in the 
results reported, the strains lacking CUS-3, lacked O-acetyltransferase activity 
(Deszo et al., 2005), thereby suggesting without CUS-3, neuO was not present on 
the genome. Further studies revealed that CUS-3 was an active mobile 
contingency locus in K1 E. coli, able to infect sensitive K1 hosts (King et al., 
2007); thereby disseminating neuO further into the population. However, a later 
study of 111 K1 clinical isolates revealed that although 61% carried the neuO 
gene, 11% of those NeuO-positive strains lacked CUS-3 (King et al., 2007). This 
indicated for the first time that CUS-3 has been potentially excised or lost from 
these strains, leaving neuO, or that neuO was potentially integrated into the 
genome on a different MGE. PHASTER analysis of the CE10 genome revealed 15 
different genomic regions in which prophages had been identified, including an 
incomplete prophage of 16.2 kb between nucleotide positions 824561-840854 bp, 
immediately upstream of the endosialidase gene and neuO. PHASTER analysis 
revealed the phage with the closest homology was the HK620 phage. HK620 
phages encode a tail-spike protein and can recognise host cell receptor 
polysaccharides in E. coli (Barbirz et al., 2008). Intriguingly, CUS-3 has been 
reported to be a close relative of HK620, differing in CUS-3’s acquisition of neuO 
and the endosialidase gene (King et al., 2007). 
Further BLAST analysis, using EasyFig, revealed homology between the 
incomplete prophage and CUS-3 at the start and at the end of the prophage, 
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with 37 genes in the centre having no homology (Fig. 5-3). As the PHASTER 
analysis revealed, the incomplete prophage is only 16.2 kb long, which indicates 
that it is not big enough to be a different prophage to CUS-3 and is likely 
therefore to be either a degraded CUS-3, or neuO is encoded on a separate MGE 
(Touchon et al., 2016). Due to the high homology between the two prophage 
regions, this potentially indicates that neuO was likely integrated into the CE10 
genome on CUS-3, however CUS-3 has subsequently been lost. Indeed, over 
time, prophage genes can be lost from the genome and prophages can be 
degraded so much that the few genes remaining can no longer be characterised 
as a prophage (Touchon et al., 2016). Analysis of bacterial genomes revealed 
that after successful lysogenisation into the bacterial host, prophages undergo a 
complex decay, consisting of genomic rearrangements, inactivation of genes due 
to point mutations, and modular exchanges (Canchaya et al., 2003). This 
“domestication” of prophages allows the bacteria to retain desired functions, 
which in the case of neuO is the ability to O-acetylate the capsule, whilst 
removing a molecular “time bomb” (Bobay et al., 2014). Further, analysis has 
indicated that genes encoded in the central part of the prophage are more 
frequently deleted than genes at the edges (Bobay et al., 2014), which appears 
to be the case in the incomplete prophage in CE10 and further indicates that 
CUS-3 originally integrated into the CE10 genome, but has since been lost. 
However, neuO has been retained, suggesting its importance to CE10. 
5.6.2 DsdC regulates neuO, the O-acetyltransferase 
Using the ChIP-Seq analysis it was shown that DsdC, the D-serine metabolism 
locus regulator, binds to the DNA sequence encoding NeuO, the O-
acetyltransferase. Interestingly the binding peak of DsdC1 and DsdC2 in neuO 
was in the ORF of the gene. As discussed in section 3.6.2, intragenic binding 
peaks have become more common in the analysis of ChIP-Seq data sets and this 
could be for a multitude of reasons (Galagan et al., 2012). Often however it is 
only repressors that bind after the TSS, with one study showing the binding sites 
of activators only occurred before the TSS (Babu & Teichmann, 2003b). This 
suggests therefore that DsdC is repressing neuO. However, directly testing this 
hypothesis using transcriptomics and RT-qPCR data contradicts this assumption, 
as in the DDdsdC1/2 mutant background neuO is down-regulated, indicating that 
DsdC is an activator of neuO. 
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Transcription is a tightly controlled process within bacteria and is often 
regulated in response to environmental signals and cues. Investigating the 
regulation of neuO by DsdC in the presence and absence of D-serine, revealed 
new insights into the role of this metabolite. The RNA-Seq data presented in 
Chapter 3 revealed that in the absence of D-serine, neuO expression was 
reduced -7.9-fold in the DDdsdC1/2 mutant background. Upon exposure to D-
serine, the fold-change increased to -4.57-fold, indicating that when D-serine 
was present, DsdC reduces its activation of neuO. However, when pDsdA was 
transformed into DDdsdC1/2, neuO expression decreased -8.15-fold, similar to 
the neuO levels of transcript observed in the absence of D-serine data. This 
suggests that the accumulation of D-serine affected the transcription of neuO, 
rather than exposure to D-serine. Overall, this indicated that DsdC regulates 
neuO independently of D-serine presence. 
As discussed above, O-acetylation of the capsule can change the biophysical 
properties of the capsular polysaccharides (Fusco et al., 2007), as well as 
potentially affecting the virulence status of the bacterial cell (Frasa et al., 
1993). Intriguingly, non-enzymatic acetylation has been suggested to be in 
response to environmental signals and the metabolism status of the cell 
(reviewed in Christensen et al., 2019). Indeed, depending on the concentrations 
of glucose, lactate, fructose, and xylose, these carbon sources have all been 
reported to potentially affect acetylation in E. coli (reviewed in Christensen et 
al., 2019). As DsdC is the D-serine metabolism locus regulator, this could 
indicate a putative link between O-acetylation of the capsule and the host 
environment. 
5.6.3 NeuO mediates protection from K1 
bacteriophage lysis in CE10 
Prophages that encode receptor modifying enzymes often do so to prevent 
further phage entry into the host bacterial cell, thereby stopping bacteriophage 
“super-infections” (reviewed in Labrie, Samson & Moineau, 2010). Indeed, a 
recent study reported that 29 out of 30 prophages that could infect 
Pseudomonas aeruginosa mediated resistance to at least 3 phages (Bondy-
Denomy et al., 2016). Furthermore, 12 of these phages had the capacity to 
mediate resistance to over 20 different phages (Bondy-Denomy et al., 2016). 
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From the CE10 genome sequence, it indicated that neuO appeared to have been 
integrated into the genome by a MGE (Fig. 5-3). To test the hypothesis that 
NeuO-mediated O-acetylation modifies the bacteriophage receptor on the 
capsule surface, and this in turn is regulated by DsdC, a K1 bacteriophage titre 
and killing assays were performed on CE10 and isogenic mutants. 
The common assumption is that each plaque present on a plate is initiated by a 
single virus particle (Gallet et al., 2011). As can be seen in Figure 5-5, there was 
no significant difference between the ability of the K1 bacteriophage to form 
plaques on CE10 and isogenic mutants. Therefore, it was assumed that the K1 
bacteriophage is able to infect CE10 and the mutants at similar frequency. 
Strikingly however, there was a difference between WT and some of the mutants 
in plaque size and morphology (Fig. 5-6). Circular plaque morphology is due to a 
cycle of infections of the bacterial cell by bacteriophages disseminating 
outwards from the original infected host (Gallet et al., 2011). All of the plaques 
formed by the K1 phage were clear and had a clean periphery, typical for lytic 
virulent phages (Jurczak-Kurek et al., 2016). However, some of the plaques 
formed on DdsdC1, DDdsdC1/2 and DneuO had haloes surrounding them (Fig. 5-
7). Haloes have been described as semi-transparent zones around the plaque, 
which have been suggested to be formed by phage-produced depolymerases, 
which are destroying the bacterial cell surface structures (Jurczak-Kurek et al., 
2016; Pires et al., 2016). Bacteriophages produce degrading enzymes, for 
example sialidases, in order to cleave the glycosidic bonds in the capsule, 
enabling adsorption and invasion into the host bacteria (Pires et al., 2016). 
Intriguingly, O-acetylation of bacterial cell wall polysaccharides have been 
shown to increase resistance to degradative enzymes (Bernard et al., 2011). As 
the haloes indicated an increase in depolymerase activity of the K1 
bacteriophage on the DdsdC1, DDdsdC1/2 and DneuO bacterial lawns, this 
indicated that potentially these mutants were unable to O-acetylate their 
capsule, thus allowing for increased depolymerisation. 
Furthermore, there was also a difference in the size of the plaques formed. 
Plaques formed on DdsdC1, DDdsdC1/2 and DneuO were significantly larger than 
plaques formed on CE10 WT and DdsdC2 (Fig. 5-6). A recent paper classed 
plaques that were £1 mm in size as ‘small’ and plaques that were ³2 mm as 
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‘large’ (Montso et al., 2019). Clearly, the data presented here shows that the 
plaques formed on the WT and DdsdC2 were small-medium, whereas the plaques 
formed on DdsdC1, DDdsdC1/2 and DneuO were large plaques. As phage 
replication often ceases when the bacteria reach stationary phase (Abedon, 
2021), the size of a plaque can reveal several interesting characteristics of the 
behaviour of the bacteriophage. Although larger plaques could be due to a 
number of reasons including, shorter phage latent periods, virion physical 
properties and greater nutrient availability (Abedon, 2021), it was assumed due 
to the conditions staying constant between all of the experiments, that the only 
difference was the mutations in the bacterial hosts, and corresponding changes 
in the capsule. Therefore, the size of plaque likely corresponded to how quickly 
the virion diffused out of the initial infected cell and subsequent bacterial lysis. 
K1 bacteriophages use tailspike proteins, that act as capsule depolymerases, to 
recognise and bind to the host bacterial capsular polysaccharide (Stummeyer et 
al., 2006). O-acetylation of bacterial outer surface structures has been shown to 
effect phage adsorption, with acetyl groups on the O-antigen protecting E. coli 
4s from infection (reviewed in Prokhorov et al., 2017). Furthermore, some 
bacteriophages have counter-evolved enzymes that can deacetylate the cell 
surface structures, thereby allowing infection (Prokhorov et al., 2017). The 
bacteriophage G7C encodes the tailspike protein gp63.1, which can deacetylate 
the polysaccharide of E. coli 4s, whilst leaving the polysaccharide backbone 
intact (Prokhorov et al., 2017), thus enabling recognition and subsequent 
infection of the cell. These results therefore potentially indicate that the O-
acetylation of the K1 capsule, mediated by the O-acetyltransferase NeuO and 
activated by DsdC1, inhibits K1 bacteriophage dissemination in CE10, evidenced 
by the smaller plaque sizes observed in the WT and DdsdC2 mutant. 
Furthermore, using a K1 bacteriophage killing assay, it was shown that DneuO 
and DdsdC1 were “hyper-susceptible” to the K1 bacteriophage and almost 
entirely lysed 1.5-hours PI, whereas the WT and DdsdC2 were not lysed until 3-
hours PI (Fig. 5-9). This again further supports the hypothesis that NeuO, 
regulated by DsdC1, modifies the K1 capsule by O-acetylation of the polysialic 
acid, thereby preventing immediate lysis by the K1 bacteriophage. Furthermore, 
overexpression of NeuO partially restored the survival phenotype observed of the 
WT (Fig. 5-10) and fully restored the plaque size phenotype observed on the WT 
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bacterial lawn (Fig. 5-11). These data combined suggests that neuO regulation is 
a DsdC1-mediated specific phenotype, not facilitated by DsdC2, showing 
different roles for these highly homologous TFs. 
Strikingly, original work by Vimr and colleagues suggested that NeuO did not 
mediate protection against K1 bacteriophages (King, Steenbergen & Vimr., 
2007). However, the data presented here clearly supports the hypothesis that 
NeuO mediates protection against K1 bacteriophages. The differences in data 
reported could be due to the differences in genetic makeup between the two 
strains. Vimr and colleagues used the strain RS218, which has the full CUS-3 
prophage including neuO encoded on its genome, unlike CE10 which has a 
degraded incomplete prophage. Further, neuO is integrated downstream of dsdC 
in RS218, whereas in CE10, neuO is integrated 2 mb away from dsdC. These 
differences in genetic makeup may have led to the observation that NeuO does 
not protect against K1 bacteriophage, and further highlights how even highly 
conserved genes may play differing roles in strains of the same pathotype. 
NeuO was also shown to be responsible for protection against K1 bacteriophage 
lysis, due to the two different WT phenotypes that arose from the phage killing 
assay. It was established through sequencing that the WT colonies that were 
able to protect against K1 bacteriophage were “phase ON”, whereas the WT 
colonies that were not able to protect against K1 bacteriophage were “phase 
OFF”. Phase variation of the capsule is not uncommon, indeed as stated above, 
it is a mechanism used by multiple bacteria and fungi. Why though, if O-
acetylation of the capsule prevents K1 bacteriophage-mediated lysis, is the 
capsule not O-acetylated all of the time? Certainly, it has been reported that the 
degree of acetylation can vary between isolates, ranging from 5-95% (King, 
Steenbergen & Vimr., 2007). However, by modifying capsular states by phase 
variation, this allows bacteria to evade specific immune responses against one 
capsule form. The K1 polysialic capsule mimics host N-CAM surfaces, thus 
minimising immune responses from the host (Silver & Vimr, 1990). However, 
further heterogeneity of the population, mediated through O-acetylation of the 
capsule, means that in an event of antibody recognition to one phase state, the 
other will survive and proliferate (Van Der Woude & Bäumler, 2004). Further, 
recent research has suggested that O-acetylation plays a role in environmental 
survival, with O-acetylated strains more resistant to desiccation, but having a 
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reduced ability to form biofilms (Mordhorst et al., 2009). Therefore, like most 
phase variable genes there is a delicate balance between phase switching, likely 
in relation to the host environment. 
5.6.4 Phase variation as a putative indirect 
mechanism of transcriptional regulation of neuO 
The data above suggests that a DsdC1-specific regulatory mechanism mediates 
transcription of neuO. Interestingly however, the RT-qPCR data suggested that 
phase state of the colonies correlated with the level of transcription of neuO 
(Fig. 5-13). Indeed, when the WT population was a mix between “phase ON” and 
“phase OFF” colonies, there was a -4.32 decrease in fold change of neuO 
between WT and DdsdC1. However, when the WT population was selected for 
only “phase ON” colonies, there was a decrease in fold change of -42.35 
between WT and DdsdC1. Moreover, when the WT population was comprised of 
“phase OFF” colonies the fold change was -2.75. Although these colonies were 
not sequenced, they were determined to be “phase ON” or “phase OFF” using 
the K1 bacteriophage killing assay. 
This suggests therefore that phase variation affects transcription of neuO. In 
CE10, it is the random event of SSM that causes NeuO to be “phase ON” or 
“phase OFF”. SSM commonly occurs in genes that benefit from phase variation 
between “ON” and “OFF” states, such as those involved the production of 
antigenic surface appendages. Indeed, SSM occurs in the Neisseria spp. for phase 
variation of the capsule (reviewed in Tzeng, Thomas & Stephens, 2016). SSM can 
affect transcription or translation, dependent on where the repeated 
homologous regions are (Henderson et al., 1999). The SSM of neuO occurs within 
the ORF of the gene, and hence, alters the reading frame of the mRNA 
produced. SSM also causes phase variation of the N. meninigitis capsule, 
mediated via the polysialyltransferase gene siaD (Hammerschmidt et al., 1996). 
Interestingly, it has been reported that transcription of the “phase OFF” siaD 
can be prematurely terminated (Lavitola et al., 1999). It was shown that Rho, 
the canonical transcription termination factor, was responsible for premature 
transcription termination of the out of frame siaD (Lavitola et al., 1999). 
Potentially therefore, a similar mechanism is occurring in CE10, and the “phase 
OFF” neuO is prematurely transcriptionally terminated, thereby explaining how 
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phase variation is affecting the transcriptional levels in the RT-qPCR. 
Interestingly it appears from this data that DsdC1 affects the SSM of NeuO. When 
DdsdC1 is knocked out, this caused neuO to remain in a “locked off” position 
(Table 5-2).  
5.6.5 Conclusion 
It has been stated that up to 50% of prokaryotic genes may have arisen from 
gene duplication (Brenner et al., 1995; Teichmann et al., 1998; Teichmann & 
Babu, 2004). In 2006, it was noted that in K1 strains, there were two genetically 
unlinked copies of the dsdCXA locus, with both copies retaining functionality for 
metabolising D-serine (Moritz & Welch, 2006). When TFs evolve by duplication, 
regulatory networks are either inherited or lost (Teichmann & Babu, 2004). 
Although Chapter 3 indicated that, in CE10, DsdC1 and DsdC2 regulated the same 
set of genes, the results presented in Chapter 5 have revealed novel differing 
roles between the highly homologous proteins. Indeed, the data in Chapter 5 has 
revealed novel phenotypical properties of DsdC1 in E. coli K1 pathogenicity. The 
data presented here have shown that DsdC1 mediates protection from K1 
bacteriophage lysis, through the regulation of neuO, likely therefore affecting 
the O-acetylation state of the capsule and thus blocking K1 bacteriophage 
receptors. This work indicates that DsdC1 has been tailored in CE10 in a strain-
specific manner.
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Chapter 6 Investigating further putative roles of 
DsdC in uropathogenic Escherichia coli and 
neonatal meningitis-associated Escherichia coli   
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6.1 Introduction 
Whilst E. coli is an incredibly diverse species, a key virulence trait shared by all 
E. coli is the presence of the LPS (Ebbensgaard et al., 2018). LPS is an integral 
element of the E. coli outer membrane, protecting the cell from the host 
environment and providing resistance to host complement (Heinrichs et al., 
1998; Lerouge & Vanderleyden, 2002). E. coli LPS comprises of three 
components: lipid A (the hydrophobic anchor that is embedded in the cell outer 
membrane); the core oligosaccharide (core OS) composed of sugar molecules; 
and the O-antigen, a structurally variable polysaccharide composed of several 
repeating side chains (Whitfield et al., 1999). There are over 170 O-antigen 
serogroups that have been found in E. coli, reflecting the hypervariability of the 
polysaccharide (Whitfield et al., 1999). Conversely, there is much less structural 
diversity within the core OS, with only 5 currently known outer core OS 
structures in E. coli; R1, R2, R3, R4, and K12 (Whitfield et al., 1999). In E. coli, 
the core OS biosynthesis genes are encoded on the waa locus (Heinrichs et al., 
1998). Analysis of the CE10DsdC ChIP-Seq data revealed that DsdC bound to the 
waa locus. Furthermore, upon exposure to D-serine, the transcriptomic data 
revealed that several of the waa genes were differentially regulated, indicating 
a direct regulatory role for DsdC in LPS biosynthesis. 
Another key virulence determinant for some E. coli strains is the presence of an 
extracellular polysaccharide layer, the capsule. There are over 70 distinct 
capsular (K) antigens in E. coli, differing in several properties including sugar 
residues, branching and charge density (Jann & Jann, 1992). The capsule is of 
particular biological importance, with some K-antigens known to play roles in 
immune evasion and serum resistance (Jann & Jann, 1992). In E. coli, a ~20 kb 
region encodes the capsule biosynthesis genes, termed the kps island (Silver & 
Vimr, 1990). The kps island is organised into three adjacent genomic regions: 
Regions 1, 2 and 3 (Vimr et al., 1995). Regions 1 and 3 are generally conserved 
amongst group 2 capsule expressing strains, and encode for proteins involved in 
the transport of the capsular polysaccharides to the cell surface, whereas Region 
2 is serotype specific, and therefore in K1 strains it encodes the sialic acid 
biosynthesis proteins (reviewed in Whitfield & Roberts, 1999). The capsule is 
transcribed from two major promoter elements, PR1 and PR3, that sit upstream 
of Regions 1 and 3 respectively (reviewed in Jia et al., 2017). Comparisons of 
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the CE10 ChIP-Seq and RNA-Seq data had revealed DsdC differentially expresses 
genes encoded on the kps island, thus indicating a direct regulatory role for 
DsdC in K1 capsule synthesis. 
As well as protecting themselves from the host environment through LPS and 
capsule synthesis, E. coli can mediate pathogenesis by the production of toxins. 
Colibactin is a bacterial-produced genotoxin that interferes with the eukaryotic 
cell cycle, inducing DNA double stranded breaks (DSB) and cellular senescence 
(Secher et al., 2013). Colibactin-producing E. coli are over-represented in CRC 
patients, with reports suggesting they are found in up to 67% of CRC patients, 
but in less than 20% of controls (reviewed in Faïs et al., 2018). The colibactin 
synthesis genes are encoded on a 54-kb island, termed the pks island 
(Nougayrède et al., 2006), and is mainly carried in the B2 phylogroup, which 
typically comprise ExPEC strains (reviewed in Faïs et al., 2018). ClbR is the 
transcriptional activator for colibactin gene expression and is encoded within 
the pks island (Wallenstein et al., 2020). Analysis of the CFT073DsdC ChIP-Seq and 
RT-qPCR data revealed DsdC bound and differentially regulated clbR, thus 
indicating a direct role of DsdC in colibactin synthesis. 
In Chapter 5, it was described how DsdC affected the regulation of neuO, the 
capsule O-acetyltransferase. Using a combination of the ChIP-Seq and RNA-Seq 
data, as indicators of potential regulation, this chapter will focus on any further 
phenotypes that were mediated by DsdC and the host metabolite D-serine in 
CE10 and CFT073; namely LPS expression in CE10, invasion and adhesion to an in 
vitro BBB cell model, and colibactin synthesis in CFT073. 
6.2 DsdC modulates discrete genes involved in CE10 
lipopolysaccharide expression 
As discussed above, E. coli LPS comprises of three components: lipid A, core OS, 
and the O-antigen (Yethon et al., 2000). Using the CE10 ChIP-Seq data, DsdC was 
shown to occupy several sites along the core OS biosynthesis region, the waa 
locus, binding in a broad manner across the region (Fig. 6-1A). Nucleotide 
analysis of the waa region in the UPEC strain CFT073 revealed that the region 
was A:T-rich, with the GC content comprising between 33-38% of the sequence 
(Fig. 6-1C). BLAST analysis of the waa region revealed 99% homology over 100% 
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of the sequence between CFT073 and CE10, indicating that the waa region in 
CE10 is also A:T-rich. The waa locus is comprised of several glycosyltransferases 
which sequentially elongate the core OS from a lipid A acceptor molecule, to the 
O-antigen attachment (Fig. 6-1B) (Heinrichs et al., 1998). 
 
Figure 6-1 Expanded view of the ChIP-Seq peaks at the waa locus and 
representation of the E. coli LPS core OS structure. (A) An expanded view of 
the ChIP-Seq peaks from CE10DsdC1 and CE10DsdC2, with and without D-serine, at 
the waa LPS core OS biosynthesis region. (B) Adapted from Yethon et al., 2000. 
An overview of the sugar residues in the core OS and some of the core enzymes 
that modulate it. The blue rectangles indicate ketodeoxyoctonate; yellow 
rectangles indicate L-glycero-D-manno-heptose sugars; red rectangles indicate 
phosphates; grey rectangle indicates 2-aminoethyl phosphate; green rectangles 
indicate D-glucose and salmon rectangles indicate D-galactose sugar residues. 
(C) GC content of the waa locus genes in CFT073. BLAST analysis of the CFT073 
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waa locus to CE10 revealed 99% homology over 100% of the sequence. Adapted 
from xBase (Chaudhuri & Pallen, 2006). 
Silver staining assays can be used to define LPS profiles, revealing any 
differences in core OS or O-antigen formation (Fomsgaard et al., 1990; Tsai & 
Frasch, 1982). A silver staining assay was therefore performed to determine the 
LPS profiles of CE10 and the DDdsdC1/2 mutant, in the presence of D-serine (Fig. 
6-2). 
 
Figure 6-2 DsdC modifies the LPS of CE10. Silver-stained LPS profiles from five 
biological replicates of CE10 and DDdsdC1/2, in the presence of D-serine. Black 
arrows indicate differences in intensity in O-antigen repeat units. 
Figure 6-2 showed the difference in LPS profiles between CE10 and DDdsdC1/2, 
in the presence of D-serine. The intense bands at the bottom of the gel 
represented the core OS and lipid A, and was present in all of the samples. The 
bands above the core represented the number of repeating O-antigen units in 
the samples. The DDdsdC1/2 LPS profiles appeared to have two bands that were 
thicker than in the WT LPS profiles, indicated on Figure 6-2 by two black arrows. 
This difference in banding intensity suggests that DsdC may be playing a role in 
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modifying the LPS of CE10, potentially altering the number of O-antigen repeats 
that are present on the cell surface. 
6.3 Further potential roles of DsdC in CE10 K1 capsule 
regulation 
Further to regulating neuO, the capsule O-acetyltransferase, DsdC was observed 
binding to other genes involved in the synthesis of the K1 capsular 
polysaccharide in CE10 (Fig. 6-3A). Figure 6-3(A) highlighted the two types of 
binding patterns that were observed in the ChIP-Seq data. In the intergenic 
region before kpsF and kpsM, there was a single canonical TF binding peak. 
However, within Region 2 of the kps island, DsdC bound in a broad manner, 
encompassing many of the genes. Nucleotide analysis of the kps island in UTI89, 
another K1 E. coli strain, revealed that Region 2 was heavily A:T-rich, with the 
GC content comprising between 26-32% (Fig. 6-3B). A BLAST analysis of the 
entire kps pathogenicity island between UTI89 and CE10 revealed 99% homology 
over 94% of the sequence, indicating that Region 2 in CE10 is also A:T-rich. 
As the ChIP-Seq data had revealed DsdC binding in the two major promoter 
elements of the K1 capsule pathogenicity island, RT-qPCR was performed on 
kpsF and kpsM to measure the changes in gene expression between CE10 WT and 
DDdsdC1/2, in the presence and absence of D-serine (Fig.6-3C). Intriguingly, in 
the DDdsdC1/2 mutant, expression of kpsF was 1.7-fold higher (p-value 0.002) in 
relation to the CE10 WT (Fig. 6-3C). Upon exposure to D-serine, this increased to 
2.5-fold higher (p-value 0.001) (Fig. 6-3C). This data implies that DsdC directly 
represses kpsF, the first gene in the Region 1 kps pathway. Furthermore, kpsM 
was expressed 4.6-fold higher in the DDdsdC1/2 mutant, in the presence of D-
serine, in relation to the CE10 WT (Fig. 6-3C). However, in the absence of D-
serine, there was no difference in expression of kpsM between CE10 WT and 
DDdsdC1/2, suggesting accumulation of D-serine may have led to increase in 
kpsM gene expression described above. 
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Figure 6-3 Expanded view of the ChIP-Seq peaks at the kps K1 capsular 
biosynthesis region and relative expression of kpsF and kpsM. (A) An 
expanded view of the ChIP-Seq peaks from CE10DsdC1 and CE10DsdC2, with and 
without D-serine, at the kps K1 capsular biosynthesis region. The three genomic 
regions of the K1 capsule are annotated: Region 1 in red and inclusive of genes 
from kpsF to kpsS; Region 2 in orange and inclusive of genes from neuS to neuB; 
and Region 3 in blue, inclusive of the genes kpsT and kpsM. The two major 
promoter elements are represented by the green curved arrows, which indicate 
the direction of transcription, adapted from Jia et al., 2017. (B) GC content of 
the kps locus genes in UTI89. BLAST analysis of the UTI89 kps locus to CE10 
revealed 99% homology over 94% of the sequence. Adapted from xBase 
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(Chaudhuri & Pallen, 2006). (C) RT-qPCR analysis of the kpsF and kpsM K1 
capsular genes. Fold changes were measured relative to the CE10 WT, with the 
purple dashed line indicating baseline expression of kpsF and kpsM genes in CE10 
WT. * indicates a p-£0.05; ** indicates a p-£0.01; **** indicates a p-£0.0001. 
6.3.1 Adhesion and invasion of cultured brain 
microvascular endothelial cells does not appear to be 
mediated by DsdC 
Although the full role of the NMEC K1 capsule has not been completely 
elucidated yet, it is thought to be involved in invasion and adhesion of the BBB 
in humans (Xie et al., 2004). The adhesion and invasion capacities of CE10 and 
isogenic mutants were therefore measured. An in vitro brain microvascular 
endothelial cell line, hCMEC/D3, was used as a BBB model to measure invasion 
and adhesion levels of CE10 and isogenic mutants. Adhesion and invasion assays 
were carried out by incubating hCMEC/D3 cells with bacteria at an MOI of 100 
for 2 hours. An MOI of 100 was used based upon prior NMEC in vitro research 
(Kim, 2000). 
 
Figure 6-4 DsdC does not affect invasion or adhesion efficiency of CE10 in an 
in vitro BBB model cell line. Using the hCMEC/D3 brain microvascular 
endothelial cell line, the percentage of (A) invasion efficiency and (B) adhesion 
efficiency was measured in CE10, DDdsdC1/2 and DneuO against the total 
bacterial count (adherent, invasive and unattached). The hCMEC/D3 cells were 
incubated with bacteria at an MOI of 100, for 2 hours. Cells for the adhesion 
assay were lysed and bacterial counts performed. Cells for the invasion assay 
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were treated with gentamicin and grown for a further hour. Cells were lysed and 
bacterial counts performed. An unpaired Student t-test measurement was 
performed between the WT and isogenic mutants for each assay; p-³0.05 were 
non-significant (ns). Data presented is from three independent biological 
repeats. 
Of the total bacterial count, CE10 DDdsdC1/2 displayed an invasion efficiency of 
~0.002% to the hCMEC/D3 cell line. This was not significantly different to the 
percentage of invasion displayed by the WT, nor DneuO (Fig 6-4A). Furthermore, 
there was no apparent difference in the percentage of adhesion efficiency for 
DDdsdC1/2 compared to the WT (Fig. 6-4B). Of the total bacterial count, ~20% of 
WT and DDdsdC1/2 adhered to the hCMEC/D3 cell line, and ~36% of DneuO. 
These results indicate that any alterations to the polysialic acid K1 capsule, 
mediated by DsdC, did not affect the adhesion and invasion capabilities of CE10 
in an in vitro cell line model. 
6.3.2 DsdC does not appear to affect serum resistance 
The K1 polysialic acid capsule is known to be involved in protection against host 
complement-mediated killing, providing a steric barrier to the cell (Miajlovic & 
Smith, 2014). To establish if modification of the K1 capsule by DsdC was involved 
in host complement-mediated killing, a serum resistance assay was performed 
on CE10 and DdsdC mutants, with K12 used as a serum sensitive positive control. 
Bacteria were incubated for 90 minutes with either PBS or human serum. 
Bacterial colony counts were then performed (Fig. 6-5). 
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Figure 6-5 DsdC does not appear to affect serum resistance in CE10. Serum 
resistance was measured in K12, CE10, and CE10 isogenic mutants. Bacteria 
were incubated with PBS (P) or human serum (S) for 90 minutes, at a 1:1 
concentration, and bacterial counts were performed (CFU/ml). (A) An unpaired 
Student t-test was performed on the K12, CE10 and CE10 isogenic mutant 
bacterial counts (CFU/ml (Log10)) between PBS incubation and serum incubation.  
No significant difference was observed in the bacterial colony counts between 
CE10 WT incubated in PBS, compared to CE10 WT incubated in human serum 
(Fig. 6-5). This correlates with previous data that NMEC protects against host 
complement-mediated killing. Furthermore, no differences were observed in the 
bacterial colony counts in the isogenic mutants that were incubated in PBS 
compared to those incubated in human sera (Fig. 6-5). This implies that any 
modification of the capsule via regulation by DsdC, does not play a role in serum 
resistance.  
6.4 The role of DsdC in regulating expression of genes 
involved in colibactin synthesis 
Colibactin is a bacterial genotoxin that is produced by some strains of E. coli 
(Faïs et al., 2018). Recent work in our lab has shown that D-serine can reduce 
the genotoxic effects caused by colibactin, however the mechanism for this 
remains unknown (Hallam et al., unpublished). Intriguingly, the CFT073 ChIP-Seq 
data revealed binding of DsdC, upstream of the clbR gene (Fig. 6-6). 
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Furthermore, the RT-qPCR transcriptional data showed a 4.6-fold increase in 
expression of clbR in the DdsdC mutant plus D-serine background (p-value 
0.0003) (Fig. 4-2A); indicating that DsdC, upon exposure to D-serine, represses 
clbR and thus colibactin synthesis, thereby reducing the damaging genotoxic 
effects inflicted upon the cell. To understand the role of DsdC in colibactin 
synthesis, an in vitro genotoxin infection model was used. 
 
Figure 6-6 Expanded view of the clbB-clbR ChIP-Seq peak. An expanded view 
of the ChIP-Seq peak from CFT073DsdC, in the presence and absence of D-serine, 
at the clbB-clbR intergenic region. 
6.4.1 Experimental design and transcriptional analysis 
of colibactin genes 
Colibactin synthesis can be measured in vitro using the eukaryotic model cell 
line, HeLa (Nougayrède et al., 2006). Infection of HeLa cells by colibactin-
producing E. coli results in DNA DSB, which can be measured indirectly through 
the phosphorylation of histone H2AX, and by the induction of megalocytosis, 
characterised by enlargement of the HeLa cell (Nougayrède et al., 2006). As 
UPEC already encodes several different protein toxins (Welch, 2016), the model 
commensal strain for colibactin synthesis, Nissle 1917, was used to assess if DsdC 
was affecting colibactin synthesis. A nucleotide BLAST comparison revealed that 
CFT073 dsdC and Nissle 1917 dsdC were highly conserved with 100% conservation 
across 91% of the sequence. A DdsdC mutant was therefore generated in Nissle 
1917. Growth profiles of Nissle 1917 and isogenic DdsdC mutant were performed 
to qualitatively assess growth in both M9 minimal media and MEM-HEPES, the 
media in which the in vitro infection assay would be performed. Furthermore, to 
ensure the Nissle DdsdC mutation had been successful, Nissle DdsdC was grown 
on 10 mM D-serine sole carbon source plates, with the expectation that it would 
not be able to metabolise D-serine and therefore no growth would be observed. 
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Moreover, dsdC was transformed into pACYC184 and complemented into Nissle 
DdsdC, with the expectation this would restore any growth defects observed in 
the DdsdC mutant. 
 
Figure 6-7 Growth profiles of Nissle WT and DdsdC. Growth curves of Nissle WT 
and DdsdC in (A) M9 minimal media and (B) MEM-HEPES media, supplemented 
with 1 mM of D-serine, measured as OD600 over time. Growth curves shown 
represent mean values of triplicate experiments with error bars indicating SEM. 
(C) Growth profile of Nissle WT, DdsdC, and DdsdC + pDsdC on sole carbon 
source plates supplemented with 10 mM D-serine. 
In M9 minimal media, when D-serine was present, the DdsdC mutant was unable 
to grow (Fig. 6-7A/C). From this data, it was implied that without the DsdC 
regulator, D-serine metabolism could not occur in Nissle 1917. Furthermore, 
when pDsdC was complemented into the DdsdC mutant, the growth phenotype 
was restored (Fig. 6-7C). Intriguingly, in M9 minimal media without D-serine, 
upon deletion of the DsdC regulator, there was a qualitative difference in 
growth between Nissle WT and the DdsdC mutant, with the DdsdC mutant 
appearing to grow faster than the WT (Fig. 6-7A). This phenotype was not 
observed in MEM-HEPES, where Nissle WT and the DdsdC mutant grew 
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comparably (Fig. 6-7B). Upon exposure to D-serine, there was a slight difference 
in growth, with Nissle WT proliferating faster from hour 5 (Fig. 6-7B). 
In Chapter 4, the expression of genes involved in colibactin synthesis had been 
measured using RT-qPCR in CFT073 (Fig. 4-2). This data revealed that clbR 
expression was 2-fold higher in the DdsdC mutant (p-value 0.0003), and 4.6-fold 
higher in the DdsdC mutant (p-value 0.0003) upon exposure to D-serine, in 
comparison to the CFT073 WT. As the in vitro infection would be performed with 
the Nissle 1917 strain, RT-qPCR was performed to measure the fold changes in 
gene expression of three genes involved in colibactin synthesis: clbR, the 
transcriptional regulator of colibactin synthesis; clbA, a phosphopantethinyl 
transferase; and clbB, a non-ribosomal peptide synthetase. The RT-qPCR was 
performed in M9 minimal media and MEM-HEPES on the Nissle WT and isogenic 
DdsdC mutant, in the presence and absence of D-serine. 
 
Figure 6-8 Relative expression of genes involved in colibactin synthesis. RT-
qPCR analysis of genes involved in colibactin synthesis in (A) M9 minimal media 
and (B) MEM-HEPES for Nissle WT and DdsdC, in the presence and absence of D-
serine. Fold changes were measured relative to the Nissle WT, with the purple 
dashed line indicating baseline expression of colibactin synthesis genes in Nissle 
WT. * indicates a p-£0.05; ** indicates a p-£0.01; **** indicates a p-£0.0001. 
Upon exposure to D-serine, expression of clbR in the DdsdC mutant in M9 
minimal media, was 2.5-fold higher than in Nissle WT (p-value 0.005) (Fig. 6-8A). 
This correlates with the transcriptional data obtained earlier in CFT073 where 
the fold change was 4.6-fold higher in DdsdC compared to WT (p-value 0.0003) 
(Fig.4-2). However, in M9 minimal media without D-serine, changes in expression 
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of clbR in the DdsdC mutant were not significant in relation to the Nissle WT 
(Fig.6-8A). This was in contrast to the CFT073 transcriptomic data, in which 
expression of clbR in the DdsdC mutant was 2-fold higher compared to the 
CFT073 WT (p-value 0.0003) (Fig.4-2). Expression of clbA, the 
phosphopantethinyl transferase also required for production of colibactin, was 
2.83-fold higher in the DdsdC mutant with D-serine in comparison to the Nissle 
WT (p-value 0.00002), which further correlates with the CFT073 data (Fig.6-
8A/Fig.4-2). Expression of clbA was also 1.4-fold higher in the DdsdC mutant in 
the absence of D-serine (p-value 0.04). This indicates that upon exposure to D-
serine in M9 minimal media, DsdC represses the expression of colibactin 
synthesis genes clbR and clbA. However, as clbR expression did not change in the 
DdsdC mutant and the change in clbA was only 1.4-fold increased, the changes in 
expression described above could be due to D-serine accumulation, rather than 
transcriptional effects mediated by DsdC. 
The expression of colibactin synthesis genes were also measured in MEM-HEPES, 
as the in vitro infection cell assay would be performed in this media. This data 
revealed that there was no significant difference in expression of clbR between 
the DdsdC mutant and Nissle WT in MEM-HEPES, in the presence or absence of D-
serine (Fig. 6-8B). This data indicated that DsdC is not regulating clbR. However, 
expression of clbA (-1.9-fold; p-value 0.007) and clbB (-2.4-fold; p-value 0.01) 
were both reduced in the DdsdC mutant in relation to the Nissle WT, indicating 
that DsdC is indirectly involved in the regulation of two colibactin synthesis 
genes. Expression of clbB was also -2.3-fold lower in the Nissle WT upon 
exposure to D-serine, in relation to the Nissle WT without D-serine (p-value 
0.051), correlating to previous data obtained in our lab. 
This data demonstrated that in different media, the expression of clbA and clbR 
changes in the DdsdC mutant compared to the Nissle WT. In MEM-HEPES, clbR is 
no longer differentially expressed by DsdC, indicating that DsdC does not 
regulate colibactin synthesis through the colibactin synthesis regulator. Thus, 
any differences therefore observed in the in vitro infection assay, would not be 
due to this regulatory mechanism. However, clbA and clbB, which are both also 
essential in colibactin synthesis, were repressed in the DdsdC mutant, suggesting 
that DsdC is involved in activation of colibactin synthesis in Nissle WT, in MEM-
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HEPES. As the in vitro infection assay will be performed in MEM-HEPES, the 
transcriptional data indicates that the DdsdC mutation may potentially 
exacerbate any phenotypes observed. 
6.4.2 DsdC does not appear to affect colibactin 
production in the in vitro infection assay 
Previous work from our lab has revealed that upon exposure to D-serine, 
colibactin synthesis is reduced (Hallam et al., unpublished). This was measured 
transcriptionally through the reduced expression of clbB in Nissle WT upon 
addition of D-serine. Furthermore, this was indirectly measured in vitro through 
Western blot analysis of the phosphorylated gH2A.X, a sensitive indicator of DNA 
DSB, and by the induction of megalocytosis (“giant cell phenotype”) in the HeLa 
cells. To understand the potential role of DsdC in colibactin synthesis, an in 
vitro infection assay was performed on Nissle WT and the DdsdC mutant, in the 
presence and absence of D-serine. Briefly, the megalocytosis phenotype was 
observed by infecting HeLa cells with bacteria at an MOI of 400 for 4 hours. The 
HeLa cells were then treated with gentamicin and incubated for a further 48 
hours, to elicit the genotoxic effect of colibactin. To measure, indirectly, the 
DNA DSB, the HeLa cells were infected with bacteria at an MOI of 400 for 4 
hours. The HeLa cells were then treated with gentamicin and incubated for a 
further 4 hours, before the cells were removed for Western blot analysis. The in 
vitro infection experiments were completed in co-ordination with a fellow PhD 
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Figure 6-9 DsdC does not affect induction of megalocytosis in HeLa cells. 
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Figure 6-9 DsdC does not affect induction of megalocytosis in HeLa cells. 
Using the HeLa model cell line, colibactin-induced megalocytosis was observed 
microscopically. HeLa cells were incubated with bacteria at an MOI of 400. 
Images are representative immunofluorescence images of HeLa cells, 48 hours 
after infection with (B) Nissle 1917, (C) Nissle ∆dsdC, (D) Nissle 1917 + D-ser, (E) 
Nissle ∆dsdC + D-ser and (A) uninfected. Filamentous-actin was stained with 
Phalloidin AlexaFlour 555 (red), and host nuclei stained with DAPI (blue). Images 
were taken at 40X magnification. 
Figure 6-9 shows the genotoxic effects of colibactin on the host cell. Infection of 
the HeLa cells by both Nissle and the ∆dsdC mutant caused the megalocytosis 
phenotype that is characteristic of colibactin production (Fig. 6-9B/C). No 
differences were observed between WT and ∆dsdC. Moreover, exposure to D-
serine to both Nissle WT and ∆dsdC infections, produced a cell phenotype more 
characteristic of the uninfected cells (Fig. 6-9A/D/E). This correlated with 
previous data from our lab, showing that addition of D-serine to Nissle inhibits 
colibactin production. The ∆dsdC mutant did not appear to show a difference in 
colibactin production, measured qualitatively through the megalocytosis 
phenotype, in comparison to the Nissle WT, with or without D-serine. 
As colibactin can induce DNA DSB in host cells, using the in vitro infection cell 
model, the concentration of phosphorylated histone g-H2A.X was measured using 
Western blot analysis. 
 
Figure 6-10 DsdC does not appear to affect induction of host DNA DSB. 
Western blot analysis of phosphorylated histone, g-H2A.X, in both uninfected 
HeLa cells and HeLa cells infected with Nissle and ∆dsdC, in the presence and 
 206 
absence of D-serine. b-tubulin was used as a loading control. This figure is 
representative of 3 biological repeats. 
Phosphorylated histone g-H2A.X is a sensitive marker of DNA DSB. Infection of 
both the Nissle WT and ∆dsdC mutant on the HeLa cells revealed an increase in 
phosphorylated g-H2A.X in relation to the uninfected cells, indicating DNA DSB 
have occurred within the cell (Fig. 6-10). Over three biological experiments, 
Western blot analysis revealed no difference between Nissle WT and the ∆dsdC 
mutant in regard to g-H2A.X expression (Fig. 6-10). Upon exposure to D-serine, 
there was a clear reduction in g-H2A.X in both the Nissle WT and ∆dsdC mutant, 
indicating that D-serine was repressing the genotoxic effects of colibactin. In the 
presence of D-serine, there did not appear to be a difference between the Nissle 
WT and ∆dsdC mutant in regard to g-H2A.X expression (Fig. 6-10). These data 
suggest therefore, that although there appeared to be direct binding and 
regulation of DsdC to clbR in the CFT073 background, this did not translate to a 
phenotype that showed a difference in the genotoxic effects of colibactin. 
6.5 Discussion 
6.5.1 DsdC modifies the O-antigen length of CE10 LPS 
A key virulence factor of E. coli is the LPS, which constitutes a major component 
of the outer cell envelope, covering ~75% of the cell surface area (reviewed in 
Lerouge & Vanderleyden, 2002). It is the O-antigen region of the LPS molecule 
that is exposed to the host environment, thus variation in O-antigen composition 
is an important mechanism for the bacteria to evade the host immune system 
(reviewed in Liu et al., 2020). Analysis of the ChIP-Seq binding data revealed 
occupancy of DsdC along the full waa operon, the major operon responsible for 
core LPS biosynthesis (Fig. 6-1A). Nucleotide analysis of this region revealed it 
was A:T-rich, with a GC content comprising between 33-38% of the sequence 
(Fig. 6-1C). The GC content amongst all strains of E. coli is relatively constant, 
~50% (Muto & Osawa, 1987); with CE10-specific GC content at 50.6% (Liu et al., 
2015). Differences in GC content in the genome can be due to the acquisition of 
“foreign” DNA by horizontal gene transfer (Mann & Chen, 2010). NAPs, for 
example H-NS, can bind to A:T-rich regions of the genome as a mode of gene 
regulation, silencing “foreign” genes (Grainger et al., 2006). As discussed in 
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section 3.6.5, DsdC has many similarities to NAPs. As the waa operon is A:T-rich, 
in comparison to the GC content of the CE10 genome, DsdC may be occupying 
the waa operon in a NAP-like manner, ensuring silencing of the operon. This 
correlates with the transcriptomic data which revealed expression of genes 
involved in LPS core OS biosynthesis (waaV, waaY, waaL, waaW, and waaT) were 
increased in the DDdsdC1/2 mutant in relation to the WT, in the presence of D-
serine, suggesting that DsdC directly represses the waa operon. 
As discussed previously, the waa operon is the major operon responsible for core 
OS biosynthesis (Heinrichs et al., 1998). Elongation of the LPS molecule is tightly 
regulated, and the assembly of sugars is mediated by a host of 
glycosyltransferases (Whitfield et al., 1999). One of the most significant DsdC 
binding peaks in the waa operon was in the region of a glycosyltransferase-
encoding gene, waaV (Table S3-6). WaaV has been shown to link the final sugar 
to the core region before the O-antigen is added by the O-antigen ligase, waaL 
(Yethon et al., 2000). Mutations of waaV have been shown to eliminate the 
ligation of the O-antigen, revealing its importance in LPS formation (Heinrichs et 
al., 1998). Using EMSAs, direct binding of DsdC to the waaV gene was 
demonstrated (Fig. 4-7). Furthermore, RT-qPCR showed a 1.36-fold increase in 
waaV expression in the DDdsdC1/2 mutant compared to the WT (Fig. 4-1). This 
suggests that DsdC represses the waaV gene, through direct binding. 
Speculatively, the repression of waaV could cause a difference in the number of 
O-antigen repeat units. Silver staining of LPS from CE10 and the DDdsdC1/2 
mutant, in the presence of D-serine, revealed two bands of increased intensity 
in the O-antigen side chain region in the DDdsdC1/2 mutant. This implies that in 
the WT, DsdC inhibits the formation of two O-antigen polysaccharides of varying 
lengths. 
Alterations of the LPS and O-antigen can occur in response to different host 
environmental stimuli (Lerouge & Vanderleyden, 2002). Indeed, Van Den Akker, 
(1998) reported that temperature affected expression of the O-antigen in 
Bordetella parapertussis. Furthermore, pathogenic Yersinia enterocolitica were 
shown to modulate their LPS profile upon exposure to differences in pH and Ca2+ 
restriction (Bengoechea et al., 2003). Intriguingly, the length of the O-antigen 
has been shown to affect complement resistance and evasion of macrophage 
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cells in Salmonella (Murray et al., 2006). Hypothetically therefore, it could be 
speculated that DsdC, upon exposure to the host metabolite D-serine, directly 
represses waaV and the waa operon, causing alterations in the LPS O-antigen 
length as a defence mechanism of immune evasion. Although it has not been 
definitively proven if direct regulation of waaV by DsdC causes the difference in 
O-antigen length, it does appear using the silver staining data that DsdC, upon 
exposure to D-serine, modifies the composition of the LPS, a key virulence 
determinant in E. coli. 
6.5.2 Further putative regulatory roles of DsdC in 
CE10 K1 capsule regulation 
E. coli is one of the leading causes of blood-stream infections, with 
bacteraemia-causing strains often associated with serum resistance (Miajlovic & 
Smith, 2014). Human serum contains over thirty proteins involved in the 
complement-killing system, one of the primary defences in the host’s immune 
response (Miajlovic & Smith, 2014). The K1 capsule is a known virulence factor 
that protects against complement-mediated killing (reviewed in Abreu & 
Barbosa, 2017). Analysis of the CE10 ChIP-Seq data revealed that DsdC bound in 
a broad manner in the A:T-rich Region 2 of the kps pathogenicity island (Fig. 6-
3A/B), the island responsible for K1 capsule synthesis (Silver & Vimr, 1990). This 
suggests, as discussed above, that DsdC may potentially be acting in a similar 
manner as a NAP, and silencing “foreign” DNA. Furthermore, DsdC was shown to 
bind in the two major promoter regions of the kps island, upstream of kpsF and 
kpsM (Fig. 6-3A). RT-qPCR analysis revealed expression of the capsular gene, 
kpsF, was higher in the DDdsdC1/2 mutant in relation to the WT, implying that 
DsdC represses kpsF, the first gene in the Region 1 operon (Fig. 6-3C). 
To determine if binding and differential expression of capsular genes by DsdC 
affected protection from complement-mediated killing, a serum resistance assay 
was performed on CE10 and the isogenic DdsdC mutants. As expected of the 
CE10 WT with a functioning capsule, there was no difference in bacterial growth 
between samples incubated in PBS and samples incubated in human serum, 
whereas the K12 serum sensitive strain was fully killed (Fig.6-5) (Leying et al., 
1990). Furthermore, the serum resistance assay revealed no difference in 
bacterial growth of the isogenic DdsdC mutants between the samples incubated 
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in PBS and the samples incubated in human serum, suggesting that the capsule is 
intact in the DdsdC isogenic mutants (Fig. 6-5). 
As discussed above, DsdC was shown to repress the first gene in Region 1 of the 
kps island, kpsF. KpsF functions as an accessory translocation factor for capsular 
components, with DkpsF mutations reducing capsular expression in E. coli 
(Cieslewicz & Vimr, 1997). Serum resistance has been linked to the proportion of 
K capsule present, with strains producing more K-antigen having an enhanced 
resistance to serum (Glynn & Howard, 1970). This suggests that the DdsdC 
mutant should have enhanced survival in serum. However, analysis of serum 
survival in DdsdC mutants showed no significant difference. Conversely, 
Vermeulen et al., (1988) suggested that there is a threshold level of K1 capsular 
polysaccharide that is needed to confer protection from complement-mediated 
killing. Hypothetically therefore, increased expression of kpsF in the DDdsdC1/2 
mutant may not have affected serum resistance, as the cell is already expressing 
the maximal amount of capsule needed to confer protection. Conversely, other 
capsular genes (neuB, neuE, neuC, neuA, and neuS) were only upregulated in the 
DDdsdC1/2 mutant, in relation to the WT, in the presence of D-serine. 
Therefore, a difference in serum resistance may have been seen if the samples 
had been exposed to D-serine during the experiment. Indeed, exposure to 
environmental factors have been known to modify E. coli K1 resistance to serum, 
with exposure to 0.2 M NaCl eliciting a 3.3-fold decrease in survival (Badger & 
Kim, 1998). Although an interesting hypothesis, this experiment was not carried 
out in this project, but could be the subject of future work. 
Furthermore, the K1 capsule is also one of many determinants that is required 
for successful invasion of the BBB (reviewed in Xie, Kim & Kim, 2004). Indeed, 
84% of 77 isolates recovered from the CSF of neonates with meningitis had the 
K1 polysaccharide (Robbins et al., 1974). An in vitro model cell line was 
therefore used to indirectly assess the role of DsdC on adherence and invasion of 
the BBB, through adhesion and invasion of brain endothelial cells. In the in vitro 
model, no difference in adhesion and invasion of CE10 and the DDdsdC1/2 
mutant was observed. Strikingly however, invasion to the hCMEC/D3 cells was 
low, with the bacteria showing an invasion efficiency of ~0.002% of the total 
bacterial cells. In comparison, an in vitro study that used HBMEC cells, E. coli K1 
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were shown to invade routinely at an efficiency of 0.1%-0.5% (Badger et al., 
2000). Indeed, a non-invasive K12 was used as a negative control and was shown 
to bind to the HBMEC cells at a similar percentage as the data presented here, 
£0.002% (Badger et al., 2000). This insinuates that the CE10 WT is not efficiently 
invading the hCMEC/D3 cell line, thus no differences could be observed between 
WT and DDdsdC1/2. It should be noted however, that Badger et al., (2000) based 
their invasion efficiency percentages off the initial inoculum used, unlike the 
data presented here which was based off the total number of bacteria in the 
experiment (adherent, invasive and unattached bacteria). 
The BBB is a dynamic interface between the brain and vasculature, composed of 
endothelial cells and connected by tight junctions (reviewed in Jamieson, 
Searson & Gerecht, 2017). Transwell models are often employed in in vitro 
studies, in order to mediate the dynamic nature of the BBB (reviewed in Stone, 
England & O’Sullivan, 2019). HBMEC confluent monolayers are grown on a porous 
membrane (transwell) that separates apical and basolateral chambers (Jamieson 
et al., 2017). Addition of further cells involved in the maintenance of the BBB, 
including astrocytes and pericytes, can be added to the basolateral chamber, 
upregulating barrier function and allowing for a more dynamic BBB in vitro cell 
model (Jamieson et al., 2017). For the in vitro invasion assays presented in this 
work, transwells were not used, and hCMEC/D3 cells were grown to a confluent 
monolayer in collagen coated wells. Potentially therefore, invasion efficiency 
was low because the in vitro cell model cell line was not optimised. Further 
studies could use transwell inserts to optimise CE10 WT binding before further 
studying the difference in invasion efficiency between CE10 and DDdsdC1/2. 
There was also no difference in adhesion and invasion between CE10 and DneuO. 
This corresponds with data obtained with NMEC strain RS218, which also showed 
no dependency on NeuO for adherence or invasion of HBMEC cells (Mordhorst et 
al., 2009). Therefore, it appears from this data that neither DsdC nor NeuO plays 
a role in invasion of CE10 into hCMEC/D3 cells. However, invasion efficiencies 
were so low for CE10 WT in the in vitro BBB cell model, further studies would 
need to be performed in order to fully rule out the role of DsdC in K1 capsule 
invasion. 
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6.5.3 DsdC does not mediate the reduction in 
colibactin synthesis, induced upon exposure to D-
serine, in Nissle 1917 
Previous work in our lab had revealed that, upon exposure to D-serine, the 
genotoxic effects to eukaryotic cells mediated by the bacterial genotoxin, 
colibactin, was reduced (Hallam et al., unpublished). Although this was an 
exciting discovery, the molecular mechanism underpinning the reduction in 
colibactin synthesis, mediated by D-serine, remained unknown. Analysis of the 
CFT073DsdC ChIP-Seq data had revealed binding on the pks island, at the 
intergenic region between clbR, the colibactin transcriptional activator and clbB 
(Fig. 6-6). Transcriptional analysis revealed that expression of clbR was 2-fold 
higher in the CFT073 DdsdC mutant in relation to the WT and moreover, upon 
exposure to D-serine, this increased to 4.6-fold higher (Fig. 4-2). This indicated 
that in CFT073, DsdC represses clbR and thus colibactin expression. 
Furthermore, upon exposure to D-serine, this repression was exacerbated, and 
thus theoretically could explain how the induction of D-serine causes a 
repression of colibactin synthesis. 
As UPEC encodes multiple toxins (Shah et al., 2019; Welch et al., 2002; Welch, 
2016), the probiotic Nissle 1917 is used as the model UPEC strain in in vitro 
assays. Indeed, a recent analysis revealed few genetic differences between 
CFT073 and Nissle 1917, with only 308 CFT073 genes absent in Nissle 1917 
(Vejborg et al., 2010). A nucleotide BLAST analysis between CFT073 and Nissle 
1917 revealed dsdC is highly conserved between the two strains. A Nissle DdsdC 
mutant was therefore made to assess the effects of DsdC on colibactin synthesis 
in vitro. Intriguingly it was qualitatively observed in a growth profile, in M9 
minimal media, that the Nissle DdsdC mutant proliferated faster than the Nissle 
WT. This potentially implies that DsdC is repressing a gene involved in 
metabolism in Nissle. This phenotype was not present in the CFT073 DdsdC 
mutant and potentially shows strain-specific regulation of carbon sources 
between CFT073 and Nissle. Although this was an interesting observation, this 
was not investigated further due to time constraints. 
Conversely, unlike the CFT073 transcriptomic data, in the Nissle DdsdC there 
was no difference in gene expression of clbR in relation to the Nissle WT, 
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suggesting that DsdC does not repress colibactin synthesis in Nissle. However, 
upon exposure to D-serine, clbR was repressed by DsdC in M9 minimal media. As 
LTTR need a co-inducer in order to differentially regulate genes, perhaps this 
was why a difference was seen in clbR expression in the presence of D-serine 
(reviewed in Maddocks & Oyston, 2008). Conversely, perhaps the difference in 
clbR expression in the DdsdC mutant was due to the inability to break down D-
serine. Therefore, it is the negative effects associated with D-serine 
accumulation that is causing clbR to be differentially expressed. Strikingly 
though in MEM-HEPES, clbR expression was no longer significantly differentiated 
in the mutant, with or without D-serine. Different medias have been known to 
affect gene expression in bacteria (Ray et al., 2009). Indeed in S. aureus, it was 
shown that transcription of hla (a-haemolysin) was reduced in CYGP media 
compared to BHI or LB media (Ray et al., 2009). Furthermore, even slight 
changes in the carbon content of medias can vastly influence bacterial gene 
expression. In Streptococcus mutans, genes related to biofilm formation (atlA, 
sacB, and wapA) were significantly upregulated in 1% xylitol-supplemented 
media in comparison to media containing 0.58% glucose (Decker et al., 2014). 
These studies highlight the complexity of researching gene regulation and how 
the different components of media can vastly affect gene expression. Overall, 
from this data however, it appeared that DsdC does not regulate colibactin 
synthesis through the transcriptional activator, clbR, in MEM-HEPES. 
Intriguingly in MEM-HEPES, RT-qPCR analysis revealed clbA and clbB were 
downregulated in the Nissle DdsdC mutant. This suggested that DsdC is indirectly 
activating the expression of colibactin. This did not however translate into a 
phenotype in the in vitro infection assay. Western blot analysis of a marker of 
DNA DSB did not show a difference between Nissle WT and DdsdC mutant, in the 
presence or absence of D-serine, over three biological replicates. Furthermore, 
no differences were observed in the megalocytosis phenotype between Nissle WT 
and DdsdC mutant, suggesting that DsdC does not play a significant role in the 
regulation of colibactin in Nissle. 
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6.5.4 Conclusion 
Exposure to environmental signals can cause rapid changes in bacterial gene 
expression. The work presented in this chapter revealed that upon exposure to 
D-serine, DsdC mediated changes in the O-antigen length of the LPS, potentially 
as a mechanism for immune evasion. This adds to the evidence presented in this 
thesis that DsdC plays a larger role in gene regulation in CE10 and does not 
solely regulate the dsdCXA locus. Further, although no differences were 
observed between the CE10 WT and DDdsdC1/2 mutant in serum resistance and 
invasion to the in vitro BBB model cell line, the possibility that DsdC modulates 
properties of the K1 capsule cannot be ruled out, and further experiments are 
required for conclusiveness.
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Chapter 7 Final conclusions 
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E. coli is estimated to kill more than 2 million humans per year, posing a serious 
clinical threat to the world (reviewed in Tenaillon et al., 2010). With 
extraintestinal infections on the rise (Vihta et al., 2018), as well as the 
impending anti-microbial resistance (AMR) crisis, it is essential that we 
understand the fundamental processes that govern bacterial survival. CFT073 
and CE10 are both prototypical UPEC and NMEC strains, that elicit disease in the 
urinary tract, and the brain respectively. Both UPEC and NMEC are able to use D-
serine as a carbon source, and thus DsdC plays an integral role in the success of 
these two ExPEC strains. Tight regulatory control of genes in response to 
fluctuating metabolic and environmental signals is central to bacterial success. 
Indeed, E. coli has been reported to dedicate up to 6% of its genome on TFs, 
reportedly encoding over 300 DNA-binding regulatory proteins (Pérez-Rueda & 
Collado-Vides, 2000). Although, Anfora et al., 2007 speculated a larger role in 
gene regulation for DsdC, to our knowledge this has yet to be ascertained. 
Therefore, there were three main questions that this work aimed to elucidate. 
Firstly, what was the direct regulon of DsdC in two E. coli pathotypes? Secondly, 
was there any significance in CE10 carrying two copies of the dsdCXA locus? And 
lastly, did DsdC-dependent regulation affect the physiology of either CFT073 or 
CE10. 
Using a combination approach of ChIP-Seq and RNA-Seq, the direct regulon of 
DsdC was elucidated. It was revealed that DsdC bound to 217 regions of the CE10 
genome and 129 regions of the CFT073 genome, indicating that DsdC plays a 
global role in E. coli regulation. Upon cross-examination with the RNA-Seq and 
RT-qPCR data, DsdC was found to directly regulate the colibactin master 
regulator clbR, in CFT073, and LPS and K1 capsular biosynthesis genes in CE10. 
Intriguingly, this revealed that DsdC has been adapted for strain-specific 
regulation within two distinct ExPEC pathotypes. The genetic diversity between 
E. coli strains is often ascribed to the relative plasticity of the genome, with 
some studies suggesting that up to 75% of genes were acquired through HGT 
(Touchon et al., 2009; reviewed in Juhas, 2015). However, the E. coli genome is 
finite, and multiple selective pressures often dictate the acquisition or loss of 
genes, leading to vast phenotypic differences between strains of the same 
species (reviewed in Perez & Groisman, 2009b). Indeed, Welch et al., 2002 
described the relative mosaic fluidity of the E. coli genome; revealing that 
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between K12, UPEC, and EHEC, only 39.2% of combined proteins were shared 
between the three E. coli strains. Many characteristic virulence factors are 
encoded on PAI and thus were likely acquired through HGT. However, newly 
acquired genes are only beneficial if they are expressed at the optimum time, 
thus requiring a need to be integrated into the ancestral regulatory network of 
the cell (Perez & Groisman, 2009b). Ancestral TFs have therefore been 
discovered to be repurposed and tailored to regulate newly acquired genes 
(Perez & Groisman, 2009a; Connolly et al., 2019). The results presented here 
indicate that is the case for DsdC, regulating distinct virulence factors in two 
strains of E. coli. Therefore, these findings further support that the common 
assumption that TFs regulate the same network within strains of the same 
species is not always correct, and TF studies using “model” laboratory strains 
should be interpretated with care. 
The role of gene duplication in driving regulatory network evolution cannot be 
understated (Teichmann & Babu, 2004). Duplications are often pathotype 
specific, and are typically associated with the adaption of cells to a fluctuating 
environment (Bernabeu et al., 2019). In 2006, Moritz and Welch, revealed that 
30 out of 41 K1 strains were reported to carry two copies of the dsdCXA operon, 
with both copies able to catabolise D-serine, indicating that they are 
functionally redundant. This suggests an importance of duplication of the operon 
to K1 strains. Amino acid BLAST analysis revealed that in CE10, DsdC1 and DsdC2 
were 98% homologous over 98% of the sequence. When genes evolve by 
duplication, regulatory networks are either conserved, lost or new interactions 
are gained (Teichmann & Babu, 2004). From the CE10 ChIP-Seq binding data, it 
appeared that the regulatory network between DsdC1 and DsdC2 had been 
conserved, as there were no differences observed between the two TFs. 
Furthermore, there appeared to be no demonstratable observable differences in 
D-serine metabolism between either copy, nor any difference in expression 
levels. However, genes with identical functions are often not stably maintained 
within the genome, unless the additional expression of gene product is 
advantageous (Zhang, 2003); leading to the conclusion that high levels of DsdC 
must be physiologically important for CE10. Indeed, both DsdC1 and DsdC2 were 
more abundant when compared to CFT073 DsdC, when native levels of DsdC 
were compared by Western blot analysis in Chapter 3. 
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While functionally redundant in their shared capacity to activate D-serine 
catabolism and appearing to share similar genomic binding sites, a distinction in 
regulatory potential between DsdC1 and DsdC2 was revealed during an analysis 
of neuO, a capsular O-acetyltransferase encoding gene that appeared to be 
bound by both DsdC1 and DsdC2. The capsule is a key virulence determinant for 
E. coli and is the first line of defence against the host immune system. Although 
there are over 70 capsular antigens, the K1 polysialic acid capsule is often over-
represented in NMEC infections (Robbins et al., 1974; Jann & Jann, 1992), 
indicating its importance in NMEC survival. Indeed, other pathogens that are 
associated with neonatal meningitis, such as K. pneumoniae and N. meningitidis, 
commonly possess a similar polysialic acid capsule (Opal, 2014; Stephens et al., 
1993). O-acetylation of the polysialic acids that comprise the capsule occurs 
through the phase variable gene, neuO (Deszo et al., 2005). Although O-
acetylation of the N. meningitidis capsule has been implicated in virulence of 
the strain, the role of O-acetylation of the E. coli K1 capsule has been more 
obscure, with conflicting reports on its role in virulence (Frasa et al., 1993; 
Colino & Outschoorn, 1999; Fusco et al., 2007). 
As neuO was originally described as being encoded on the prophage CUS-3, a 
logical hypothesis would suggest that O-acetylation of the capsule modifies the 
bacteriophage receptor, thereby preventing further phage entry and stopping 
bacteriophage “super-infections” (Deszo et al., 2005; Labrie, Samson & 
Moineau, 2010). In this work it was speculated that CUS-3 has been lost in CE10, 
with sequence homology between the incomplete prophage in CE10 and CUS-3 
revealing potential degradation. Conversely, the neuO gene was conserved, 
further indicating its importance to NMEC and thereby its potential role in 
receptor modification. Indeed, the data presented here revealed that deletion 
of neuO resulted in “hyper-susceptibility” to K1-specific bacteriophage, 
supporting the idea that NeuO prevents “super-infection” by modifying the 
bacteriophage receptor. Furthermore, it was revealed that deletion of dsdC1 but 
not dsdC2 caused a similar “hyper-susceptible” phenotype, suggesting that 
DsdC1 may be required for activation of NeuO. O-acetylation of LPS has been 
shown to effect phage adsorption, with acetylation protecting E. coli 4s from 
infection (reviewed in Prokhorov et al., 2017). This potentially indicates that 
NeuO-mediated O-acetylation of the K1 capsule likely provides a similar 
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protection. Conversely, previous work by Vimr and colleagues suggested that 
NeuO had no effect against K1 bacteriophage-mediated lysis in archetypal NMEC 
strain RS218 (King, Steenbergen & Vimr., 2007) . However, NeuO-dependent 
survival was further evidenced by two distinct phenotypes that arose from the 
CE10 WT population. Through DNA sequencing, it was revealed that colonies that 
were protected from the K1 bacteriophage were NeuO “phase ON”, whereas 
those that were rapidly killed were NeuO “phase OFF”. The differences 
therefore in data reported, could be due to differences in the genetic makeup 
between CE10 and RS218. 
Metabolic signals have been demonstrated to affect non-enzymatic acetylation 
in E. coli, with glucose, lactate, fructose, and xylose inducing acetylation 
(reviewed in Christensen et al., 2019). Although D-serine did not appear to 
affect the transcriptional regulation of neuO, DsdC is the D-serine metabolism 
regulator, and therefore could integrate host metabolic signals with virulence. 
The results presented here indicated a DsdC1-specific regulatory mechanism 
that mediated transcription of neuO, which potentially indicates why CE10 
carries two homologous TFs with seemingly redundant functionalities. However, 
the exact mechanism of DsdC1-specific regulation of neuO is yet to be solved. 
Preliminary data suggested that the phase variation of neuO affected 
transcription. Previous reports on siaD, a capsular polysialyltransferase in N. 
meningitidis, have revealed that the transcription of “phase OFF” siaD was 
prematurely terminated (Lavitola et al., 1999); indicating that this mechanism is 
not unique to NMEC. Further, preliminary sequencing data has alluded to the 
hypothesis that DsdC1 affects the SSM of neuO. In the DdsdC1 mutant, neuO was 
found to be in a constant “phase OFF” position. Although the regulatory 
mechanism at play has yet to be solved, it has been demonstrated in this thesis 
that DsdC1 affects the survival of CE10 against K1 bacteriophage-mediated lysis. 
However, this is not the complete story of DsdC’s role in E. coli gene regulation. 
The binding and transcriptomic data presented in Chapters 3 and 4 alluded to 
putative roles for DsdC in regulation of colibactin biosynthesis in CFT073, and 
LPS and capsule biosynthesis in CE10. Indeed, upon exposure to D-serine, it was 
revealed that DsdC modified the O-antigen length of LPS in CE10. Silver staining 
of LPS revealed two bands of increased intensity in the O-antigen side chain of 
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the DDdsdC1/2 mutant compared to the WT. As alterations of the O-antigen can 
occur in response to environmental signals (Lerouge & Vanderleyden, 2002), it 
could be speculated that upon sensing D-serine, DsdC represses LPS biosynthesis 
genes, causing alterations in the exposed O-antigen as a defence mechanism for 
immune evasion. Furthermore, although no differences were observed in the 
assays performed to elucidate the role of DsdC in K1 capsule regulation; the 
possibility that there are further physiological effects mediated by DsdC, in 
regard to capsule formation, cannot be ruled out, with further experiments 
therefore required. 
In an era where AMR is on the rise, it is crucial to understand the fundamental 
processes underpinning bacterial success. Indeed, through the widespread 
overuse and misuse of anti-microbials, multi-drug resistant bacteria are now 
endemic in certain regions of the world (reviewed in Christaki, Marcou & 
Tofarides, 2020). Approximately 700,000 people die annually from deaths 
attributed to AMR and it is estimated that by 2050 this figure could rise to 10 
million, indicating it is a serious and imminent threat to the human population 
(reviewed in Christaki, Marcou & Tofarides, 2020). Due to the cytotoxic nature 
of antimicrobials, there is a strong selective pressure for bacteria to evolve to 
resist them, with genetic AMR arising from horizontally-acquired AMR genes or 
mutations within the genome (reviewed in Schrader, Vaubourgeix & Nathan, 
2020). Anti-virulence (or anti-infective) strategies aim to supersede this inherent 
problem by using small molecules to block or interfere in bacterial virulence 
pathways (reviewed in Rasko & Sperandio, 2010). This, in theory, disables the 
bacteria from colonising the host or preventing toxin production, amongst other 
processes, while applying less evolutionary pressure to evolve resistance 
(reviewed in Rasko & Sperandio, 2010). 
Further, anti-virulence strategies, in theory, do not compromise the host 
commensal microbiota in the same way that traditional antibiotics do, providing 
an extra layer of protection to the host (reviewed in Dickey, Cheung & Otto, 
2017). Anti-bactericidal molecular inhibitors of LcrF, a TF involved in the 
regulation of Yersinia pseudotuberculosis T3SS, were revealed to reduce 
virulence in vitro and in vivo (Garrity-Ryan et al., 2010); indicating that the 
inhibition of virulence-associated transcriptional regulators are a viable novel 
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strategy for preventing infection. Due to the role that DsdC plays in the survival 
of CE10 against K1 bacteriophages, DsdC could potentially make an attractive 
target for anti-virulence strategies. A DsdC inhibitor, used in tandem with a K1-
specific bacteriophage, could therefore present a novel pathogen-specific 
alternative to treating NMEC, without the use of antibiotics. 
In conclusion, this work has elucidated the direct regulon of DsdC in two 
clinically relevant ExPEC strains, CFT073 and CE10. These data led to the 
conclusion that DsdC has been tailored in distinct E. coli strains to mediate 
strain-specific regulation. Further, a novel role of DsdC1 in protection against K1 
bacteriophages has been elucidated, through the regulation of the O-
acetyltransferase gene, neuO. Whilst E. coli cases are on the rise across Europe, 
these findings provide a greater understanding into the complex world of E. coli 
gene regulation, enabling for future utilisation of this knowledge for the 
potential development of new antibacterial strategies.
221 
References 
Abedon, S. T. (2021). Detection of bacteriophages: phage plaques. In: Harper D.R., 
Abedon S.T., Burrowes B.H., McConville M.L. (eds). Bacteriophages pp. 507–538. 
Springer International Publishing. doi.org/10.1007/978-3-319-41986-2_16. 
Abreu, A. G., & Barbosa, A. S. (2017). How Escherichia coli circumvent complement-
mediated killing. Frontiers in Immunology, 8(452), pp. 1–6. 
doi.org/10.3389/fimmu.2017.00452. 
Alteri, C. J., Smith, S. N., & Mobley, H. L. T. (2009). Fitness of Escherichia coli during 
urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS 
Pathogens, 5(5), pp. e1000448. doi.org/10.1371/journal.ppat.1000448. 
Anderson, G. G., Palermo, J. J., Schilling, J. D., Roth, R., Heuser, J., & Hultgren, S. J. 
(2003). Intracellular bacterial biofilm-like pods in urinary tract infections. Science, 
301(5629), pp. 105–107. doi.org/10.1126/science.1084550. 
Anfora, A. T., Haugen, B. J., Roesch, P., Redford, P., & Welch, R. A. (2007). Roles of 
serine accumulation and catabolism in the colonization of the murine urinary tract 
by Escherichia coli CFT073. Infection and Immunity, 75(11), pp. 5298–5304. 
doi.org/10.1128/IAI.00652-07 
Anfora, A. T., & Welch, R. A. (2006). DsdX is the second D-serine transporter in 
uropathogenic Escherichia coli clinical isolate CFT073. Journal of Bacteriology, 
188(18), pp. 6622–6628. doi.org/10.1128/JB.00634-06 
Arndt, D., Grant, J. R., Marcu, A., Sajed, T., Pon, A., Liang, Y., & Wishart, D. S. (2016). 
PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids 
Research, 44(W1), W16–W21. doi.org/10.1093/nar/gkw387 
Arnster-Choder, O., & Wright, A. (1993). Transcriptional regulation of the bgl operon of 
Escherichia coli involves phosphotransferase system-mediated phosphorylation of a 
transcriptional antiterminator. Journal of Cellular Biochemistry, 51(1), pp. 83–90. 
doi.org/doi: 10.1002/jcb.240510115 
Azam, T. A., Iwata, A., Nishimura, A., Ueda, S., & Ishihama, A. (1999). Growth phase-
dependent variation in protein composition of the Escherichia coli nuclei. Journal 
 222 
of Bacteriology, 181(20), pp. 6361–6370. doi: 10.1128/JB.181.20.6361-6370.1999 
Babitzke, P. (1997). Regulation of tryptophan biosynthesis: Trp-ing the TRAP or how 
Bacillus subtilis reinvented the wheel. Molecular Microbiology, 26(1), pp. 1–9. doi: 
10.1046/j.1365-2958.1997.5541915.x. 
Babu, M. M., & Teichmann, S. A. (2003a). Functional determinants of transcription 
factors in Escherichia coli: protein families and binding sites. Trends in Genetics, 
19(2), pp. 75–79. doi: 10.1016/S0168-9525(02)00039-2. 
Babu, M. M., & Teichmann, S. A. (2003b). Evolution of transcription factors and the 
gene regulatory network in Escherichia coli. Nucleic Acids Research, 31(4), pp. 
1234–1244. doi: 10.1093/nar/gkg210 
Badger, J. L., & Kim, K. S. (1998). Environmental growth conditions influence the ability 
of Escherichia coli K1 To invade brain microvascular endothelial cells and confer 
serum resistance. Infection and Immunity, 66(12), pp. 5692–5697. doi: 
10.1128/IAI.66.12.5692-5697.1998. 
Badger, J. L., Wass, C. A., & Kim, K. S. (2000). Identification of Escherichia coli K1 
genes contributing to human brain microvascular endothelial cell invasion by 
differential fluorescence induction. Molecular Microbiology, 36(1), pp. 174–182. 
doi: 10.1046/j.1365-2958.2000.01840.x. 
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, 
W. W., & Noble, W. S. (2009). MEME Suite: Tools for motif discovery and searching. 
Nucleic Acids Research, 37, pp. W202–W208. doi.org/10.1093/nar/gkp335 
Barbirz, S., Müller, J. J., Uetrecht, C., Clark, A. J., Heinemann, U., & Seckler, R. 
(2008). Crystal structure of Escherichia coli phage HK620 tailspike: Podoviral 
tailspike endoglycosidase modules are evolutionarily related. Molecular 
Microbiology, 69(2), pp. 303–316. doi.org/10.1111/j.1365-2958.2008.06311.x 
Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Schones, D. E., Wang, Z., Wei, G., 
Chepelev, I., & Zhao, K. (2007). High-resolution profiling of histone methylations in 
the human genome. Cell, 129(4), pp. 823–837. doi.org/10.1016/j.cell.2007.05.009 
Bateman, A., Martin, M. J., Orchard, S., Magrane, M., Agivetova, R., Ahmad, S., Alpi, 
E., Bowler-Barnett, E. H., Britto, R., Bursteinas, B., Bye-A-Jee, H., Coetzee, R., 
 223 
Cukura, A., Silva, A. Da, Denny, P., Dogan, T., Ebenezer, T. G., Fan, J., Castro, L. 
G., … Zhang, J. (2021). UniProt: The universal protein knowledgebase in 2021. 
Nucleic Acids Research, 49(D1), pp. D480–D489. doi.org/10.1093/nar/gkaa1100 
Bengoechea, J. A., Brandenburg, K., Arraiza, M. D., Seydel, U., Skurnik, M., & Moriyón, 
I. (2003). Pathogenic Yersinia enterocolitica strains increase the outer membrane 
permeability in response to environmental stimuli by modulating lipopolysaccharide 
fluidity and lipid A structure. Infection and Immunity, 71(4), pp. 2014-2021. 
doi.org/10.1128/IAI.71.4.2014-2021.2003 
Benz, R., Schmid, A., Wagner, W., & Goebel, W. (1989). Pore formation by the 
Escherichia coli hemolysin: Evidence for an association-dissociation equilibrium of 
the pore-forming aggregates. Infection and Immunity, 57(3), pp. 887–895. doi: 
10.1128/iai.57.3.887-895.1989 
Bernabeu, M., Sánchez-Herrero, J. F., Huedo, P., Prieto, A., Hüttener, M., Rozas, J., & 
Juárez, A. (2019). Gene duplications in the E. coli genome: Common themes among 
pathotypes. BMC Genomics, 20(313), pp. 1–11. doi.org/10.1186/s12864-019-5683-4 
Bernard, E., Rolain, T., Courtin, P., Guillot, A., Langella, P., Hols, P., & Chapot-
Chartier, M. P. (2011). Characterization of O-acetylation of N-acetylglucosamine: A 
novel structural variation of bacterial peptidoglycan. Journal of Biological 
Chemistry, 286(27), pp. 23950–23958. doi.org/10.1074/jbc.M111.241414 
Bertani, B., & Ruiz, N. (2018). Function and Biogenesis of Lipopolysaccharides. EcoSal 
Plus, 8(1), pp. 1–33. doi.org/10.1128/ecosalplus.esp-0001-2018 
Bervoets, I., & Charlier, D. (2019). Diversity, versatility and complexity of bacterial 
gene regulation mechanisms: Opportunities and drawbacks for applications in 
synthetic biology. FEMS Microbiology Reviews, 43(3), pp. 304–339. 
doi.org/10.1093/femsre/fuz001 
Bhakdi, S., & Tranum-Jensen, J. (1986). Membrane damage by pore-forming bacterial 
cytolysins. Microbial Pathogenesis, 1, pp. 5–14. doi: 10.1016/0882-4010(86)90027-
6. 
Bobay, L. M., Touchon, M., & Rocha, E. P. C. (2014). Pervasive domestication of 
defective prophages by bacteria. Proceedings of the National Academy of Sciences 
of the United States of America, 111(33), pp. 12127–12132. 
 224 
doi.org/10.1073/pnas.1405336111 
Bolognesi, B., & Lehner, B. (2018). Protein Overexpression: Reaching the limit. ELife, 
7(e39804), pp. 1–3. doi.org/10.7554/eLife.34595 
Bonacorsi, S., & Bingen, E. (2005). Molecular epidemiology of Escherichia coli causing 
neonatal meningitis. International Journal of Medical Microbiology, 295(6–7), pp. 
373–381. doi.org/10.1016/j.ijmm.2005.07.011 
Bondy-Denomy, J., Qian, J., Westra, E. R., Buckling, A., Guttman, D. S., Davidson, A. 
R., & Maxwell, K. L. (2016). Prophages mediate defense against phage infection 
through diverse mechanisms. ISME Journal, 10(12), pp. 2854–2866. 
doi.org/10.1038/ismej.2016.79 
Bonocora, R. P., & Wade, J. T. (2015). ChIP-seq for genome-scale analysis of bacterial 
DNA-binding proteins. In I. Artsimovitch & T. Santangelo (Eds.), Bacterial 
Transcriptional Control: Methods in molecular biology, 1276, pp. 327–340. Humana 
Press. doi.org/10.1007/978-1-4939-2392-2_20 
Bornstein-Forst, S. M., McFall, E., & Palchaudhuri, S. (1987). In vivo D-Serine deaminase 
transcription start sites in wild-type Escherichia coli and in dsdA promoter 
mutants. Journal of Bacteriology, 169(3), pp. 1056–1060. doi.org/doi: 
10.1128/jb.169.3.1056-1060.1987 
Brauer, A. L., White, A. N., Learman, B. S., Johnson, A. O., & Armbruster, C. E. (2019). 
D-Serine degradation by Proteus mirabilis contributes to fitness during single-
species and polymicrobial catheter-associated urinary tract infection. MSphere, 
4(1), pp. e00020-19. doi.org/10.1128/msphere.00020-19 
Brenner, S. E., Hubbard, T., Murzin, A., & Chothia, C. (1995). Gene duplications in H. 
influenza. Nature, 378(6553), pp. 140–140. doi: 10.1038/378140a0. 
Browning, D. F., & Busby, S. J. W. (2004). The regulation of bacterial transcription 
initiation. Nature Reviews Microbiology, 2(1), pp. 57–65. 
doi.org/10.1038/nrmicro787 
Browning, D. F., & Busby, S. J. W. (2016). Local and global regulation of transcription 
initiation in bacteria. Nature Reviews Microbiology, 14(10), pp. 638–650. 
doi.org/10.1038/nrmicro.2016.103 
 225 
Browning, D. F., Butala, M., & Busby, S. J. W. (2019). Bacterial Transcription Factors: 
Regulation by Pick “N” Mix. Journal of Molecular Biology, 431(20), pp. 4067–4077. 
doi.org/10.1016/j.jmb.2019.04.011 
Browning, D. F., Grainger, D. C., & Busby, S. J. W. (2010). Effects of nucleoid-
associated proteins on bacterial chromosome structure and gene expression. 
Current Opinion in Microbiology, 13(6), pp. 773–780. 
doi.org/10.1016/j.mib.2010.09.013 
Busby, S., & Ebright, R. H. (1994). Promoter structure, promoter recognition, and 
transcription activation in prokatyotes. Cell, 79(5), pp. 743–746. doi: 
10.1016/0092-8674(94)90063-9 
Cameron, E. A., & Sperandio, V. (2015). Frenemies: signaling and nutritional integration 
in pathogen-microbiota-host interactions. Cell Host and Microbe, 18(3), pp. 275–
284. doi.org/10.1016/j.chom.2015.08.007 
Canchaya, C., Proux, C., Fournous, G., Bruttin, A., & Brüssow, H. (2003). Prophage 
genomics. Microbiology and Molecular Biology Reviews, 67(2), pp. 238–276. 
doi.org/10.1128/mmbr.67.2.238-276.2003 
Casaburi, G., Duar, R. M., Brown, H., Mitchell, R. D., Kazi, S., Chew, S., Cagney, O., 
Flannery, R. L., Sylvester, K. G., Frese, S. A., Henrick, B. M., & Freeman, S. L. 
(2021). Metagenomic insights of the infant microbiome community structure and 
function across multiple sites in the United States. Scientific Reports, 11(1472), 
pp. 1–12. doi.org/10.1038/s41598-020-80583-9 
Cava, F., Lam, H., De Pedro, M. A., & Waldor, M. K. (2011). Emerging knowledge of 
regulatory roles of D-amino acids in bacteria. Cellular and Molecular Life Sciences, 
68, pp. 817–831. doi.org/10.1007/s00018-010-0571-8 
Chaudhuri, R. R., & Pallen, M. J. (2006). xBASE, a collection of online databases for 
bacterial comparative genomics. Nucleic Acids Research, 34, pp. D335–D337. 
doi.org/10.1093/nar/gkj140 
Christaki, E., Marcou, M., & Tofarides, A. (2020). Antimicrobial resistance in bacteria: 
Mechanisms, evolution, and persistence. Journal of Molecular Evolution, 88(1), pp. 
26–40. doi.org/10.1007/s00239-019-09914-3 
 226 
Christensen, D. G., Xie, X., Basisty, N., Byrnes, J., McSweeney, S., Schilling, B., & 
Wolfe, A. J. (2019). Post-translational protein acetylation: An elegant mechanism 
for bacteria to dynamically regulate metabolic functions. Frontiers in 
Microbiology, 10(1604), pp. 1-22. doi.org/10.3389/fmicb.2019.01604 
Cieslewicz, M., & Vimr, E. (1997). Reduced polysialic acid capsule expression in 
Escherichia coli K1 mutants with chromosomal defects in kpsF. Molecular 
Microbiology, 26(2), pp. 237–249. doi: 10.1046/j.1365-2958.1997.5651942.x. 
Colino, J., & Outschoorn, I. (1999). The form variation of the capsular polysaccharide 
K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model 
of infection. Pathogenesis, 27(4), pp. 187–196. doi: 10.1006/mpat.1999.0291 
Connell, H., Agace, W., Klemm, P., Schembri, M., Marild$, S., & Svanborg, C. (1996). 
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary 
tract. Proceedings of the National Academy of Sciences USA, 93(18), pp. 9827–
9832. doi: 10.1073/pnas.93.18.9827 
Connolly, J. P. R., Finlay, B, B., & Roe, A. J. (2015). From ingestion to colonization: The 
influence of the host environment on regulation of the LEE encoded type III 
secretion system in enterohaemorrhagic Escherichia coli. Frontiers in Microbiology, 
6(568), pp. 1–15. doi.org/10.3389/fmicb.2015.00568 
Connolly, J. P. R., Goldstone, R. J., Burgess, K., Cogdell, R. J., Beatson, S. A., Vollmer, 
W., Smith, D. G. E., & Roe, A. J. (2015). The host metabolite D-serine contributes 
to bacterial niche specificity through gene selection. ISME Journal, 9(4), pp. 1039–
1051. doi.org/10.1038/ismej.2014.242 
Connolly, J. P. R., O’Boyle, N., Turner, N. C. A., Browning, D. F., & Roe, A. J. (2019). 
Distinct intraspecies virulence mechanisms regulated by a conserved transcription 
factor. Proceedings of the National Academy of Sciences of the United States of 
America, 116(39), pp. 19695–19704. doi.org/10.1073/pnas.1903461116 
Connolly, J. P. R., Turner, N. C. A., Hallam, J. C., Rimbi, P. T., Flett, T., McCormack, 
M. J., Roe, A. J., & O’Boyle, N. (2021). d-Serine induces distinct transcriptomes in 
diverse Escherichia coli pathotypes. Microbiology, 167(10), pp. 1-6. 
doi.org/10.1099/mic.0.001093 
Cosloy, S. D., & McFall, E. (1973). Metabolism of D-Serine in Escherichia coli K-12: 
 227 
Mechanism of growth inhibition. Journal of Bacteriology, 114(2), pp. 685–694. doi: 
10.1128/jb.114.2.685-694.1973. 
Cross, A. S., Kim, K. S., Wright, D. C., Sadoff, J. C., & Gemski, P. (1986). Role of 
lipopolysaccharide and capsule in the serum resistance of bacteremic strains of 
Escherichia coli. The Journal of Infectious Diseases, 154(3), pp. 497–503. doi: 
10.1093/infdis/154.3.497. 
Croxen, M. A., & Finlay, B. B. (2010). Molecular mechanisms of Escherichia coli 
pathogenicity. Nature Reviews Microbiology, 8(1), pp. 26–38. 
doi.org/10.1038/nrmicro2265 
D’haeseleer, P. (2006). What are DNA sequence motifs? Nature Biotechnology, 24(4), 
pp. 423–425. doi:10.1038/nbt0406-423. 
Dale, A. P., & Woodford, N. (2015). Extra-intestinal pathogenic Escherichia coli 
(ExPEC): Disease, carriage and clones. Journal of Infection, 71(6), pp. 615–626. 
doi.org/10.1016/j.jinf.2015.09.009 
Dame, R. T. (2005). The role of nucleoid-associated proteins in the organization and 
compaction of bacterial chromatin. Molecular Microbiology, 56(4), pp. 858–870. 
doi.org/10.1111/j.1365-2958.2005.04598.x 
Dame, R. T., Wyman, C., & Goosen, N. (2000). H-NS mediated compaction of DNA 
visualised by atomic force microscopy. Nucleic Acids Research, 28(18), pp. 3504–
3510. doi: 10.1093/nar/28.18.3504. 
Datsenko, K. A., & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proceedings of the National Academy of 
Sciences, 97(12), pp. 6640–6645. doi.org/10.1073/pnas.120163297 
Decker, E. M., Klein, C., Schwindt, D., & Von Ohle, C. (2014). Metabolic activity of 
Streptococcus mutans biofilms and gene expression during exposure to xylitol and 
sucrose. International Journal of Oral Science, 6, pp. 195–204. 
doi.org/10.1038/ijos.2014.38 
Denamur, E., Clermont, O., Bonacorsi, S., & Gordon, D. (2021). The population genetics 
of pathogenic Escherichia coli. Nature Reviews Microbiology, 19(1), pp. 37–54. 
doi.org/10.1038/s41579-020-0416-x 
 228 
Deszo, E. L., Steenbergen, S. M., Freedberg, D. I., Vimr, E. R., & Robbins, J. B. (2005). 
Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the 
mechanism of capsule form variation involving a mobile contingency locus. 
Proceedings of the National Academy of Sciences, 102(15), pp. 5564–5569. doi: 
10.1073/pnas.0407428102. 
Dhakal, B. K., & Mulvey, M. A. (2012). The UPEC pore-forming toxin α-hemolysin triggers 
proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival 
pathways. Cell Host and Microbe, 11(1), pp. 58–69. 
doi.org/10.1016/j.chom.2011.12.003 
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017). Different drugs for bad bugs: 
Antivirulence strategies in the age of antibiotic resistance. Nature Reviews Drug 
Discovery, 16(7), pp. 457–471. doi.org/10.1038/nrd.2017.23 
Dillon, S. C., Cameron, A. D. S., Hokamp, K., Lucchini, S., Hinton, J. C. D., & Dorman, 
C. J. (2010). Genome-wide analysis of the H-NS and Sfh regulatory networks in 
Salmonella Typhimurium identifies a plasmid-encoded transcription silencing 
mechanism. Molecular Microbiology, 76(5), pp. 1250–1265. 
doi.org/10.1111/j.1365-2958.2010.07173.x 
Dillon, S. C., & Dorman, C. J. (2010). Bacterial nucleoid-associated proteins, nucleoid 
structure and gene expression. Nature Reviews Microbiology, 8(3), pp. 185–195. 
doi.org/10.1038/nrmicro2261 
Dillon, S. C., Espinosa, E., Hokamp, K., Ussery, D. W., Casadesús, J., & Dorman, C. J. 
(2012). LeuO is a global regulator of gene expression in Salmonella enterica serovar 
Typhimurium. Molecular Microbiology, 85(6), pp. 1072–1089. 
doi.org/10.1111/j.1365-2958.2012.08162.x 
Dorman, C. J. (2007). H-NS, the genome sentinel. Nature Reviews Microbiology, 5(2), 
pp. 157–161. doi:10.1038/nrmicro1598. 
Dorman, C. J., Schumacher, M. A., Bush, M. J., Brennan, R. G., & Buttner, M. J. (2020). 
When is a transcription factor a NAP? Current Opinion in Microbiology, 55, pp. 26–
33. doi.org/10.1016/j.mib.2020.01.019 
Dunkelberger, J. R., & Song, W. C. (2010). Complement and its role in innate and 
adaptive immune responses. Cell Research, 20(1), pp. 34–50. 
 229 
doi.org/10.1038/cr.2009.139 
Dunn, T. M., Hahn, S., Ogdent, S., & Schleif, R. F. (1984). An operator at-280 base pairs 
that is required for repression of araBAD operon promoter: Addition of DNA helical 
turns between the operator and promoter cyclically hinders repression. 
Proceedings of the National Academy of Sciences, 81, pp. 5017–5020. doi: 
10.1073/pnas.81.16.5017. 
Ebbensgaard, A., Mordhorst, H., Aarestrup, F. M., & Hansen, E. B. (2018). The role of 
outer membrane proteins and lipopolysaccharides for the sensitivity of Escherichia 
coli to antimicrobial peptides. Frontiers in Microbiology, 9(2153), pp. 1–13. 
doi.org/10.3389/fmicb.2018.02153 
Essler, M., Linder, S., Schell, B., Hüfner, K., Wiedemann, A., Randhahn, K., Staddon, J. 
M., & Aepfelbacher, M. (2003). Cytotoxic necrotizing factor 1 of Escherichia coli 
stimulates Rho/Rho-kinase-dependent myosin light-chain phosphorylation without 
inactivating myosin light-chain phosphatase in endothelial cells. Infection and 
Immunity, 71(9), pp. 5188–5193. doi.org/10.1128/IAI.71.9.5188-5193.2003 
Ezezika, O. C., Haddad, S., Neidle, E. L., & Momany, C. (2007). Oligomerization of 
BenM, a LysR-type transcriptional regulator: Structural basis for the aggregation of 
proteins in this family. Acta Crystallographica Section F: Structural Biology and 
Crystallization Communications, 63(5), pp. 361–368. 
doi.org/10.1107/S1744309107019185 
Fabbri, A., Travaglione, S., & Fiorentini, C. (2010). Escherichia coli cytotoxic 
necrotizing factor 1 (CNF1): Toxin biology, in vivo applications and therapeutic 
potential. Toxins, 2, pp. 283–296. doi.org/10.3390/toxins2020282 
Faïs, T., Delmas, J., Barnich, N., Bonnet, R., & Dalmasso, G. (2018). Colibactin: More 
than a new bacterial toxin. Toxins, 10(151), pp. 1-16. 
doi.org/10.3390/toxins10040151 
Fang, Z., & Cui, X. (2011). Design and validation issues in RNA-seq experiments. 
Briefings in Bioinformatics, 12(3), pp. 280–287. doi.org/10.1093/bib/bbr004 
Feklístov, A., Sharon, B. D., Darst, S. A., & Gross, C. A. (2014). Bacterial sigma factors: 
A historical, structural, and genomic perspective. Annual Review of Microbiology, 
68, pp. 357–376. doi.org/10.1146/annurev-micro-092412-155737 
 230 
Felmlee, T., Pellett, S., & Welch, R. A. (1985). Nucleotide sequence of an Escherichia 
coli chromosomal hemolysin. Journal of Bacteriology, 163(1), pp. 94–105. doi: 
10.1128/jb.163.1.94-105.1985. 
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015). Urinary tract 
infections: Epidemiology, mechanisms of infection and treatment options. Nature 
Reviews Microbiology, 13(5), pp. 269–284. doi.org/10.1038/nrmicro3432 
Fomsgaard, A., Freudenberg, M. A., & Galanos, C. (1990). Modification of the silver 
staining technique to detect lipopolysaccharide in polyacrylamide gels. Journal of 
Clinical Microbiology, 28(12), pp. 2627–2631. doi: 10.1128/jcm.28.12.2627-
2631.1990. 
Fox, S., Goswami, C., Holden, M., Connolly, J. P. R., Mordue, J., O’Boyle, N., Roe, A., 
Connor, M., Leanord, A., & Evans, T. J. (2020). A highly conserved complete 
accessory Escherichia coli type III secretion system 2 is widespread in bloodstream 
isolates of the ST69 lineage. Scientific Reports, 10(4135), pp. 1–11. 
doi.org/10.1038/s41598-020-61026-x 
Frasa, H., Procee, J., Torensma, R., Verbruggen, A., Algra, A., Rozenberg-Arska, M., 
Kraaijeveld, K., & Verhoef Eijkman-Winkler, J. (1993). Escherichia coli in 
bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-
acetylated K1 strains. Journal of Clinical Microbiology, 31(12), pp. 3174–3178. doi: 
10.1128/jcm.31.12.3174-3178.1993. 
Friedman, M. (2010). Origin, microbiology, nutrition, and pharmacology of D-amino 
acids. Chemistry and Biodiversity, 7(6), pp. 1491–1530. doi: 
10.1002/cbdv.200900225. 
Fusco, P. C., Farley, E. K., Huang, C. H., Moore, S., & Michon, F. (2007). Protective 
meningococcal capsular polysaccharide epitopes and the role of O acetylation. 
Clinical and Vaccine Immunology, 14(5), pp. 577–584. doi.org/10.1128/CVI.00009-
07 
Galagan, J., Lyubetskaya, A., & Gomes, A. (2012). ChIP-Seq and the Complexity of 
Bacterial Transcriptional Regulation. Systems Biology: Current topics in 
microbiology and immunology. (M. Katza (ed.); Vol. 363). pp. 43-68. Springer. doi: 
10.1007/82_2012_257. 
 231 
Galas, D. J., & Schmitz, A. (1978). DNAse footprinting: a simple method for the 
detection of protein-DNA binding specificity. Nucleic Acids Research, 5(9), pp. 
3157–3170. doi:10.1093/nar/5.9.3157. 
Gallet, R., Kannoly, S., & Wang, I. N. (2011). Effects of bacteriophage traits on plaque 
formation. BMC Microbiology, 11(181), pp. 1–16. doi.org/10.1186/1471-2180-11-
181 
Gao, C., Garren, M., Penn, K., Fernandez, V. I., Seymour, J. R., Thompson, J. R., 
Raina, J. B., & Stocker, R. (2021). Coral mucus rapidly induces chemokinesis and 
genome-wide transcriptional shifts toward early pathogenesis in a bacterial coral 
pathogen. ISME Journal, 15, pp. 1–15. doi.org/10.1038/s41396-021-01024-7 
Garcia, E. C., Brumbaugh, A. R., & Mobley, H. L. T. (2011). Redundancy and specificity 
of Escherichia coli iron acquisition systems during urinary tract infection. Infection 
and Immunity, 79(3), pp. 1225–1235. doi.org/10.1128/IAI.01222-10 
Garrity-Ryan, L. K., Kim, O. K., Balada-Llasat, J. M., Bartlett, V. J., Verma, A. K., 
Fisher, M. L., Castillo, C., Songsungthong, W., Tanaka, S. K., Levy, S. B., Mecsas, 
J., & Alekshun, M. N. (2010). Small molecule inhibitors of LcrF, a Yersinia 
pseudotuberculosis transcription factor, attenuate virulence and limit infection in 
a murine pneumonia model. Infection and Immunity, 78(11), pp. 4683–4690. 
doi.org/10.1128/IAI.01305-09 
Genchi, G. (2017). An overview on D-amino acids. Amino Acids, 49, pp. 1521–1533. 
doi.org/10.1007/s00726-017-2459-5 
Geno, K. A., Gilbert, G. L., Song, J. Y., Skovsted, I. C., Klugman, K. P., Jones, C., 
Konradsen, H. B., & Nahm, M. H. (2015). Pneumococcal capsules and their types: 
Past, present, and future. Clinical Microbiology Reviews, 28(3), pp. 871–899. 
doi.org/10.1128/CMR.00024-15 
Ghosh, T., Bose, D., & Zhang, X. (2010). Mechanisms for activating bacterial RNA 
polymerase. FEMS Microbiology Reviews, 34(5), pp. 611–627. 
doi.org/10.1111/j.1574-6976.2010.00239.x 
Glynn, A. A., & Howard, C. J. (1970). The sensitivity to complement of strains of 
Escherichia coli related to their K antigens. Immunology, 18(3), pp. 331–346. PMID: 
4986073. 
 232 
Goethals, K., Van Montagu, M., & Holsters, M. (1992). Conserved motifs in a divergent 
nod box of Azorhizobium caulinodans ORS571 reveal a common structure in 
promoters regulated by LysR-type proteins. Proceedings of the National Academy 
of Sciences USA, 89(5), pp. 1646–1650. doi: 10.1073/pnas.89.5.1646. 
Goh, K. G. K., Phan, M. D., Forde, B. M., Chong, T. M., Yin, W. F., Chan, K. G., Ulett, 
G. C., Sweet, M. J., Beatson, S. A., & Schembri, M. A. (2017). Genome-wide 
discovery of genes required for capsule production by uropathogenic Escherichia 
coli. MBio, 8(5), pp. e01558-17. doi.org/10.1128/mBio.01558-17 
Grainger, D. C., Goldberg, M. D., Lee, D. J., & Busby, S. J. W. (2008). Selective 
repression by Fis and H-NS at the Escherichia coli dps promoter. Molecular 
Microbiology, 68(6), pp. 1366–1377. doi.org/10.1111/j.1365-2958.2008.06253.x 
Grainger, D. C., Hurd, D., Goldberg, M. D., & Busby, S. J. W. (2006). Association of 
nucleoid proteins with coding and non-coding segments of the Escherichia coli 
genome. Nucleic Acids Research, 34(16), pp. 4642–4652. 
doi.org/10.1093/nar/gkl542 
Hacker, J., & Blum-Oehler, G. (2007). In appreciation of Theodor Escherich. Nature 
Reviews Microbiology, 5, pp. 902. doi.org/10.1038/nrmicro1810 
Hammerschmidt, S., Muller, A., Sillmann, H., Muhlenhoff, M., Borrow, R., Fox, A., Van 
Putten, J., Zollinger, W. D., Gerardy-Schahn, R., & Frosch, M. (1996). Capsule 
phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing 
in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the 
outbreak of meningococcal disease. Molecular Microbiology, 20(6), pp. 1211–1220. 
doi: 10.1111/j.1365-2958.1996.tb02641.x. 
Haraoka, M., Hang, L., Frendéus, B., Godaly, G., Burdick, M., Strieter, R., & Svanborg, 
C. (1999). Neutrophil recruitment and resistance to urinary tract infection. The 
Journal of Infectious Diseases, 180(4), pp. 1220–1229. doi: 10.1086/315006. 
Haugen, B. J., Pellett, S., Redford, P., Hamilton, H. L., Roesch, P. L., & Welch, R. A. 
(2007). In vivo gene expression analysis identifies genes required for enhanced 
colonization of the mouse urinary tract by uropathogenic Escherichia coli strain 
CFT073 dsdA. Infection and Immunity, 75(1), pp. 278–289. 
doi.org/10.1128/IAI.01319-06 
 233 
Heincz, M. C., Bornstein, S. M., & McFall, E. (1984). Purification and characterization of 
D-Serine deaminase activator protein. Journal of Bacteriology, 160(1), pp. 42–49. 
doi: 10.1128/jb.160.1.42-49.1984. 
Heincz, M. C., & McFall, E. (1978). Role of the dsdC activator in regulation of D-Serine 
deaminase synthesis. Journal of Bacteriology, 136(1), pp. 96–103. doi: 
10.1128/jb.136.1.96-103.1978. 
Heinrichs, D. E., Yethon, J. A., Amor, P. A., & Whitfield, C. (1998). The assembly 
system for the outer core portion of R1- and R4-type lipopolysaccharides of 
Escherichia coli: the R1 core-specific b-glucosyltransferase provides a novel 
attachment site for O-polysaccharides. Journal of Biological Chemistry, 273(45), 
pp. 29497–29505. doi:10.1074/jbc.273.45.29497. 
Heldwein, E. E. Z., & Brennan, R. G. (2001). Crystal structure of the transcription 
activator BmrR bound to DNA and a drug. Nature, 409(6818), pp. 378–382. doi: 
10.1038/35053138. 
Hellman, L. M., & Fried, M. G. (2007). Electrophoretic mobility shift assay (EMSA) for 
detecting protein-nucleic acid interactions. Nature Protocols, 2(8), pp. 1849–1861. 
doi.org/10.1038/nprot.2007.249 
Henderson, I. R., Owen, P., & Nataro, J. P. (1999). Molecular switches - the ON and OFF 
of bacterial phase variation. Molecular Microbiology, 33(5), pp. 919–932. doi: 
10.1046/j.1365-2958.1999.01555.x. 
Henikoff, S., Haughno, G. W., Calvot, J. M., & Wallace, J. C. (1988). A large family of 
bacterial activator proteins. Proceedings of the National Academy of Sciences USA, 
85(18), pp. 6602–6606. doi: 10.1073/pnas.85.18.6602. 
Henkin, T. M. (2000). Transcription termination control in bacteria. Current Opinion in 
Microbiology, 3(2), pp. 149–153. doi: 10.1016/s1369-5274(00)00067-9. 
Hibbing, M. E., Fuqua, C., Parsek, M. R., & Peterson, S. B. (2010). Bacterial 
competition: Surviving and thriving in the microbial jungle. Nature Reviews 
Microbiology, 8(1), pp. 15–25. doi.org/10.1038/nrmicro2259 
Ho-Sui, S. J., Fedynak, A., Hsiao, W. W. L., Langille, M. G. I., & Brinkman, F. S. L. 
(2009). The association of virulence factors with genomic Islands. PLoS ONE, 4(12), 
 234 
pp. 1–11. doi.org/10.1371/journal.pone.0008094 
Holden, N. S., & Tacon, C. E. (2011). Principles and problems of the electrophoretic 
mobility shift assay. Journal of Pharmacological and Toxicological Methods, 63(1), 
pp. 7–14. doi.org/10.1016/j.vascn.2010.03.002 
Hooton, T. M. (2012). Uncomplicated urinary tract infection. The New England Journal 
of Medicine, 366(11), pp. 1028–1037. doi.org/10.1056/NEJMcp1104429 
Hryckowian, A. J., Baisa, G. A., Schwartz, K. J., & Welch, R. A. (2015). DsdA does not 
affect colonization of the murine urinary tract by Escherichia coli CFT073. PLoS 
ONE, 10(9), pp. e0138121. doi.org/10.1371/journal.pone.0138121 
Huang, S-H., Chen, Y.-H., Fu, Q. I., Stins, M., Wang, Y., Wass, C., Kwang, A., & Kim, S. 
(1999). Identification and characterization of an Escherichia coli invasion gene 
locus, ibeB, required for penetration of brain microvascular endothelial cells. 
Infection and Immunity, 67(5), pp. 2103–2109. doi: 10.1128/IAI.67.5.2103-
2109.1999. 
Huang, S-H., Wass, C., Fu, Q. I., Prasadarao, N. V, Stins, M., Kwang, A., & Kim, S. 
(1995). Escherichia coli invasion of brain microvascular endothelial cells in vitro 
and in vivo: molecular cloning and characterization of invasion gene ibe10. 
Infection and Immunity, 63(11), pp. 4470–4475. doi: 10.1128/iai.63.11.4470-
4475.1995. 
Ishihama, A. (2000). Functional modulation of Escherichia coli RNA polymerase. Annual 
Review of Microbiology, 54, pp. 499–518. doi: 10.1146/annurev.micro.54.1.499. 
Iwata, Y., Sakai, N., Yoneda, I., Senda, Y., Sakai-Takemori, Y., Oshima, M., Nakagawa-
Yoneda, S., Ogura, H., Sato, K., Minami, T., Kitajima, S., Toyama, T., Yamamura, 
Y., Miyagawa, T., Hara, A., Shimizu, M., Furuichi, K., Matsushima, K., & Wada, T. 
(2021). D-Serine inhibits the attachment and biofilm formation of methicillin-
resistant Staphylococcus aureus. Biochemical and Biophysical Research 
Communications, 537, pp. 50–56. doi.org/10.1016/j.bbrc.2020.12.078. 
Jacob, F., & Monod, J. (1961). Genetic regulatory mechanisms in the synthesis of 
proteins. Journal of Molecular Biology, 3, pp. 318–356. doi.org/10.1016/S0022-
2836(61)80072-7. 
 235 
Jain, D., Baldi, S., Zabel, A., Straub, T., & Becker, P. B. (2015). Active promoters give 
rise to false positive “Phantom Peaks” in ChIP-seq experiments. Nucleic Acids 
Research, 43(14), pp. 6959–6968. doi.org/10.1093/nar/gkv637 
Jamieson, J. J., Searson, P. C., & Gerecht, S. (2017). Engineering the human blood-
brain barrier in vitro. Journal of Biological Engineering, 11(37), pp. 1-11. 
doi.org/10.1186/s13036-017-0076-1 
Jann, K., & Jann, B. (1992). Capsules of Escherichia coli, expression and biological 
significance. Canadian Journal of Microbiology, 38(7), pp. 705–710. doi: 
10.1139/m92-116. 
Jia, J., King, J. E., Goldrick, M. C., Aldawood, E., & Roberts, I. S. (2017). Three tandem 
promoters, together with IHF, regulate growth phase dependent expression of the 
Escherichia coli kps capsule gene cluster. Scientific Reports, 7(1), pp. 1-11. 
doi.org/10.1038/s41598-017-17891-0 
Johnson, David, S., Mortazavi, A., Myers, Richard, M., & Wold, B. (2007). Genome-wide 
mapping of in vivo protein-DNA interactions. Science, 316(5830), pp. 1497–1502. 
doi.org/10.1126/science.1142265 
Johnson, J. R., & Russo, T. A. (2002). Extraintestinal pathogenic Escherichia coli: “The 
other bad E coli.” Journal of Laboratory and Clinical Medicine, 139(3), pp. 155–
162. doi.org/10.1067/mlc.2002.121550 
Juhas, M. (2015). Horizontal gene transfer in human pathogens. Critical Reviews in 
Microbiology, 41(1), pp. 101–108. doi.org/10.3109/1040841X.2013.804031 
Jurczak-Kurek, A., Gasior, T., Nejman-Faleńczyk, B., Bloch, S., Dydecka, A., Topka, G., 
Necel, A., Jakubowska-Deredas, M., Narajczyk, M., Richert, M., Mieszkowska, A., 
Wróbel, B., Wȩgrzyn, G., & Wȩgrzyn, A. (2016). Biodiversity of bacteriophages: 
Morphological and biological properties of a large group of phages isolated from 
urban sewage. Scientific Reports, 6(34338), pp. 1-17. 
https://doi.org/10.1038/srep34338 
Kahramanoglou, C., Seshasayee, A. S. N., Prieto, A. I., Ibberson, D., Schmidt, S., 
Zimmermann, J., Benes, V., Fraser, G. M., & Luscombe, N. M. (2011). Direct and 
indirect effects of H-NS and Fis on global gene expression control in Escherichia 
coli. Nucleic Acids Research, 39(6), pp. 2073–2091. doi.org/10.1093/nar/gkq934 
 236 
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004). Pathogenic Escherichia coli. 
Nature Reviews Microbiology, 2, pp. 123–140. doi.org/10.1038/nrmicro818 
Kapust, R. B., & Waugh, D. S. (1999). Escherichia coli maltose-binding protein is 
uncommonly effective at promoting the solubility of polypeptides to which it is 
fused. Protein Science, 8(8), pp. 1668–1674. doi: 10.1110/ps.8.8.1668. 
Khalessi, N., & Afsharkas, L. (2014). Neonatal meningitis: Risk factors, causes, and 
neurologic complications. Iran J Child Neurol, 8(4), pp. 46–50. PCMID: PMC4307368. 
Khan, N. A., Kim, Y., Shin, S., & Kim, K. S. (2007). FimH-mediated Escherichia coli K1 
invasion of human brain microvascular endothelial cells. Cellular Microbiology, 
9(1), pp. 169–178. doi.org/10.1111/j.1462-5822.2006.00779.x 
Khan, N. A., Wang, Y., Kim, K. J., Chung, J. W., Wass, C. A., & Kim, K. S. (2002). 
Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the 
central nervous system. Journal of Biological Chemistry, 277(18), pp. 15607–15612. 
doi.org/10.1074/jbc.M112224200 
Kim, K. J., Chung, J. W., & Kim, K. S. (2005). 67-kDa laminin receptor promotes 
internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into 
human brain microvascular endothelial cells. Journal of Biological Chemistry, 
280(2), pp. 1360–1368. doi.org/10.1074/jbc.M410176200 
Kim, K. S. (2012). Current concepts on the pathogenesis of Escherichia coli meningitis: 
Implications for therapy and prevention. Current Opinion in Infectious Diseases, 
25(3), pp. 273–278. doi.org/10.1097/QCO.0b013e3283521eb0 
Kim, K. S. (2000). E. coli invasion of brain microvascular endothelial cells as a 
pathogenetic basis of meningitis. In T. Oelschlaeger & J. Hacker (Eds.), Bacterial 
Invasion into Eukaryotic Cells. Subcellular Biochemistry. 33, pp. 47–59. doi: 
10.1007/978-1-4757-4580-1_3. 
Kim, K. S, Itabashi, H., Gemski, P., Sadoff, J., Warren, R. L., & Cross, A. S. (1992). The 
K1 capsule is the critical determinant in the development of Escherichia coli 
meningitis in the rat. Journal of Clinical Investigation, 90(3), pp. 897–905. 
doi.org/10.1172/JCI115965 
King, C. H., Desai, H., Sylvetsky, A. C., LoTempio, J., Ayanyan, S., Carrie, J., Crandall, 
 237 
K. A., Fochtman, B. C., Gasparyan, L., Gulzar, N., Howell, P., Issa, N., Krampis, 
K., Mishra, L., Morizono, H., Pisegna, J. R., Rao, S., Ren, Y., Simonyan, V., … 
Mazumder, R. (2019). Baseline human gut microbiota profile in healthy people and 
standard reporting template. PLoS ONE, 14(9), pp. e0206484. 
doi.org/10.1371/journal.pone.0206484 
King, M. R., Steenbergen, S. M., & Vimr, E. R. (2007). Going for baroque at the 
Escherichia coli K1 cell surface. Trends in Microbiology, 15(5), pp. 196–202. 
doi.org/10.1016/j.tim.2007.03.006 
King, M. R., Vimr, R. P., Steenbergen, S. M., Spanjaard, L., Plunkett, G., Blattner, F. 
R., & Vimr, E. R. (2007). Escherichia coli K1-specific bacteriophage CUS-3 
distribution and function in phase-variable capsular polysialic acid O acetylation. 
Journal of Bacteriology, 189(17), pp. 6447–6456. doi.org/10.1128/JB.00657-07 
Kleinman, C. L., Sycz, G., Bonomi, H. R., Rodriguez, R. M., Zorreguieta, A., & Sieira, R. 
(2017). ChIP-seq analysis of the LuxR-type regulator VjbR reveals novel insights into 
the Brucella virulence gene expression network. Nucleic Acids Research, 45(10), 
pp. 5757–5769. doi.org/10.1093/nar/gkx165 
Koide, T., Reiss, D. J., Bare, J. C., Pang, W. L., Facciotti, M. T., Schmid, A. K., Pan, M., 
Marzolf, B., Van, P. T., Lo, F. Y., Pratap, A., Deutsch, E. W., Peterson, A., Martin, 
D., & Baliga, N. S. (2009). Prevalence of transcription promoters within archaeal 
operons and coding sequences. Molecular Systems Biology, 5(285), pp. 1–16. 
doi.org/10.1038/msb.2009.42 
Kolodkin-Gal, I., Romero, D., Cao, S., Clardy, J., Kolter, R., & Losick, R. (2010). D-
amino acids trigger biofilm disassembly. Science, 328(5978), pp. 627–629. 
https://doi.org/10.1126/science.1187113 
Korotkov, K. V., Johnson, T. L., Jobling, M. G., Pruneda, J., Pardon, E., Héroux, A., 
Turley, S., Steyaert, J., Holmes, R. K., Sandkvist, M., & Hol, W. G. J. (2011). 
Structural and functional studies on the interaction of GspC and GspD in the type ii 
secretion system. PLoS Pathogens, 7(9), pp. e1002228. 
doi.org/10.1371/journal.ppat.1002228 
Korte-Berwanger, M., Sakinc, T., Kline, K., Nielsen, H. V., Hultgren, S., & Gatermann, 
S. G. (2013). Significance of the D-serine-deaminase and D-serine metabolism of 
Staphylococcus saprophyticus for virulence. Infection and Immunity, 81(12), pp. 
 238 
4525–4533. doi.org/10.1128/IAI.00599-13 
Ku, L. C., Boggess, K. A., & Cohen-Wolkowiez, M. (2015). Bacterial meningitis in infants. 
Clinics in Perinatology, 42(1), pp. 29–45. doi.org/10.1016/j.clp.2014.10.004 
Kulkarni, R., Dhakal, B. K., Slechta, E. S., Kurtz, Z., Mulvey, M. A., & Thanassi, D. G. 
(2009). Roles of putative type II secretion and type IV pilus systems in the virulence 
of uropathogenic Escherichia coli. PLoS ONE, 4(3), pp. e4752. 
doi.org/10.1371/journal.pone.0004752 
Labrie, S. J., Samson, J. E., & Moineau, S. (2010). Bacteriophage resistance 
mechanisms. Nature Reviews Microbiology, 8(5), pp. 317–327. 
doi.org/10.1038/nrmicro2315 
Lam, H., Oh, D-C., Cava, F., Takacs, C. N., Clardy, J., de Pedro, M. A., & Waldor, M. K. 
(2009). D-amino acids govern stationary phase cell wall remodeling in bacteria. 
Science, 325(5947), pp. 1552–1555. doi.org/10.1098/rsif.2008.0435 
Lavitola, A., Bucci, C., Salvatore, P., Maresca, G., Bruni, C. B., & Alifano, P. (1999). 
Intracistronic transcription termination in polysialyltransferase gene (siaD) affects 
phase variation in Neisseria meningitidis. Molecular Microbiology, 33(1), pp. 119–
127. doi: 10.1046/j.1365-2958.1999.01454.x. 
Lemichez, E., Flatau, G., Bruzzone, M., Boquet, P., & Gauthier, M. (1997). Molecular 
localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding 
and catalytic domains. Molecular Microbiology, 24(5), pp. 1061–1070. doi: 
10.1046/j.1365-2958.1997.4151781.x. 
Lerouge, I., & Vanderleyden, J. (2002). O-antigen structural variation: mechanisms and 
possible roles in animal/plant–microbe interactions. FEMS Microbiology Reviews, 
26(1), pp. 17–47. doi.org/10.1111/j.1574-6976.2002.tb00597.x 
Leying, H., Suerbaum, S., Kroll, H-P., Stahl, D. and Opferkuch, W. (1990). The capsular 
polysaccharide is a major determinant of serum resistance in K-1-positive blood 
culture isolates of Escherichia coli. Infection and Immunity, 58(1), 222–227. doi: 
10.1128/iai.58.1.222-227.1990. 
Li, H., Limenitakis, J. P., Fuhrer, T., Geuking, M. B., Lawson, M. A., Wyss, M., 
Brugiroux, S., Keller, I., Macpherson, J. A., Rupp, S., Stolp, B., Stein, J. V., 
 239 
Stecher, B., Sauer, U., McCoy, K. D., & Macpherson, A. J. (2015). The outer mucus 
layer hosts a distinct intestinal microbial niche. Nature Communications, 6(8292), 
pp. 1–13. doi.org/10.1038/ncomms9292 
Li, K., Wu, G., Liao, Y., Zeng, Q., Wang, H., & Liu, F. (2020). RpoN1 and RpoN2 play 
different regulatory roles in virulence traits, flagellar biosynthesis, and basal 
metabolism in Xanthomonas campestris. Molecular Plant Pathology, 21(7), pp. 907–
922. doi.org/10.1111/mpp.12938 
Li, Z., Quan, G., Jiang, X., Yang, Y., Ding, X., Zhang, D., Wang, X., Hardwidge, P. R., 
Ren, W., & Zhu, G. (2018). Effects of metabolites derived from gut microbiota and 
hosts on pathogens. Frontiers in Cellular and Infection Microbiology, 8(314), pp. 1-
12. doi.org/10.3389/fcimb.2018.00314 
Lin, S-Y., & Riggs, A. D. (1975). The general affinity of lac repressor for E. coli DNA : 
implications for gene regulation in procaryotes and eucaryotes. Cell, 4(2), pp. 107–
111. doi: 10.1016/0092-8674(75)90116-6. 
Lindquist, S., Lindberg, F., & Normark, S. (1989). Binding of the Citrobacter freundii 
AmpR regulator to a single DNA site provides both autoregulation and activation of 
the inducible ampC B-Lactamase gene. Journal of Bacteriology, 171(7), pp. 3746–
3753. doi: 10.1128/jb.171.7.3746-3753.1989. 
Liu, B., Furevi, A., Perepelov, A. V., Guo, X., Cao, H., Wang, Q., Reeves, P. R., Knirel, 
Y. A., Wang, L., & Widmalm, G. (2020). Structure and genetics of Escherichia coli 
O antigens. FEMS Microbiology Reviews, 44(6), pp. 655–683. 
doi.org/10.1093/femsre/fuz028 
Liu, C., Zheng, H., Yang, M., Xu, Z., Wang, X., Wei, L., Tang, B., Liu, F., Zhang, Y., 
Ding, Y., Tang, X., Wu, B., Johnson, T. J., Chen, H., & Tan, C. (2015). Genome 
analysis and in vivo virulence of porcine extraintestinal pathogenic Escherichia coli 
strain PCN033. BMC Genomics, 16(717) pp. 1-18. doi.org/10.1186/s12864-015-1890-
9 
Lonetto, M., Gribskov, M., & Gross, C. A. (1992). The sigma factor 70 family: sequence 
conservation and evolutionary relationships. Journal of Bacteriology, 174(12), pp. 
3843–3849. doi: 10.1128/jb.174.12.3843-3849.1992. 
Lopez, M. S., Tan, I. S., Yan, D., Kang, J., McCreary, M., Modrusan, Z., Austin, C. D., 
 240 
Xu, M., & Brown, E. J. (2017). Host-derived fatty acids activate type VII secretion 
in Staphylococcus aureus. Proceedings of the National Academy of Sciences of the 
United States of America, 114(42), pp. 11223–11228. 
doi.org/10.1073/pnas.1700627114 
Lu, S., Jin, D., Wu, S., Yang, J., Lan, R., Bai, X., Liu, S., Meng, Q., Yuan, X., Zhou, J., 
Pu, J., Chen, Q., Dai, H., Hu, Y., Xiong, Y., Ye, C., & Xu, J. (2016). Insights into 
the evolution of pathogenicity of Escherichia coli from genomic analysis of 
intestinal E. coli of Marmota himalayana in Qinghai-Tibet plateau of China. 
Emerging Microbes and Infections, 5(e122), pp. 1–9. doi.org/10.1038/emi.2016.122 
Lu, S., Zhang, X., Zhu, Y., Kim, K. S., Yang, J., & Jin, Q. (2011). Complete genome 
sequence of the neonatal-meningitis-associated Escherichia coli strain CE10. 
Journal of Bacteriology, 193(24), pp. 7005. doi.org/10.1128/JB.06284-11 
Luethy, P. M., Huynh, S., Ribardo, D. A., Winter, S. E., Parker, C. T., & Hendrixson, D. 
R. (2017). Microbiota-derived short-chain fatty acids modulate expression of 
Campylobacter jejuni determinants required for commensalism and virulence. 
MBio, 8(3), pp. e00407-17. https://doi.org/10.1128/mBio 
Maas, W. K., & Davis, B. D. (1950). Interference by D-serine and L-aspartic acid with 
pantothenate synthesis in Escherichia coli. Pantothenate Studies, 60(6), pp. 733–
745. doi: 10.1128/jb.60.6.733-745.1950. 
MacQuarrie, K. L., Fong, A. P., Morse, R. H., & Tapscott, S. J. (2011). Genome-wide 
transcription factor binding: Beyond direct target regulation. Trends in Genetics, 
27(4), pp. 141–148. doi.org/10.1016/j.tig.2011.01.001. 
Maddocks, S. E., & Oyston, P. C. F. (2008). Structure and function of the LysR-type 
transcriptional regulator (LTTR) family proteins. Microbiology, 154(12), pp. 3609–
3623. doi.org/10.1099/mic.0.2008/022772-0 
Magnusson, L. U., Farewell, A., & Nyström, T. (2005). ppGpp: A global regulator in 
Escherichia coli. Trends in Microbiology, 13(5), pp. 236–242. 
doi.org/10.1016/j.tim.2005.03.008 
Manges, A. R., Geum, H. M., Guo, A., Edens, T. J., Fibke, C. D., & Pitout, J. D. D. 
(2019). Global extraintestinal pathogenic Escherichia coli (Expec) lineages. Clinical 
Microbiology Reviews, 32(3), pp. e00135-18. doi.org/10.1128/CMR.00135-18 
 241 
Mann, K., & Jackson, M. A. (2008). Meningitis. Pediatrics in Review, 29(12), pp. 417–
430. doi.org/10.1542/pir.29-12-417 
Mann, S., & Chen, Y. P. P. (2010). Bacterial genomic G + C composition-eliciting 
environmental adaptation. Genomics, 95, pp. 7–15. 
https://doi.org/10.1016/j.ygeno.2009.09.002 
Martínez-Antonio, A., & Collado-Vides, J. (2003). Identifying global regulators in 
transcriptional regulatory networks in bacteria. Current Opinion in Microbiology, 
6(5), pp. 482–489. doi.org/10.1016/j.mib.2003.09.002 
Martinez, J. J., Mulvey, M. A., Schilling, J. D., Pinkner, J. S., & Hultgren, S. J. (2000). 
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. The EMBO 
Journal, 19(12), pp. 2803–2812. doi: 10.1093/emboj/19.12.2803. 
Maruvada, R., & Kim, K. S. (2012). IbeA and OmpA of Escherichia coli K1 exploit Rac1 
activation for invasion of human brain microvascular endothelial cells. Infection 
and Immunity, 80(6), pp. 2035–2041. doi.org/10.1128/IAI.06320-11 
Marx, V. (2019). What to do about those immunoprecipitation blues. Nature Methods, 
16(4), pp. 289–292. doi.org/10.1038/s41592-019-0365-3 
Mathew, R., & Chatterji, D. (2006). The evolving story of the omega subunit of bacterial 
RNA polymerase. Trends in Microbiology, 14(10), pp. 450–455. 
doi.org/10.1016/j.tim.2006.08.002 
Mazzulli, T. (2012). Diagnosis and management of simple and complicated urinary tract 
infections (UTIs). The Canadian Journal of Urology, 19, pp. 42–48. PMID: 23089347. 
McDaniel, T. K., Jarvis, K. G., Donnenberg, M. S., & Kaper, J. B. (1995). A genetic locus 
of enterocyte effacement conserved among diverse enterobacterial pathogens. 
Proceedings of the National Academy of Sciences USA, 92(5), 1664–1668. doi: 
10.1073/pnas.92.5.1664. 
McFall, E. (1964). Genetic structure of the D-serine deaminase system of Escherichia 
coli. Journal of Molecular Biology, 9(3), 746–753. doi.org/10.1016/S0022-
2836(64)80179-0 
McFall, E. (1967). Dominance studies with stable merodiploids in the D-Serine 
 242 
deaminase system of Escherichia coli K-12. Journal of Bacteriology, 94(6), pp. 
1982–1988. doi: 10.1128/jb.94.6.1982-1988.1967. 
McFall, E., & Heincz, M. C. (1983). Identification and control of synthesis of the dsdC 
activator protein. Journal of Bacteriology, 153(2), pp. 872–877. doi: 
10.1128/jb.153.2.872-877.1983. 
McFall, S. M., Chugani, S. A., & Chakrabarty, A. M. (1998). Transcriptional activation of 
the catechol and chlorocatechol operons: variations on a theme. Gene, 223, pp. 
257–267. doi: 10.1016/s0378-1119(98)00366-7. 
McFall, S. M., Klem, T. J., Fujita, N., Ishihama, A., & Chakrabarty, A. M. (1997). DNase I 
footprinting, DNA bending and in vitro transcription analyses of ClcR and CatR 
interactions with the clcABD promoter: evidence of a conserved transcriptional 
activation mechanism. Molecular Microbiology, 24(5), pp. 965–976. doi: 
10.1046/j.1365-2958.1997.4041763.x. 
Mejía-Almonte, C., Busby, S. J. W., Wade, J. T., van Helden, J., Arkin, A. P., Stormo, 
G. D., Eilbeck, K., Palsson, B. O., Galagan, J. E., & Collado-Vides, J. (2020). 
Redefining fundamental concepts of transcription initiation in bacteria. Nature 
Reviews Genetics, 21(11), pp. 699–714. doi.org/10.1038/s41576-020-0254-8 
Melekos, M. D., & Naber, K. G. (2000). Complicated urinary tract infections. 
International Journal of Antimicrobial Agents, 15(4), pp. 247-256. doi: 
10.1016/s0924-8579(00)00168-0. 
Mellies, J. L., Elliott, S. J., Sperandio, V., Donnenberg, M. S., & Kaper, J. B. (1999). 
The Per regulon of enteropathogenic Escherichia coli : identification of a regulatory 
cascade and a novel transcriptional activator, the locus of enterocyte effacement 
(LEE)-encoded regulator (Ler). Molecular Microbiology, 33(2), pp. 296–306. doi: 
10.1046/j.1365-2958.1999.01473.x. 
Merrick, M. J. (1993). In a class of its own - the RNA polymerase sigma factor 54. 
Molecular Microbiology, 10(5), pp. 903–909. doi: 10.1111/j.1365-
2958.1993.tb00961.x. 
Miajlovic, H., & Smith, S. G. (2014). Bacterial self-defence: How Escherichia coli evades 
serum killing. FEMS Microbiology Letters, 354, pp. 1–9. doi.org/10.1111/1574-
6968.12419. 
 243 
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, 
P., Brockman, W., Kim, T. K., Koche, R. P., Lee, W., Mendenhall, E., O’Donovan, 
A., Presser, A., Russ, C., Xie, X., Meissner, A., Wernig, M., Jaenisch, R., … 
Bernstein, B. E. (2007). Genome-wide maps of chromatin state in pluripotent and 
lineage-committed cells. Nature, 448(7153), pp. 553–560. 
doi.org/10.1038/nature06008 
Mitrophanov, A. Y., & Groisman, E. A. (2008). Signal integration in bacterial two-
component regulatory systems. Genes and Development, 22(19), pp. 2601–2611. 
doi.org/10.1101/gad.1700308 
Mobley, H. L. T., Green, D. M., Trifillis, A. L., Johnson, D. E., Chippendale, G. R., 
Lockatell, C. V., Jones, B. D., & Warren, J. W. (1990). Pyelonephritogenic 
Escherichia coli and killing of cultured human renal proximal tubular epithelial 
cells: role of hemolysin in some strains. Infection and Immunity, 58(5), pp. 1281–
1289. doi: 10.1128/iai.58.5.1281-1289.1990. 
Monroe, R. S., Ostrowski, J., Hryniewicz, M. M., & Kredich, N. M. (1990). In vitro 
interactions of CysB protein with the cysK and cysJIH promoter regions of 
Salmonella typhimurium. Journal of Bacteriology, 172(12), pp. 6919–6929. doi: 
10.1128/jb.172.12.6919-6929.1990. 
Montso, P. K., Mlambo, V., & Ateba, C. N. (2019). Characterization of lytic 
bacteriophages infecting multidrug-resistant shiga toxigenic atypical Escherichia 
coli O177 strains isolated from cattle feces. Frontiers in Public Health, 7(355), pp. 
1-13. doi.org/10.3389/fpubh.2019.00355 
Moon, H. W., Whipp, S. C., Argenzio, R. A., Levine, M. M., & Giannella, R. A. (1983). 
Attaching and effacing activities of rabbit and human Enteropathogenic Escherichia 
coli in pig and rabbit intestines. Infection and Immunity, 41(3), pp. 1340–1351. doi: 
10.1128/iai.41.3.1340-1351.1983. 
Moon, K., Bonocora, R. P., Kim, D. D., Chen, Q., Wade, J. T., Stibitz, S., & Hinton, D. 
M. (2017). The BvgAS Regulon of Bordetella pertussis. MBio, 8(5), pp. e01526-17. 
doi.org/10.1128/mBio 
Mordhorst, I. L., Claus, H., Ewers, C., Lappann, M., Schoen, C., Elias, J., Batzilla, J., 
Dobrindt, U., Wieler, L. H., Bergfeld, A. K., Mühlenhoff, M., & Vogel, U. (2009). O-
acetyltransferase gene neuO is segregated according to phylogenetic background 
 244 
and contributes to environmental desiccation resistance in Escherichia coli K1. 
Environmental Microbiology, 11(12), pp. 3154–3165. doi.org/10.1111/j.1462-
2920.2009.02019.x 
Moritz, R. L., & Welch, R. A. (2006). The Escherichia coli argW-dsdCXA genetic island is 
highly variable, and E. coli K1 strains commonly possess two copies of dsdCXA. 
Journal of Clinical Microbiology, 44(11), pp. 4038–4048. 
doi.org/10.1128/JCM.01172-06 
Mulvey, M. A., Lopez-Boado, Y. S., Wilson, C. L., Roth, R., Parks, W. C., Heuser, J., & 
Hultgren, S. J. (1998). Induction and evasion of host defences by Type 1-piliated 
Uropathogenic Escherichia coli. Science, 282(5393), pp. 1494–1497. doi: 
10.1126/science.282.5393.1494. 
Murakami, K. S. (2015). Structural biology of bacterial RNA polymerase. Biomolecules, 
5(2), pp. 848–864. doi.org/10.3390/biom5020848. 
Muraoka, S., Okumura, R., Ogawa, N., Nonaka, T., Miyashita, K., & Senda, T. (2003). 
Crystal Structure of a full-length LysR-type transcriptional regulator, CbnR: Unusual 
combination of two subunit forms and molecular bases for causing and changing 
DNA bend. Journal of Molecular Biology, 328(3), pp. 555–566. 
doi.org/10.1016/S0022-2836(03)00312-7 
Murray, G. L., Attridge, S. R., & Morona, R. (2006). Altering the length of the 
lipopolysaccharide O antigen has an impact on the interaction of Salmonella 
enterica serovar typhimurium with macrophages and complement. Journal of 
Bacteriology, 188(7), pp. 2735–2739. doi.org/10.1128/JB.188.7.2735-2739.2006 
Muto, A., & Osawa, S. (1987). The guanine and cytosine content of genomic DNA and 
bacterial evolution. Proceedings of the National Academy of Sciences USA, 84(1), 
166–169. doi: 10.1073/pnas.84.1.166. 
Najafi, A., Hasanpour, M., Askary, A., Aziemzadeh, M., & Hashemi, N. (2018). 
Distribution of pathogenicity island markers and virulence factors in new 
phylogenetic groups of uropathogenic Escherichia coli isolates. Folia 
Microbiologica, 63, pp. 335–343. doi.org/10.1007/s12223-017-0570-3 
Navarro-Garcia, F., Ruiz-Perez, F., Cataldi, Á., & Larzábal, M. (2019). Type VI secretion 
system in pathogenic Escherichia coli: Structure, role in virulence, and acquisition. 
 245 
Frontiers in Microbiology, 10(1965), pp. 1-17. doi.org/10.3389/fmicb.2019.01965 
Nishikawa, T. (2011). Analysis of free D-serine in mammals and its biological relevance. 
Journal of Chromatography B, 879(29), pp. 3169–3183. 
doi.org/10.1016/j.jchromb.2011.08.030 
Njoroge, J. W., Nguyen, Y., Curtis, M. M., Moreira, C. G., & Sperandio, V. (2012). 
Virulence meets metabolism: Cra and KdpE gene regulation in enterohemorrhagic 
Escherichia coli. MBio, 3(5), pp. e00280-12. doi.org/10.1128/mBio.00280-12 
Nørregaard-Madsen, M., McFall, E., & Valentin-Hansen, P. (1995). Organization and 
transcriptional regulation of the Escherichia coli K-12 D-Serine tolerance locus. 
Journal of Bacteriology, 177(22), pp. 6456–6461. doi: 10.1128/jb.177.22.6456-
6461.1995. 
Nougayrède, J-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., 
Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006). Escherichia coli 
induces DNA double-strand breaks in eukaryotic cells. Science, 313(5788), pp. 848–
851. doi.org/10.1126/science.1128439 
O’Boyle, N., Turner, N. C. A., Roe, A. J., & Connolly, J. P. R. (2020). Plastic circuits: 
regulatory flexibility in fine tuning pathogen success. Trends in Microbiology, 
28(5), pp. 360–371. doi.org/10.1016/j.tim.2020.01.002 
O’Meara, T. R., & Alspaugh, J. A. (2012). The Cryptococcus neoformans capsule: A 
sword and a shield. Clinical Microbiology Reviews, 25(3), pp. 387–408. 
doi.org/10.1128/CMR.00001-12 
Oliveros, J. (2007). Venny. An interactive tool for comparing lists with Venn’s 
diagrams. Https://Bioinfogp.Cnb.Csic.Es/Tools/Venny/Index.Html. 
Opal, S. M. (2014). Significance of sialic acid in Klebsiella pneumoniae K1 capsules. 
Virulence, 5(6), pp. 648–649. doi.org/10.4161/viru.34349 
Orskov, F., Orskov, I., Sutton, A., Schneerson, R., Lin, W., Egan, W., Hoff, E., & 
Robbins, J. B. (1979). Form variation in Escherichia coli K1: Determined by O-
acetylation of the capsular polysaccheride. Journal of Experimental Medicine, 
149(3), pp. 669–685. doi: 10.1084/jem.149.3.669. 
 246 
Pacheco, A. R., Munera, D., Waldor, M. K., Sperandio, V., & Ritchie, J. M. (2012). 
Fucose sensing regulates bacterial intestinal colonization. Nature, 492, pp. 113–
117. doi.org/10.1038/nature11623 
Paget, M. S. (2015). Bacterial sigma factors and anti-sigma factors: Structure, function 
and distribution. Biomolecules, 5(3), pp. 1245–1265. doi.org/10.3390/biom5031245 
Pareja, E., Pareja-Tobes, P., Manrique, M., Pareja-Tobes, E., Bonal, J., & Tobes, R. 
(2006). ExtraTrain: A database of extragenic regions and transcriptional 
information in prokaryotic organisms. BMC Microbiology, 6(29), pp. 1–10. 
doi.org/10.1186/1471-2180-6-29 
Pérez-Rueda, E., & Collado-Vides, J. (2000). The repertoire of DNA-binding 
transcriptional regulators in Escherichia coli K-12. Nucleic Acids Research, 28(8), 
pp. 1838–1847. doi: 10.1093/nar/28.8.1838. 
Perez, J. C., & Groisman, E. A. (2009a). Transcription factor function and promoter 
architecture govern the evolution of bacterial regulons. Proceedings of the 
National Academy of Sciences USA, 106(11), pp. 4319–4324. doi: 
10.1073/pnas.0810343106. 
Perez, J. C., & Groisman, E. A. (2009b). Evolution of Transcriptional Regulatory Circuits 
in Bacteria. Cell, 138(2), pp. 233–244. doi.org/10.1016/j.cell.2009.07.002 
Pickrell, J. K., Gaffney, D. J., Gilad, Y., & Pritchard, J. K. (2011). False positive peaks 
in ChIP-seq and other sequencing-based functional assays caused by unannotated 
high copy number regions. Bioinformatics, 27(15), pp. 2144–2146. 
doi.org/10.1093/bioinformatics/btr354 
Pires, D. P., Oliveira, H., Melo, L. D. R., Sillankorva, S., & Azeredo, J. (2016). 
Bacteriophage-encoded depolymerases: their diversity and biotechnological 
applications. Applied Microbiology and Biotechnology, 100(5), pp. 2141–2151. 
doi.org/10.1007/s00253-015-7247-0 
Polin, R. A., & Harris, M. C. (2001). Neonatal bacterial meningitis. Seminars in 
Neonatology, 6(2), pp. 157–172. doi.org/10.1053/siny.2001.0045 
Pollegioni, L., & Sacchi, S. (2010). Metabolism of the neuromodulator D-serine. Cellular 
and Molecular Life Sciences, 67(14), pp. 2387–2404. doi.org/10.1007/s00018-010-
 247 
0307-9 
Poncet, S., Milohanic, E., Mazé, A., Abdallah, J. N., Aké, F., Larribe, M., Deghmane, A.-
E., Taha, M-K., Dozot, M., De Bolle, X., Letesson, J. J., & Deutscher, J. (2009). 
Correlations between carbon metabolism and virulence in bacteria. In M. Collin & 
R. Schuch (Eds.), Bacterial sensing and signalling, 16, pp. 88–102. doi: 
10.1159/000219374. 
Poulsen, L. K., Lan, F., Kristensen, C. S., Hobolth, P., Molin, S., & Krogfelt, K. A. 
(1994). Spatial distribution of Escherichia coli in the mouse large intestine inferred 
from rRNA in situ hybridization. Infection and Immunity, 62(11), pp. 5191–
5194. doi: 10.1128/iai.62.11.5191-5194.1994. 
Prasadarao, N. V. (2002). Identification of Escherichia coli outer membrane protein A 
receptor on human brain microvascular endothelial cells. Infection and Immunity, 
70(8), pp. 4556–4563. doi.org/10.1128/IAI.70.8.4556-4563.2002 
Prasadarao, N. V., Wass, C. A., Weiser, J. N., Stins, M. F., Huang, S-H., & Kim, K. S. 
(1996). Outer membrane protein A of Escherichia coli contributes to invasion of 
brain microvascular endothelial cells. Infection and Immunity, 64(1), pp. 146–
153. doi: 10.1128/iai.64.1.146-153.1996. 
Prokhorov, N. S., Riccio, C., Zdorovenko, E. L., Shneider, M. M., Browning, C., Knirel, 
Y. A., Leiman, P. G., & Letarov, A. V. (2017). Function of bacteriophage G7C 
esterase tailspike in host cell adsorption. Molecular Microbiology, 105(3), pp. 385–
398. doi.org/10.1111/mmi.13710 
Raetz, C. R. H., & Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annual Review 
of Biochemistry, 71, pp. 635–700. 
doi.org/10.1146/annurev.biochem.71.110601.135414 
Rasko, D. A., Rosovitz, M. J., Myers, G. S. A., Mongodin, E. F., Fricke, W. F., Gajer, P., 
Crabtree, J., Sebaihia, M., Thomson, N. R., Chaudhuri, R., Henderson, I. R., 
Sperandio, V., & Ravel, J. (2008). The pangenome structure of Escherichia coli: 
Comparative genomic analysis of E. coli commensal and pathogenic isolates. 
Journal of Bacteriology, 190(20), pp. 6881–6893. doi.org/10.1128/JB.00619-08. 
Rasko, D. A., & Sperandio, V. (2010). Anti-virulence strategies to combat bacteria-
mediated disease. Nature Reviews Drug Discovery, 9(2), pp. 117–128. 
 248 
doi.org/10.1038/nrd3013. 
Ray, B., Ballal, A., & Manna, A. C. (2009). Transcriptional variation of regulatory and 
virulence genes due to different media in Staphylococcus aureus. Microbial 
Pathogenesis, 47(2), pp. 94–100. doi.org/10.1016/j.micpath.2009.05.001. 
Reigstad, C. S., Hultgren, S. J., & Gordon, J. I. (2007). Functional genomic studies of 
uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial 
communities are assembled. Journal of Biological Chemistry, 282(29), pp. 21259–
21267. doi.org/10.1074/jbc.M611502200 
Reister, M., Hoffmeier, K., Krezdorn, N., Rotter, B., Liang, C., Rund, S., Dandekar, T., 
Sonnenborn, U., & Oelschlaeger, T. A. (2014). Complete genome sequence of the 
Gram-negative probiotic Escherichia coli strain Nissle 1917. Journal of 
Biotechnology, 187, pp. 106–107. doi.org/10.1016/j.jbiotec.2014.07.442 
Ren, C. P., Chaudhuri, R. R., Fivian, A., Bailey, C. M., Antonio, M., Barnes, W. M., & 
Pallen, M. J. (2004). The ETT2 gene cluster, encoding a second type III secretion 
system from Escherichia coli, is present in the majority of strains but has 
undergone widespread mutational attrition. Journal of Bacteriology, 186(11), pp. 
3547–3560. doi.org/10.1128/JB.186.11.3547-3560.2004 
Robbins, J. B., McCracken Jr, G. H., Gotschlich, E. C., Orskov, F., Orskov, I., & Hanson, 
L. A. (1974). Escherichia coli K1 capsular polysaccharide associated with neonatal 
meningitis. The New England Journal of Medicine, 290(22), pp. 1216–1220. doi: 
10.1056/NEJM197405302902202. 
Roberts, J. W. (2019). Mechanisms of bacterial transcription termination. Journal of 
Molecular Biology, 431(20), 4030–4039. doi.org/10.1016/j.jmb.2019.04.003. 
Robertson, G., Hirst, M., Bainbridge, M., Bilenky, M., Zhao, Y., Zeng, T., Euskirchen, 
G., Bernier, B., Varhol, R., Delaney, A., Thiessen, N., Griffith, O. L., He, A., 
Marra, M., Snyder, M., & Jones, S. (2007). Genome-wide profiles of STAT1 DNA 
association using chromatin immunoprecipitation and massively parallel 
sequencing. Nature Methods, 4(8), pp. 651–657. doi.org/10.1038/nmeth1068. 
Roesch, P. L., Redford, P., Batchelet, S., Moritz, R. L., Pellett, S., Haugen, B. J., 
Blattner, F. R., & Welch, R. A. (2003). Uropathogenic Escherichia coli use D-serine 
deaminase to modulate infection of the murine urinary tract. Molecular 
 249 
Microbiology, 49(1), pp. 55–67. doi.org/10.1046/j.1365-2958.2003.03543.x 
Roos, V., & Klemm, P. (2006). Global gene expression profiling of the asymptomatic 
bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infection and 
Immunity, 74(6), pp. 3565–3575. doi.org/10.1128/IAI.01959-05 
Russo, T. A., & Johnson, J. R. (2000). Proposal for a new inclusive designation for 
extraintestinal pathogenic isolates of Escherichia coli: ExPEC. The Journal of 
Infectious Diseases, 181(5), 1753–1754. doi: 10.1086/315418.   
Russo, T. A., & Johnson, J. R. (2003). Medical and economic impact of extraintestinal 
infections due to Escherichia coli: focus on an increasingly important endemic 
problem. Microbes and Infection, 5, pp. 449–456. doi: 10.1016/s1286-
4579(03)00049-2. 
Sachdev, D., & Chirgwin, I. M. (2000). Fusions to maltose-binding protein: control of 
folding and solubility in protein purification. Methods in Enzymology, 326, pp. 312–
321. doi: 10.1016/s0076-6879(00)26062-x. 
Sanchez-Vazquez, P., Dewey, C. N., Kitten, N., Ross, W., & Gourse, R. L. (2019). 
Genome-wide effects on Escherichia coli transcription from ppGpp binding to its 
two sites on RNA polymerase. Proceedings of the National Academy of Sciences of 
the USA, 116(17), pp. 8310–8319. doi.org/10.1073/pnas.1819682116. 
Santangelo, T. J., & Roberts, J. W. (2004). Forward translocation is the natural pathway 
of RNA release at an intrinsic terminator. Molecular Cell, 14(1), 117–126. doi: 
10.1016/s1097-2765(04)00154-6. 
Sarkar, S., Ulett, G. C., Totsika, M., Phan, M. D., & Schembri, M. A. (2014). Role of 
capsule and O antigen in the virulence of uropathogenic Escherichia coli. PLoS 
ONE, 9(4), pp. e94786. doi.org/10.1371/journal.pone.0094786 
Sasabe, J., Miyoshi, Y., Rakoff-Nahoum, S., Zhang, T., Mita, M., Davis, B. M., Hamase, 
K., & Waldor, M. K. (2016). Interplay between microbial D-amino acids and host D-
amino acid oxidase modifies murine mucosal defence and gut microbiota. Nature 
Microbiology, 1, pp. 16125. doi.org/10.1038/nmicrobiol.2016.125. 
Schell, M. A. (1993). Molecular biology of the LysR family of transcriptional regulators. 
Annual Review of Microbiology, 47, pp. 597–626. doi: 
 250 
10.1146/annurev.mi.47.100193.003121. 
Scholl, D., Adhya, S., & Merril, C. (2005). Escherichia coli K1’s capsule is a barrier to 
bacteriophage T7. Applied and Environmental Microbiology, 71(8), pp. 4872–4874. 
doi.org/10.1128/AEM.71.8.4872-4874.2005 
Schrader, S. M., Vaubourgeix, J., & Nathan, C. (2020). Biology of antimicrobial 
resistance and approaches to combat it. Sci. Transl. Med, 12, pp. eaaz6992. doi: 
10.1126/scitranslmed.aaz6992. 
Schwechheimer, C., & Kuehn, M. J. (2015). Outer-membrane vesicles from Gram-
negative bacteria: Biogenesis and functions. Nature Reviews Microbiology, 13(10), 
pp. 605–619. doi.org/10.1038/nrmicro3525. 
Secher, T., Samba-Louaka, A., Oswald, E., & Nougayrède, J. P. (2013). Escherichia coli 
producing colibactin triggers premature and transmissible senescence in 
mammalian cells. PLoS ONE, 8(10), pp. e77157. 
doi.org/10.1371/journal.pone.0077157 
Seo, S. W., Kim, D., Szubin, R., & Palsson, B. O. (2015). Genome-wide reconstruction of 
OxyR and SoxRS transcriptional regulatory networks under oxidative stress in 
Escherichia coli K-12 MG1655. Cell Reports, 12, pp. 1289–1299. 
doi.org/10.1016/j.celrep.2015.07.043 
Shah, C., Baral, R., Bartaula, B., & Shrestha, L. B. (2019). Virulence factors of 
uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial 
resistance. BMC Microbiology, 19(204), pp. 1–6. doi.org/10.1186/s12866-019-1587-
3 
Shimada, T., Ishihama, A., Busby, S. J. W., & Grainger, D. C. (2008). The Escherichia 
coli RutR transcription factor binds at targets within genes as well as intergenic 
regions. Nucleic Acids Research, 36(12), pp. 3950–3955. 
doi.org/10.1093/nar/gkn339 
Shimizu, K. (2013). Regulation systems of bacteria such as Escherichia coli in response 
to nutrient limitation and environmental stresses. Metabolites, 4, pp. 1–35. 
doi.org/10.3390/metabo4010001 
Silver, R., & Vimr, E. R. (1990). Polysialic acid capsule of Escherichia coli K1. In B. 
 251 
Iglewski & V. Clark (Eds.), Molecular Basis of Bacterial Pathogenesis, 11, pp. 39–54. 
Academic Press Ltd, London, NW1 7DX.  
Singh, S. S., Singh, N., Bonocora, R. P., Fitzgerald, D. M., Wade, J. T., & Grainger, D. 
C. (2014). Widespread suppression of intragenic transcription initiation by H-NS. 
Genes and Development, 28, pp. 214–219. doi.org/10.1101/gad.234336.113 
Slater, S. L., Sågfors, A. M., Pollard, D. J., Ruano-Gallego, D., & Frankel, G. (2018). The 
type III secretion system of pathogenic Escherichia coli. Current Topics in 
Microbiology and Immunology. Escherichia coli: A versatile pathogen, 416, pp. 51–
72. doi.org/10.1007/82_2018_116 
Stark, R., Grzelak, M., & Hadfield, J. (2019). RNA sequencing: the teenage years. 
Nature Reviews Genetics, 20(11), pp. 631–656). doi.org/10.1038/s41576-019-0150-
2 
Starmer, J., & Magnuson, T. (2016). Detecting broad domains and narrow peaks in ChIP-
seq data with hiddenDomains. BMC Bioinformatics, 17(144), pp. 1-10. 
doi.org/10.1186/s12859-016-0991-z 
Starosta, A. L., Lassak, J., Jung, K., & Wilson, D. N. (2014). The bacterial translation 
stress response. FEMS Microbiology Reviews, 38(6), pp. 1172–1201. 
doi.org/10.1111/1574-6976.12083 
Stephens, D. S., Spellman, P. A., & Swartley, J. S. (1993). Effect of the (a2-8)-linked 
polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal 
cells. Journal of Infectious Diseases, 167, pp. 475–478. doi: 
10.1093/infdis/167.2.475. 
Stone, N. L., England, T. J., & O’Sullivan, S. E. (2019). A novel transwell blood brain 
barrier model using primary human cells. Frontiers in Cellular Neuroscience, 
13(230), pp. 1-11. doi.org/10.3389/fncel.2019.00230 
Stummeyer, K., Schwarzer, D., Claus, H., Vogel, U., Gerardy-Schahn, R., & Mühlenhoff, 
M. (2006). Evolution of bacteriophages infecting encapsulated bacteria: Lessons 
from Escherichia coli K1-specific phages. Molecular Microbiology, 60(5), pp. 1123–
1135. doi.org/10.1111/j.1365-2958.2006.05173.x 
Sullivan, M. J., Petty, N. K., & Beatson, S. A. (2011). Easyfig: A genome comparison 
 252 
visualizer. Bioinformatics, 27(7), pp. 1009–1010. 
doi.org/10.1093/bioinformatics/btr039 
Suzuki, M., Sujino, T., Chiba, S., Harada, Y., Goto, M., Takahashi, R., Mita, M., 
Hamase, K., Kanai, T., Ito, M., Waldor, M. K., Yasui, M., & Sasabe, J. (2021). Host-
microbe cross-talk governs amino acid chirality to regulate survival and 
differentiation of B cells. Science Advances, 7(10), pp. eabd6480. doi: 
10.1126/sciadv.abd6480. 
Teichmann, S. A., & Babu, M. M. (2004). Gene regulatory network growth by 
duplication. Nature Genetics, 36(5), pp. 492–496. doi.org/10.1038/ng1340 
Teichmann, S. A., Park, J., & Chothia, C. (1998). Structural assignments to the 
Mycoplasma genitalium proteins show extensive gene duplications and domain 
rearrangements. Proceedings of the National Academy of Sciences USA, 95, pp. 
14658–14663. doi: 10.1073/pnas.95.25.14658. 
Tenaillon, O., Skurnik, D., Picard, B., & Denamur, E. (2010). The population genetics of 
commensal Escherichia coli. Nature Reviews Microbiology, 8, pp. 207–217. 
doi.org/10.1038/nrmicro2298 
Terlizzi, M. E., Gribaudo, G., & Maffei, M. E. (2017). UroPathogenic Escherichia coli 
(UPEC) infections: Virulence factors, bladder responses, antibiotic, and non-
antibiotic antimicrobial strategies. Frontiers in Microbiology, 8(1566), pp. 1-23. 
doi.org/10.3389/fmicb.2017.01566 
Thomas-White, K., Forster, S. C., Kumar, N., Van Kuiken, M., Putonti, C., Stares, M. D., 
Hilt, E. E., Price, T. K., Wolfe, A. J., & Lawley, T. D. (2018). Culturing of female 
bladder bacteria reveals an interconnected urogenital microbiota. Nature 
Communications, 9(1557), pp. 1-7. doi.org/10.1038/s41467-018-03968-5 
Touchon, M., Bernheim, A., & Rocha, E. P. C. (2016). Genetic and life-history traits 
associated with the distribution of prophages in bacteria. ISME Journal, 10(11), pp. 
2744–2754. doi.org/10.1038/ismej.2016.47 
Touchon, M., Hoede, C., Tenaillon, O., Barbe, V., Baeriswyl, S., Bidet, P., Bingen, E., 
Bonacorsi, S., Bouchier, C., Bouvet, O., Calteau, A., Chiapello, H., Clermont, O., 
Cruveiller, S., Danchin, A., Diard, M., Dossat, C., El Karoui, M., Frapy, E., … 
Denamur, E. (2009). Organised genome dynamics in the Escherichia coli species 
 253 
results in highly diverse adaptive paths. PLoS Genetics, 5(1), pp. e1000344. 
doi.org/10.1371/journal.pgen.1000344 
Tsai, C-M., & Frasch, C. E. (1982). A sensitive silver stain for detecting 
lipopolysaccharides in polyacrylamide gels. Analytical Biochemistry, 119, pp. 115–
119. doi: 10.1016/0003-2697(82)90673-x. 
Turner, N. C. A., Connolly, J. P. R., & Roe, A. J. (2018). Control freaks—signals and cues 
governing the regulation of virulence in attaching and effacing pathogens. 
Biochemical Society Transactions, 47(1), pp. 229–238. 
doi.org/10.1042/BST20180546 
Tzeng, Y. L., Thomas, J., & Stephens, D. S. (2016). Regulation of capsule in Neisseria 
meningitidis. Critical Reviews in Microbiology, 42(5), pp. 759–772. 
doi.org/10.3109/1040841X.2015.1022507 
Uzureau, S., Lemaire, J., Delaive, E., Dieu, M., Gaigneaux, A., Raes, M., De Bolle, X., & 
Letesson, J. J. (2010). Global analysis of quorum sensing targets in the intracellular 
pathogen Brucella melitensis 16 M. Journal of Proteome Research, 9(6), pp. 3200–
3217. doi.org/10.1021/pr100068p 
Van Den Akker, W. M. R. (1998). Lipopolysaccharide expression within the genus 
Bordetella: influence of temperature and phase variation. Microbiology, 144, pp. 
1527–1535. doi: 10.1099/00221287-144-6-1527 
Van Der Woude, M. W., & Bäumler, A. J. (2004). Phase and antigenic variation in 
bacteria. Clinical Microbiology Reviews, 17(3), pp. 581–611. 
doi.org/10.1128/CMR.17.3.581-611.2004 
Vannini, A., Pinatel, E., Costantini, P. E., Pelliciari, S., Roncarati, D., Puccio, S., De 
Bellis, G., Peano, C., & Danielli, A. (2017). Comprehensive mapping of the 
Helicobacter pylori NikR regulon provides new insights in bacterial nickel 
responses. Scientific Reports, 7(45458), pp. 1–14. doi.org/10.1038/srep45458 
Vejborg, R. M., Friis, C., Hancock, V., Schembri, M. A., & Klemm, P. (2010). A virulent 
parent with probiotic progeny: Comparative genomics of Escherichia coli strains 
CFT073, Nissle 1917 and ABU 83972. Molecular Genetics and Genomics, 283(5), pp. 
469–484. doi.org/10.1007/s00438-010-0532-9 
 254 
Vermeulen, C., Cross, A., Byrne, W. R., & Zollinger2, A. W. (1988). Quantitative 
relationship between capsular content and killing of K1-encapsulated Escherichia 
coli. Infection and Immunity, 56(10), pp. 2723–2730. doi: 10.1128/iai.56.10.2723-
2730.1988. 
Vihta, K. D., Stoesser, N., Llewelyn, M. J., Quan, T. P., Davies, T., Fawcett, N. J., 
Dunn, L., Jeffery, K., Butler, C. C., Hayward, G., Andersson, M., Morgan, M., 
Oakley, S., Mason, A., Hopkins, S., Wyllie, D. H., Crook, D. W., Wilcox, M. H., 
Johnson, A. P., … Walker, A. S. (2018). Trends over time in Escherichia coli 
bloodstream infections, urinary tract infections, and antibiotic susceptibilities in 
Oxfordshire, UK, 1998–2016: a study of electronic health records. The Lancet 
Infectious Diseases, 18(10), pp. 1138–1149. doi.org/10.1016/S1473-3099(18)30353-
0 
Vimr, E., Steenbergen, S., & Cieslewicz, M. (1995). Biosynthesis of the polysialic acid 
capsule in Escherichia coli K1. Journal of Industrial Microbiology, 15, pp. 352–
360. doi: 10.1007/BF01569991. 
Vörös, Z., Yan, Y., Kovari, D. T., Finzi, L., & Dunlap, D. (2017). Proteins mediating DNA 
loops effectively block transcription. Protein Science, 26, pp. 1427–1438. 
doi.org/10.1002/pro.3156 
Wade, J. T. (2015). Mapping transcription regulatory networks with ChIP-seq and RNA-
seq. Advances in Experimental Medicine and Biology, 883, pp. 119–134). 
doi.org/10.1007/978-3-319-23603-2_7 
Wallenstein, A., Rehm, N., Brinkmann, M., Selle, M., Bossuet-Greif, N., Sauer, D., Bunk, 
B., Spröer, C., Wami, H. T., Homburg, S., Von Bünau, R., König, S., Nougayrède, J-
P., Overmann, J., Oswald, E., Müller, R., & Dobrindt, U. (2020). ClbR Is the key 
transcriptional activator of colibactin gene expression in Escherichia coli. MSphere, 
5(4), pp. e00591-20. doi.org/10.1128/mSphere 
Wang, I-N., Dykhuizen, D. E., & Slobodkin, L. B. (1996). The evolution of phage lysis 
timing. Evolutionary Ecology, 10(5), pp. 545–558. doi:10.1007/BF01237884 
Wang, X., & Quinn, P. J. (2010). Endotoxins: Lipopolysaccharides of Gram-negative 
bacteria. Endotoxins: Structure, function and recognition, Subcellular 
Biochemistry, 53, pp. 3–27. doi: 10.1007/978-90-481-9078-2_1. 
 255 
Washburn, R. S., & Gottesman, M. E. (2015). Regulation of transcription elongation and 
termination. Biomolecules, 5(2), pp. 1063–1078. doi.org/10.3390/biom5021063 
Watts, R. E., Totsika, M., Challinor, V. L., Mabbett, A. N., Ulett, G. C., Voss, J. J. D., & 
Schembri, M. A. (2012). Contribution of siderophore systems to growth and urinary 
tract colonization of asymptomatic bacteriuria Escherichia coli. Infection and 
Immunity, 80(1), pp. 333–344. doi.org/10.1128/IAI.05594-11 
Waugh, D. S. (2011). An overview of enzymatic reagents for the removal of affinity tags. 
Protein Expression and Purification, 80(2), pp. 283–293. 
doi.org/10.1016/j.pep.2011.08.005 
Wei, Q., Le Minh, P. N., Dötsch, A., Hildebrand, F., Panmanee, W., Elfarash, A., Schulz, 
S., Plaisance, S., Charlier, D., Hassett, D., Häussler, S., & Cornelis, P. (2012). 
Global regulation of gene expression by OxyR in an important human opportunistic 
pathogen. Nucleic Acids Research, 40(10), pp. 4320–4333. 
doi.org/10.1093/nar/gks017 
Welch, R A, Burland, V., Plunkett III, G., Redford, P., Roesch, P., Rasko, D., Buckles, E. 
L., Liou, S.-R., Boutin, A., Hackett, J., Stroud, D., Mayhew, G. F., Rose, D. J., 
Zhou, S., Schwartz, D. C., Perna, N. T., Mobley, H. L. T., & Blattner, F. R. (2002). 
Extensive mosaic structure revealed by the complete genome sequence of 
uropathogenic Escherichia coli. Proceedings of the National Academy of Sciences 
USA, 99(26), pp. 17020-17024. doi: 10.1073/pnas.252529799. 
Welch, R A. (2016). Uropathogenic Escherichia coli-associated exotoxins. Microbiology 
Spectrum, 4(3), pp. 1–16. doi.org/10.1128/microbiolspec.uti-0011-2012 
Whitfield, C., Heinrichs, D. E., Yethon, J. A., Amor, K. L., Monteiro, M. A., & Perry, M. 
B. (1999). Assembly of the R1-type core oligosaccharide of Escherichia coli 
lipopolysaccharide. Journal of Endotoxin Research, 5(3), pp. 151-156. doi: 
10.1074/jbc.273.45.29497. 
Whitfield, C., & Roberts, I. S. (1999). Structure, assembly and regulation of expression 
of capsules in Escherichia coli. Molecular Microbiology, 31(5), pp. 1307–1319. doi: 
10.1046/j.1365-2958.1999.01276.x. 
Wijetunge, D. S. S., Gongati, S., Debroy, C., Kim, K. S., Couraud, P. O., Romero, I. A., 
Weksler, B., & Kariyawasam, S. (2015). Characterizing the pathotype of neonatal 
 256 
meningitis causing Escherichia coli (NMEC). BMC Microbiology, 15(211), pp. 1–15. 
doi.org/10.1186/s12866-015-0547-9 
Wilson, K. S., & Von Hippel, P. H. (1995). Transcription termination at intrinsic 
terminators: The role of the RNA hairpin. Proceedings of the National Academy of 
Sciences USA, 92, pp. 8793–8797. doi: 10.1073/pnas.92.19.8793. 
Wolf, S. G., Frenkiel, D., Arad, T., Finkel, S. E., Kolter, R., & Minsky, A. (1999). DNA 
protection by stress-induced biocrystallization. Nature, 400, pp. 83–85. doi: 
10.1038/21918. 
Xie, Y., Kim, K. J., & Kim, K. S. (2004). Current concepts on Escherichia coli K1 
translocation of the blood-brain barrier. FEMS Immunology and Medical 
Microbiology, 42(3), pp. 271–279. doi.org/10.1016/j.femsim.2004.09.001 
Yao, Y., Xie, Y., & Kim, K. S. (2006). Genomic comparison of Escherichia coli K1 strains 
isolated from the cerebrospinal fluid of patients with meningitis. Infection and 
Immunity, 74(4), pp. 2196–2206. doi.org/10.1128/IAI.74.4.2196-2206.2006 
Yao, Y., Xie, Y., Perace, D., Zhong, Y., Lu, J., Tao, J., Guo, X., & Kim, K. S. (2009). 
The type III secretion system is involved in the invasion and intracellular survival of 
Escherichia coli K1 in human brain microvascular endothelial cells. FEMS 
Microbiology Letters, 300(1), pp. 18–24. doi.org/10.1111/j.1574-6968.2009.01763.x 
Yarnell, W. S., & Roberts, J. W. (1999). Mechanism of intrinsic transcription termination 
and antitermination. Science, 284(5414), pp. 611–615. doi: 
10.1126/science.284.5414.611. 
Yethon, J. A., Vinogradov, E., Perry, M. B., & Whitfield, C. (2000). Mutation of the 
lipopolysaccharide core glycosyltransferase encoded by waaG destabilizes the 
outer membrane of Escherichia coli by interfering with core phosphorylation. 
Journal of Bacteriology, 182(19), pp. 5620–5623. doi: 10.1128/JB.182.19.5620-
5623.2000. 
Young, C. L., Britton, Z. T., & Robinson, A. S. (2012). Recombinant protein expression 
and purification: A comprehensive review of affinity tags and microbial 
applications. Biotechnology Journal, 7(5), pp. 620–634. 
doi.org/10.1002/biot.201100155 
 257 
Zagon, J., Dehne, L-I., & Bogl, K.-W. (1994). D-amino acids in organisms and food. 
Nutrition Research, 14(3), pp. 445–463. doi.org/10.1016/S0271-5317(05)80182-4 
Zhang, C., An, H., Hu, J., Li, J., Zhang, W., Lan, X., Deng, H., & Zhang, J. (2021). MetR 
is a molecular adaptor for pneumococcal carriage in the healthy upper airway. 
Molecular Microbiology, 116(2), pp. 438-458. doi.org/10.1111/mmi.14724 
Zhang, J. (2003). Evolution by gene duplication: An update. Trends in Ecology and 
Evolution, 18(6), pp. 292–298. doi.org/10.1016/S0169-5347(03)00033-8 
Zhou, Y., Zhang, X., & Ebright, R. H. (1993). Identification of the activating region of 
catabolite gene activator protein (CAP): Isolation and characterization of mutants 
of CAP specifically defective in transcription activation. Proceedings of National 





Table S-1 CFT073 binding sites (no D-serine). 
      Replicate 1 Replicate 2 
Gene 
Dist. 
Gene Context Co-ordinates Centre Length p-value Co-ordinates Centre Length p-value 
c0346 -54 Intergenic 322255..322761 322527 507 3.93E-15 322294..322729 322542 436 3.31E-03 
c1208 -72 Intergenic 1164775..1165252 1165010 478 5.09E-14 1164795..1165240 1165052 446 1.83E-03 
c3694 0 Intragenic 3525736..3526315 3526079 580 8.71E-10 3525893..3526313 3526125 421 9.48E-04 
rfaJ 0 Intergenic 4234841..4235368 4235076 528 2.33E-09 4234927..4235349 4235116 423 3.55E-05 
wzy 128 Intragenic 2399200..2399768 2399437 569 2.08E-08 2399020..2399493 2399305 474 5.34E-04 
waaL 705 Intragenic 4230281..4230846 4230516 566 2.37E-08 4230274..4230719 4230531 446 2.39E-04 
rfaY 0 Intragenic 4233801..4234394 4234038 594 2.38E-08 4233850..4234354 4234038 505 6.11E-03 
c0327 0 Intergenic 299056..299527 299293 472 2.55E-08 299096..299478 299284 383 1.00E-02 
yrhA 0 Intragenic 4022294..4022777 4022529 484 3.79E-08 4022325..4022703 4022514 379 3.13E-03 
waaV 0 Intergenic 4232118..4232633 4232400 516 4.08E-08 4232132..4232518 4232334 387 5.49E-05 
c3766 0 Intragenic 3600396..3600931 3600633 536 5.12E-08 3600475..3600858 3600670 384 7.93E-03 
yhiM 0 Intergenic 4068883..4069381 4069147 499 3.79E-07 4068903..4069318 4069131 416 4.87E-04 
c5209 -224 Intragenic 4964289..4964816 4964524 528 3.81E-07 4964007..4964569 4964196 563 3.35E-03 
c4303 0 Intergenic 4082826..4083296 4083061 471 4.61E-07 4082833..4083261 4083022 429 1.00E-02 
c5426 146 Intragenic 5171549..5172100 5171786 552 6.92E-07 5171634..5172097 5171909 464 1.00E-02 
yhhZ 0 Intragenic 4021035..4021608 4021272 574 1.14E-06 4021051..4021435 4021247 385 4.68E-04 
c0430 -159 Intergenic 415182..415654 415420 473 1.21E-06 415260..415780 415593 521 2.18E-03 
c2897 0 Intergenic 2757208..2757733 2757445 526 1.24E-06 2757362..2757847 2757551 486 3.46E-04 
c3302 0 Intergenic 3148558..3149079 3148843 522 2.08E-06 3148463..3148959 3148652 497 2.00E-02 
c4739 0 Intergenic 4507151..4507687 4507453 537 2.12E-06 4507120..4507601 4507413 482 1.72E-03 
ycdT 0 Intergenic 1125620..1126089 1125855 470 1.06E-05 1125678..1126058 1125871 381 3.89E-03 
cydA 0 Intragenic 792719..793303 792954 585 1.58E-05 792750..793161 792939 412 2.00E-02 
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tauA 0 Intergenic 459923..460449 460158 527 1.90E-05 460046..460429 460241 384 4.47E-03 
c4423 0 Intergenic 4204869..4205392 4205106 524 2.18E-05 4204877..4205275 4205087 399 3.05E-03 
yicL -71 Intragenic 4342419..4342916 4342653 498 2.20E-05 4342634..4343028 4342840 395 1.00E-02 
yfcV -19 Intergenic 2737741..2738222 2737988 482 3.19E-05 2737711..2738226 2738038 516 2.45E-03 
arcA 0 Intragenic 5094971..5095445 5095211 475 3.54E-05 5094933..5095340 5095097 408 3.00E-02 
c0080 0 Intragenic 74758..75274 75040 517 4.19E-05 74744..75153 74933 410 1.13E-03 
c5435 0 Intergenic 5181592..5182228 5181992 637 4.72E-05 5181803..5182216 5182036 414 3.00E-02 
tssB 0 Intergenic 3222515..3223024 3222750 510 4.94E-05 3222504..3223023 3222693 520 2.83E-03 
asst 0 Intergenic 3618369..3618857 3618623 489 5.68E-05 3618438..3618843 3618655 406 1.80E-04 
c4498 585 Intergenic 4282736..4283276 4282971 541 1.16E-04 4282822..4283234 4283011 413 6.68E-03 
caiT 0 Intergenic 44606..45107 44841 502 1.33E-04 44597..45059 44871 463 9.97E-03 
c0322 0 Intergenic 292356..292924 292591 569 1.94E-04 292333..292766 292522 434 5.12E-03 
hemB -41 Intergenic 465027..465546 465262 520 2.37E-04 464974..465388 465163 415 7.11E-03 
c4214 0 Intergenic 3999566..4000053 3999801 488 2.67E-04 3999704..4000094 3999906 391 3.00E-03 
cmtB 0 Intergenic 3372727..3373422 3373186 696 2.89E-04 3373068..3373500 3373314 433 2.58E-03 
c0321 20 Intragenic 291198..291685 291451 488 3.28E-04 291150..291637 291449 488 8.83E-03 
leuO -115 Intergenic 87602..88079 87839 478 3.36E-04 87710..88087 87899 378 7.60E-03 
yjjQ -47 Intergenic 5191907..5192418 5192184 512 4.58E-04 5192005..5192417 5192191 413 2.00E-02 
c0077 0 Intergenic 73819..74471 74056 653 4.59E-04 73931..74480 74292 550 8.17E-03 
c3686 -151 Intergenic 3511416..3511940 3511704 525 4.66E-04 3511413..3511823 3511602 411 2.00E-02 
c2383 0 Intergenic 2185354..2185881 2185645 528 5.22E-04 2185385..2185931 2185743 547 2.00E-02 
c2405 95 Intragenic 2208165..2208658 2208424 494 5.42E-04 2208150..2208572 2208384 423 8.25E-03 
hlyC -412 Intergenic 3417354..3417959 3417591 606 5.79E-04 3418038..3418550 3418363 513 7.32E-03 
c5164 0 Intergenic 4931257..4931885 4931651 629 6.81E-04 4931424..4931959 4931613 536 3.00E-02 
ygiK 0 Intragenic 3588884..3589367 3589118 484 1.00E-03 3588918..3589335 3589147 418 5.00E-02 
yfaL 0 Intergenic 2630987..2631481 2631245 495 1.24E-03 2631013..2631424 2631202 412 2.31E-04 
c2406 -190 Intergenic 2209958..2210494 2210195 537 1.32E-03 2210043..2210457 2210269 415 8.27E-03 
 261 
ygiL 0 Intergenic 3624039..3624631 3624395 593 1.35E-03 3624167..3624606 3624418 440 9.37E-04 
fimE 0 Intergenic 5136286..5136775 5136521 490 1.52E-03 5136363..5136759 5136552 397 4.00E-02 
envR 0 Intergenic 3845140..3845648 3845414 509 2.14E-03 3845218..3845607 3845419 390 2.39E-03 
c4896 0 Intragenic 4655944..4656436 4656181 493 2.15E-03 4656051..4656439 4656251 389 7.32E-03 
c2348 0 Intergenic 2160258..2160757 2160493 500 2.21E-03 2160279..2160658 2160468 380 3.06E-04 
yadN 0 Intergenic 167376..167865 167613 490 2.31E-03 167517..167920 167732 404 2.14E-04 
yjdA 0 Intergenic 4885292..4885787 4885551 496 2.57E-03 4885358..4885754 4885547 397 4.89E-03 
fucP 0 Intragenic 3208553..3209172 3208788 620 2.65E-03 3208638..3209130 3208827 493 4.00E-02 
nanC 0 Intergenic 5134074..5134599 5134309 526 3.38E-03 5134134..5134528 5134341 395 2.00E-02 
ydbA_1 0 Intergenic 1663930..1664429 1664195 500 3.91E-03 1663913..1664348 1664160 436 7.37E-03 
ompC 0 Intergenic 1421035..1421524 1421271 490 4.73E-03 1421060..1421453 1421248 394 6.79E-03 
bglG 0 Intergenic 4407383..4408063 4407827 681 4.81E-03 4407738..4408118 4407932 381 3.00E-02 
c5298 0 Intergenic 5038053..5038523 5038288 471 4.84E-03 5038057..5038439 5038246 383 3.87E-03 
yicO 0 Intragenic 4348267..4348913 4348677 647 5.01E-03 4348556..4348934 4348745 379 3.00E-02 
frc 0 Intergenic 2775657..2776157 2775924 501 5.94E-03 2775616..2776057 2775805 442 6.82E-03 
c1618 0 Intragenic 1460905..1461431 1461195 527 6.11E-03 1460930..1461353 1461119 424 3.00E-02 
c0407 0 Intragenic 388028..388586 388262 559 6.37E-03 387986..388442 388254 457 5.00E-02 
c4894 0 Intergenic 4652769..4653327 4653004 559 6.40E-03 4652686..4653084 4652897 399 2.00E-02 
sat 0 Intergenic 3460036..3460533 3460297 498 6.68E-03 3460091..3460470 3460282 380 1.00E-02 
pitB 0 Intergenic 3558084..3558565 3558331 482 6.90E-03 3558160..3558572 3558384 413 1.00E-02 
tnaA 0 Intergenic 4390079..4390574 4390316 496 1.00E-02 4390047..4390517 4390329 471 3.00E-02 
tdcB 0 Intergenic 3705304..3705792 3705541 489 1.00E-02 3705354..3705737 3705549 384 3.00E-02 
ypdI 0 Intergenic 2776873..2777347 2777110 475 1.00E-02 2776854..2777242 2777054 389 2.00E-02 
c5088 0 Intragenic 4863274..4863764 4863528 491 1.00E-02 4863446..4863833 4863635 388 2.00E-02 
c4492 0 Intergenic 4275822..4276303 4276067 482 1.00E-02 4275872..4276340 4276061 469 2.10E-03 
c2815 0 Intergenic 2670640..2671153 2670875 514 1.00E-02 2670713..2671119 2670902 407 5.76E-03 
iraD 18 Intergenic 5149972..5150464 5150207 493 1.00E-02 5149969..5150413 5150225 445 1.00E-02 
 262 
c3712 0 Intergenic 3544866..3545334 3545101 469 1.00E-02 3544928..3545394 3545206 467 2.00E-02 
yegR 0 Intergenic 2459372..2459884 2459607 513 1.00E-02 2459456..2459853 2459643 398 2.00E-02 
c4020 0 Intergenic 3836796..3837307 3837031 512 2.00E-02 3836896..3837303 3837085 408 1.00E-02 
yebN -133 Intergenic 2056751..2057226 2056988 476 2.00E-02 2056859..2057294 2057048 436 2.00E-02 
yliE 483 Intragenic 894352..894882 894648 531 2.00E-02 894394..894792 894604 399 3.00E-02 
c3031 0 Intergenic 2903888..2904394 2904122 507 2.00E-02 2903942..2904350 2904162 409 1.62E-03 
yjcS 0 Intergenic 4865626..4866130 4865863 505 2.00E-02 4865608..4866002 4865815 395 2.00E-02 
dsdC 0 Intergenic 2759612..2760084 2759848 473 3.00E-02 2759962..2760486 2760151 525 9.03E-04 
stpA 0 Intergenic 3076982..3077460 3077219 479 3.00E-02 3077052..3077532 3077241 481 4.00E-02 
yeeN 0 Intergenic 2256940..2257468 2257177 529 4.00E-02 2256986..2257371 2257175 386 2.00E-02 
yheE 0 Intragenic 3886779..3887278 3887016 500 5.00E-02 3886745..3887144 3886956 400 4.00E-02 
fdeC 0 Intergenic 395223..395931 395460 709 5.00E-02 395288..395692 395477 405 2.00E-02 
 
Table S-2 CFT073 binding sites (+ D-ser) 
      Replicate 1 Replicate 2 
Gene 
Dist. 
Gene Context  Co-ordinates Centre Length  p-value Co-ordinates Centre Length  p-value 
rfaJ 0 Intragenic 4234886..4235313 4235116 428 1.83E-15 4234953..4235367 4235155 415 6.13E-19 
c4214 -88 Intergenic 3999713..4000110 3999911 398 1.31E-12 3999692..4000097 3999896 406 5.78E-10 
waaL 511 Intragenic 4230330..4230726 4230528 397 2.78E-11 4230325..4230760 4230526 436 3.29E-16 
waaV 0 Intergenic 4232110..4232540 4232343 431 6.50E-11 4232127..4232555 4232357 429 1.91E-14 
yhhZ 0 Intergenic 4021047..4021474 4021245 428 3.42E-10 4020894..4021491 4021096 598 1.22E-10 
ygiL 0 Intergenic 3624118..3624613 3624416 496 5.70E-10 3624129..3624532 3624332 404 6.51E-08 
yadN -44 Intergenic 167507..167907 167705 401 7.12E-10 167478..167898 167697 421 2.25E-10 
 263 
c0080 0 Intragenic 74758..75189 74955 432 2.39E-09 74949..75356 75151 408 1.88E-10 
c3694 0 Intragenic 3525853..3526314 3526117 462 2.54E-09 3525897..3526325 3526099 429 3.43E-10 
c4739 0 Intergenic 4507176..4507645 4507448 470 3.87E-09 4507165..4507576 4507375 412 4.87E-12 
c2897 -52 Intergenic 2757411..2757939 2757609 529 2.96E-08 2757468..2757891 2757692 424 8.94E-11 
c4498 847 Intergenic 4282776..4283226 4282974 451 4.43E-08 4282810..4283273 4283012 464 4.17E-07 
c5435 0 Intergenic 5181703..5182135 5181901 433 4.45E-08 5181701..5182152 5181951 452 3.37E-07 
c3692 776 Intergenic 3519957..3520396 3520155 440 5.56E-08 3519956..3520336 3520158 381 1.83E-06 
c4896 0 Intergenic 4656052..4656453 4656256 402 6.68E-08 4656015..4656455 4656254 441 6.45E-08 
yfcV -33 Intergenic 2737755..2738225 2738028 471 7.76E-08 2737762..2738198 2737998 437 4.27E-06 
c3686 -144 intergenic 3511546..3511947 3511750 402 1.29E-07 3511502..3511925 3511724 424 1.00E-09 
c4492 -71 Intergenic 4275814..4276225 4276012 412 2.28E-07 4275811..4276260 4276059 450 3.24E-11 
asst 0 Intergenic 3618401..3618899 3618702 499 2.80E-07 3618370..3618840 3618639 471 2.75E-08 
leuO 0 Intergenic 87703..88224 87901 522 2.82E-07 87736..88181 87938 446 2.37E-06 
cmtB 0 Intergenic 3373110..3373525 3373328 416 3.62E-07 3373088..3373543 3373342 456 2.96E-07 
c0322 0 Intergenic 292319..292758 292517 440 3.99E-07 292337..292791 292539 455 1.31E-07 
ycdT 0 Intergenic 1125690..1126096 1125900 407 4.74E-07 1125693..1126125 1125895 433 5.07E-06 
c4423 0 Intergenic 4204935..4205359 4205162 425 7.60E-07 4204879..4205363 4205162 485 8.04E-07 
rfaY 0 Intragenic 4233877..4234333 4234073 457 7.70E-07 4233832..4234313 4234034 482 5.15E-13 
papA 0 Intergenic 3438020..3438517 3438320 498 1.13E-06 3438032..3438492 3438291 461 3.14E-08 
yfaL 0 Intergenic 2631023..2631424 2631221 402 1.17E-06 2630979..2631459 2631181 481 4.47E-07 
c0327 -22 Intergenic 299139..299565 299337 427 1.32E-06 299083..299498 299297 416 1.68E-07 
caiT 0 Intergenic 44502..45047 44700 546 1.58E-06 44497..45045 44699 549 2.67E-07 
yjjQ -27 Intergenic 5191990..5192438 5192188 449 1.85E-06 5191968..5192375 5192174 408 7.68E-07 
fimE -15 Intergenic 5136346..5136753 5136544 408 2.22E-06 5136282..5136722 5136521 441 5.52E-10 
pitB 0 Intergenic 3558153..3558579 3558351 427 2.31E-06 3558159..3558582 3558381 424 8.80E-07 
c0077 0 Intergenic 73941..74415 74218 475 2.50E-06 73872..74426 74225 555 6.85E-08 
c5298 0 Intergenic 5038049..5038452 5038255 404 2.54E-06 5038053..5038523 5038255 471 1.82E-11 
 264 
c5209 -157 Intragenic 4964202..4964678 4964481 477 2.63E-06 4963981..4964586 4964183 606 1.88E-08 
yhiM 0 Intergenic 4068821..4069290 4069019 470 2.83E-06 4068879..4069312 4069111 434 1.03E-10 
pagP -67 Intergenic 696667..697080 696883 414 3.48E-06 696605..697166 696807 562 4.66E-08 
hlyC -486 Intergenic 3417322..3417723 3417520 402 3.64E-06 3418168..3418696 3418370 529 8.40E-06 
envR 0 Intergenic 3845196..3845596 3845394 401 3.66E-06 3845204..3845621 3845420 418 1.47E-09 
c0325 822 Intragenic 297396..297797 297600 402 3.81E-06 297399..297913 297600 515 5.78E-08 
c3031 0 Intergenic 2903918..2904358 2904162 441 3.95E-06 2903936..2904363 2904162 428 3.09E-08 
c4303 0 Intergenic 4082825..4083321 4083023 497 4.56E-06 4082875..4083342 4083077 468 1.20E-08 
c5426 182 Intragenic 5171570..5171978 5171768 409 4.74E-06 5171408..5171969 5171769 562 1.20E-06 
garP 0 Intergenic 3712121..3712663 3712319 543 5.12E-06 3712191..3712685 3712391 495 3.29E-06 
cydA -944 Intergenic 792774..793183 792986 410 5.20E-06 792775..793255 792977 481 2.57E-04 
yjdA 0 Intergenic 4885306..4885790 4885504 485 6.20E-06 4885309..4885732 4885511 424 1.15E-08 
tauA -85 Intergenic 460039..460438 460241 400 6.69E-06 459988..460394 460190 407 8.09E-09 
tnaA 0 Intragenic 4390031..4390481 4390229 451 7.73E-06 4390075..4390547 4390346 473 3.51E-08 
c3766 0 Intragenic 3600368..3600870 3600566 503 9.08E-06 3600466..3600989 3600668 524 6.70E-07 
c4994 0 Intergenic 4771197..4771598 4771395 402 1.07E-05 4771190..4771600 4771399 411 4.69E-07 
c0430 -178 Intergenic 415201..415788 415591 588 1.20E-05 415235..415742 415541 508 1.66E-06 
c3302 0 Intragenic 3148555..3148969 3148753 415 1.33E-05 3148531..3148975 3148733 445 6.04E-07 
arcA -39 Intergenic 5094995..5095446 5095193 452 1.48E-05 5094903..5095360 5095159 458 2.63E-07 
frc 0 Intergenic 2775625..2776068 2775823 444 1.64E-05 2775657..2776110 2775909 454 1.18E-06 
yiiE 0 Intergenic 4603113..4603511 4603311 399 1.86E-05 4603087..4603490 4603289 404 4.56E-06 
yghT 0 Intergenic 3555739..3556173 3555977 435 2.15E-05 3555714..3556137 3555936 424 6.30E-06 
wzy -129 Intragenic 2399205..2399624 2399403 420 2.18E-05 2399200..2399653 2399402 454 6.20E-06 
dpiB 0 Intergenic 692480..692916 692719 437 2.55E-05 692470..693001 692671 532 1.15E-05 
ompC -1 Intergenic 1421091..1421510 1421313 420 2.60E-05 1421062..1421481 1421280 420 2.08E-07 
tssB -39 Intergenic 3222559..3222962 3222757 404 2.74E-05 3222592..3223034 3222794 443 7.29E-06 
c4920 0 Intergenic 4685058..4685508 4685256 451 3.40E-05 4685058..4685482 4685260 425 1.31E-04 
 265 
yiaY 0 Intergenic 4193450..4193849 4193652 400 3.46E-05 4193398..4193822 4193621 425 4.56E-09 
fdeC 0 Intergenic 395279..395770 395477 492 3.53E-05 395267..395775 395467 509 3.51E-04 
gadA 0 Intergenic 4106198..4106634 4106394 437 3.63E-05 4106162..4106645 4106364 484 1.94E-06 
c3712 0 Intergenic 3544937..3545337 3545140 401 3.93E-05 3544890..3545332 3545131 443 5.09E-07 
tdcB 0 Intergenic 3705272..3705738 3705541 467 5.65E-05 3705256..3705718 3705524 463 7.11E-06 
c0346 0 Intragenic 322315..322739 322542 425 5.78E-05 322298..322742 322542 445 3.12E-04 
sat 0 Intergenic 3460004..3460473 3460276 470 5.88E-05 3460045..3460516 3460315 472 1.39E-07 
c1271 140 Intragenic 1222173..1222602 1222405 430 6.27E-05 1221994..1222596 1222396 603 7.71E-06 
hemB -16 Intergenic 465002..465419 465200 418 6.50E-05 465037..465525 465239 489 1.51E-06 
c1208 -75 Intragenic 1164820..1165259 1165062 440 7.39E-05 1164817..1165259 1165019 443 2.46E-05 
ypdI 0 Intergenic 2776802..2777225 2777028 424 9.36E-05 2776782..2777206 2777006 425 1.10E-04 
c4020 0 Intergenic 3836892..3837293 3837096 402 9.76E-05 3836949..3837363 3837150 415 3.63E-05 
wzx 0 Intragenic 2399822..2400397 2400200 576 1.14E-04 2399804..2400354 2400153 551 1.73E-05 
nanC 0 Intergenic 5134093..5134568 5134291 476 1.26E-04 5134148..5134623 5134350 476 1.18E-07 
bglG 0 Intergenic 4407620..4408101 4407904 482 1.33E-04 4407663..4408091 4407890 429 3.94E-05 
livK 0 Intergenic 4036062..4036463 4036266 402 1.35E-04 4036072..4036507 4036306 436 4.65E-07 
hcp 0 Intragenic 4521230..4521804 4521608 575 1.37E-04 4521256..4521815 4521614 560 1.43E-07 
c5088 0 Intergenic 4863464..4863897 4863700 434 1.37E-04 4863425..4863862 4863661 438 6.86E-06 
yjeJ 0 Intergenic 4982924..4983378 4983182 455 1.48E-04 4982892..4983346 4983147 455 2.94E-06 
c2383 0 Intergenic 2185351..2185883 2185686 533 1.59E-04 2185507..2185921 2185709 415 6.37E-06 
agaB 0 Intergenic 3723469..3723879 3723667 411 2.21E-04 3723574..3724084 3723776 511 4.65E-05 
c4488 0 Intergenic 4269841..4270240 4270039 400 2.30E-04 4269762..4270366 4270165 605 6.08E-05 
yicO 0 Intergenic 4348466..4348882 4348685 417 2.33E-04 4348477..4348891 4348690 415 4.06E-07 
yebN -137 Intergenic 2056792..2057222 2057025 431 2.47E-04 2056808..2057244 2057043 437 1.04E-05 
c2348 0 Intergenic 2160276..2160721 2160474 446 2.94E-04 2160271..2160721 2160473 451 4.35E-06 
adiY 0 Intergenic 4896255..4896822 4896625 568 3.06E-04 4896371..4896845 4896644 475 5.31E-05 
yheE 0 Intergenic 3886738..3887177 3886936 440 3.21E-04 3886740..3887182 3886942 443 1.31E-03 
 266 
c2815 0 Intergenic 2670706..2671101 2670903 396 3.36E-04 2670699..2671213 2670901 515 3.62E-04 
fimA -43 Intergenic 5137381..5137802 5137578 422 3.47E-04 5137377..5137833 5137632 457 1.34E-06 
aslA 0 Intergenic 4486185..4486610 4486413 426 3.53E-04 4486170..4486587 4486372 418 4.94E-05 
fucP 0 Intergenic 3208564..3209130 3208762 567 4.02E-04 3208613..3209029 3208828 417 1.26E-05 
yliE 525 Intragenic 894436..894847 894650 412 4.11E-04 894428..894834 894630 407 6.69E-05 
yjcS 0 Intergenic 4865663..4866083 4865861 421 4.43E-04 4865638..4866047 4865840 410 1.04E-05 
yegR 0 Intergenic 2459395..2459841 2459644 447 4.46E-04 2459427..2459835 2459629 409 1.61E-06 
c4983 0 Intragenic 4762924..4763345 4763122 422 4.56E-04 4762918..4763329 4763129 412 5.62E-04 
c5356 0 Intergenic 5098404..5098854 5098657 451 5.61E-04 5098440..5098906 5098642 467 2.92E-05 
c1166 0 Intragenic 1130647..1131048 1130845 402 5.75E-04 1130507..1131038 1130837 532 9.96E-04 
chiA 0 Intergenic 3901180..3901576 3901379 397 5.93E-04 3901085..3901616 3901287 532 1.38E-03 
c0407 -249 Intergenic 388135..388577 388333 443 6.27E-04 388091..388542 388293 452 4.87E-06 
yhbX 0 Intergenic 3755096..3755491 3755294 396 6.38E-04 3755062..3755519 3755318 458 9.79E-05 
c1892 0 Intragenic 1726230..1726742 1726428 513 7.00E-04 1726250..1726720 1726451 471 4.17E-04 
c1618 0 Intragenic 1460993..1461393 1461197 401 7.14E-04 1461015..1461465 1461217 451 1.50E-04 
yebB 0 Intragenic 2097660..2098115 2097858 456 7.40E-04 2097660..2098263 2097861 604 3.19E-03 
ydbA_1 0 Intergenic 1663883..1664336 1664139 454 7.72E-04 1663929..1664335 1664134 407 1.82E-03 
ykgI 0 Intragenic 402822..403248 403051 427 8.51E-04 402817..403255 403054 439 1.23E-04 
yhfL 0 Intergenic 3930528..3930927 3930725 400 1.14E-03 3930598..3931017 3930816 420 1.83E-05 
dsdC 0 Intergenic 2759996..2760586 2760194 591 1.15E-03 2759949..2760549 2760151 601 6.20E-07 
yeeN 0 Intergenic 2257022..2257582 2257220 561 1.40E-03 2257054..2257516 2257256 463 2.03E-05 
c4986 0 Intergenic 4764725..4765138 4764941 414 1.49E-03 4764689..4765105 4764889 417 3.10E-04 
c4502 0 Intergenic 4289649..4290046 4289849 398 1.55E-03 4289593..4290035 4289834 443 9.44E-04 
stpA 0 Intergenic 3077102..3077562 3077300 461 1.65E-03 3077092..3077555 3077294 464 9.26E-06 
c2406 -296 Intergenic 2210064..2210461 2210262 398 1.78E-03 2210618..2211182 2210981 565 8.23E-06 
fdrA 0 Intergenic 615034..615477 615232 444 2.19E-03 615068..615503 615302 436 1.20E-04 
cyoA -126 Intergenic 525665..526079 525882 415 2.22E-03 525588..525993 525790 406 9.98E-04 
 267 
c4015 0 Intragenic 3833074..3833654 3833457 581 2.41E-03 3833248..3833688 3833489 441 1.52E-04 
rpiB 0 Intergenic 4872115..4872551 4872313 437 2.55E-03 4872035..4872514 4872317 480 1.89E-03 
iraP 0 Intergenic 475076..475575 475274 500 3.11E-03 475090..475506 475305 417 2.72E-06 
iraD -36 Intergenic 5149995..5150446 5150192 452 3.14E-03 5149971..5150394 5150193 424 3.70E-04 
ompN 0 Intergenic 1654547..1654942 1654745 396 3.36E-03 1654537..1655003 1654802 467 4.80E-03 
c4539 0 Intergenic 4318776..4319205 4319008 430 4.57E-03 4318823..4319242 4319024 420 1.00E-02 
yffB 0 Intergenic 2861671..2862106 2861909 436 5.69E-03 2861706..2862127 2861926 422 1.16E-03 
yciF 0 Intergenic 1559655..1560054 1559853 400 5.84E-03 1559522..1559938 1559737 417 1.19E-03 
araE 0 Intergenic 3290174..3290572 3290372 399 6.63E-03 3290122..3290525 3290324 404 6.48E-03 
ais 0 Intergenic 2651820..2652398 2652201 579 7.24E-03 2651952..2652392 2652191 441 2.71E-04 
c0363 0 Intergenic 340655..341100 340903 446 8.01E-03 340627..341037 340829 411 2.39E-03 
bdm 0 Intergenic 1749132..1749601 1749404 470 8.76E-03 1749199..1749617 1749416 419 1.98E-03 
c0410 0 Intergenic 390881..391284 391079 404 2.00E-02 390857..391392 391048 536 1.00E-02 
clbR -158 Intergenic 2313770..2314181 2313984 412 3.00E-02 2314636..2315118 2314831 483 4.01E-03 
 
Table S-3 CE10 DsdC1 binding data (no D-ser). 
      Replicate 1 Replicate 2 
Gene 
Dist. 
Gene Context  Co-ordinates Centre Length  p-value Co-ordinates Centre Length  p-value 
CE10_0023 -701 Intragenic 27441..27818 27655 378 0.00+00E 27570..27709 27655 140 6.54E-45 
CE10_0067 0 Intragenic 79557..79975 79725 419 0.00+00E 79539..79698 79594 160 5.26E-17 
yadN 0 Intergenic 166926..167348 167185 423 0.00+00E 166217..166355 166272 139 6.19E-12 
tauA -100 Intergenic 365148..365547 365378 400 0.00+00E 365288..365432 365378 145 3.50E-23 
CE10_0889 0 Intergenic  940940..941277 941109 338 0.00+00E 941073..941226 941173 154 6.93E-17 
 268 
ysdS 0 Intergenic 2249533..2249989 2249820 457 0.00+00E 2249802..2249931 2249877 130 1.99E-18 
wbbC 0 Intragenic 2367786..2368225 2368057 440 0.00+00E 2367937..2368062 2368008 126 7.20E-71 
wzy -105 Intergenic 2368985..2369359 2369154 375 0.00+00E 2369039..2369172 2369118 134 8.65E-37 
CE10_2740 4 Intergenic 2788664..2789046 2788830 383 0.00+00E 2788877..2788999 2788949 123 1.66E-31 
dsdC1 0 Intergenic  2791235..2791582 2791414 348 0.00+00E 2791368..2791477 2791423 110 9.87E-156 
CE10_3076 0 Intergenic 3138070..3138508 3138240 439 0.00+00E 3138181..3138283 3138234 103 9.80E-26 
yqeI -59 Intergenic  3340403..3340735 3340557 333 0.00+00E 3340524..3340674 3340624 151 4.97E-33 
ygeG -62 Intergenic 3343448..3343743 3343556 296 0.00+00E 3343481..3343606 3343533 126 3.75E-43 
prgI 28 Intragenic 3350452..3350809 3350656 358 0.00+00E 3350640..3350776 3350722 137 1.71E-28 
eprH 0 Intergenic 3351564..3351974 3351806 411 0.00+00E 3351640..3351757 3351705 118 4.76E-34 
epaS 0 Intragenic 3354052..3354436 3354278 385 0.00+00E 3354192..3354316 3354262 125 2.86E-46 
epaO 0 Intergenic  3356511..3356931 3356764 421 0.00+00E 3356785..3356857 3356814 73 1.17E-20 
neuE -169 Intragenic 3544618..3544986 3544780 369 0.00+00E 3544725..3544861 3544780 137 7.61E-24 
neuA -364 Intragenic  3547233..3547655 3547381 423 0.00+00E 3546798..3546956 3546853 159 4.32E-14 
neuB -278 Intergenic 3548187..3548660 3548503 474 0.00+00E 3548362..3548475 3548417 114 9.15E-29 
slp -296 Intragenic 4101919..4102392 4102088 474 0.00+00E 4102402..4102530 4102477 129 2.34E-29 
rfaL 0 Intragenic 4258249..4258601 4258438 353 0.00+00E 4258330..4258481 4258436 152 3.80E-26 
waaV 0 Intergenic  4260038..4260392 4260235 355 0.00+00E 4260181..4260334 4260235 154 1.76E-29 
waaT 0 Intergenic 4262851..4263201 4263019 351 0.00+00E 4262962..4263125 4263017 164 7.34E-31 
dsdC2 0 Intergenic  4332276..4332616 4332446 341 0.00+00E 4332401..4332520 4332456 120 7.67E-151 
sipD 0 Intergenic  4365627..4366074 4365905 448 0.00+00E 4365896..4366048 4365996 153 2.65E-18 
CE10_4297 0 Intergenic  4367298..4367739 4367571 442 0.00+00E 4367521..4367649 4367595 129 7.93E-24 
espY4 0 Intragenic 4441550..4442034 4441719 485 0.00+00E 4441179..4441292 4441238 114 2.01E-19 
CE10_4362 118 Intragenic  4442253..4442560 4442395 308 0.00+00E 4442079..4442190 4442136 112 1.52E-29 
CE10_4466 -357 Intragenic  4553284..4553676 4553453 393 0.00+00E 4552933..4553055 4553001 123 1.16E-09 
espX4 0 Intragenic 4852614..4853038 4852784 425 0.00+00E 4852729..4852847 4852784 119 1.33E-26 
 269 
ubiC -671 Intragenic 4853255..4853725 4853565 471 0.00+00E 4853445..4853536 4853500 92 3.11E-32 
yjbM 0 Intragenic 4862216..4862614 4862386 399 0.00+00E 4863124..4863266 4863178 143 2.15E-15 
CE10_4768 163 Intragenic  4870355..4870783 4870524 429 0.00+00E 4870388..4870551 4870443 164 3.25E-26 
CE10_4943 0 Intergenic 5047562..5047946 5047777 385 0.00+00E 5047680..5047795 5047735 116 5.73E-34 
fimE -48 Intergenic  5174559..5174954 5174728 396 0.00+00E 5174609..5174720 5174663 112 1.45E-08 
yjiC 0 Intergenic 5189283..5189779 5189610 497 0.00+00E 5189546..5189702 5189653 157 3.65E-27 
yhhZ 0 Intragenic 4029255..4029623 4029454 369 6.40E-322 4029061..4029192 4029138 132 2.26E-29 
yfaL 0 Intergenic 2651239..2651608 2651399 370 8.47E-318 2650745..2650878 2650824 134 6.18E-13 
eivC -375 Intragenic  3360277..3360778 3360445 502 2.69E-314 3360412..3360544 3360493 133 8.52E-23 
hutU 0 Intergenic  769533..769906 769737 374 2.62E-312 769648..769781 769727 134 2.00E-14 
dusA -266 Intragenic  4862853..4863311 4863013 459 1.23E-307 4862252..4862408 4862306 157 3.57E-33 
sipB 0 Intergenic 4362509..4363016 4362847 508 1.02E-306 4362820..4362943 4362875 124 1.88E-25 
CE10_4870 0 Intergenic 4974868..4975249 4975038 382 7.45E-303 4863124..4863266 4863178 143 2.15E-15 
rfaY 0 Intragenic 4261765..4262267 4261929 503 4.35E-293 4974995..4975105 4975051 111 2.72E-38 
fucA -12 Intergenic 3285996..3286441 3286164 446 3.97E-291 3286095..3286228 3286149 134 1.41E-21 
leuO -90 Intergenic 92721..93073 92888 353 5.01E-291 92834..92931 92887 98 2.96E-16 
yghJ 0 Intergenic 3567445..3567945 3567615 501 3.00E-283 3567538..3567665 3567579 128 7.89E-16 
cmtB 0 Intragenic 3449900..3450402 3450233 503 1.08E-270 3450052..3450182 3450106 131 9.36E-16 
ydeK -49 Intergenic 1743092..1743461 1743292 370 9.24E-265 1743217..1743352 1743298 136 1.71E-19 
CE10_2939 0 Intergenic 2996411..2996816 2996581 406 2.17E-264 2996566..2996705 2996651 140 1.34E-18 
envR 0 Intergenic 3874440..3874808 3874610 369 6.73E-263 3874519..3874636 3874566 118 5.87E-21 
caiT -60 Intergenic 50204..50678 50509 475 1.12E-260 50442..50571 50517 130 1.62E-14 
CE10_4228 -73 Intergenic 4305007..4305391 4305176 385 7.04E-259 4305108..4305261 4305163 154 7.41E-09 
sfmA 0 Intergenic 561180..561551 561349 372 9.25E-253 561286..561403 561349 118 4.50E-31 
yliE -718 Intragenic 908923..909268 909093 346 2.83E-243 909011..909154 909066 144 3.70E-16 
CE10_3627 0 Intergenic 3707366..3707869 3707701 504 2.06E-242 3707646..3707779 3707736 134 1.38E-13 
 270 
yhfL 0 Intergenic 3944853..3945223 3945023 371 2.62E-240 3944945..3945046 3945001 102 1.47E-17 
ycbQ 0 Intergenic 1039138..1039516 1039308 379 2.65E-235 1039278..1039383 1039330 106 2.83E-13 
kpsM -233 Intragenic 3550328..3550769 3550600 442 4.32E-233 3550189..3550321 3550267 133 7.16E-13 
yjbE 0 Intergenic 4839210..4839675 4839506 466 1.67E-230 4839462..4839591 4839493 130 1.79E-15 
CE10_1660 299 Intragenic  1690807..1691181 1691023 375 1.10E-227 1690990..1691128 1691045 139 1.47E-09 
CE10_1948 -40 Intergenic 1970983..1971368 1971152 386 3.21E-212 1971119..1971281 1971227 163 1.67E-07 
yeeN 0 Intergenic 2298004..2298367 2298203 364 6.41E-204 2298099..2298252 2298203 154 1.92E-10 
CE10_4567 -60 Intergenic 4657507..4657867 4657703 361 1.60E-203 4657648..4657784 4657701 137 4.46E-18 
CE10_4598 0 Intergenic 4685814..4686203 4686034 390 4.41E-200 4685991..4686151 4686046 161 7.97E-21 
setC -19 Intergenic 4358033..4358399 4358240 367 9.56E-199 4358168..4358290 4358216 123 6.06E-14 
CE10_0066 0 Intergenic 78738..79150 78986 413 4.80E-195 78834..78948 78896 115 7.89E-17 
yiiG 0 Intergenic 4651369..4651762 4651539 394 7.58E-194 4651497..4651615 4651561 119 7.52E-27 
csiD -303 Intragenic 3140284..3140638 3140454 355 3.30E-184 3140404..3140518 3140458 115 6.38E-21 
stpA 0 Intergenic 3150387..3150730 3150557 344 5.20E-184 3150497..3150637 3150551 141 1.18E-12 
CE10_1661 0 Intergenic 1692605..1692994 1692825 390 1.37E-181 1692767..1692883 1692821 117 7.50E-15 
yiaW 0 Intergenic  4217589..4217945 4217759 357 2.10E-166 4217675..4217805 4217751 131 4.27E-12 
ecpD 0 Intergenic 166102..166449 166272 348 1.22E-165 166217..166355 166272 139 6.19E-12 
fimB 0 Intergenic 5173511..5173987 5173681 477 1.33E-164 5173596..5173706 5173649 111 3.52E-05 
speF -187 Intergenic 730553..731056 730887 504 1.88E-164 730743..730811 730784 69 1.12E-11 
CE10_5175 999 Intragenic 5280007..5280442 5280177 436 3.62E-163 5280928..5281088 5281034 161 1.08E-26 
fucP 0 Intragenic 3286583..3286944 3286776 362 2.65E-162 3286722..3286845 3286777 124 2.52E-23 
yiaY 0 Intergenic 4222357..4222771 4222602 415 9.83E-157 4222623..4222735 4222681 113 5.49E-13 
fdrA 0 Intergenic 549560..550008 549839 449 7.72E-156 549686..549819 549741 134 8.66E-16 
yqiK 0 Intergenic 3647776..3648120 3647951 345 3.20E-155 3647855..3647992 3647938 138 1.81E-10 
ais 0 Intergenic 2677305..2677651 2677475 347 1.35E-151 2677414..2677528 2677464 115 3.48E-16 
yfbL 0 Intergenic 2697398..2697781 2697568 384 5.01E-151 2697489..2697584 2697547 96 1.13E-11 
 271 
ypdI 0 Intergenic 2808139..2808484 2808306 346 2.05E-147 2808225..2808359 2808279 135 7.36E-09 
nanC 0 Intergenic 5172391..5172767 5172598 377 2.72E-144 5172451..5172570 5172517 120 4.46E-12 
rpmE2 -210 Intergenic 281778..282115 281951 338 6.69E-143 281850..282013 281905 164 1.19E-08 
yeiT 0 Intergenic  2539340..2539736 2539510 397 4.77E-137 2539468..2539591 2539520 124 5.37E-13 
yobF -202 Intergenic 2126724..2127140 2126973 417 1.52E-135 2126925..2127080 2127028 156 2.51E-12 
yahL 0 Intergenic 326755..327210 326924 456 2.96E-127 326904..327028 326959 125 4.71E-11 
CE10_0335 -24 Intergenic 370032..370485 370193 454 3.63E-121 370106..370265 370211 160 2.08E-09 
CE10_3982 0 Intragenic  4045074..4045400 4045219 327 1.26E-120 4045141..4045246 4045203 106 1.91E-11 
agaB 0 Intergenic 3746884..3747262 3747100 379 9.08E-109 3747000..3747149 3747095 150 3.80E-16 
neuO 59 Intragenic 839634..840140 839803 507 1.98E-106 839932..840043 839987 112 4.87E-07 
ycbR 0 Intergenic 1039827..1040283 1039995 457 1.61E-103 1039972..1040091 1040027 120 3.18E-18 
yjeJ 0 Intergenic 4993586..4993924 4993757 339 1.01E-101 4993712..4993820 4993766 109 6.35E-11 
 
Table S-4 CE10 DsdC1 binding sites (+ D-ser). 
      Replicate 1 Replicate 2 
Gene Dist. Gene Context Co-ordinates Centre Length  p-value Co-ordinates Centre Length  p-value 
CE10_0023 -671 Intragenic 27499..27746 27649 248 0.00E+00 27439..27831 27664 393 7.89E-127 
tauA -160 Intergenic 365260..365487 365354 228 0.00E+00 365165..365532 365363 368 2.09E-98 
wbbC 0 Intragenic 2367910..2368130 2368008 221 0.00E+00 2367780..2368239 2368070 460 3.24E-141 
CE10_2740 -203 Intergenic 2788863..2789052 2788948 190 0.00E+00 2789978..2790338 2790146 361 3.88E-100 
dsdC1 -5 Intergenic 2791325..2791520 2791423 196 0.00E+00 2791243..2791582 2791413 340 3.73E-196 
CE10_2939 0 Intergenic 2996531..2996749 2996652 219 0.00E+00 2996439..2996793 2996624 355 2.76E-77 
ygeG 0 Intergenic 3343554..3343783 3343652 230 0.00E+00 3342998..3343347 3343186 350 5.89E-100 
CE10_3282 0 Intergenic 3347661..3347860 3347759 200 0.00E+00 3347572..3348074 3347740 503 1.92E-126 
 272 
eprH -55 Intergenic 3351683..3351896 3351799 214 0.00E+00 3351566..3351932 3351763 367 2.50E-88 
neuB -378 Intergenic 3548287..3548559 3548384 273 0.00E+00 3548221..3548619 3548480 399 1.97E-111 
yhhZ 0 Intergenic  4029031..4029235 4029138 205 0.00E+00 4029334..4029732 4029497 399 2.42E-77 
yiaW 0 Intergenic 4217648..4217872 4217775 225 0.00E+00 4217597..4217952 4217784 356 4.65E-42 
CE10_4160 0 Intragenic 4233642..4233911 4233814 270 0.00E+00 4233461..4233943 4233774 483 3.25E-97 
rfaL 615 Intragenic  4258299..4258534 4258437 236 0.00E+00 4258248..4258605 4258436 358 2.53E-115 
waaV 0 Intergenic  4260105..4260377 4260280 273 0.00E+00 4260039..4260378 4260209 340 6.41E-100 
waaT 0 Intergenic 4262918..4263149 4263016 232 0.00E+00 4262799..4263173 4263006 375 1.34E-121 
CE10_4229 0 Intergenic 4308317..4308519 4308422 203 0.00E+00 4308239..4308607 4308409 369 1.28E-72 
dsdC2 0 Intergenic 4332349..4332573 4332447 225 0.00E+00 4332272..4332621 4332452 350 5.07E-201 
CE10_4270 0 Intragenic 4347338..4347592 4347497 255 0.00E+00 4347255..4347740 4347425 486 7.41E-121 
sipD 0 Intergenic 4365860..4366057 4365960 198 0.00E+00 4365603..4366105 4365937 503 4.38E-86 
CE10_4297 0 Intergenic 4367470..4367709 4367612 240 0.00E+00 4368027..4368395 4368231 369 5.29E-74 
yjbE -61 Intergenic 4839351..4839589 4839492 239 0.00E+00 4839261..4839654 4839430 394 9.42E-73 
espX4 0 Intragenic 4852657..4852854 4852754 198 0.00E+00 4852605..4853086 4852775 482 8.16E-99 
ubiC 0 Intragenic 4853401..4853639 4853499 239 0.00E+00 4853330..4853734 4853565 405 6.39E-119 
yjbM 0 Intragenic 4862291..4862525 4862389 235 0.00E+00 4862208..4862551 4862375 344 8.68E-96 
CE10_4768 317 Intragenic 4870344..4870630 4870442 287 0.00E+00 4870317..4870811 4870487 495 2.86E-98 
CE10_4870 0 Intergenic 4974954..4975169 4975072 216 0.00E+00 4974872..4975235 4975066 364 2.33E-75 
CE10_4943 0 Intergenic 5047640..5047864 5047738 225 0.00E+00 5047570..5047909 5047740 340 2.50E-93 
yjiC -179 Intergenic 5189472..5189709 5189613 238 0.00E+00 5189325..5189740 5189571 416 1.33E-108 
epaS 265 Intragenic 3354076..3354339 3354242 264 3.10E-322 3354022..3354405 3354242 384 3.64E-116 
wzy -116 Intergenic  2368996..2369247 2369093 252 1.20E-320 2368912..2369293 2369124 382 5.19E-111 
CE10_5175 0 Intragenic 5280860..5281131 5281034 272 6.89E-319 5280803..5281146 5280973 344 6.96E-73 
lpfA -13 Intergenic 4456513..4456771 4456674 259 6.76E-318 4456436..4456798 4456603 363 4.85E-76 
wzx 0 Intergenic  2373675..2373872 2373770 198 1.03E-315 2373570..2373904 2373739 335 1.04E-74 
slp -116 Intergenic  4102360..4102572 4102475 213 4.15E-312 4101932..4102290 4102101 359 9.09E-99 
envR -40 Intergenic 3874501..3874703 3874606 203 6.27E-311 3874440..3874838 3874610 399 1.01E-73 
setC -60 Intergenic 4358138..4358358 4358235 221 4.00E-300 4358063..4358415 4358232 353 1.34E-56 
 273 
sfmA -14 Intergenic  561287..561490 561385 204 2.03E-298 561191..561547 561360 357 1.03E-65 
CE10_3398 -118 Intergenic 3470862..3471063 3470966 202 4.24E-297 3470796..3471222 3470966 427 1.14E-55 
CE10_4363 504 Intragenic 4445578..4445794 4445697 217 1.65E-293 4445543..4445908 4445713 366 8.52E-110 
yhiM 0 Intergenic 4083276..4083495 4083398 220 4.91E-289 4083128..4083475 4083298 348 7.63E-93 
ygiL 0 Intergenic 3641678..3641883 3641776 206 7.17E-286 3641600..3641975 3641769 376 2.33E-90 
CE10_3627 -18 Intergenic 3707654..3707851 3707755 198 4.22E-284 3707493..3707888 3707719 396 1.23E-73 
yhaI 0 Intergenic 3713998..3714219 3714096 222 1.23E-276 3713925..3714268 3714095 344 1.69E-58 
eivC -437 Intragenic 3360339..3360630 3360437 292 7.47E-275 3360325..3360830 3360495 506 3.90E-64 
CE10_0067 -52 Intragenic 79557..79762 79665 206 5.62E-273 79497..79989 79666 493 3.48E-111 
pitB -45 Intergenic 3592013..3592252 3592155 240 8.54E-273 3591908..3592286 3592117 379 9.69E-67 
espY4 0 Intragenic 4441633..4441849 4441731 217 1.33E-270 4439564..4439923 4439734 360 7.93E-101 
yqeI -39 Intergenic 3340559..3340755 3340657 197 2.99E-270 3340364..3340802 3340634 439 4.91E-67 
torY -12 Intergenic 2176815..2177022 2176913 208 1.36E-264 2176745..2177084 2176915 340 1.67E-57 
fepE -80 Intergenic  638504..638708 638602 205 1.92E-262 638447..638874 638617 428 2.12E-33 
CE10_4312 398 Intragenic 4390373..4390601 4390505 229 7.09E-262 4390143..4390586 4390417 444 5.52E-88 
yfaL -40 Intergenic  2651310..2651511 2651408 202 7.95E-256 2651224..2651650 2651394 427 3.47E-87 
prgI -96 Intragenic 3350520..3350752 3350656 233 5.93E-251 3350469..3350830 3350638 362 5.96E-100 
yhaC 716 Intragenic 3730344..3730635 3730538 292 2.88E-248 3730245..3730703 3730535 459 3.01E-110 
yadN -146 Intergenic 167088..167288 167192 201 3.31E-243 166959..167353 167184 395 1.95E-85 
epaO -41 Intergenic 3356717..3356947 3356814 231 5.27E-237 3356528..3356943 3356774 416 1.14E-79 
CE10_4466 -433 Intragenic 4553360..4553551 4553453 192 5.16E-236 4553249..4553607 4553438 359 6.84E-91 
yfcV -209 Intergenic 2769906..2770124 2770029 219 5.43E-236 2769710..2770190 2770021 481 3.64E-89 
speF -416 Intergenic 730782..730985 730888 204 2.45E-235 730580..731027 730858 448 2.97E-58 
rfaY 0 Intragenic 4261842..4262076 4261940 235 5.12E-234 4261768..4262126 4261938 359 5.43E-75 
CE10_4598 0 Intergenic 4685949..4686161 4686047 213 8.07E-234 4685820..4686203 4686034 384 3.02E-58 
garP 0 Intragenic 3735586..3735781 3735684 196 5.16E-231 3735500..3735905 3735670 406 9.92E-53 
tnaA 0 Intergenic 4430400..4430614 4430498 215 9.00E-231 4430100..4430607 4430438 508 1.44E-51 
yqiK 0 Intergenic 3647840..3648034 3647938 195 2.68E-229 3647709..3648091 3647922 383 9.47E-43 
CE10_4228 -155 Intergenic 4305094..4305309 4305212 216 2.04E-228 4305017..4305384 4305215 368 4.03E-73 
 274 
yghT 0 Intergenic 3589574..3589779 3589672 206 4.42E-228 3589494..3589850 3589681 357 5.52E-50 
yiiG 0 Intergenic 4651447..4651642 4651545 196 7.59E-228 4651380..4651744 4651550 365 2.49E-47 
CE10_4613 0 Intergenic 4703832..4704039 4703929 208 7.96E-223 4703697..4704049 4703880 353 9.86E-58 
CE10_3508 0 Intergenic 3578743..3578967 3578870 225 1.03E-222 3578557..3579003 3578834 447 7.73E-57 
ytcA -32 Intergenic 4904288..4904497 4904384 210 4.02E-221 4904108..4904552 4904384 445 3.10E-42 
kpsF -306 Intergenic 3533457..3533707 3533614 251 2.85E-220 3533443..3533784 3533615 342 2.02E-101 
cmtB 0 Intragenic 3450039..3450329 3450233 291 4.82E-218 3449910..3450401 3450233 492 6.04E-73 
sipB 0 Intergenic 4362810..4363009 4362913 200 4.07E-216 4362523..4363030 4362861 508 1.28E-67 
ybcK 0 Intragenic 569810..570028 569907 219 4.50E-216 569765..570178 569935 414 1.87E-67 
CE10_4997 -145 Intergenic 5106630..5106836 5106727 207 1.89E-212 5106531..5106937 5106701 407 1.17E-69 
yghJ 0 Intergenic 3567481..3567702 3567579 222 2.98E-212 3567439..3567947 3567609 509 6.03E-53 
fdrA -40 Intergenic 549671..549893 549796 223 4.04E-211 549602..549982 549816 381 1.17E-48 
yfgH 0 Intergenic 2938103..2938308 2938211 206 3.32E-208 2938013..2938372 2938180 360 1.28E-42 
espX1 0 Intergenic 28494..28696 28587 203 2.06E-208 28364..28727 28558 364 1.72E-93 
ecpD 0 Intergenic 166165..166403 166306 239 4.46E-207 166136..166494 166305 359 1.29E-51 
caiT 0 Intergenic 50069..50289 50192 221 5.56E-199 50350..50667 50498 318 7.46E-57 
yicO 0 Intergenic 4380906..4381144 4381052 239 2.01E-198 4380817..4381160 4380987 344 3.12E-51 
CE10_4567 -102 Intergenic 4657609..4657825 4657707 217 2.19E-196 4657528..4657918 4657698 391 1.82E-46 
yhfL 0 Intergenic 3944903..3945145 3945001 243 4.41E-196 3944872..3945215 3945042 344 4.10E-55 
yliE 796 Intragenic 908996..909193 909096 198 1.42E-195 908922..909264 909092 343 7.78E-52 
yiaY -38 Intergenic 4222519..4222737 4222640 219 1.65E-194 4222372..4222797 4222628 426 5.94E-51 
fimE -169 Intergenic 5174629..5174833 5174736 205 3.78E-194 5174540..5174936 5174710 397 1.07E-86 
sat 0 Intergenic 3517517..3517729 3517614 213 1.46E-192 3517436..3517832 3517606 397 1.07E-58 
agaB 0 Intergenic 3746962..3747189 3747092 228 5.33E-191 3746910..3747252 3747086 343 2.30E-37 
yajR -72 Intergenic  429382..429611 429480 230 1.44E-190 429398..429750 429581 353 2.38E-66 
hutU -51 Intergenic 769569..769824 769727 256 1.87E-190 769528..769895 769726 368 4.87E-62 
neuA 0 Intragenic 3546798..3547023 3546926 226 7.23E-187 3546711..3547074 3546941 364 4.16E-62 
adiY -41 Intergenic 4937233..4937436 4937331 204 1.46E-184 4937018..4937510 4937348 493 1.84E-47 
ygcG 0 Intergenic 3256315..3256517 3256420 203 3.92E-183 3256239..3256739 3256409 501 3.71E-60 
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fucA -74 Intergenic 3286052..3286271 3286149 220 1.64E-182 3286026..3286389 3286220 364 5.68E-67 
CE10_3076 0 Intergenic 3138278..3138518 3138421 241 1.80E-182 3138028..3138521 3138197 494 8.55E-77 
kpsM -524 Intergenic 3550543..3550703 3550600 161 3.08E-181 3550428..3550768 3550597 341 2.02E-50 
CE10_0335 -219 Intergenic 370073..370290 370171 218 3.30E-180 370014..370522 370184 509 3.69E-34 
CE10_0889 0 Intergenic 941040..941265 941168 226 1.17E-180 941351..941810 941515 460 9.99E-86 
fucP 133 Intragenic 3286700..3286946 3286798 247 6.66E-178 3286645..3286999 3286811 355 9.10E-35 
ycdT -65 Intergenic 1166824..1167033 1166936 210 9.38E-178 1166755..1167115 1166925 361 5.86E-60 
CE10_0818 0 Intragenic  865714..865932 865835 219 1.77E-176 865675..866139 865844 465 4.21E-80 
ycbQ -5 Intergenic 1039210..1039454 1039357 245 6.27E-175 1039140..1039489 1039310 350 5.18E-70 
nmpC 0 Intergenic 2501916..2502198 2502014 283 1.89E-174 2501889..2502245 2502076 357 2.96E-64 
csiD -377 Intergenic 3140357..3140564 3140454 208 6.51E-174 3140288..3140657 3140458 370 5.22E-44 
CE10_3557 478 Intragenic 3627437..3627729 3627535 293 6.87E-174 3627343..3627745 3627512 403 6.65E-55 
fimZ 398 Intragenic 567147..567345 567245 199 1.06E-172 567095..567597 567265 503 1.49E-38 
iraP -31 Intergenic 380127..380352 380255 226 1.63E-172 380050..380418 380220 369 1.43E-58 
yfbL 0 Intergenic 2697449..2697698 2697547 250 4.75E-172 2697376..2697715 2697546 340 8.05E-51 
CE10_5091 -2 Intergenic 5210721..5210948 5210852 228 1.60E-171 5210688..5211031 5210858 344 1.44E-85 
leuO -181 Intergenic 92770..92982 92887 213 5.50E-171 92719..93064 92885 346 5.60E-61 
gadA -136 Intergenic 4125363..4125562 4125465 200 1.99E-167 4125231..4125617 4125450 387 1.35E-36 
ibrA -245 Intergenic 2313456..2313668 2313582 213 4.87E-166 2313396..2313798 2313629 403 1.05E-77 
gadX -69 Intergenic 4123627..4123890 4123794 264 3.56E-162 4123422..4123929 4123760 508 3.30E-51 
dusA -308 Intergenic 4862982..4863269 4863176 288 4.14E-161 4862851..4863319 4863150 469 8.07E-79 
yeiT -45 Intergenic 2539401..2539612 2539515 212 1.15E-159 2539367..2539714 2539545 348 3.52E-32 
yjeJ 0 Intergenic 4993629..4993865 4993771 237 3.01E-159 4993556..4993922 4993726 367 1.55E-42 
CE10_4295 0 Intergenic 4364825..4365038 4364941 214 3.42E-159 4364740..4365136 4364908 397 6.97E-59 
yebN -218 Intergenic 2124196..2124399 2124302 204 1.17E-158 2123968..2124471 2124302 504 1.15E-41 
yehD 0 Intergenic  2455198..2455489 2455392 292 5.01E-157 2455067..2455497 2455329 431 1.36E-64 
CE10_0523 -40 Intergenic 575784..576005 575882 222 7.25E-155 575775..576281 575943 507 6.50E-44 
tdcR 0 Intragenic 3728505..3728731 3728638 227 1.96E-153 3728426..3728879 3728593 454 4.00E-55 
CE10_4234 0 Intragenic 4313033..4313233 4313131 201 2.02E-151 4312961..4313314 4313131 354 2.88E-56 
 276 
ysdS 0 Intergenic 2249761..2250048 2249951 288 5.19E-146 2249711..2250083 2249914 373 5.24E-63 
eivF -67 Intergenic 3365626..3365891 3365724 266 5.28E-144 3365542..3365916 3365747 375 1.33E-57 
CE10_4553 0 Intergenic 4641285..4641558 4641383 274 6.98E-143 4641242..4641633 4641404 392 1.34E-62 
yiaT 0 Intergenic 4215061..4215279 4215182 219 5.40E-142 4214988..4215356 4215187 369 3.42E-45 
CE10_3277 0 Intragenic 3342009..3342207 3342107 199 7.34E-142 3341909..3342253 3342079 345 1.84E-61 
CE10_3982 0 Intragenic 4045106..4045312 4045203 207 1.22E-141 4045036..4045387 4045219 352 6.70E-42 
matA -95 Intergenic 280175..280390 280295 216 4.62E-141 280131..280478 280301 348 4.97E-63 
CE10_4519 0 Intragenic 4605362..4605587 4605490 226 1.43E-140 4605298..4605800 4605464 503 4.75E-33 
ydeK -129 Intergenic 1743172..1743407 1743311 236 2.12E-138 1743100..1743465 1743267 366 2.67E-58 
eivG 0 Intragenic 3364690..3364893 3364787 204 6.94E-137 3364593..3364953 3364758 361 1.79E-38 
ybcM 0 Intragenic 571111..571326 571229 216 1.92E-136 571058..571422 571253 365 1.33E-43 
CE10_0264 -129 Intergenic 289056..289330 289154 275 9.27E-136 289032..289427 289202 396 5.29E-36 
ybdN -50 Intergenic 656899..657119 656997 221 9.56E-133 656777..657283 656947 507 2.34E-43 
msbB 0 Intergenic 5142221..5142418 5142322 198 1.67E-132 5142143..5142485 5142313 343 5.59E-36 
yegH -88 Intergenic 2401797..2402036 2401895 240 2.68E-132 2401624..2402086 2401919 463 2.66E-45 
stpA 0 Intergenic 3150441..3150636 3150539 196 2.77E-132 3150362..3150767 3150531 406 3.51E-38 
CE10_2689 -7 Intergenic 2734495..2734703 2734593 209 4.65E-132 2734379..2734787 2734618 409 1.60E-46 
CE10_5099 -189 Intergenic 5220663..5220891 5220794 229 8.19E-130 5220619..5221045 5220788 427 9.50E-53 
ais 0 Intergenic 2677370..2677597 2677500 228 8.62E-130 2677304..2677649 2677480 346 7.77E-38 
CE10_0734 0 Intergenic 789835..790057 789932 223 3.57E-126 789781..790118 789951 338 3.55E-35 
CE10_0366 0 Intragenic 403466..403659 403562 194 1.01E-124 403407..403808 403575 402 2.50E-56 
rpmE2 -259 Intergenic 281827..282055 281958 229 7.77E-124 281766..282121 281935 356 6.00E-44 
yjcS 0 Intergenic 4906402..4906633 4906536 232 1.54E-122 4906293..4906678 4906510 386 1.42E-20 
eutS -77 Intergenic 2884428..2884644 2884526 217 1.54E-121 2884321..2884700 2884491 380 7.52E-21 
ykgI 0 Intergenic 296714..296948 296852 235 5.29E-121 296520..296971 296802 452 3.14E-49 
ydeP -21 Intergenic 1733197..1733430 1733295 234 1.76E-120 1733150..1733514 1733320 365 1.09E-39 
ycbR 0 Intergenic  1039926..1040129 1040024 204 4.40E-118 1039865..1040268 1040029 404 2.23E-25 
CE10_1660 0 Intergenic 1691377..1691573 1691470 197 6.44E-116 1690525..1690914 1690695 390 2.80E-52 
CE10_3790 -120 Intergenic 3866170..3866358 3866272 189 2.74E-116 3866095..3866520 3866265 426 2.63E-39 
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ugd -66 Intergenic 2361658..2361857 2361756 200 1.90E-115 2361443..2361917 2361748 475 1.01E-34 
yeeN -21 Intergenic 2298060..2298291 2298196 232 2.40E-115 2297991..2298362 2298196 372 2.61E-48 
fimB -128 Intergenic 5173598..5173794 5173696 197 1.51E-114 5173458..5173870 5173701 413 9.51E-54 
sfmC 0 Intergenic 562157..562355 562258 199 6.27E-114 562039..562383 562208 345 4.47E-24 
ttdR 344 Intragenic 3660788..3661007 3660910 220 2.18E-113 3660728..3661075 3660906 348 4.99E-25 
glgS -21 Intergenic 3647068..3647359 3647262 292 5.66E-112 3647009..3647421 3647179 413 2.37E-36 
CE10_3626 0 Intragenic 3706899..3707188 3706995 290 5.89E-112 3706849..3707273 3707017 425 3.39E-48 
frc -189 Intergenic 2806933..2807132 2807029 200 1.08E-111 2806858..2807355 2807027 498 3.98E-33 
yegR 0 Intergenic 2432662..2432859 2432760 198 1.90E-110 2432420..2432900 2432733 481 2.75E-31 
CE10_1948 132 Intergenic 1971088..1971324 1971227 237 5.92E-110 1970982..1971354 1971152 373 2.15E-60 
CE10_4706 0 Intergenic 4811342..4811545 4811448 204 6.76E-108 4811275..4811649 4811440 375 6.56E-19 
ybdO 0 Intergenic 657859..658149 658053 291 1.45E-107 657677..658144 657975 468 1.13E-55 
rfbC 0 Intragenic 2374416..2374657 2374560 242 1.47E-106 2374347..2374712 2374543 366 1.22E-38 
focA -136 Intergenic 994945..995227 995042 283 2.04E-106 994832..995219 995053 388 2.10E-47 
CE10_0066 -319 Intergenic 78407..78640 78505 234 3.75E-106 78828..79327 78997 500 1.85E-45 
yebB 0 Intergenic 2165015..2165237 2165140 223 3.18E-105 2164914..2165333 2165084 420 2.72E-36 
rcsA -174 Intergenic 2239506..2239729 2239604 224 1.76E-104 2239450..2239788 2239620 339 6.76E-26 
CE10_1671 0 Intragenic 1703020..1703237 1703140 218 2.06E-103 1702934..1703307 1703104 374 8.84E-29 
ypdI 0 Intergenic 2808200..2808425 2808328 226 7.97E-103 2808133..2808473 2808306 341 7.17E-50 
ymgG -64 Intergenic 1355774..1356066 1355872 293 5.18E-100 1355756..1356137 1355968 382 3.68E-52 
yobF -398 Intergenic 2126920..2127135 2127038 216 1.83E-99 2126725..2127180 2127011 456 1.04E-34 
CE10_4717 -163 Intragenic 4821040..4821329 4821234 290 2.00E-98 4820987..4821333 4821157 347 2.37E-27 
nanC 0 Intergenic 5172449..5172718 5172547 270 2.52E-98 5172384..5172835 5172554 452 3.17E-49 
hlyE 0 Intergenic 1363183..1363379 1363279 197 7.77E-98 1363069..1363423 1363254 355 3.71E-42 
yfdF 0 Intragenic 2776998..2777270 2777173 273 8.77E-98 2776795..2777230 2776961 436 7.15E-51 
yahL 0 Intergenic 326795..327027 326893 233 1.72E-96 326738..327153 326908 416 2.19E-42 
CE10_1661 -8 Intergenic 1692752..1692955 1692849 204 2.21E-94 1692610..1692983 1692814 374 8.73E-41 
nanR -71 Intergenic 3825000..3825209 3825116 210 3.06E-93 3824959..3825338 3825169 380 2.19E-34 
yjdA -14 Intergenic 4926152..4926382 4926250 231 4.06E-93 4926072..4926458 4926239 387 3.31E-38 
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yiiE -72 Intergenic 4643647..4643845 4643748 199 4.16E-93 4643595..4643982 4643765 388 2.08E-38 
dpiB -28 Intergenic 670822..671031 670934 210 3.28E-92 670615..671120 670952 506 8.14E-53 
CE10_0275 0 Intragenic 303267..303554 303457 288 1.47E-91 303067..303573 303404 507 4.24E-43 
feoA -134 Intergenic 3980944..3981174 3981042 231 5.68E-91 3980903..3981321 3981073 419 1.07E-19 
ybbW 0 Intergenic 540830..541052 540928 223 1.87E-90 540772..541143 540942 372 4.05E-27 
CE10_0560 185 Intergenic 604888..605102 605005 215 8.20E-90 604795..605170 604965 376 5.60E-39 
CE10_0290 0 Intergenic 320948..321212 321041 265 3.26E-86 320887..321231 321063 345 9.13E-39 
CE10_0724 -72 Intergenic 777616..777815 777712 200 2.72E-86 777554..777900 777723 347 8.78E-51 
ompN -2 Intergenic 1605511..1605798 1605702 288 1.11E-85 1605472..1605820 1605642 349 1.44E-41 
CE10_4709 0 Intergenic 4813131..4813407 4813229 277 4.69E-83 4813065..4813417 4813250 353 4.26E-21 
CE10_3786 35 Intragenic 3862473..3862763 3862666 291 5.35E-82 3862492..3862833 3862662 342 3.94E-27 
CE10_3301 53 Intragenic 3367459..3367708 3367557 250 1.32E-80 3366310..3366720 3366556 411 1.06E-40 
yiaO 0 Intragenic 4204947..4205166 4205070 220 1.22E-77 4204828..4205239 4205070 412 1.07E-24 
ydjO 0 Intergenic 2033450..2033735 2033638 286 7.78E-74 2033079..2033399 2033253 321 8.73E-58 
yhbX 345 Intragenic 3778658..3778875 3778756 218 8.12E-74 3778577..3778957 3778747 381 3.79E-28 
tsx2 0 Intergenic 4700453..4700681 4700551 229 5.95E-72 4700384..4700722 4700553 339 5.83E-26 
yfgF -101 Intragenic 2937553..2937750 2937653 198 7.91E-72 2937413..2937810 2937641 398 2.80E-31 
araE -58 Intergenic 3334534..3334729 3334632 196 2.18E-71 3334435..3334801 3334632 367 1.26E-21 
agaC 0 Intragenic 3747549..3747788 3747647 240 3.24E-70 3747454..3747902 3747735 449 9.92E-12 
cyoA -269 Intergenic 436794..436990 436892 197 4.01E-70 436528..437034 436865 507 1.87E-25 
pagP 0 Intergenic 675237..675495 675335 259 3.40E-70 675121..675484 675316 364 7.51E-49 
ybeF -190 Intergenic 680395..680594 680499 200 2.07E-69 679992..680353 680162 362 1.15E-34 
yjgN 0 Intragenic 5110033..5110322 5110225 290 3.40E-68 5109929..5110378 5110099 450 1.01E-36 
yahA -152 Intergenic 310056..310291 310195 236 3.32E-65 309708..310090 309878 383 6.96E-30 
ydjE 769 Intragenic 2071605..2071861 2071764 257 5.06E-64 2071601..2071970 2071771 370 1.14E-26 
CE10_0258 0 Intergenic 283608..283893 283706 286 2.65E-64 283551..283948 283779 398 1.13E-42 
yceJ 0 Intragenic 1190137..1190368 1190234 232 3.88E-63 1190093..1190540 1190263 448 3.09E-22 
yciD -271 Intergenic 1500835..1501071 1500974 237 3.97E-62 1500310..1500676 1500509 367 8.60E-22 
mocA 0 Intragenic 3383931..3384148 3384051 218 1.57E-61 3383875..3384289 3384044 415 1.92E-09 
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CE10_5101 0 Intragenic 5223835..5224127 5223933 293 2.44E-59 5223824..5224191 5223994 368 1.94E-14 
sfmH 159 Intragenic 565835..566060 565930 226 1.15E-55 565700..566062 565869 363 1.34E-17 
gadB -153 Intergenic 1718885..1719158 1719062 274 2.52E-54 1718763..1719137 1718933 375 3.85E-29 
yffB 0 Intergenic 2899548..2899793 2899696 246 7.69E-54 2899433..2899823 2899602 391 1.12E-30 
neuO 269 Intragenic  839812..840043 839946 232 5.43E-50 839606..839902 839776 297 1.89E-19 
CE10_4222 0 Intergenic 4299049..4299300 4299203 252 8.13E-48 4298934..4299442 4299104 509 2.55E-18 
 
Table S-5 CE10 DsdC2 binding sites (no D-ser). 
      Replicate 1 Replicate 2 
Gene Dist. Gene Context  Co-ordinates Centre Length  p-value Co-ordinates Centre Length  p-value 
CE10_0023 -534 Intragenic 27362..27811 27681 450 0.00E+00 27442..27871 27704 430 9.35E-213 
ycgX -686 Intergenic  1342133..1342499 1342311 367 0.00E+00 1342023..1342527 1342193 505 1.23E-214 
wbbC 0 Intragenic 2367810..2368203 2367985 394 0.00E+00 2367814..2368253 2367984 440 0.00E+00 
dsdC1 0 Intergenic  2791240..2791618 2791420 379 0.00E+00 2791226..2791600 2791395 375 0.00E+00 
waaT 0 Intragenic  4262774..4263197 4263021 424 0.00E+00 4262768..4263185 4263017 418 8.06E-166 
dsdC2 0 Intergenic  4332279..4332649 4332458 371 0.00E+00 4332276..4332631 4332446 356 0.00E+00 
CE10_4270  0 Intragenic  4347265..4347784 4347430 520 0.00E+00 4347264..4347758 4347434 495 7.32E-239 
CE10_4363 1061 Intragenic  4444704..4445178 4445027 475 0.00E+00 4445502..4445873 4445654 372 1.25E-237 
lpfA 0 Intergenic  4456422..4456804 4456599 383 0.00E+00 4456392..4456771 4456628 380 1.11E-108 
vioA 0 Intragenic  2372516..2372867 2372689 352 8.90E-323 2372423..2372664 2372593 242 1.76E-150 
wzy 0 Intergenic  2368896..2369216 2369049 321 1.82E-315 2368871..2369265 2369173 395 4.50E-193 
neuB -421 Intergenic  3548330..3548635 3548441 306 1.37E-302 3548251..3548595 3548412 345 9.22E-194 
CE10_2740 -18 Intergenic  2788678..2789063 2788885 386 4.43E-302 2788665..2789166 2789003 502 7.81E-172 
waaV 0 Intergenic  4259991..4260437 4260258 447 7.38E-296 4260082..4260441 4260280 360 2.76E-188 
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rfaL 499 Intragenic 4258236..4258626 4258447 391 2.78E-295 4258276..4258652 4258442 377 1.61E-154 
epaS 188 Intragenic 3354065..3354430 3354251 366 5.54E-287 3354022..3354464 3354304 443 8.69E-206 
ubiC 706 Intragenic 4853339..4853690 4853591 352 1.30E-281 4853266..4853700 4853584 435 7.05E-211 
yfcV -55 Intergenic  2769752..2770201 2769931 450 1.33E-278 2769693..2770190 2770021 498 1.69E-116 
yjbM 0 Intragenic 4862245..4862634 4862363 390 7.55E-274 4862245..4862639 4862414 395 1.45E-131 
yjiC 0 Intergenic  5189271..5189805 5189628 535 1.45E-264 5189302..5189756 5189464 455 1.38E-162 
espX1 0 Intergenic  28370..28773 28600 404 1.10E-262 28209..28538 28287 330 6.41E-134 
ygiL 0 Intergenic  3641569..3642041 3641733 473 3.65E-259 3641572..3642003 3641740 432 1.39E-111 
yhaC 667 Intragenic 3730287..3730712 3730466 426 4.99E-252 3730447..3730759 3730597 313 2.64E-165 
CE10_4160 0 Intragenic  4233464..4233945 4233766 482 2.26E-250 4233513..4233854 4233685 342 1.41E-179 
ybjQ -414 Intragenic 942239..942775 942418 537 2.53E-243 942545..942818 942645 274 5.34E-117 
CE10_0067 0 Intergenic  79472..79809 79662 338 4.14E-243 79624..80018 79862 395 7.90E-167 
tauA -100 Intergenic  365174..365547 365353 374 1.34E-241 365200..365553 365384 354 1.45E-127 
espX4 0 Intragenic 4852588..4853001 4852768 414 4.71E-239 4852613..4852982 4852813 370 1.46E-150 
yjbE 0 Intergenic  4839307..4839675 4839496 369 6.74E-237 4839305..4839662 4839494 358 1.31E-110 
hutU -14 Intergenic  769437..769861 769682 425 1.17E-236 769481..769849 769651 369 2.76E-105 
CE10_4870 0 Intergenic  4974849..4975240 4975061 392 5.12E-234 4974865..4975238 4975086 374 2.38E-104 
yhhZ 0 Intergenic  4028972..4029264 4029151 293 3.40E-231 4029028..4029274 4029198 247 5.48E-104 
CE10_4297 0 Intergenic  4367341..4367731 4367502 391 2.40E-228 4367294..4367769 4367619 476 7.47E-108 
kpsF -102 Intergenic  3533379..3533911 3533557 533 3.43E-227 3533361..3533868 3533531 508 6.94E-156 
ibrA -228 Intergenic  2313439..2313870 2313580 432 2.33E-226 2313352..2313794 2313522 443 2.46E-114 
dusA -227 Intragenic  4862943..4863300 4863027 358 6.78E-226 4862921..4863413 4863244 493 8.59E-143 
CE10_4943 0 Intergenic  5047548..5047940 5047770 393 6.65E-225 5047602..5047974 5047772 373 4.37E-143 
CE10_0818 0 Intragenic  865658..866109 865838 452 9.36E-203 865680..866090 865850 411 5.01E-107 
yqeI 0 Intergenic  3340261..3340795 3340619 535 5.84E-201 3340376..3340781 3340630 406 2.98E-106 
sipB 0 Intergenic  4362531..4363052 4362886 522 1.32E-200 4362545..4362997 4362828 453 1.78E-113 
yfaL 0 Intergenic  2651212..2651655 2651388 444 3.05E-198 2650598..2651022 2650754 425 2.54E-62 
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cmtB 0 Intragenic 3449979..3450401 3450155 423 3.05E-193 3449934..3450266 3450154 333 6.45E-75 
leuO -103 Intergenic  92697..93060 92877 364 2.90E-190 92685..93057 92888 373 2.35E-108 
sfmA 0 Intergenic  561144..561543 561365 400 9.68E-188 561186..561544 561375 359 5.48E-105 
nmpC 0 Intergenic  2501882..2502248 2502062 367 9.00E-185 2501915..2502252 2502082 338 4.42E-84 
envR 0 Intergenic  3874432..3874842 3874602 411 3.50E-184 3874441..3874892 3874608 452 1.39E-107 
CE10_1948 0 Intergenic  1970999..1971344 1971161 346 6.71E-179 1970975..1971377 1971145 403 9.16E-88 
ykgI 0 Intragenic  296587..297000 296821 414 1.03E-177 296534..296957 296802 424 5.01E-114 
CE10_4228 -48 Intergenic  4305007..4305416 4305187 410 2.78E-177 4305007..4305370 4305176 364 3.90E-117 
yadN -20 Intergenic  166962..167347 167171 386 2.17E-175 166987..167325 167156 339 2.42E-149 
yhaI 0 Intergenic  3713935..3714331 3714114 397 5.08E-174 3713932..3714346 3714096 415 7.53E-92 
CE10_2939 0 Intergenic  2996428..2996801 2996622 374 1.64E-172 2996395..2996787 2996556 393 1.02E-72 
ecpD 0 Intergenic  166089..166455 166319 367 5.10E-171 166137..166580 166307 444 1.51E-69 
ysdS -2 Intergenic  2249696..2249982 2249774 287 9.91E-170 2249697..2250095 2249928 399 8.53E-103 
fimE 0 Intergenic  5174540..5175005 5174719 466 2.90E-167 5174553..5174991 5174706 439 1.24E-115 
eivF 0 Intergenic  3365537..3365942 3365766 406 3.43E-167 3365476..3365951 3365641 476 2.06E-86 
CE10_5099 -53 Intergenic  5220615..5221027 5220787 413 4.82E-167 5220846..5221065 5220944 220 3.91E-60 
CE10_2689 0 Intergenic  2734378..2734801 2734629 424 8.09E-166 2734336..2734811 2734648 476 1.47E-88 
CE10_4295 0 Intragenic  4364621..4365097 4364979 477 8.67E-166 4364636..4365088 4364974 453 7.28E-86 
yfdF 0 Intergenic  2776752..2777229 2776930 478 2.97E-164 2776797..2777268 2776946 472 2.01E-82 
ycbQ 0 Intergenic  1039076..1039514 1039335 439 5.13E-162 1039143..1039484 1039313 342 7.36E-104 
yiiG 0 Intergenic  4651354..4651747 4651569 394 9.84E-162 4651373..4651738 4651542 366 6.90E-60 
CE10_3508 0 Intergenic  3578622..3579000 3578826 379 6.22E-154 3578596..3578958 3578866 363 4.72E-77 
CE10_3627 0 Intergenic  3707535..3707897 3707711 363 1.21E-152 3707473..3707903 3707634 431 8.84E-101 
ymgG 0 Intergenic  1355705..1356177 1355885 473 3.86E-152 1355703..1356174 1355872 472 1.75E-83 
fucA -48 Intergenic  3286026..3286411 3286206 386 8.73E-149 3285981..3286374 3286151 394 2.09E-114 
torY 0 Intergenic  2176727..2177084 2176887 358 2.30E-148 2176744..2177192 2176914 449 6.53E-80 
kpsM -372 Intergenic  3550391..3550760 3550608 370 2.32E-148 3550432..3550730 3550509 299 1.12E-112 
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matA -57 Intergenic  280137..280561 280314 425 7.16E-147 280121..280598 280262 478 2.11E-86 
CE10_4598 0 Intragenic  4685849..4686220 4686045 372 1.38E-146 4685779..4686266 4686099 488 2.64E-60 
ydjO 225 Intragenic 2033083..2033319 2033244 237 4.06E-146 2033342..2033737 2033576 396 3.47E-90 
yfbL 0 Intergenic  2697381..2697743 2697560 363 2.99E-145 2697379..2697799 2697547 421 1.31E-74 
ygcG 0 Intergenic  3256240..3256635 3256419 396 6.84E-145 3256265..3256590 3256454 326 2.13E-89 
yhfL 0 Intergenic  3944842..3945211 3945021 370 2.46E-144 3944850..3945263 3945015 414 2.95E-107 
ycdT 0 Intergenic  1166750..1167135 1166927 386 2.46E-142 1166695..1167145 1166976 451 2.84E-91 
yliE 650 Intragenic 908860..909306 909139 447 1.70E-139 908896..909299 909149 404 2.95E-70 
CE10_4613 0 Intergenic  4703706..4704134 4703859 429 1.40E-137 4703716..4704119 4703886 404 1.55E-87 
ydeK -14 Intergenic  1743057..1743518 1743342 462 2.95E-136 1743081..1743453 1743251 373 1.87E-63 
yiaY 0 Intergenic  4222409..4222788 4222589 380 3.93E-136 4222384..4222793 4222553 410 8.17E-72 
caiT 0 Intergenic  50024..50329 50201 306 4.09E-135 50023..50271 50191 249 7.11E-115 
iraP 0 Intergenic  380060..380434 380239 375 5.10E-135 379991..380420 380286 430 2.05E-79 
yajR -8 Intergenic  429318..429824 429492 507 9.68E-135 429366..429789 429533 424 4.88E-111 
yghJ 0 Intragenic 3567434..3567898 3567611 465 2.95E-134 3567470..3567875 3567638 406 1.60E-103 
pagP -249 Intergenic  674770..675139 674944 370 3.87E-132 675168..675524 675334 357 2.58E-65 
CE10_4234 0 Intragenic 4312928..4313380 4313105 453 2.38E-131 4312961..4313301 4313131 341 3.97E-79 
pitB 0 Intergenic  3591899..3592395 3592078 497 1.32E-129 3591909..3592352 3592183 444 4.22E-66 
ybdO 0 Intergenic  657734..658132 657967 399 2.06E-129 657795..658194 658025 400 2.99E-64 
rfbC 0 Intragenic 2374333..2374738 2374559 406 2.65E-128 2374329..2374695 2374569 367 1.62E-59 
setC 0 Intergenic  4358051..4358447 4358274 397 1.32E-127 4358061..4358437 4358231 377 7.13E-79 
ais 0 Intergenic  2677273..2677731 2677556 459 1.78E-126 2677300..2677681 2677521 382 1.81E-38 
CE10_3398 0 Intergenic  3470812..3471198 3471026 387 6.90E-125 3470820..3471244 3470982 425 1.41E-81 
hipB -500 Intragenic 1739028..1739535 1739358 508 8.72E-125 1739163..1739521 1739352 359 2.40E-56 
CE10_3626 0 Intergenic  3706823..3707193 3707003 371 2.74E-124 3706855..3707229 3707025 375 5.77E-93 
fimB 0 Intergenic  5173476..5174004 5173646 529 1.21E-119 5173463..5173786 5173685 324 4.73E-47 
fdrA 0 Intergenic  549610..549982 549790 373 4.95E-118 549513..549940 549801 428 2.69E-74 
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sat 0 Intergenic  3517461..3517916 3517634 456 1.00E-118 3517411..3517844 3517677 434 5.79E-75 
tnaA 0 Intergenic  4430054..4430587 4430234 534 1.80E-117 4430209..4430597 4430434 389 1.23E-59 
yqiG 0 Intragenic 3642402..3642914 3642582 513 6.12E-117 3642397..3642702 3642630 306 5.57E-80 
garP 0 Intragenic 3735483..3735991 3735662 509 9.76E-116 3735486..3735929 3735640 444 3.60E-96 
yghT 0 Intergenic  3589485..3589864 3589685 380 1.17E-114 3589507..3589892 3589723 386 1.65E-38 
CE10_4567 0 Intergenic  4657542..4657936 4657770 395 4.47E-114 4657524..4657832 4657743 309 9.52E-70 
CE10_2267 -177 Intergenic  2290168..2290519 2290432 352 2.20E-113 2290164..2290552 2290331 389 2.86E-94 
CE10_3557 500 Intragenic 3627487..3627733 3627536 247 9.24E-113 3627485..3627894 3627655 410 4.27E-74 
yiaT 0 Intergenic  4214955..4215397 4215127 443 3.12E-111 4214986..4215330 4215154 345 4.85E-83 
yicO 0 Intergenic  4380807..4381176 4380977 370 2.84E-110 4380736..4381220 4381051 485 3.75E-65 
yegH -48 Intergenic  2401698..2402076 2401876 379 5.27E-110 2401645..2402032 2401772 388 7.60E-91 
yeeN 0 Intergenic  2298026..2298400 2298206 375 7.14E-110 2297949..2298402 2298256 454 1.18E-74 
CE10_0275 0 Intragenic 303207..303549 303328 343 1.07E-107 303163..303556 303388 394 9.07E-54 
speF -275 Intergenic  730641..731053 730874 413 1.91E-107 730585..731020 730853 436 9.40E-62 
fimA -167 Intergenic  5175542..5175912 5175798 371 2.15E-107 5175600..5175850 5175782 251 6.78E-76 
CE10_3982 0 Intragenic 4045022..4045392 4045213 371 5.01E-107 4044997..4045435 4045146 439 2.07E-64 
yfgH 0 Intergenic  2938010..2938381 2938208 372 1.47E-104 2938055..2938475 2938221 421 2.75E-64 
nanC 0 Intergenic  5172434..5172888 5172605 455 1.06E-102 5172427..5172782 5172614 356 1.34E-50 
CE10_1661 0 Intergenic  1692553..1693004 1692835 452 1.53E-101 1692581..1693019 1692850 439 1.74E-54 
yiaW 0 Intergenic  4217591..4217912 4217775 322 9.98E-101 4217635..4218015 4217800 381 1.77E-61 
dpiB 0 Intergenic  670720..671107 670863 388 1.83E-99 670710..671140 670973 431 2.79E-52 
gadX 0 Intergenic  4123396..4123905 4123732 510 1.90E-99 4123414..4123921 4123752 508 1.63E-117 
adiY 0 Intergenic  4937134..4937553 4937314 420 7.88E-99 4937053..4937508 4937362 456 2.93E-73 
gadA 0 Intergenic  4125210..4125622 4125383 413 8.81E-99 4125220..4125686 4125373 467 2.15E-61 
stpA 0 Intergenic  3150326..3150740 3150505 415 1.51E-98 3150388..3150759 3150596 372 2.76E-67 
yebB 0 Intergenic  2164887..2165369 2165056 483 2.07E-98 2164900..2165404 2165070 505 1.06E-61 
fucP 75 Intragenic 3286606..3287099 3286748 494 1.15E-97 3286596..3287010 3286764 415 5.54E-55 
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ykgE -86 Intergenic  299401..299767 299579 367 3.46E-97 299337..299757 299588 421 1.86E-35 
CE10_0735 -119 Intergenic  790984..791457 791318 474 2.25E-94 791118..791462 791299 345 3.46E-51 
rpmE2 -218 Intergenic  281786..282149 281959 364 1.37E-92 281769..282123 281954 355 3.63E-47 
CE10_0366 0 Intragenic 403367..403755 403545 389 4.75E-92 403415..403787 403585 373 1.88E-60 
fimZ 285 Intragenic  567051..567472 567230 422 1.56E-91 567094..567464 567264 371 4.27E-76 
csiD -967 Intragenic  3139530..3139974 3139705 445 4.09E-89 3139562..3139981 3139812 420 4.07E-53 
ypdI 0 Intergenic  2808118..2808499 2808324 382 3.40E-88 2808126..2808526 2808357 401 1.18E-50 
yobF -268 Intergenic  2126790..2127203 2127024 414 7.30E-88 2126793..2127148 2126962 356 2.65E-58 
CE10_0724 0 Intergenic  777533..777898 777683 366 3.45E-83 777556..777950 777645 395 1.95E-45 
glgS 0 Intergenic  3647029..3647437 3647258 409 6.00E-83 3647008..3647465 3647178 458 1.05E-45 
yjdA 0 Intergenic  4926058..4926477 4926298 420 2.80E-82 4926030..4926402 4926289 373 3.04E-47 
frc 0 Intergenic  2806899..2807342 2807163 444 1.45E-81 2806880..2807282 2807017 403 7.72E-45 
yebN -138 Intergenic  2124095..2124479 2124275 385 1.53E-81 2123997..2124498 2124330 502 7.66E-57 
ytcA 0 Intergenic  4904194..4904592 4904372 399 7.52E-81 4904214..4904550 4904382 337 2.48E-61 
lfpB 0 Intragenic 4455596..4455976 4455809 381 1.06E-80 4455579..4456010 4455842 432 4.25E-63 
yihN 0 Intergenic  4624721..4625143 4624988 423 3.42E-78 4624732..4625142 4624976 411 7.21E-46 
neuO  180 Intragenic 839731..840037 839842 307 2.50E-74 839122..839433 839361 312 2.24E-22 
CE10_4222 0 Intergenic  4299056..4299433 4299236 378 1.43E-47 4299050..4299330 4299238 281 2.40E-32 
 
Table S-6 CE10 DsdC2 binding sites (+ D-ser). 
      Replicate 1 Replicate 2 
Gene Dist. Gene Context  Co-ordinates Centre Length  p-value Co-ordinates Centre Length  p-value 
dsdC1 0 Intergenic 2791201..2791623 2791424 423 0.00E+00 2791239..2791631 2791405 393 0.00E+00 
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dsdC2 0 Intergenic 4332245..4332661 4332462 417 0.00E+00 4332276..4332653 4332446 378 0.00E+00 
wbbC 0 Intragenic 2367801..2368218 2368019 418 7.61E-246 2367849..2368187 2368018 339 0.00E+00 
CE10_4270 0 Intragenic 4347302..4347887 4347499 586 1.37E-196 4347239..4347682 4347409 444 0.00E+00 
CE10_4160 0 Intragenic 4233415..4233971 4233772 557 6.72E-166 4233478..4233946 4233779 469 0.00E+00 
wzy -61 Intergenic 2368941..2369336 2369143 396 9.88E-163 2368949..2369329 2369075 381 0.00E+00 
CE10_0023 -567 Intragenic 27395..27867 27682 473 1.75E-161 27398..27802 27567 405 0.00E+00 
neuB -351 Intergenic 3548260..3548659 3548505 400 5.44E-160 3548210..3548563 3548377 354 0.00E+00 
CE10_2740 -31 Intergenic 2788691..2789078 2788926 388 2.70E-158 2789250..2789602 2789408 353 0.00E+00 
waaV 0 Intergenic 4259986..4260392 4260149 407 9.89E-158 4260036..4260393 4260224 358 0.00E+00 
ygiL 0 Intergenic 3641588..3642068 3641783 481 3.73E-154 3641569..3642072 3641737 504 0.00E+00 
espX4 0 Intragenic 4852560..4852976 4852760 417 1.24E-150 4852574..4852929 4852769 356 0.00E+00 
rfaL 419 Intragenic 4258187..4258738 4258380 552 4.45E-146 4258266..4258601 4258436 336 0.00E+00 
epaS 154 Intragenic 3353928..3354450 3354126 523 1.66E-144 3354034..3354408 3354242 375 0.00E+00 
yjiC 0 Intergenic 5189241..5189815 5189623 575 2.49E-144 5189297..5189760 5189591 464 0.00E+00 
ycgX 600 Intergenic 1342145..1342585 1342410 441 5.17E-144 1342107..1342478 1342309 372 0.00E+00 
waaT 0 Intragenic 4262782..4263209 4263010 428 5.22E-142 4262767..4263185 4263019 419 0.00E+00 
espY4 349 Intragenic 4441008..4441461 4441273 454 4.53E-140 4440975..4441325 4441190 351 2.83E-300 
CE10_4870  0 Intergenic 4974839..4975298 4975038 460 9.58E-137 4974862..4975255 4975032 394 0.00E+00 
CE10_0067 0 Intragenic 79527..80036 79718 510 4.12E-135 79505..79780 79674 276 0.00E+00 
prgI -15 Intragenic 3350439..3350870 3350639 432 6.54E-130 3350441..3350883 3350611 443 0.00E+00 
yhhZ 0 Intergenic 4028998..4029273 4029197 276 2.42E-124 4028968..4029295 4029138 328 0.00E+00 
yfaL 0 Intergenic 2651189..2651693 2651494 505 5.57E-123 2651235..2651598 2651405 364 1.92E-267 
yjbM 70 Intragenic 4862267..4862581 4862385 315 3.24E-112 4862932..4863330 4863089 399 2.32E-275 
kpsF -135 Intergenic 3533449..3533878 3533679 430 8.64E-112 3533422..3533766 3533614 345 1.14E-298 
ubiC -640 Intragenic 4853358..4853756 4853561 399 8.80E-112 4853286..4853763 4853597 478 0.00E+00 
CE10_4297 0 Intergenic 4367262..4367846 4367652 585 2.91E-108 4367300..4367779 4367611 480 0.00E+00 
tauA -124 Intergenic 365045..365523 365326 479 4.47E-107 365186..365528 365359 343 0.00E+00 
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ibrA -150 Intergenic 2313361..2313946 2313549 586 4.04E-102 2313418..2313818 2313583 401 1.44E-293 
yhaC 601 Intragenic 3730248..3730669 3730558 422 1.23E-101 3730146..3730645 3730316 500 0.00E+00 
eivC -386 Intragenic 3360288..3360700 3360502 413 7.30E-99 3360273..3360679 3360443 407 1.52E-292 
yghJ 0 Intragenic 3567495..3567903 3567694 409 1.32E-96 3567412..3567851 3567579 440 5.16E-274 
eprH 0 Intergenic 3351518..3352032 3351839 515 1.81E-96 3351593..3351969 3351800 377 0.00E+00 
envR 0 Intergenic 3874394..3874832 3874633 439 1.33E-94 3874434..3874804 3874604 371 0.00E+00 
dusA -251 Intragenic 4862922..4863326 4863120 405 1.79E-90 4862932..4863330 4863089 399 2.32E-275 
ybcK 0 Intragenic 569700..570111 569916 412 9.24E-90 569742..570133 569908 392 1.21E-293 
CE10_3508 0 Intergenic 3578606..3579015 3578816 410 2.43E-87 3578606..3579032 3578863 427 2.23E-263 
setC 0 Intergenic 4357955..4358444 4358246 490 8.58E-87 4358028..4358401 4358232 374 2.00E-219 
espX1 0 Intergenic  28309..28800 28603 492 1.97E-87 28392..28756 28559 365 0.00E+00 
sfmA 0 Intergenic 561132..561550 561351 419 1.71E-85 561191..561560 561361 370 7.04E-234 
CE10_0818 -110 Intragenic 865607..866128 865806 522 3.95E-85 865643..866088 865813 446 0.00E+00 
CE10_3398 -4 Intergenic 3470772..3471177 3470964 406 6.67E-84 3470777..3471175 3470947 399 7.28E-225 
yjbE 0 Intergenic 4839264..4839724 4839462 461 9.84E-83 4839262..4839689 4839521 428 0.00E+00 
CE10_4943 0 Intergenic  5047521..5048012 5047717 492 7.13E-83 5047518..5047942 5047773 425 0.00E+00 
sipB 0 Intergenic 4362518..4363039 4362894 522 3.76E-82 4362542..4363020 4362854 479 0.00E+00 
gadX 0 Intergenic 4123530..4123934 4123735 405 1.66E-81 4123408..4123914 4123745 507 1.24E-201 
eivF 0 Intergenic 3365516..3365886 3365686 371 3.69E-80 3365504..3365952 3365783 449 5.75E-162 
ysdS 0 Intergenic 2249552..2250108 2249911 557 4.69E-80 2249708..2250086 2249917 379 4.66E-197 
CE10_4228 0 Intergenic 4304996..4305491 4305195 496 8.81E-79 4305009..4305514 4305179 506 1.88E-286 
yehD 0 Intergenic  2455112..2455543 2455344 432 6.98E-78 2455141..2455485 2455307 345 2.52E-134 
CE10_3557 0 Intergenic 3628241..3628807 3628437 567 2.16E-78 3628255..3628751 3628424 497 1.25E-246 
rfaY 0 Intragenic 4261738..4262158 4261857 421 3.44E-75 4261801..4262123 4261980 323 1.47E-278 
lpfA 0 Intergenic 4456369..4456823 4456624 455 5.57E-75 4456471..4456810 4456642 340 0.00E+00 
fimZ 271 Intragenic 567067..567513 567317 447 2.79E-74 567021..567429 567266 409 1.58E-149 
ycbQ 0 Intergenic  1039119..1039559 1039363 441 8.68E-74 1039098..1039524 1039356 427 2.36E-311 
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yiaY 0 Intergenic 4222437..4222812 4222611 376 3.07E-73 4222380..4222772 4222603 393 3.22E-220 
neuA 0 Intragenic 3546713..3547161 3546913 449 4.29E-73 3546735..3547143 3546897 409 3.46E-227 
cmtB 0 Intragenic 3449964..3450395 3450164 432 6.85E-73 3449903..3450404 3450235 502 4.11E-218 
tnaA 0 Intergenic  4430163..4430581 4430363 419 9.87E-73 4430328..4430607 4430441 280 2.34E-184 
yliE 583 Intragenic 908813..909295 909096 483 2.28E-71 908913..909264 909096 352 4.15E-157 
hutU -18 Intergenic 769262..769857 769658 596 1.78E-71 769533..769887 769718 355 0.00E+00 
nmpC 0 Intergenic  2501805..2502289 2502090 485 2.12E-70 2501843..2502269 2502013 427 9.50E-291 
yajR 0 Intergenic  429282..429793 429477 512 9.81E-70 429395..429749 429580 355 5.17E-257 
CE10_4598 0 Intragenic  4685781..4686273 4686074 493 2.38E-70 4685806..4686215 4686046 410 9.96E-268 
yadN 0 Intergenic  166932..167338 167148 407 1.12E-69 166938..167356 167187 419 0.00E+00 
fimE -4 Intergenic 5174588..5174998 5174788 411 1.28E-69 5174557..5174977 5174727 421 2.97E-284 
fucA 0 Intragenic 3285938..3286459 3286138 522 2.45E-68 3285970..3286380 3286213 411 2.94E-236 
CE10_4567 0 Intergenic 4657513..4657954 4657713 442 8.36E-68 4657572..4657925 4657738 354 7.83E-180 
CE10_2939 0 Intergenic  2996379..2996812 2996579 434 1.72E-67 2996461..2996801 2996632 341 0.00E+00 
sipD 0 Intergenic  4364806..4365170 4364944 365 2.48E-66 4365735..4366090 4365923 356 0.00E+00 
yhaI 0 Intergenic 3713855..3714452 3714055 598 1.68E-65 3713910..3714266 3714080 357 0.00E+00 
garP 0 Intragenic 3735491..3736089 3735691 599 1.79E-65 3735521..3735844 3735691 324 2.52E-287 
CE10_2689 0 Intergenic 2734327..2734783 2734587 457 3.07E-65 2734299..2734791 2734626 493 1.40E-233 
pitB 0 Intergenic  3591846..3592320 3592045 475 3.33E-64 3591924..3592289 3592120 366 3.87E-315 
caiT 0 Intergenic 50113..50672 50478 560 6.57E-64 50362..50693 50524 332 4.33E-240 
yegH -1 Intergenic 2401649..2402123 2401924 475 3.00E-63 2401704..2402035 2401865 332 2.50E-178 
CE10_3627 0 Intergenic 3707414..3707887 3707688 474 4.51E-63 3707478..3707905 3707736 428 5.20E-295 
kpsM -250 Intergenic 3550245..3550773 3550588 529 4.71E-62 3550359..3550819 3550650 461 3.54E-182 
CE10_4613 0 Intergenic 4703675..4704137 4703869 463 8.55E-61 4703713..4704075 4703906 363 8.90E-220 
sat 0 Intergenic 3517434..3517910 3517626 477 5.64E-60 3517389..3517834 3517674 446 3.14E-183 
ydeP 0 Intergenic 1733125..1733538 1733339 414 1.65E-59 1733128..1733543 1733374 416 1.02E-100 
focA -42 Intergenic 994851..995268 995072 418 5.48E-58 994837..995244 995079 408 7.45E-156 
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ecpD 0 Intergenic  166100..166433 166301 334 7.55E-58 166101..166485 166271 385 4.73E-279 
neuO  460 Intragenic  839980..840574 840375 595 2.92E-57 839682..840049 839850 368 1.84E-62 
fimB 0 Intergenic  5173383..5173942 5173582 560 2.79E-55 5172313..5172781 5172613 469 9.36E-174 
matA -7 Intergenic 280087..280499 280309 413 5.70E-55 280132..280487 280302 356 2.54E-128 
stpA 0 Intragenic 3150391..3150799 3150588 409 1.20E-53 3150389..3150796 3150557 408 8.81E-172 
leuO 0 Intergenic  92657..93240 92857 584 1.38E-53 92696..93128 92864 433 1.97E-268 
ykgE -118 Intergenic 299238..299735 299431 498 1.88E-53 299344..299739 299582 396 1.72E-142 
ycdT 0 Intergenic 1166780..1167160 1166947 381 6.48E-53 1166719..1167223 1167057 505 4.78E-190 
ydeK -11 Intergenic  1743054..1743494 1743254 441 2.64E-52 1743103..1743473 1743304 371 3.33E-245 
yiaW 0 Intergenic  4217559..4218001 4217802 443 5.78E-52 4217589..4217942 4217759 354 9.29E-199 
ykgI 0 Intergenic  296616..296991 296780 376 5.62E-52 296611..296965 296801 355 1.20E-119 
ymgG 0 Intergenic 1355685..1356124 1355885 440 5.64E-51 1355700..1356166 1355868 467 1.60E-203 
yfcV -6 Intergenic  2769704..2770197 2769884 494 6.00E-50 2769666..2770169 2770000 504 0.00E+00 
CE10_4234 0 Intragenic 4312886..4313336 4313141 451 1.57E-49 4312952..4313319 4313117 368 7.90E-259 
CE10_0724 0 Intergenic  777460..777936 777740 477 1.10E-49 777542..778046 777712 505 1.50E-89 
CE10_3790 0 Intergenic  3866043..3866625 3866432 583 1.02E-47 3866051..3866515 3866177 465 2.54E-94 
ybcM 62 Intragenic 571029..571426 571230 398 1.17E-47 571034..571492 571201 459 6.70E-133 
pagP 0 Intergenic  675200..675525 675326 326 1.18E-47 675148..675511 675275 364 4.33E-165 
glgS 0 Intergenic  3646974..3647421 3647225 448 3.61E-47 3646900..3647400 3647231 501 1.02E-146 
CE10_0366 0 Intragenic 403402..404000 403602 599 7.37E-47 403365..403834 403525 470 9.80E-149 
yiiG 0 Intergenic  4651287..4651811 4651615 525 1.66E-46 4651381..4651749 4651582 369 1.11E-243 
nanR 0 Intergenic  3824875..3825370 3825171 496 1.79E-46 3824940..3825262 3825109 323 1.35E-97 
CE10_0258 0 Intergenic  283534..283987 283733 454 2.03E-46 283567..283945 283776 379 7.20E-88 
yfbL 0 Intergenic 2697340..2697935 2697537 596 3.90E-46 2697375..2697816 2697545 442 1.20E-250 
ttdR 270 Intragenic 3660664..3661092 3660915 429 1.03E-45 3660735..3661078 3660909 344 3.99E-113 
yeaI 0 Intragenic 2088989..2089430 2089240 442 2.68E-45 2089041..2089446 2089211 406 1.11E-122 
ygcG 0 Intergenic 3256217..3256779 3256399 563 2.45E-45 3256230..3256703 3256400 474 5.06E-206 
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yeeN 0 Intergenic 2297945..2298387 2298145 443 2.37E-44 2297960..2298355 2298198 396 7.72E-118 
adiY 0 Intergenic  4937037..4937578 4937380 542 2.98E-44 4937059..4937501 4937332 443 5.50E-216 
agaB 0 Intergenic 3746867..3747317 3747125 451 3.16E-44 3746875..3747245 3747078 371 5.87E-178 
nanC 0 Intergenic  5172352..5172793 5172545 442 3.35E-44 5172313..5172781 5172613 469 9.36E-174 
ybbW 0 Intergenic  540753..541206 540951 454 5.86E-44 540741..541217 540907 477 3.44E-86 
yjfI 0 Intragenic 5028723..5029121 5028920 399 6.16E-44 5028685..5029152 5028839 468 2.05E-168 
ytcA 0 Intergenic  4904147..4904575 4904347 429 1.22E-43 4904104..4904563 4904397 460 5.28E-175 
yhfL 0 Intergenic 3944807..3945277 3945083 471 2.46E-43 3944846..3945244 3945014 399 0.00E+00 
yiaT 0 Intergenic 4214953..4215409 4215149 457 5.93E-43 4214983..4215330 4215162 348 3.70E-220 
CE10_5099 0 Intergenic 5220777..5221310 5221111 534 6.42E-43 5220623..5221088 5220791 466 1.36E-202 
CE10_3982 0 Intragenic 4044927..4045465 4045270 539 9.27E-43 4045050..4045404 4045220 355 3.81E-142 
iraP 0 Intergenic 379970..380442 380156 473 3.42E-42 380017..380409 380184 393 2.64E-141 
ais 0 Intergenic 2677253..2677737 2677543 485 1.24E-40 2677245..2677642 2677476 398 2.37E-188 
speF -254 Intergenic  730620..731105 730906 486 1.76E-40 730699..731027 730863 329 1.83E-211 
fdrA 0 Intergenic 549578..549979 549774 402 1.83E-40 549626..549978 549809 353 3.33E-180 
torY 0 Intergenic  2176663..2177104 2176905 442 1.42E-39 2176728..2177090 2176896 363 9.43E-313 
rpmE2 -185 Intergenic 281753..282201 282006 449 1.43E-39 281742..282113 281907 372 6.57E-194 
yeiT 0 Intragenic 2539229..2539663 2539426 435 5.14E-39 2539357..2539676 2539509 320 2.29E-129 
CE10_0735 -142 Intergenic 791007..791403 791214 397 5.41E-39 791122..791460 791290 339 2.71E-128 
yiiE 0 Intergenic  4643638..4644071 4643838 434 2.57E-38 4643550..4644028 4643718 479 1.65E-91 
gadA 0 Intergenic  4125236..4125634 4125437 399 4.55E-38 4125267..4125633 4125437 367 3.83E-176 
CE10_0066 0 Intergenic  78824..79258 79024 435 7.11E-38 78777..79156 78987 380 3.96E-150 
fimA -83 Intergenic  5175568..5175996 5175763 429 9.04E-38 5175462..5175893 5175735 432 4.64E-137 
CE10_1661 0 Intergenic  1692466..1693013 1692815 548 1.40E-37 1692603..1692999 1692836 397 4.86E-142 
feoA -23 Intergenic 3980886..3981285 3981088 400 3.87E-37 3980897..3981257 3981092 361 1.21E-138 
siiCA 0 Intergenic  498197..498591 498397 395 3.90E-37 498178..498672 498346 495 7.15E-138 
fucP 104 Intragenic 3286630..3287054 3286819 425 5.55E-36 3286611..3287057 3286781 447 6.53E-187 
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CE10_0335 -39 Intergenic  370082..370470 370282 389 1.41E-35 370039..370542 370209 504 5.41E-146 
yghT 0 Intergenic 3589432..3589897 3589699 466 1.01E-34 3589472..3589821 3589642 350 6.43E-149 
yqiG 0 Intragenic 3642370..3642917 3642523 548 2.24E-34 3642410..3642844 3642579 435 6.14E-132 
CE10_4295 -781 Intragenic 4363563..4364019 4363746 457 1.26E-33 4364266..4364621 4364436 356 3.76E-104 
CE10_0290 0 Intergenic  320797..321310 321125 514 1.69E-32 320918..321276 321088 359 2.39E-86 
CE10_1948 0 Intragenic 1971012..1971415 1971220 404 7.04E-32 1970976..1971340 1971146 365 4.95E-210 
yebN -190 Intergenic  2123960..2124427 2124236 468 1.39E-32 2124036..2124415 2124206 380 2.78E-216 
yicO 0 Intergenic 4380780..4381184 4380980 405 5.56E-31 4380813..4381260 4380983 448 2.23E-193 
lfpB 0 Intergenic 4455502..4456088 4455702 587 1.21E-31 4455601..4455950 4455771 350 1.26E-109 
CE10_0275 0 Intergenic  303172..303592 303358 421 1.37E-31 303137..303577 303408 441 6.99E-144 
yffB 0 Intergenic 2899415..2899899 2899611 485 1.07E-31 2899399..2899841 2899673 443 4.55E-113 
yfgH 0 Intergenic  2938015..2938399 2938226 385 4.07E-30 2938024..2938372 2938194 349 1.66E-286 
ompN 0 Intergenic  1605353..1605864 1605666 512 4.66E-30 1605480..1605815 1605645 336 1.00E-122 
yobF -210 Intergenic 2126732..2127148 2126929 417 1.51E-30 2126788..2127160 2126958 373 7.80E-119 
yjgN 0 Intergenic 5109874..5110390 5110236 517 2.24E-30 5109939..5110347 5110107 409 6.79E-116 
yjeJ 0 Intergenic 4993504..4993937 4993748 434 4.27E-30 4993567..4993930 4993761 364 7.73E-241 
yhbX 155 Intragenic  3778601..3779064 3778786 464 9.46E-29 3778615..3779013 3778750 399 9.12E-75 
yfgF 0 Intergenic 2937368..2937800 2937603 433 8.10E-29 2937404..2937812 2937643 409 3.31E-126 
yihN 0 Intergenic 4624725..4625147 4624948 423 3.25E-29 4624711..4625155 4624991 445 1.68E-84 
tsx2 0 Intergenic 4700266..4700782 4700587 517 1.90E-28 4700378..4700758 4700546 381 2.16E-106 
CE10_4706  0 Intergenic  4811266..4811714 4811449 449 5.86E-28 4811301..4811756 4811462 456 1.27E-73 
dpiB 0 Intergenic  670579..671136 670939 558 1.18E-27 670718..671125 670968 408 1.91E-160 
hipB -478 Intragenic  1739006..1739567 1739206 562 5.88E-27 1739164..1739566 1739321 403 1.77E-130 
CE10_1671 0 Intragenic 1702964..1703370 1703173 407 2.02E-25 1702938..1703343 1703105 406 2.64E-121 
yihQ 0 Intergenic 4631789..4632250 4632053 462 1.76E-25 4631790..4632294 4632125 505 5.24E-65 
gadB 0 Intergenic  1718702..1719278 1719096 577 2.75E-24 1718780..1719174 1718950 395 5.54E-89 
yceJ 0 Intragenic 1190063..1190659 1190261 597 1.24E-24 1190104..1190554 1190255 451 4.84E-51 
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ydjE 741 Intragenic  2071515..2071933 2071734 419 1.47E-24 2071492..2071971 2071823 480 2.56E-108 
yjfZ 0 Intragenic 5045764..5046347 5046162 584 3.90E-24 5045991..5046332 5046161 342 8.84E-96 
CE10_3786 0 Intragenic 3863969..3864391 3864192 423 6.32E-23 3862491..3862827 3862644 337 1.93E-156 
CE10_4709 0 Intergenic  4812986..4813474 4813276 489 2.45E-22 4813018..4813406 4813265 389 6.79E-83 
CE10_3570 0 Intergenic 3639848..3640320 3640144 473 9.64E-22 3639939..3640229 3640086 291 2.45E-87 
ypdI 0 Intergenic 2808050..2808461 2808249 412 2.78E-22 2808140..2808489 2808306 350 1.33E-261 
yegR 0 Intergenic 2432401..2432923 2432753 523 1.99E-21 2432457..2432888 2432721 432 7.56E-115 
ompT 0 Intragenic 607490..607945 607749 456 2.04E-21 607592..608028 607728 437 6.42E-48 
araE 0 Intergenic 3334405..3334850 3334605 446 2.35E-21 3334471..3334797 3334626 327 1.54E-40 
CE10_0264 0 Intergenic 289003..289480 289200 478 2.88E-21 289016..289498 289185 483 1.02E-149 
yeiL 313 Intragenic 2560996..2561409 2561216 414 2.69E-20 2561140..2561398 2561222 259 1.36E-51 
allB 0 Intragenic 542144..542568 542344 425 4.19E-20 542248..542581 542412 334 2.68E-44 
yjdA 0 Intergenic 4926009..4926492 4926209 484 3.01E-19 4926068..4926402 4926254 335 4.39E-125 
CE10_4222 0 Intergenic 4299036..4299530 4299227 495 5.03E-14 4298913..4299400 4299083 488 5.06E-53 
292 
Table S-7 Overlap of the ChIP binding hits between CFT073 and CE10 (+ D-
ser). 
CE10 DsdC1 ChIP peak 
hits Overlap of ChIP peak hits 
CFT073 DsdC ChIP peak 
hits 
CE10_0023  adiY arcA 
agaC agaB aslA  
CE10_0275 ais asst 
CE10_0290 araE bglG  
CE10_0366 bdm/CE10_1671 c0322 
CE10_0523 c0077/CE10_0066  c0325 
CE10_0560  c0080/CE10_0067 c0327 
CE10_0724 c0346/yahA c0363 
CE10_0734 c0410/CE10_0258 c0430 
CE10_0818 fdeC/CE10_0264 c1166 
CE10_0889 c1618/ymgG c1208 
CE10_1660 c2348/nmpC c1271 
CE10_1661 c2383/ysdS  c1892 
CE10_1948 c2815/yfbL c2406 
CE10_2689 c2897/CE10_2740 c3302 
CE10_3076 c3031/CE10_2939 c3692 
CE10_3277 c3686/kpsF c3694 
CE10_3282 c3712/CE10_3508  c4214 
CE10_3301 c3766/CE10_3557  c4303 
CE10_3398 c4015/CE10_3786 c4498  
CE10_3626 c4020/CE10_3790 c4502 
CE10_3627 c4423/CE10_4160  c4539 
CE10_4229  c4488/CE10_4222 c4920 
CE10_4234 c4492/CE10_4228 clbR 
CE10_4270 c4739/CE10_4466   chiA 
CE10_4295 c4896/CE10_4613 cydA  
CE10_4297 c4983/CE10_4706 fimA 
CE10_4312 c4986/CE10_4709  hcp  
CE10_4363 c4994/yjbE  hlyC 
CE10_4519  c5088 /ytcA iraD  
CE10_4553 c5209/ibrA  ompC 
CE10_4567 c5298/CE10_4943 papA 
CE10_4598 c5356/yjgN  rpiB 
CE10_4717 c5426/CE10_5091  tdcB 
CE10_4768 c5435/CE10_5099 tssB  
CE10_4870  caiT yciF  
CE10_4997 cmtB ydbA_1  
CE10_5101 cyoA yheE 
CE10_5175 dpiB yjjQ  
csiD  dsdC   
dsdC2  envR   
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dusA  fdrA   
ecpD  fimE   
eivC frc   
eivF fucP   
eivG gadA   
epaO garP   
epaS  hemB/CE10_0335   
eprH iraP   
espX1 leuO   
espX4 livK/CE10_3982   
espY4 nanC   
eutS  ompN   
feoA  pagP   
fepE   pitB   
fimB  rfaJ/waaT    
fimZ rfaY   
focA  sat   
fucA  stpA   
gadB tauA   
gadX tnaA   
glgS  waaL/rfaL    
hlyE  waaV   
hutU wzx   
kpsM wzy   
lpfA yadN   
matA  ycdT   
mocA yebB   
msbB  yebN   
nanR  yeeN   
neuA yegR   
neuB yfaL   
neuO yfcV   
prgI yffB   
rcsA  yghT   
rfbC ygiL   
setC yhbX   
sfmA yhfL   
sfmC yhhZ   
sfmH yhiM   
sipB yiaY   
sipD yicO   
slp  yiiE   
speF  yjcS   
tdcR yjdA   
torY  yjeJ   
tsx2  ykgI   
ttdR  c0407/rpmE2   
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ubiC  yliE   
ugd ypdI   
wbbC    
yahL     
yajR      
ybbW      
ybcK     
ybcM      
ybdN      
ybdO      
ybeF      
ycbQ    
ycbR     
yceJ     
yciD     
ydeK     
ydeP     
ydjE     
ydjO     
yegH     
yehD      
yeiT     
yfdF     
yfgF       
yfgH     
ygcG      
ygeG     
yghJ     
yhaC     
yhaI     
yiaO      
yiaT     
yiaW     
yiiG      
yjbM     
yjiC     
yobF      
yqeI     





Table S-8 Overlap of genes involved in binding sites and genes that were 
differentially expressed 
CFT073 no D-ser CFT073 + D-ser CE10 no D-ser CE10 + D-ser 
dsdC dsdC dsdC2 neuA 
  ypdI neuB 
  gadB neuO 
  neuO rfaY 
   wbbC 
   wzx 
   waaT 
   waaV 
   dsdC2 
 
